<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />



<meta name="date" content="2024-11-04" />

<title>cTWAS Gene Summary</title>

<script src="site_libs/header-attrs-2.28/header-attrs.js"></script>
<script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/cosmo.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="site_libs/jqueryui-1.13.2/jquery-ui.min.js"></script>
<link href="site_libs/tocify-1.9.1/jquery.tocify.css" rel="stylesheet" />
<script src="site_libs/tocify-1.9.1/jquery.tocify.js"></script>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<link href="site_libs/highlightjs-9.12.0/textmate.css" rel="stylesheet" />
<script src="site_libs/highlightjs-9.12.0/highlight.js"></script>
<link href="site_libs/font-awesome-6.4.2/css/all.min.css" rel="stylesheet" />
<link href="site_libs/font-awesome-6.4.2/css/v4-shims.min.css" rel="stylesheet" />

<link rel="icon" href="https://github.com/workflowr/workflowr-assets/raw/main/img/reproducible.png">
<!-- Add a small amount of space between sections. -->
<style type="text/css">
div.section {
  padding-top: 12px;
}
</style>



<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>









<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->



<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}

@media print {
.toc-content {
  /* see https://github.com/w3c/csswg-drafts/issues/4434 */
  float: right;
}
}

.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
}

.tocify .list-group-item {
  border-radius: 0px;
}


</style>



</head>

<body>


<div class="container-fluid main-container">


<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div class="navbar navbar-default  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">Multigroup_cTWAS</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="index.html">Home</a>
</li>
<li>
  <a href="about.html">About</a>
</li>
<li>
  <a href="license.html">License</a>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://github.com/yy896/Multigroup_cTWAS">
    <span class="fab fa-github"></span>
     
    Source code
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">cTWAS Gene Summary</h1>
<h4 class="date">2024-11-04</h4>

</div>


<p>
<button type="button" class="btn btn-default btn-workflowr btn-workflowr-report" data-toggle="collapse" data-target="#workflowr-report">
<span class="glyphicon glyphicon-list" aria-hidden="true"></span>
workflowr <span class="glyphicon glyphicon-ok text-success"
aria-hidden="true"></span>
</button>
</p>
<div id="workflowr-report" class="collapse">
<ul class="nav nav-tabs">
<li class="active">
<a data-toggle="tab" href="#summary">Summary</a>
</li>
<li>
<a data-toggle="tab" href="#checks"> Checks <span
class="glyphicon glyphicon-ok text-success" aria-hidden="true"></span>
</a>
</li>
<li>
<a data-toggle="tab" href="#versions">Past versions</a>
</li>
</ul>
<div class="tab-content">
<div id="summary" class="tab-pane fade in active">
<p>
<strong>Last updated:</strong> 2024-11-04
</p>
<p>
<strong>Checks:</strong> <span
class="glyphicon glyphicon-ok text-success" aria-hidden="true"></span> 7
<span class="glyphicon glyphicon-exclamation-sign text-danger"
aria-hidden="true"></span> 0
</p>
<p>
<strong>Knit directory:</strong> <code>Multigroup_cTWAS/</code> <span
class="glyphicon glyphicon-question-sign" aria-hidden="true"
title="This is the local directory in which the code in this file was executed.">
</span>
</p>
<p>
This reproducible <a href="https://rmarkdown.rstudio.com">R Markdown</a>
analysis was created with <a
  href="https://github.com/workflowr/workflowr">workflowr</a> (version
1.7.1). The <em>Checks</em> tab describes the reproducibility checks
that were applied when the results were created. The <em>Past
versions</em> tab lists the development history.
</p>
<hr>
</div>
<div id="checks" class="tab-pane fade">
<div id="workflowr-checks" class="panel-group">
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongRMarkdownfilestronguptodate">
<span class="glyphicon glyphicon-ok text-success"
aria-hidden="true"></span> <strong>R Markdown file:</strong> up-to-date
</a>
</p>
</div>
<div id="strongRMarkdownfilestronguptodate"
class="panel-collapse collapse">
<div class="panel-body">
<p>Great! Since the R Markdown file has been committed to the Git
repository, you know the exact version of the code that produced these
results.</p>
</div>
</div>
</div>
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongEnvironmentstrongempty">
<span class="glyphicon glyphicon-ok text-success"
aria-hidden="true"></span> <strong>Environment:</strong> empty </a>
</p>
</div>
<div id="strongEnvironmentstrongempty" class="panel-collapse collapse">
<div class="panel-body">
<p>Great job! The global environment was empty. Objects defined in the
global environment can affect the analysis in your R Markdown file in
unknown ways. For reproduciblity it’s best to always run the code in an
empty environment.</p>
</div>
</div>
</div>
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongSeedstrongcodesetseed20241004code">
<span class="glyphicon glyphicon-ok text-success"
aria-hidden="true"></span> <strong>Seed:</strong>
<code>set.seed(20241004)</code> </a>
</p>
</div>
<div id="strongSeedstrongcodesetseed20241004code"
class="panel-collapse collapse">
<div class="panel-body">
<p>The command <code>set.seed(20241004)</code> was run prior to running
the code in the R Markdown file. Setting a seed ensures that any results
that rely on randomness, e.g. subsampling or permutations, are
reproducible.</p>
</div>
</div>
</div>
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongSessioninformationstrongrecorded">
<span class="glyphicon glyphicon-ok text-success"
aria-hidden="true"></span> <strong>Session information:</strong>
recorded </a>
</p>
</div>
<div id="strongSessioninformationstrongrecorded"
class="panel-collapse collapse">
<div class="panel-body">
<p>Great job! Recording the operating system, R version, and package
versions is critical for reproducibility.</p>
</div>
</div>
</div>
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongCachestrongnone">
<span class="glyphicon glyphicon-ok text-success"
aria-hidden="true"></span> <strong>Cache:</strong> none </a>
</p>
</div>
<div id="strongCachestrongnone" class="panel-collapse collapse">
<div class="panel-body">
<p>Nice! There were no cached chunks for this analysis, so you can be
confident that you successfully produced the results during this
run.</p>
</div>
</div>
</div>
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongFilepathsstrongrelative">
<span class="glyphicon glyphicon-ok text-success"
aria-hidden="true"></span> <strong>File paths:</strong> relative </a>
</p>
</div>
<div id="strongFilepathsstrongrelative" class="panel-collapse collapse">
<div class="panel-body">
<p>Great job! Using relative paths to the files within your workflowr
project makes it easier to run your code on other machines.</p>
</div>
</div>
</div>
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongRepositoryversionstrongahrefhttpsgithubcomyy896MultigroupcTWAStreeff0e266b6d9d8ac4875171f08b9ecd869f834361targetblankff0e266a">
<span class="glyphicon glyphicon-ok text-success"
aria-hidden="true"></span> <strong>Repository version:</strong>
<a href="https://github.com/yy896/Multigroup_cTWAS/tree/ff0e266b6d9d8ac4875171f08b9ecd869f834361" target="_blank">ff0e266</a>
</a>
</p>
</div>
<div
id="strongRepositoryversionstrongahrefhttpsgithubcomyy896MultigroupcTWAStreeff0e266b6d9d8ac4875171f08b9ecd869f834361targetblankff0e266a"
class="panel-collapse collapse">
<div class="panel-body">
<p>
Great! You are using Git for version control. Tracking code development
and connecting the code version to the results is critical for
reproducibility.
</p>
<p>
The results in this page were generated with repository version
<a href="https://github.com/yy896/Multigroup_cTWAS/tree/ff0e266b6d9d8ac4875171f08b9ecd869f834361" target="_blank">ff0e266</a>.
See the <em>Past versions</em> tab to see a history of the changes made
to the R Markdown and HTML files.
</p>
<p>
Note that you need to be careful to ensure that all relevant files for
the analysis have been committed to Git prior to generating the results
(you can use <code>wflow_publish</code> or
<code>wflow_git_commit</code>). workflowr only checks the R Markdown
file, but you know if there are other scripts or data files that it
depends on. Below is the status of the Git repository when the results
were generated:
</p>
<pre><code>
Ignored files:
    Ignored:    .DS_Store
    Ignored:    .Rhistory
    Ignored:    analysis/.DS_Store
    Ignored:    analysis/.Rhistory

</code></pre>
<p>
Note that any generated files, e.g. HTML, png, CSS, etc., are not
included in this status report because it is ok for generated content to
have uncommitted changes.
</p>
</div>
</div>
</div>
</div>
<hr>
</div>
<div id="versions" class="tab-pane fade">
<p>
These are the previous versions of the repository in which changes were
made to the R Markdown
(<code>analysis/cTWAS_LD_european_GENE_SUMMARY.Rmd</code>) and HTML
(<code>docs/cTWAS_LD_european_GENE_SUMMARY.html</code>) files. If you’ve
configured a remote Git repository (see <code>?wflow_git_remote</code>),
click on the hyperlinks in the table below to view the files as they
were in that past version.
</p>
<div class="table-responsive">
<table class="table table-condensed table-hover">
<thead>
<tr>
<th>
File
</th>
<th>
Version
</th>
<th>
Author
</th>
<th>
Date
</th>
<th>
Message
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
Rmd
</td>
<td>
<a href="https://github.com/yy896/Multigroup_cTWAS/blob/ff0e266b6d9d8ac4875171f08b9ecd869f834361/analysis/cTWAS_LD_european_GENE_SUMMARY.Rmd" target="_blank">ff0e266</a>
</td>
<td>
yy896
</td>
<td>
2024-11-04
</td>
<td>
UPDATED RESULTS
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/yy896/Multigroup_cTWAS/1fe76b66009ae9bf71fee1e135b5028c82181543/docs/cTWAS_LD_european_GENE_SUMMARY.html" target="_blank">1fe76b6</a>
</td>
<td>
yy896
</td>
<td>
2024-10-30
</td>
<td>
Build site.
</td>
</tr>
<tr>
<td>
Rmd
</td>
<td>
<a href="https://github.com/yy896/Multigroup_cTWAS/blob/ce519e801a74dba01ba12d64d6910df1b0e2b6b1/analysis/cTWAS_LD_european_GENE_SUMMARY.Rmd" target="_blank">ce519e8</a>
</td>
<td>
yy896
</td>
<td>
2024-10-30
</td>
<td>
UPDATED RESULTS
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/yy896/Multigroup_cTWAS/1c49b73fe48dbf0cb1f3ffb5bb0aeafafdfe0fa8/docs/cTWAS_LD_european_GENE_SUMMARY.html" target="_blank">1c49b73</a>
</td>
<td>
yy896
</td>
<td>
2024-10-30
</td>
<td>
Build site.
</td>
</tr>
<tr>
<td>
Rmd
</td>
<td>
<a href="https://github.com/yy896/Multigroup_cTWAS/blob/de48032def3beb54243f86e0b0cb708c6cb153a1/analysis/cTWAS_LD_european_GENE_SUMMARY.Rmd" target="_blank">de48032</a>
</td>
<td>
yy896
</td>
<td>
2024-10-30
</td>
<td>
UPDATED RESULTS
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/yy896/Multigroup_cTWAS/73bbc0e5d48a9bd6f4f86081de24e6e169133d22/docs/cTWAS_LD_european_GENE_SUMMARY.html" target="_blank">73bbc0e</a>
</td>
<td>
yy896
</td>
<td>
2024-10-26
</td>
<td>
Build site.
</td>
</tr>
<tr>
<td>
Rmd
</td>
<td>
<a href="https://github.com/yy896/Multigroup_cTWAS/blob/387d920fc9668cbf0a37a1442c17aca4fc75b6fb/analysis/cTWAS_LD_european_GENE_SUMMARY.Rmd" target="_blank">387d920</a>
</td>
<td>
yy896
</td>
<td>
2024-10-26
</td>
<td>
UPDATED RESULTS
</td>
</tr>
</tbody>
</table>
</div>
<hr>
</div>
</div>
</div>
<p><a
href="https://www.perplexity.ai/search/gene-cep250-in-prostate-cancer-C3sswli0Te6195jJiZeFGQ"
class="uri">https://www.perplexity.ai/search/gene-cep250-in-prostate-cancer-C3sswli0Te6195jJiZeFGQ</a></p>
<p><a
href="https://www.perplexity.ai/search/what-is-the-immune-function-of-V1KXq8E9Rhqng5pP5n8Rww"
class="uri">https://www.perplexity.ai/search/what-is-the-immune-function-of-V1KXq8E9Rhqng5pP5n8Rww</a></p>
<div id="basic-functions" class="section level2">
<h2>Basic Functions</h2>
<div id="cep250" class="section level3">
<h3>CEP250</h3>
<p>CEP250, also known as centrosomal protein 250, is a gene that has
been associated with prostate cancer. Here’s what we know about its role
in this context:</p>
<p><strong>Expression in Prostate Cancer</strong></p>
<p>CEP250 has been found to be expressed in prostate cancer tissues. The
Human Protein Atlas reports that CEP250 protein expression has been
detected in prostate cancer samples[4]. This suggests that the gene is
active in prostate cancer cells, although its specific function in this
context requires further investigation.</p>
<p><strong>Presence in Urinary Biomarkers</strong></p>
<p>Interestingly, CEP250 has been identified in studies examining
urinary biomarkers for prostate cancer:</p>
<ol style="list-style-type: decimal">
<li><p>The protein encoded by CEP250 has been detected in urine and
urinary extracellular vesicles from prostate cancer
patients[5].</p></li>
<li><p>Specific peptide sequences from the CEP250 protein have been
found in urinary samples, with one peptide (ALREDVEKLTVDWSR) being
detected in 71 samples at a median log2 intensity of 24.29[8].</p></li>
</ol>
<p>These findings suggest that CEP250 or its protein products may have
potential as a biomarker for prostate cancer detection or
monitoring.</p>
<p><strong>Molecular Function</strong></p>
<p>While not specific to prostate cancer, it’s important to understand
the general function of CEP250:</p>
<ol style="list-style-type: decimal">
<li><p>CEP250 encodes a core centrosomal protein that is required for
centriole-centriole cohesion during the interphase of the cell
cycle[2].</p></li>
<li><p>Its role in centrosome function suggests it may be involved in
cell division processes, which could be relevant to cancer development
or progression.</p></li>
</ol>
<p><strong>Genetic Alterations</strong></p>
<p>The Catalogue of Somatic Mutations in Cancer (COSMIC) database
includes CEP250 in its gene analysis, indicating that somatic mutations
in this gene have been observed in cancer samples[7]. However, it’s not
designated as a hallmark cancer gene, suggesting its role may be more
subtle or context-dependent.</p>
<p>While these findings indicate a potential role for CEP250 in prostate
cancer, more research is needed to fully elucidate its specific
functions and significance in prostate cancer development, progression,
or diagnosis. The presence of CEP250 in urinary biomarker studies is
particularly intriguing and may warrant further investigation for
potential diagnostic applications.</p>
<p>Citations: [1] <a
href="https://atlasgeneticsoncology.org/gene/54212/cep250-(centrosomal-protein-250)"
class="uri">https://atlasgeneticsoncology.org/gene/54212/cep250-(centrosomal-protein-250)</a>
[2] <a href="https://www.ncbi.nlm.nih.gov/gene/11190"
class="uri">https://www.ncbi.nlm.nih.gov/gene/11190</a> [3] <a
href="https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=11190"
class="uri">https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&amp;Db=gene&amp;Term=11190</a>
[4] <a href="https://www.proteinatlas.org/ENSG00000126001-CEP250"
class="uri">https://www.proteinatlas.org/ENSG00000126001-CEP250</a> [5]
<a href="http://kislingerlab.uhnres.utoronto.ca/ev/protein/?gn=CEP250"
class="uri">http://kislingerlab.uhnres.utoronto.ca/ev/protein/?gn=CEP250</a>
[6] <a href="https://www.proteinatlas.org/ENSG00000126001-CEP250/cancer"
class="uri">https://www.proteinatlas.org/ENSG00000126001-CEP250/cancer</a>
[7] <a href="https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=CEP250"
class="uri">https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=CEP250</a>
[8] <a
href="http://kislingerlab.uhnres.utoronto.ca/ev/gpeptides/?ds=p20&amp;gn=CEP250"
class="uri">http://kislingerlab.uhnres.utoronto.ca/ev/gpeptides/?ds=p20&amp;gn=CEP250</a></p>
</div>
<div id="chmp2b" class="section level3">
<h3>CHMP2B</h3>
<p>Based on the search results provided, there is limited direct
information about the role of CHMP2B specifically in prostate cancer.
However, I can provide some relevant information about CHMP2B and its
potential connections to cancer, including prostate cancer:</p>
<p><strong>CHMP2B Gene and Protein</strong></p>
<p>CHMP2B (Charged Multivesicular Body Protein 2B) is a gene that
encodes a protein involved in cellular processes related to vesicle
formation and trafficking[1]. Specifically:</p>
<ol style="list-style-type: decimal">
<li><p>It forms part of the ESCRT-III (Endosomal Sorting Complex
Required for Transport-III) complex.</p></li>
<li><p>CHMP2B is involved in cell membrane remodeling and vesicle
budding.</p></li>
<li><p>The protein forms long chains that spiral around the neck of
budding vesicles, helping to constrict them before they separate from
the membrane[1].</p></li>
</ol>
<p><strong>Potential Role in Cancer</strong></p>
<p>While not specifically linked to prostate cancer in the provided
results, CHMP2B has been associated with cancer-related processes:</p>
<ol style="list-style-type: decimal">
<li><p>In a study examining prostate cancer risk variants and gene
expression, CHMP2B was identified as one of the genes whose expression
was significantly associated with certain risk variants[2].</p></li>
<li><p>The gene is included in analyses of cancer-related genes in
resources like The Human Protein Atlas[7].</p></li>
</ol>
<p><strong>Expression in Prostate Tissue</strong></p>
<p>The Human Protein Atlas provides information on CHMP2B expression in
various tissues, including prostate:</p>
<ol style="list-style-type: decimal">
<li><p>CHMP2B protein expression has been detected in prostate
tissue[7].</p></li>
<li><p>The gene is expressed in normal prostate tissue, though the
specific levels or patterns are not detailed in the provided
results.</p></li>
</ol>
<p><strong>Genetic Associations</strong></p>
<p>A study on prostate cancer risk SNPs (Single Nucleotide
Polymorphisms) found:</p>
<ol style="list-style-type: decimal">
<li><p>The CHMP2B gene region contains several prostate cancer risk SNPs
with varying degrees of linkage disequilibrium between them[3].</p></li>
<li><p>This suggests that genetic variations in or near CHMP2B might
contribute to prostate cancer risk, though the exact mechanisms are not
specified.</p></li>
</ol>
<p><strong>Broader Cancer Context</strong></p>
<p>While not specific to prostate cancer, it’s worth noting that CHMP2B
has been studied in the context of other cancers:</p>
<ol style="list-style-type: decimal">
<li><p>The Human Protein Atlas includes CHMP2B in its analysis of
protein expression across 17 different forms of human
cancer[7].</p></li>
<li><p>This suggests that CHMP2B may have broader relevance in cancer
biology, potentially including prostate cancer.</p></li>
</ol>
<p>In conclusion, while CHMP2B is not prominently highlighted as a key
player in prostate cancer based on these results, there are indications
of its potential involvement. Its role in cellular processes like
vesicle formation, its expression in prostate tissue, and its
association with cancer risk variants suggest that CHMP2B could be
relevant to prostate cancer biology. However, more focused research
would be needed to clarify its specific role, if any, in prostate cancer
development or progression.</p>
<p>Citations: [1] <a href="https://en.wikipedia.org/wiki/CHMP2B"
class="uri">https://en.wikipedia.org/wiki/CHMP2B</a> [2] <a
href="https://pubmed.ncbi.nlm.nih.gov/25371445/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/25371445/</a> [3] <a
href="https://www.nature.com/articles/ncomms9653"
class="uri">https://www.nature.com/articles/ncomms9653</a> [4] <a
href="https://www.proteinatlas.org/ENSG00000126001-CEP250/cancer"
class="uri">https://www.proteinatlas.org/ENSG00000126001-CEP250/cancer</a>
[5] <a
href="https://atlasgeneticsoncology.org/gene/54212/cep250-(centrosomal-protein-250)"
class="uri">https://atlasgeneticsoncology.org/gene/54212/cep250-(centrosomal-protein-250)</a>
[6] <a href="https://www.proteinatlas.org/ENSG00000126001-CEP250"
class="uri">https://www.proteinatlas.org/ENSG00000126001-CEP250</a> [7]
<a href="https://www.proteinatlas.org/ENSG00000083937-CHMP2B"
class="uri">https://www.proteinatlas.org/ENSG00000083937-CHMP2B</a> [8]
<a href="https://www.ncbi.nlm.nih.gov/gene/11190"
class="uri">https://www.ncbi.nlm.nih.gov/gene/11190</a></p>
</div>
<div id="ano7" class="section level3">
<h3>ANO7</h3>
<p>Based on the search results, ANO7 (Anoctamin 7) appears to play a
significant role in prostate cancer. Here’s a summary of the key
findings:</p>
<p><strong>Expression and Function</strong></p>
<p>ANO7 is a prostate-specific gene highly expressed in the luminal
cells of the human prostate[3]. It belongs to a family of
calcium-activated chloride channels, though its exact function is still
unclear[3]. In normal prostate tissue, ANO7 is strongly expressed in
glandular cells[2].</p>
<p><strong>Association with Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p>ANO7 has been identified as a potential prostate cancer
susceptibility gene[1].</p></li>
<li><p>Its expression is often reduced or lost in prostate cancer cells
compared to normal prostate tissue[2][5].</p></li>
<li><p>Low ANO7 expression is associated with more aggressive prostate
cancer and poorer patient outcomes[2][5].</p></li>
</ol>
<p><strong>Genetic Variants</strong></p>
<p>Two significant genetic variants of ANO7 have been identified:</p>
<ol style="list-style-type: decimal">
<li><p>rs77559646: This variant is associated with both increased
prostate cancer risk (OR 1.40; p = 0.009) and aggressive prostate
cancer[1]. It’s also linked to ANO7 expression levels[1][5].</p></li>
<li><p>rs148609049: While not associated with cancer risk, this variant
is related to shorter survival (HR 1.56)[1].</p></li>
</ol>
<p><strong>Prognostic Value</strong></p>
<ol style="list-style-type: decimal">
<li><p>Reduced ANO7 staining in prostate cancer tissues is strongly
linked to adverse tumor features, including high Gleason grade, lymph
node metastasis, advanced tumor stage, and early biochemical
recurrence[2].</p></li>
<li><p>The prognostic impact of ANO7 expression was found to be
independent of established pre- or postoperatively available
parameters[2].</p></li>
<li><p>Paradoxically, one study found that high ANO7 expression was
independently linked to poor survival (HR 18.4)[1].</p></li>
</ol>
<p><strong>Potential Mechanisms</strong></p>
<ol style="list-style-type: decimal">
<li><p>ANO7 may play a role in cell-cell adhesion and vesicle
trafficking[5].</p></li>
<li><p>Recent research suggests ANO7 might influence prostate cancer
metabolism by rewiring mitochondrial functions[3].</p></li>
<li><p>The rs77559646 variant has been shown to disrupt mRNA splicing,
potentially explaining its impact on ANO7 protein production and
function[5].</p></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<ol style="list-style-type: decimal">
<li><p>ANO7 expression levels and genetic variants could potentially
serve as biomarkers for prostate cancer aggressiveness and
prognosis[1][2].</p></li>
<li><p>The rs77559646 variant has been associated with a favorable
response to docetaxel treatment in prostate cancer patients[5].</p></li>
</ol>
<p>In conclusion, ANO7 appears to be a promising gene for further
research in prostate cancer. Its expression patterns, genetic variants,
and potential roles in cancer metabolism and progression make it an
interesting target for both diagnostic and therapeutic applications in
prostate cancer management.</p>
<p>Citations: [1] <a href="https://pubmed.ncbi.nlm.nih.gov/30157291/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/30157291/</a> [2] <a
href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [3] <a
href="https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in"
class="uri">https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in</a>
[4] <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746</a>
[5] <a href="https://academic.oup.com/hmg/article/31/12/2063/6511390"
class="uri">https://academic.oup.com/hmg/article/31/12/2063/6511390</a>
[6] <a href="https://www.nature.com/articles/s41391-023-00722-x"
class="uri">https://www.nature.com/articles/s41391-023-00722-x</a> [7]
<a href="https://pubmed.ncbi.nlm.nih.gov/25371445/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/25371445/</a> [8] <a
href="https://www.nature.com/articles/ncomms9653"
class="uri">https://www.nature.com/articles/ncomms9653</a></p>
</div>
<div id="mmp7" class="section level3">
<h3>MMP7</h3>
<p>Based on the search results, MMP7 (Matrix Metalloproteinase 7)
appears to play a significant role in prostate cancer progression and
metastasis. Here’s a summary of the key findings:</p>
<p><strong>Expression and Function</strong></p>
<ol style="list-style-type: decimal">
<li><p>MMP7 is often elevated in prostate cancer cells compared to
normal prostate tissue[1].</p></li>
<li><p>It is expressed in both the cytoplasm and nucleus of malignant
prostate tumor cells[1].</p></li>
<li><p>MMP7 belongs to a family of matrix metalloproteinases involved in
extracellular matrix degradation and tissue remodeling[2].</p></li>
</ol>
<p><strong>Role in Prostate Cancer Progression</strong></p>
<ol style="list-style-type: decimal">
<li><p>MMP7 promotes prostate cancer-induced osteolysis (bone
destruction) in metastatic disease[2].</p></li>
<li><p>It processes RANKL (Receptor Activator of Nuclear Factor Kappa-Β
Ligand) to a soluble form that promotes osteoclast activation,
contributing to bone metastasis[2].</p></li>
<li><p>MMP7 interacts with ARF (Alternative Reading Frame protein) in
the nucleus, potentially potentiating tumor progression[1].</p></li>
<li><p>The crosstalk between ARF and MMP7 in the nucleus contributes to
changes in the extracellular matrix (ECM) network in tumor
microenvironments[1].</p></li>
</ol>
<p><strong>Clinical Significance</strong></p>
<ol style="list-style-type: decimal">
<li><p>Elevated MMP7 expression correlates with advanced tumor stage,
high Gleason grade, and metastasis in prostate cancer[4].</p></li>
<li><p>MMP7 expression is an independent predictor of poor prognosis in
some studies[4].</p></li>
<li><p>The density of MMP7-positive blood vessels in tumor areas
correlates with metastasis[4].</p></li>
</ol>
<p><strong>Molecular Interactions</strong></p>
<ol style="list-style-type: decimal">
<li><p>MMP7 physically binds to ARF and shows co-localization in the
nucleus[1].</p></li>
<li><p>ARF is essential for MMP7 expression, and ARF knockdown markedly
reduces MMP7 levels in prostate cancer cells[1].</p></li>
<li><p>Co-expression of MMP7 and ARF promotes cell migration in prostate
cancer cells[1].</p></li>
</ol>
<p><strong>Potential Therapeutic Implications</strong></p>
<ol style="list-style-type: decimal">
<li><p>Inhibition of MMP7 may have therapeutic benefits in treating
prostate cancer-induced osteolysis[2].</p></li>
<li><p>MMP7 could be a potential target for advanced prostate cancer
treatment, particularly in cases with bone metastasis[1][2].</p></li>
</ol>
<p>In conclusion, MMP7 appears to be an important player in prostate
cancer progression, particularly in promoting metastasis and bone
destruction. Its interactions with other proteins like ARF and its role
in modifying the tumor microenvironment make it a promising target for
further research and potential therapeutic interventions.</p>
<p>Citations: [1] <a
href="https://www.oncotarget.com/article/10251/text/"
class="uri">https://www.oncotarget.com/article/10251/text/</a> [2] <a
href="https://pubmed.ncbi.nlm.nih.gov/15894268/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/15894268/</a> [3] <a
href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [4] <a
href="https://aacrjournals.org/clincancerres/article/12/23/6998/191506/Expression-of-Matrix-Metalloproteinase-7-on-Cancer"
class="uri">https://aacrjournals.org/clincancerres/article/12/23/6998/191506/Expression-of-Matrix-Metalloproteinase-7-on-Cancer</a>
[5] <a href="https://pubmed.ncbi.nlm.nih.gov/30157291/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/30157291/</a> [6] <a
href="https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in"
class="uri">https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in</a>
[7] <a href="https://www.nature.com/articles/s41598-024-62016-z"
class="uri">https://www.nature.com/articles/s41598-024-62016-z</a> [8]
<a href="https://academic.oup.com/carcin/article/22/6/965/2733844"
class="uri">https://academic.oup.com/carcin/article/22/6/965/2733844</a></p>
</div>
<div id="bhlha15" class="section level3">
<h3>BHLHA15</h3>
<p>Based on the search results provided, there is limited direct
information about the role of BHLHA15 specifically in prostate cancer.
However, I can provide some relevant information about BHLHA15 and its
potential connections to prostate cancer:</p>
<p><strong>BHLHA15 Gene Overview</strong></p>
<p>BHLHA15 (Basic Helix-Loop-Helix Family Member A15) is a
protein-coding gene with the following characteristics:</p>
<ol style="list-style-type: decimal">
<li><p>It enables sequence-specific double-stranded DNA binding
activity.</p></li>
<li><p>The protein is involved in several processes, including cellular
response to glucose starvation, endoplasmic reticulum unfolded protein
response, and negative regulation of myotube differentiation.</p></li>
<li><p>It is predicted to be active in the nucleus and part of
chromatin.</p></li>
</ol>
<p><strong>Potential Relevance to Prostate Cancer</strong></p>
<p>While not directly linked to prostate cancer in the provided results,
there are some aspects of BHLHA15 that could be relevant:</p>
<ol style="list-style-type: decimal">
<li><p>In a study examining prostate cancer risk variants and gene
expression, BHLHA15 was identified as one of the genes whose expression
was significantly associated with certain risk variants.</p></li>
<li><p>The gene is expressed in normal prostate tissue, though the
specific levels or patterns are not detailed in the provided
results.</p></li>
</ol>
<p><strong>Gene Expression and Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p>BHLHA15 plays a role in controlling the transcriptional activity
of MYOD1, ensuring that expanding myoblast populations remain
undifferentiated. This function in cellular differentiation could
potentially be relevant in cancer contexts.</p></li>
<li><p>It serves as a key regulator of acinar cell function, stability,
and identity. Changes in cellular identity and function are often
associated with cancer development.</p></li>
<li><p>BHLHA15 is required for normal organelle localization in exocrine
cells and for mitochondrial calcium ion transport. Alterations in
cellular organization and metabolism are hallmarks of cancer.</p></li>
</ol>
<p><strong>Molecular Interactions</strong></p>
<p>BHLHA15 binds to the E-box consensus sequence 5’-CANNTG-3’, which is
a common binding site for many transcription factors involved in various
cellular processes, including some that are relevant to cancer.</p>
<p>While these findings do not directly implicate BHLHA15 in prostate
cancer, they suggest potential avenues for further research. The gene’s
role in cellular differentiation, organelle function, and its
association with cancer risk variants make it a candidate for more
focused studies in the context of prostate cancer. However, specific
research on BHLHA15’s role in prostate cancer appears to be limited
based on the provided information.</p>
<p>Citations: [1] <a
href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=BHLHA15"
class="uri">https://www.genecards.org/cgi-bin/carddisp.pl?gene=BHLHA15</a>
[2] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [3]
<a href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [4] <a
href="https://pubmed.ncbi.nlm.nih.gov/25371445/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/25371445/</a> [5] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[6] <a href="https://www.oncotarget.com/article/10251/text/"
class="uri">https://www.oncotarget.com/article/10251/text/</a> [7] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722594/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722594/</a>
[8] <a href="https://www.proquest.com/docview/2824047666"
class="uri">https://www.proquest.com/docview/2824047666</a></p>
</div>
<div id="myo9b" class="section level3">
<h3>MYO9B</h3>
<p>Based on the search results provided, there is limited direct
information about the role of MYO9B specifically in prostate cancer.
However, I can provide some general information about MYO9B and its
potential relevance to cancer:</p>
<p>MYO9B (Myosin IXB) is a gene that encodes a member of the myosin
superfamily of proteins. Myosins are molecular motors that play
important roles in cell motility, intracellular transport, and signal
transduction. While not directly linked to prostate cancer in the
provided results, some aspects of MYO9B function could potentially be
relevant to cancer biology:</p>
<ol style="list-style-type: decimal">
<li><p>Cell Motility: MYO9B is involved in cell migration and actin
cytoskeleton reorganization. These processes are important in cancer
metastasis, so alterations in MYO9B function could potentially impact
cancer cell invasion and spread.</p></li>
<li><p>Rho GTPase Regulation: MYO9B has been shown to function as a
Rho-GTPase activating protein (GAP), specifically for RhoA. Rho GTPases
are important regulators of cell morphology, motility, and cell cycle
progression. Dysregulation of Rho GTPase signaling has been implicated
in various cancers.</p></li>
<li><p>Epithelial Barrier Function: MYO9B plays a role in maintaining
epithelial barrier function. Loss of epithelial integrity is a hallmark
of cancer progression, so alterations in MYO9B could potentially
contribute to this process.</p></li>
<li><p>Association with Other Cancers: While not specifically linked to
prostate cancer in these results, MYO9B has been studied in the context
of other cancers. For example, variations in the MYO9B gene have been
associated with increased risk of esophageal cancer in some
populations.</p></li>
<li><p>Expression in Prostate Tissue: It’s likely that MYO9B is
expressed in prostate tissue, as it is widely expressed in many cell
types, but specific information about its expression patterns or levels
in normal prostate or prostate cancer tissue is not provided in these
results.</p></li>
</ol>
<p>Given the general functions of MYO9B in cell motility, signaling, and
epithelial integrity, it’s possible that alterations in this gene could
play a role in cancer development or progression. However, without
specific studies on MYO9B in prostate cancer, it’s difficult to draw
firm conclusions about its relevance to this particular type of
cancer.</p>
<p>To establish a clear link between MYO9B and prostate cancer, further
research would be needed, such as:</p>
<ol style="list-style-type: decimal">
<li><p>Expression studies comparing MYO9B levels in normal prostate
tissue versus prostate cancer tissue.</p></li>
<li><p>Functional studies examining the effects of MYO9B knockdown or
overexpression in prostate cancer cell lines.</p></li>
<li><p>Genetic association studies looking for links between MYO9B
variants and prostate cancer risk or outcomes.</p></li>
</ol>
<p>In conclusion, while MYO9B has functions that could potentially be
relevant to cancer biology, its specific role in prostate cancer, if
any, remains to be elucidated based on the information provided.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41598-024-62016-z"
class="uri">https://www.nature.com/articles/s41598-024-62016-z</a> [2]
<a href="https://pubmed.ncbi.nlm.nih.gov/25371445/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/25371445/</a> [3] <a
href="https://academic.oup.com/hmg/article/31/12/2063/6511390"
class="uri">https://academic.oup.com/hmg/article/31/12/2063/6511390</a>
[4] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[5] <a href="https://pubmed.ncbi.nlm.nih.gov/30157291/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/30157291/</a> [6] <a
href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [7] <a
href="https://www.oncotarget.com/article/10251/text/"
class="uri">https://www.oncotarget.com/article/10251/text/</a> [8] <a
href="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746</a></p>
</div>
<div id="pknox2" class="section level3">
<h3>PKNOX2</h3>
<p>Based on the search results provided, there is no direct information
about the role of PKNOX2 specifically in prostate cancer. However, I can
provide some relevant information about PKNOX2 and its potential
relevance to cancer in general:</p>
<ol style="list-style-type: decimal">
<li>PKNOX2 Function:</li>
</ol>
<p>PKNOX2 (PBX/Knotted 1 Homeobox 2) is a member of the three-amino acid
loop extension (TALE) family of transcription factors. These proteins
play vital roles in cell growth, differentiation, and death.</p>
<ol start="2" style="list-style-type: decimal">
<li>Role in Lung Cancer:</li>
</ol>
<p>While not directly related to prostate cancer, a recent study has
shown that PKNOX2 may act as a tumor suppressor in lung cancer:</p>
<ul>
<li><p>PKNOX2 expression was found to be downregulated in lung cancer
tissues compared to normal tissues.</p></li>
<li><p>Lower PKNOX2 expression was associated with tumor invasion, lymph
node metastasis, and advanced TNM stage in lung cancer
patients.</p></li>
<li><p>In vitro studies showed that PKNOX2 silencing promoted lung
cancer cell proliferation and inhibited cell cycle arrest.</p></li>
<li><p>PKNOX2 overexpression had the opposite effects, inhibiting cell
proliferation and promoting cell cycle arrest.</p></li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Mechanism of Action:</li>
</ol>
<p>The study on lung cancer suggests that PKNOX2 may suppress cancer
cell proliferation by inhibiting the PI3K/AKT/mTOR signaling pathway.
This pathway is known to be important in many types of cancer, including
prostate cancer.</p>
<ol start="4" style="list-style-type: decimal">
<li>Epigenetic Regulation:</li>
</ol>
<p>In lung cancer, PKNOX2 downregulation was associated with promoter
methylation. This epigenetic mechanism of gene silencing is common in
various cancers.</p>
<ol start="5" style="list-style-type: decimal">
<li>Potential Relevance to Prostate Cancer:</li>
</ol>
<p>While there’s no direct evidence provided for PKNOX2’s role in
prostate cancer, its function as a potential tumor suppressor in lung
cancer and its involvement in key cellular processes suggest it could
potentially play a role in other cancers, including prostate cancer.
However, this would need to be directly investigated.</p>
<ol start="6" style="list-style-type: decimal">
<li>Future Research Directions:</li>
</ol>
<p>To establish any role for PKNOX2 in prostate cancer, studies would
need to:</p>
<ul>
<li><p>Examine PKNOX2 expression levels in prostate cancer tissues
compared to normal prostate tissue.</p></li>
<li><p>Investigate any associations between PKNOX2 expression and
prostate cancer progression or prognosis.</p></li>
<li><p>Conduct functional studies in prostate cancer cell lines to
determine if PKNOX2 affects cell proliferation, migration, or
invasion.</p></li>
<li><p>Explore whether PKNOX2 interacts with known prostate cancer
pathways or genes.</p></li>
</ul>
<p>In conclusion, while PKNOX2 has been implicated as a potential tumor
suppressor in lung cancer, its specific role in prostate cancer, if any,
remains to be elucidated. The findings from lung cancer research suggest
that investigating PKNOX2 in prostate cancer could be a promising avenue
for future research.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10133798/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10133798/</a> [2]
<a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [3]
<a href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [4] <a
href="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746</a>
[5] <a href="https://pubmed.ncbi.nlm.nih.gov/30157291/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/30157291/</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9722594/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9722594/</a> [7] <a
href="https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in"
class="uri">https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in</a>
[8] <a href="https://www.nature.com/articles/s41598-024-62016-z"
class="uri">https://www.nature.com/articles/s41598-024-62016-z</a></p>
</div>
<div id="gdf7" class="section level3">
<h3>GDF7</h3>
<p>Based on the search results provided, there is no direct information
about the role of GDF7 specifically in prostate cancer. However, I can
provide some general information about GDF7 and its potential relevance
to cancer:</p>
<ol style="list-style-type: decimal">
<li>GDF7 Function:</li>
</ol>
<p>GDF7 (Growth Differentiation Factor 7), also known as BMP12, is a
member of the bone morphogenetic protein (BMP) family. BMPs are part of
the transforming growth factor-beta (TGF-β) superfamily and play
important roles in various biological processes, including cell growth,
differentiation, and apoptosis.</p>
<ol start="2" style="list-style-type: decimal">
<li>BMP Family in Cancer:</li>
</ol>
<p>While there’s no specific information about GDF7 in prostate cancer,
other members of the BMP family have been implicated in various cancers,
including prostate cancer. BMPs can have both tumor-promoting and
tumor-suppressing effects, depending on the context and specific BMP
involved.</p>
<ol start="3" style="list-style-type: decimal">
<li>Potential Relevance to Cancer:</li>
</ol>
<p>Given its membership in the BMP family, GDF7 could potentially play a
role in cancer-related processes such as:</p>
<ul>
<li><p>Cell proliferation and differentiation</p></li>
<li><p>Angiogenesis</p></li>
<li><p>Metastasis</p></li>
<li><p>Regulation of the tumor microenvironment</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Expression in Prostate Tissue:</li>
</ol>
<p>Without specific studies on GDF7 in prostate cancer, it’s unclear
whether it is expressed in normal prostate tissue or prostate cancer
cells. This would be an important first step in determining its
potential relevance to prostate cancer.</p>
<ol start="5" style="list-style-type: decimal">
<li>Related BMP Research in Prostate Cancer:</li>
</ol>
<p>Other BMPs have been studied in prostate cancer:</p>
<ul>
<li><p>BMP6 has been shown to promote prostate cancer bone
metastasis</p></li>
<li><p>BMP7 has demonstrated both pro- and anti-tumorigenic effects in
prostate cancer</p></li>
<li><p>BMP9 has been associated with prostate cancer
progression</p></li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Future Research Directions:</li>
</ol>
<p>To establish any role for GDF7 in prostate cancer, studies would need
to:</p>
<ul>
<li><p>Examine GDF7 expression levels in prostate cancer tissues
compared to normal prostate tissue</p></li>
<li><p>Investigate any associations between GDF7 expression and prostate
cancer progression or prognosis</p></li>
<li><p>Conduct functional studies in prostate cancer cell lines to
determine if GDF7 affects cell proliferation, migration, or
invasion</p></li>
<li><p>Explore whether GDF7 interacts with known prostate cancer
pathways or genes</p></li>
</ul>
<p>In conclusion, while there is no direct evidence provided for GDF7’s
role in prostate cancer, its membership in the BMP family suggests it
could potentially be involved in cancer-related processes. However,
specific research on GDF7 in prostate cancer would be needed to
establish any connection. The roles of other BMP family members in
prostate cancer provide a rationale for investigating GDF7 in this
context.</p>
<p>Citations: [1] <a
href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [2] <a
href="https://pubmed.ncbi.nlm.nih.gov/30157291/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/30157291/</a> [3] <a
href="https://www.oncotarget.com/article/10251/text/"
class="uri">https://www.oncotarget.com/article/10251/text/</a> [4] <a
href="https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in"
class="uri">https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in</a>
[5] <a href="https://www.nature.com/articles/s41391-023-00722-x"
class="uri">https://www.nature.com/articles/s41391-023-00722-x</a> [6]
<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746</a>
[7] <a href="https://academic.oup.com/hmg/article/31/12/2063/6511390"
class="uri">https://academic.oup.com/hmg/article/31/12/2063/6511390</a>
[8] <a href="https://www.nature.com/articles/s41598-024-62016-z"
class="uri">https://www.nature.com/articles/s41598-024-62016-z</a></p>
</div>
<div id="tbx5" class="section level3">
<h3>TBX5</h3>
<p>Based on the search results provided, there is no direct information
about the role of TBX5 specifically in prostate cancer. However, I can
provide some general information about TBX5 and its potential relevance
to cancer:</p>
<ol style="list-style-type: decimal">
<li>TBX5 Function:</li>
</ol>
<p>TBX5 (T-Box Transcription Factor 5) is a member of the T-box family
of transcription factors. These proteins play crucial roles in
developmental processes, particularly in heart and limb development.</p>
<ol start="2" style="list-style-type: decimal">
<li>TBX Family in Cancer:</li>
</ol>
<p>While there’s no specific information about TBX5 in prostate cancer,
other members of the TBX family have been implicated in various
cancers:</p>
<ul>
<li><p>TBX2 and TBX3 have been found to be overexpressed in several
cancer types, including breast, pancreatic, and melanoma[3].</p></li>
<li><p>These TBX proteins are often associated with repression of tumor
suppressor genes and promotion of cancer cell proliferation and
invasion[3].</p></li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Potential Relevance to Cancer:</li>
</ol>
<p>Given its role as a transcription factor, TBX5 could potentially
influence cancer-related processes such as:</p>
<ul>
<li><p>Cell proliferation and differentiation</p></li>
<li><p>Apoptosis</p></li>
<li><p>Gene regulation</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Expression in Prostate Tissue:</li>
</ol>
<p>Without specific studies on TBX5 in prostate cancer, it’s unclear
whether it is expressed in normal prostate tissue or prostate cancer
cells. This would be an important first step in determining its
potential relevance to prostate cancer.</p>
<ol start="5" style="list-style-type: decimal">
<li>Related TBX Research in Cancer:</li>
</ol>
<p>While not specific to TBX5 or prostate cancer, research has shown
that:</p>
<ul>
<li><p>TBX2 and TBX3 can repress tumor suppressor genes like p14ARF and
p21CIP1[3].</p></li>
<li><p>TBX3 has been associated with promoting tumor migration and
invasion in some cancer types[3].</p></li>
<li><p>TBX genes can interact with important cancer-related pathways,
such as the B-Raf signaling pathway in melanoma[3].</p></li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Future Research Directions:</li>
</ol>
<p>To establish any role for TBX5 in prostate cancer, studies would need
to:</p>
<ul>
<li><p>Examine TBX5 expression levels in prostate cancer tissues
compared to normal prostate tissue</p></li>
<li><p>Investigate any associations between TBX5 expression and prostate
cancer progression or prognosis</p></li>
<li><p>Conduct functional studies in prostate cancer cell lines to
determine if TBX5 affects cell proliferation, migration, or
invasion</p></li>
<li><p>Explore whether TBX5 interacts with known prostate cancer
pathways or genes</p></li>
</ul>
<p>In conclusion, while there is no direct evidence provided for TBX5’s
role in prostate cancer, its membership in the TBX family of
transcription factors, which have been implicated in other cancers,
suggests it could potentially be involved in cancer-related processes.
However, specific research on TBX5 in prostate cancer would be needed to
establish any connection.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [2]
<a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[3] <a
href="https://www.spandidos-publications.com/10.3892/ol.2016.5296"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2016.5296</a>
[4] <a href="https://pubmed.ncbi.nlm.nih.gov/25371445/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/25371445/</a> [5] <a
href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [6] <a
href="https://www.oncotarget.com/article/10251/text/"
class="uri">https://www.oncotarget.com/article/10251/text/</a> [7] <a
href="https://www.proquest.com/docview/2824047666"
class="uri">https://www.proquest.com/docview/2824047666</a> [8] <a
href="https://www.nature.com/articles/s41598-024-62016-z"
class="uri">https://www.nature.com/articles/s41598-024-62016-z</a></p>
</div>
<div id="lmo4" class="section level3">
<h3>LMO4</h3>
<p>Based on the search results provided, there is limited direct
information about the role of LMO4 specifically in prostate cancer.
However, I can provide some general information about LMO4 and its
potential relevance to cancer:</p>
<ol style="list-style-type: decimal">
<li>LMO4 Function:</li>
</ol>
<p>LMO4 (LIM Domain Only 4) is a protein-coding gene that encodes a
cysteine-rich protein containing two LIM domains. It is thought to play
a role as a transcriptional regulator or as an oncogene.</p>
<ol start="2" style="list-style-type: decimal">
<li>General Role in Cancer:</li>
</ol>
<p>While not specifically linked to prostate cancer in these results,
LMO4 has been associated with other types of cancer:</p>
<ul>
<li><p>It may play a role as an oncogene in some contexts.</p></li>
<li><p>It has been implicated in T-Cell Acute Lymphoblastic
Leukemia.</p></li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Molecular Function:</li>
</ol>
<p>LMO4 is involved in several molecular functions that could be
relevant to cancer processes:</p>
<ul>
<li><p>DNA-binding transcription factor activity</p></li>
<li><p>cis-regulatory region sequence-specific DNA binding</p></li>
<li><p>Transcription cofactor activity</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Cellular Processes:</li>
</ol>
<p>LMO4 plays a role in:</p>
<ul>
<li><p>Establishing motor neuron identity</p></li>
<li><p>Disrupting LDB1-LHX3 complexes, which modulates interneuron genes
in motor neurons</p></li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Expression in Prostate Tissue:</li>
</ol>
<p>The provided information does not specify whether LMO4 is expressed
in normal prostate tissue or prostate cancer cells. This would be an
important aspect to investigate to determine its potential relevance to
prostate cancer.</p>
<ol start="6" style="list-style-type: decimal">
<li>Related Pathways:</li>
</ol>
<p>LMO4 is associated with pathways that could be relevant to cancer
development:</p>
<ul>
<li><p>SHP2 signaling</p></li>
<li><p>Validated nuclear estrogen receptor alpha network</p></li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Potential Research Directions:</li>
</ol>
<p>To establish any role for LMO4 in prostate cancer, future studies
would need to:</p>
<ul>
<li><p>Examine LMO4 expression levels in prostate cancer tissues
compared to normal prostate tissue</p></li>
<li><p>Investigate any associations between LMO4 expression and prostate
cancer progression or prognosis</p></li>
<li><p>Conduct functional studies in prostate cancer cell lines to
determine if LMO4 affects cell proliferation, migration, or
invasion</p></li>
<li><p>Explore whether LMO4 interacts with known prostate cancer
pathways or genes</p></li>
</ul>
<p>In conclusion, while LMO4 has known roles in transcriptional
regulation and has been implicated in some types of cancer, its specific
role in prostate cancer, if any, remains to be elucidated based on the
information provided. Its functions as a transcriptional regulator and
potential oncogene suggest it could be an interesting target for
investigation in prostate cancer research.</p>
<p>Citations: [1] <a
href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [2] <a
href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [3]
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=LMO4"
class="uri">https://www.genecards.org/cgi-bin/carddisp.pl?gene=LMO4</a>
[4] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[5] <a href="https://pubmed.ncbi.nlm.nih.gov/25371445/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/25371445/</a> [6] <a
href="https://www.oncotarget.com/article/10251/text/"
class="uri">https://www.oncotarget.com/article/10251/text/</a> [7] <a
href="https://pubmed.ncbi.nlm.nih.gov/30157291/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/30157291/</a> [8] <a
href="https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in"
class="uri">https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in</a></p>
</div>
<div id="loc100506779" class="section level3">
<h3>LOC100506779</h3>
<p>Based on the search results provided, there is no specific
information about the role of LOC100506779 in prostate cancer.
LOC100506779 appears to be a non-coding RNA gene, but its function and
potential involvement in prostate cancer are not described in the given
results.</p>
<p>To provide a meaningful response about this gene in relation to
prostate cancer, further research would be needed. Here are some general
points and suggestions for investigating LOC100506779 in the context of
prostate cancer:</p>
<ol style="list-style-type: decimal">
<li>Gene Type:</li>
</ol>
<p>LOC100506779 is likely a long non-coding RNA (lncRNA) gene. Many
lncRNAs have been found to play roles in cancer development and
progression, including in prostate cancer.</p>
<ol start="2" style="list-style-type: decimal">
<li>Expression Analysis:</li>
</ol>
<p>A crucial first step would be to analyze the expression of
LOC100506779 in prostate cancer tissues compared to normal prostate
tissue. This could reveal whether the gene is up- or down-regulated in
prostate cancer.</p>
<ol start="3" style="list-style-type: decimal">
<li>Functional Studies:</li>
</ol>
<p>If expression differences are found, functional studies in prostate
cancer cell lines could help elucidate the gene’s potential role. This
might involve:</p>
<ul>
<li><p>Overexpression or knockdown experiments</p></li>
<li><p>Analyzing effects on cell proliferation, migration, invasion, or
apoptosis</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Clinical Correlations:</li>
</ol>
<p>Investigating correlations between LOC100506779 expression levels and
clinical parameters like tumor stage, Gleason score, or patient survival
could provide insights into its potential as a biomarker.</p>
<ol start="5" style="list-style-type: decimal">
<li>Molecular Interactions:</li>
</ol>
<p>Identifying any protein or RNA interactions of LOC100506779 could
help understand its molecular function in prostate cancer cells.</p>
<ol start="6" style="list-style-type: decimal">
<li>Pathway Analysis:</li>
</ol>
<p>Determining which signaling pathways or cellular processes are
affected by LOC100506779 could shed light on its role in prostate cancer
biology.</p>
<ol start="7" style="list-style-type: decimal">
<li>Genetic Association Studies:</li>
</ol>
<p>Investigating whether any genetic variants in or near LOC100506779
are associated with prostate cancer risk or aggressiveness could be
informative.</p>
<ol start="8" style="list-style-type: decimal">
<li>Epigenetic Regulation:</li>
</ol>
<p>Analyzing the epigenetic regulation of LOC100506779 in prostate
cancer cells might reveal mechanisms controlling its expression.</p>
<p>In conclusion, while there is no specific information about
LOC100506779 in prostate cancer from the provided search results, these
suggested research directions could help elucidate any potential role
this gene might have in prostate cancer development, progression, or as
a biomarker. Given its likely status as a lncRNA, it could potentially
be involved in gene regulation processes relevant to prostate cancer,
but this would need to be experimentally determined.</p>
<p>Citations: [1] <a
href="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746</a>
[2] <a href="https://pubmed.ncbi.nlm.nih.gov/30157291/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/30157291/</a> [3] <a
href="https://academic.oup.com/hmg/article/31/12/2063/6511390"
class="uri">https://academic.oup.com/hmg/article/31/12/2063/6511390</a>
[4] <a
href="https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in"
class="uri">https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in</a>
[5] <a
href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a>
[6] <a href="https://www.nature.com/articles/s41391-023-00722-x"
class="uri">https://www.nature.com/articles/s41391-023-00722-x</a> [7]
<a href="https://pubmed.ncbi.nlm.nih.gov/25371445/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/25371445/</a> [8] <a
href="https://pubmed.ncbi.nlm.nih.gov/27433846/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/27433846/</a></p>
</div>
<div id="tmprss2" class="section level3">
<h3>TMPRSS2</h3>
<p>Based on the search results, TMPRSS2 plays a significant role in
prostate cancer. Here are the key points about TMPRSS2 in prostate
cancer:</p>
<ol style="list-style-type: decimal">
<li>Gene Fusion:</li>
</ol>
<ul>
<li><p>TMPRSS2 is most frequently involved in gene fusions in prostate
cancer, particularly the TMPRSS2-ERG fusion[1][4].</p></li>
<li><p>This fusion occurs in approximately 50% of primary prostate
cancers among men of European ancestry[3].</p></li>
<li><p>The fusion places the ERG oncogene under the control of the
androgen-responsive TMPRSS2 promoter, leading to androgen-dependent ERG
expression[1][3][4].</p></li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Expression and Regulation:</li>
</ol>
<ul>
<li><p>TMPRSS2 is an androgen-regulated gene, with expression strongly
upregulated in response to androgens[3].</p></li>
<li><p>Its expression is increased in prostate cancer tissue compared to
non-cancerous prostate tissue[3].</p></li>
<li><p>TMPRSS2 is expressed on the luminal side of the prostate
epithelium[3].</p></li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Role in Cancer Progression:</li>
</ol>
<ul>
<li><p>TMPRSS2 is involved in prostate cancer cell invasion, tumor
growth, and metastasis[1].</p></li>
<li><p>It can cleave and activate various substrates, including
Matriptase, pro-HGF, and extracellular matrix components[1].</p></li>
<li><p>TMPRSS2 overexpression promotes prostate cancer metastasis in
animal models[1].</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Association with Cancer Risk:</li>
</ol>
<ul>
<li><p>Elevated TMPRSS2 expression is associated with increased prostate
cancer risk[2].</p></li>
<li><p>This association is independent of previously reported risk
variants[2].</p></li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Potential Therapeutic Target:</li>
</ol>
<ul>
<li><p>HAI-2 (Hepatocyte growth factor activator inhibitor-2) has been
identified as a potential cognate inhibitor for TMPRSS2, capable of
suppressing TMPRSS2-mediated malignancy[1].</p></li>
<li><p>Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell
invasion and metastasis[1].</p></li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Molecular Interactions:</li>
</ol>
<ul>
<li>TMPRSS2 expression levels in normal prostate tissue correlate with
ERG expression levels in TMPRSS2-ERG fusion-positive tumors, suggesting
a novel germline-somatic interaction mechanism[2].</li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Prevalence and Ethnic Differences:</li>
</ol>
<ul>
<li>The prevalence of TMPRSS2-ERG fusion is lower in prostate tumors of
both Black and Asian men compared to men of European ancestry[3].</li>
</ul>
<ol start="8" style="list-style-type: decimal">
<li>Animal Models:</li>
</ol>
<ul>
<li>Transgenic mice expressing ERG under the control of
prostate-specific promoters develop prostatic intraepithelial neoplasia
(PIN), an early stage of prostate cancer development[4].</li>
</ul>
<p>In conclusion, TMPRSS2 plays a crucial role in prostate cancer,
particularly through its involvement in gene fusions with ERG. Its
androgen-regulated expression and role in cancer progression make it an
important factor in understanding prostate cancer biology and a
potential target for therapeutic interventions.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41388-020-01413-w"
class="uri">https://www.nature.com/articles/s41388-020-01413-w</a> [2]
<a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [3]
<a
href="https://aacrjournals.org/cancerdiscovery/article/10/6/779/2830/TMPRSS2-and-COVID-19-Serendipity-or-Opportunity"
class="uri">https://aacrjournals.org/cancerdiscovery/article/10/6/779/2830/TMPRSS2-and-COVID-19-Serendipity-or-Opportunity</a>
[4] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3527835/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC3527835/</a> [5] <a
href="https://jcp.bmj.com/content/73/12/773"
class="uri">https://jcp.bmj.com/content/73/12/773</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5647090/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5647090/</a> [7] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[8] <a href="https://www.proquest.com/docview/2824047666"
class="uri">https://www.proquest.com/docview/2824047666</a></p>
</div>
<div id="pdlim5" class="section level3">
<h3>PDLIM5</h3>
<p>Based on the search results provided, there is limited direct
information about the role of PDLIM5 specifically in prostate cancer.
However, some relevant information can be extracted:</p>
<ol style="list-style-type: decimal">
<li>PDLIM5 Function:</li>
</ol>
<ul>
<li><p>PDLIM5 (PDZ and LIM domain 5) is a scaffold protein containing a
PDZ domain at the N-terminal end and three C-terminal LIM
domains.</p></li>
<li><p>It plays important roles in regulating cell proliferation,
differentiation, and cell fate decisions in multiple tissues and cell
types.</p></li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Association with Cancer:</li>
</ol>
<ul>
<li><p>PDLIM5 has been reported to be abnormally enriched in prostate
cancer tissues.</p></li>
<li><p>Knockdown of PDLIM5 has been shown to suppress proliferation,
migration, and invasion of prostate cancer cells.</p></li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Molecular Interactions:</li>
</ol>
<ul>
<li><p>PDLIM5 binds to cytoskeleton and membrane proteins through its
PDZ domain.</p></li>
<li><p>It interacts with various signaling molecules, including protein
kinases and transcription factors, through its LIM domains.</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Potential Mechanisms in Cancer:</li>
</ol>
<ul>
<li><p>PDLIM5 may be involved in the progression of multiple tumor
types, including prostate cancer.</p></li>
<li><p>Its ability to interact with multiple functional proteins and its
localization at specific subcellular sites play important roles in
cellular and physiological functions.</p></li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Gene Expression Association:</li>
</ol>
<ul>
<li>In a study examining prostate cancer risk variants and gene
expression, PDLIM5 was identified as one of the genes whose expression
was significantly associated with certain risk variants.</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Research Limitations:</li>
</ol>
<ul>
<li>While PDLIM5 has been implicated in prostate cancer, the specific
mechanisms and pathways involved are not fully elucidated in the
provided search results.</li>
</ul>
<p>In conclusion, while PDLIM5 appears to play a role in prostate
cancer, particularly in cell proliferation, migration, and invasion,
more focused research is needed to fully understand its specific
functions and potential as a therapeutic target in prostate cancer. The
association of its expression with prostate cancer risk variants
suggests it may be involved in the genetic predisposition to the
disease, but further studies are required to confirm and expand on these
findings.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full</a>
[2] <a
href="https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2020.00975/full"
class="uri">https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2020.00975/full</a>
[3] <a href="https://pubmed.ncbi.nlm.nih.gov/25371445/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/25371445/</a> [4] <a
href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [5]
<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746</a>
[6] <a href="https://pubmed.ncbi.nlm.nih.gov/30157291/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/30157291/</a> [7] <a
href="https://pubmed.ncbi.nlm.nih.gov/27433846/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/27433846/</a> [8] <a
href="https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in"
class="uri">https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in</a></p>
</div>
<div id="itpk1" class="section level3">
<h3>ITPK1</h3>
<p>Based on the search results provided, there is no specific
information about the role of ITPK1 in prostate cancer. The search
results do not contain any direct mentions or studies of ITPK1 in
relation to prostate cancer.</p>
<p>To provide a meaningful response about ITPK1 in prostate cancer,
further research would be needed. Here are some general points to
consider for investigating ITPK1 in the context of prostate cancer:</p>
<ol style="list-style-type: decimal">
<li>Gene Function:</li>
</ol>
<p>ITPK1 (Inositol-Tetrakisphosphate 1-Kinase) is an enzyme involved in
inositol phosphate metabolism. It catalyzes the formation of inositol
1,3,4,5-tetrakisphosphate.</p>
<ol start="2" style="list-style-type: decimal">
<li>Expression Analysis:</li>
</ol>
<p>A crucial first step would be to analyze the expression of ITPK1 in
prostate cancer tissues compared to normal prostate tissue. This could
reveal whether the gene is up- or down-regulated in prostate cancer.</p>
<ol start="3" style="list-style-type: decimal">
<li>Functional Studies:</li>
</ol>
<p>If expression differences are found, functional studies in prostate
cancer cell lines could help elucidate the gene’s potential role. This
might involve:</p>
<ul>
<li><p>Overexpression or knockdown experiments</p></li>
<li><p>Analyzing effects on cell proliferation, migration, invasion, or
apoptosis</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Clinical Correlations:</li>
</ol>
<p>Investigating correlations between ITPK1 expression levels and
clinical parameters like tumor stage, Gleason score, or patient survival
could provide insights into its potential as a biomarker.</p>
<ol start="5" style="list-style-type: decimal">
<li>Pathway Analysis:</li>
</ol>
<p>Determining which signaling pathways or cellular processes are
affected by ITPK1 could shed light on its role in prostate cancer
biology. Given its role in inositol phosphate metabolism, it might be
involved in cell signaling pathways.</p>
<ol start="6" style="list-style-type: decimal">
<li>Genetic Association Studies:</li>
</ol>
<p>Investigating whether any genetic variants in or near ITPK1 are
associated with prostate cancer risk or aggressiveness could be
informative.</p>
<ol start="7" style="list-style-type: decimal">
<li>Epigenetic Regulation:</li>
</ol>
<p>Analyzing the epigenetic regulation of ITPK1 in prostate cancer cells
might reveal mechanisms controlling its expression.</p>
<p>In conclusion, while there is no specific information about ITPK1 in
prostate cancer from the provided search results, these suggested
research directions could help elucidate any potential role this gene
might have in prostate cancer development, progression, or as a
biomarker. Further targeted research would be needed to establish any
connection between ITPK1 and prostate cancer.</p>
<p>Citations: [1] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[2] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [3]
<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a>
[4] <a href="https://www.nature.com/articles/s41388-020-01413-w"
class="uri">https://www.nature.com/articles/s41388-020-01413-w</a> [5]
<a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full</a>
[6] <a href="https://pubmed.ncbi.nlm.nih.gov/25371445/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/25371445/</a> [7] <a
href="https://www.proquest.com/docview/2824047666"
class="uri">https://www.proquest.com/docview/2824047666</a> [8] <a
href="https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in"
class="uri">https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in</a></p>
</div>
<div id="rgs17" class="section level3">
<h3>RGS17</h3>
<p>Based on the search results provided, here is a summary of the key
information about RGS17 in prostate cancer:</p>
<ol style="list-style-type: decimal">
<li>Function of RGS17:</li>
</ol>
<ul>
<li><p>RGS17 encodes a member of the regulator of G-protein signaling
family.</p></li>
<li><p>It contains a conserved RGS domain and a cysteine-rich
region.</p></li>
<li><p>RGS17 attenuates G-protein signaling by acting as a GTPase
activating protein (GAP) for G alpha subunits.</p></li>
<li><p>It plays a role in terminating signaling by mu opioid receptors
and in the development of tolerance to opioid analgesic drugs.</p></li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Role in Cancer:</li>
</ol>
<ul>
<li>RGS17 is considered a putative lung cancer susceptibility gene,
located in a lung cancer-associated locus on chromosome 6q in
humans.</li>
<li>It is overexpressed in both lung and prostate cancers.</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Molecular Mechanisms in Cancer:</li>
</ol>
<ul>
<li><p>RGS17 induces cAMP production, CREB phosphorylation, and
CREB-responsive gene expression in cancer cells.</p></li>
<li><p>Expression of RGS17 is required for maintaining proliferation in
lung tumor cell lines.</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Specific Role in Prostate Cancer:</li>
</ol>
<ul>
<li><p>RGS17 is overexpressed in prostate cancer tissues compared to
normal prostate tissue.</p></li>
<li><p>Its overexpression induces tumor cell proliferation through the
cyclic AMP-PKA-CREB pathway in prostate cancer.</p></li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Potential as a Therapeutic Target:</li>
</ol>
<ul>
<li>Given its role in cancer cell proliferation and its overexpression
in prostate cancer, RGS17 could potentially be a target for therapeutic
interventions, though this is not explicitly stated in the provided
information.</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Research Limitations:</li>
</ol>
<ul>
<li>While the search results provide information on RGS17’s
overexpression and role in prostate cancer proliferation, they do not
offer detailed insights into its prognostic value or potential as a
biomarker in prostate cancer.</li>
</ul>
<p>In conclusion, RGS17 appears to play a significant role in prostate
cancer, particularly through its overexpression and involvement in
pathways that promote tumor cell proliferation. Its function as a
regulator of G-protein signaling and its effects on the cAMP-PKA-CREB
pathway suggest it could be an important factor in prostate cancer
development and progression. However, more research may be needed to
fully elucidate its potential as a therapeutic target or biomarker in
prostate cancer.</p>
<p>Citations: [1] <a href="https://en.wikipedia.org/wiki/RGS17"
class="uri">https://en.wikipedia.org/wiki/RGS17</a> [2] <a
href="https://pubmed.ncbi.nlm.nih.gov/30157291/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/30157291/</a> [3] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[4] <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746</a>
[5] <a href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [6] <a
href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [7]
<a href="https://www.nature.com/articles/s41467-018-04451-x"
class="uri">https://www.nature.com/articles/s41467-018-04451-x</a> [8]
<a
href="https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in"
class="uri">https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in</a></p>
</div>
<div id="ppp1r14a" class="section level3">
<h3>PPP1R14A</h3>
<p>Based on the search results provided, here’s a summary of the
information about PPP1R14A in prostate cancer:</p>
<ol style="list-style-type: decimal">
<li>Association with Prostate Cancer Risk:</li>
</ol>
<ul>
<li>PPP1R14A was identified as one of 38 genes associated with prostate
cancer risk in a large-scale transcriptome-wide association study (TWAS)
involving 233,955 European ancestry men (14,616 prostate cancer cases,
219,339 controls) [3].</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Expression and Risk:</li>
</ol>
<ul>
<li><p>The study found that elevated expression of PPP1R14A was
associated with increased prostate cancer risk (β Discovery = 1.80)
[3].</p></li>
<li><p>This association was significant in the discovery cohort and
replicated in an independent cohort (Kaiser Permanente RPGEH)
[3].</p></li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Known Target of Prostate Cancer Risk Loci:</li>
</ol>
<ul>
<li>PPP1R14A has been previously reported as a target of prostate cancer
risk loci or microRNAs [3].</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Trans-ethnic Meta-analysis:</li>
</ol>
<ul>
<li>PPP1R14A was one of 4 genes (along with MSMB, NCOA4, and PCAT1) that
showed association with prostate cancer in a trans-ethnic meta-analysis
[3].</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Function of PPP1R14A:</li>
</ol>
<ul>
<li><p>PPP1R14A, also known as CPI-17, is a protein phosphatase 1
regulatory inhibitor subunit [2].</p></li>
<li><p>It functions as a phosphorylation-dependent inhibitor protein of
smooth muscle myosin phosphatase [2].</p></li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Clinical Significance in Cancer:</li>
</ol>
<ul>
<li><p>While not specific to prostate cancer, PPP1R14A is reported to be
up-regulated in some cancer cells and causes hyperphosphorylation of
tumor suppressor merlin/NF2 [2].</p></li>
<li><p>In prostate cancer specifically, PPP1R14A expression has been
reported to be associated with GWAS risk SNP rs7247241 T allele and
increased cell proliferation [2].</p></li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Potential Mechanism:</li>
</ol>
<ul>
<li>The association of PPP1R14A with prostate cancer risk suggests it
may play a role in prostate cancer development or progression, possibly
through its function in regulating phosphatase activity or cell
signaling pathways.</li>
</ul>
<p>In conclusion, while PPP1R14A has been identified as a gene
associated with prostate cancer risk through large-scale genetic
studies, its specific role and mechanisms in prostate cancer development
and progression are not fully elucidated. Further research would be
needed to understand its potential as a biomarker or therapeutic target
in prostate cancer.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.842975/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.842975/full</a>
[2] <a href="https://en.wikipedia.org/wiki/PPP1R14A"
class="uri">https://en.wikipedia.org/wiki/PPP1R14A</a> [3] <a
href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [4]
<a href="https://pubmed.ncbi.nlm.nih.gov/30157291/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/30157291/</a> [5] <a
href="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746</a>
[6] <a
href="https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the"
class="uri">https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the</a>
[7] <a href="https://www.nature.com/articles/s41467-018-04451-x"
class="uri">https://www.nature.com/articles/s41467-018-04451-x</a> [8]
<a href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a></p>
</div>
<div id="lgr4" class="section level3">
<h3>LGR4</h3>
<p>Based on the search results provided, here is a summary of the key
information about LGR4 in prostate cancer:</p>
<ol style="list-style-type: decimal">
<li>Expression and Role in Prostate Cancer:</li>
</ol>
<ul>
<li><p>LGR4 is highly expressed in multiple types of cancer, including
prostate cancer, and is associated with poor patient
outcomes[3].</p></li>
<li><p>LGR4 promotes tumorigenesis and metastasis in prostate
cancer[3].</p></li>
<li><p>The expression of LGR4 was elevated after prostate cancer
radiotherapy[3].</p></li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Molecular Mechanisms:</li>
</ol>
<ul>
<li><p>LGR4 enhances prostate cancer cell proliferation and invasion
through the cAMP-PKA-CREB pathway[3].</p></li>
<li><p>LGR4 ablation inhibited AR/CREB1 expression, promoted γH2A.X
staining, and reduced DNA repair in prostate cancer cells[3].</p></li>
<li><p>LGR4 may enhance carcinogenesis in prostate cancer by
potentiating Wnt signaling[4].</p></li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Stem Cell Maintenance:</li>
</ol>
<ul>
<li>LGR4 plays a role in maintaining stem cell self-renewal in the
prostate[3].</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Potential Therapeutic Target:</li>
</ol>
<ul>
<li>Due to its involvement in prostate cancer progression, LGR4 is
considered an appealing therapeutic target for the treatment of prostate
cancer[3].</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Signaling Pathways:</li>
</ol>
<ul>
<li><p>LGR4 can activate the cAMP/PKA pathway, enhancing the expression
of target genes such as mineralocorticoid receptor and estrogen receptor
α[3].</p></li>
<li><p>LGR4 also interacts with the Wnt signaling pathway, potentially
contributing to its oncogenic effects[3][4].</p></li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Genetic Aspects:</li>
</ol>
<ul>
<li>While not specific to prostate cancer, mutations in LGR4-related
genes are commonly found in adrenal tumors, suggesting a potential role
in endocrine-related cancers[4].</li>
</ul>
<p>In conclusion, LGR4 appears to play a significant role in prostate
cancer progression through multiple mechanisms, including enhancement of
cell proliferation and invasion, maintenance of cancer stem cells, and
interaction with key signaling pathways like Wnt and cAMP/PKA. Its
elevated expression after radiotherapy and association with poor
outcomes make it a potential target for therapeutic interventions in
prostate cancer.</p>
<p>Citations: [1] <a
href="https://www.spandidos-publications.com/10.3892/or.2016.4663"
class="uri">https://www.spandidos-publications.com/10.3892/or.2016.4663</a>
[2] <a
href="https://aacrjournals.org/cancerres/article/81/17/4441/670293/A-Wnt-Independent-LGR4-EGFR-Signaling-Axis-in"
class="uri">https://aacrjournals.org/cancerres/article/81/17/4441/670293/A-Wnt-Independent-LGR4-EGFR-Signaling-Axis-in</a>
[3] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.728827/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.728827/full</a>
[4] <a href="https://academic.oup.com/edrv/article/44/4/647/7040426"
class="uri">https://academic.oup.com/edrv/article/44/4/647/7040426</a>
[5] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [6]
<a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full</a>
[7] <a href="https://www.proquest.com/docview/2824047666"
class="uri">https://www.proquest.com/docview/2824047666</a> [8] <a
href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a></p>
</div>
<div id="tsen34" class="section level3">
<h3>TSEN34</h3>
<p>Based on the search results provided, there is no specific
information about the role of TSEN34 in prostate cancer. The search
results do not contain any direct mentions or studies of TSEN34 in
relation to prostate cancer.</p>
<p>The information provided about TSEN34 is mostly related to its normal
function:</p>
<ol style="list-style-type: decimal">
<li><p>TSEN34 encodes a subunit of the tRNA splicing endonuclease
complex.</p></li>
<li><p>This complex is involved in processing transfer RNA (tRNA)
molecules, particularly in removing introns from some tRNAs.</p></li>
<li><p>It may also play a role in processing messenger RNA (mRNA),
specifically in the polyadenylation process.</p></li>
<li><p>Mutations in TSEN34 have been associated with pontocerebellar
hypoplasia, a disorder of brain development.</p></li>
</ol>
<p>To determine if TSEN34 has any role in prostate cancer, further
research would be needed. This could include:</p>
<ol style="list-style-type: decimal">
<li><p>Expression analysis to determine if TSEN34 is differentially
expressed in prostate cancer tissues compared to normal prostate
tissue.</p></li>
<li><p>Functional studies in prostate cancer cell lines to investigate
if altering TSEN34 expression affects cancer-related processes like cell
proliferation or invasion.</p></li>
<li><p>Genetic association studies to see if any variants in TSEN34 are
associated with prostate cancer risk or outcomes.</p></li>
<li><p>Investigation of potential interactions between TSEN34 and known
prostate cancer-related genes or pathways.</p></li>
</ol>
<p>In conclusion, based on the provided information, there is no
established link between TSEN34 and prostate cancer. Its known functions
in RNA processing do not immediately suggest a role in cancer, but this
does not rule out the possibility. More targeted research would be
needed to determine if TSEN34 has any relevance to prostate cancer
biology.</p>
<p>Citations: [1] <a
href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a>
[2] <a
href="https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the"
class="uri">https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the</a>
[3] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [4]
<a href="https://pubmed.ncbi.nlm.nih.gov/25371445/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/25371445/</a> [5] <a
href="https://medlineplus.gov/genetics/gene/tsen34/"
class="uri">https://medlineplus.gov/genetics/gene/tsen34/</a> [6] <a
href="https://www.nature.com/articles/s41467-018-04451-x"
class="uri">https://www.nature.com/articles/s41467-018-04451-x</a> [7]
<a href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [8] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.842975/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.842975/full</a></p>
</div>
<div id="loc100505545" class="section level3">
<h3>LOC100505545</h3>
<p>Based on the search results provided, there is no specific
information about the role of LOC100505545 in prostate cancer. The
search results do not contain any direct mentions or studies of
LOC100505545 in relation to prostate cancer.</p>
<p>To provide a meaningful response about LOC100505545 in prostate
cancer, further research would be needed. Here are some general points
to consider for investigating this gene in the context of prostate
cancer:</p>
<ol style="list-style-type: decimal">
<li>Gene Function:</li>
</ol>
<p>LOC100505545 is likely a long non-coding RNA (lncRNA) gene, as
indicated by the “LOC” prefix. However, its specific function is not
described in the provided search results.</p>
<ol start="2" style="list-style-type: decimal">
<li>Expression Analysis:</li>
</ol>
<p>A crucial first step would be to analyze the expression of
LOC100505545 in prostate cancer tissues compared to normal prostate
tissue. This could reveal whether the gene is up- or down-regulated in
prostate cancer.</p>
<ol start="3" style="list-style-type: decimal">
<li>Functional Studies:</li>
</ol>
<p>If expression differences are found, functional studies in prostate
cancer cell lines could help elucidate the gene’s potential role. This
might involve:</p>
<ul>
<li><p>Overexpression or knockdown experiments</p></li>
<li><p>Analyzing effects on cell proliferation, migration, invasion, or
apoptosis</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Clinical Correlations:</li>
</ol>
<p>Investigating correlations between LOC100505545 expression levels and
clinical parameters like tumor stage, Gleason score, or patient survival
could provide insights into its potential as a biomarker.</p>
<ol start="5" style="list-style-type: decimal">
<li>Molecular Interactions:</li>
</ol>
<p>Identifying any protein or RNA interactions of LOC100505545 could
help understand its molecular function in prostate cancer cells.</p>
<ol start="6" style="list-style-type: decimal">
<li>Pathway Analysis:</li>
</ol>
<p>Determining which signaling pathways or cellular processes are
affected by LOC100505545 could shed light on its role in prostate cancer
biology.</p>
<ol start="7" style="list-style-type: decimal">
<li>Genetic Association Studies:</li>
</ol>
<p>Investigating whether any genetic variants in or near LOC100505545
are associated with prostate cancer risk or aggressiveness could be
informative.</p>
<p>In conclusion, while there is no specific information about
LOC100505545 in prostate cancer from the provided search results, these
suggested research directions could help elucidate any potential role
this gene might have in prostate cancer development, progression, or as
a biomarker. Further targeted research would be needed to establish any
connection between LOC100505545 and prostate cancer.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full</a>
[2] <a href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [3] <a
href="https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in"
class="uri">https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in</a>
[4] <a href="https://pubmed.ncbi.nlm.nih.gov/30157291/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/30157291/</a> [5] <a
href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a>
[6] <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746</a>
[7] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[8] <a
href="https://www.spandidos-publications.com/10.3892/or.2016.4663"
class="uri">https://www.spandidos-publications.com/10.3892/or.2016.4663</a></p>
</div>
<div id="agpat3" class="section level3">
<h3>AGPAT3</h3>
<p>Based on the search results provided, there is no specific
information about the role of AGPAT3 in prostate cancer. The search
results do not contain any direct mentions or studies of AGPAT3 in
relation to prostate cancer.</p>
<p>To provide a meaningful response about AGPAT3 in prostate cancer,
further research would be needed. Here are some general points to
consider for investigating this gene in the context of prostate
cancer:</p>
<ol style="list-style-type: decimal">
<li>Gene Function:</li>
</ol>
<p>AGPAT3 (1-Acylglycerol-3-Phosphate O-Acyltransferase 3) is an enzyme
involved in phospholipid biosynthesis. It catalyzes the conversion of
lysophosphatidic acid to phosphatidic acid, a key step in
glycerophospholipid biosynthesis.</p>
<ol start="2" style="list-style-type: decimal">
<li>Expression Analysis:</li>
</ol>
<p>A crucial first step would be to analyze the expression of AGPAT3 in
prostate cancer tissues compared to normal prostate tissue. This could
reveal whether the gene is up- or down-regulated in prostate cancer.</p>
<ol start="3" style="list-style-type: decimal">
<li>Functional Studies:</li>
</ol>
<p>If expression differences are found, functional studies in prostate
cancer cell lines could help elucidate the gene’s potential role. This
might involve:</p>
<ul>
<li><p>Overexpression or knockdown experiments</p></li>
<li><p>Analyzing effects on cell proliferation, migration, invasion, or
apoptosis</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Clinical Correlations:</li>
</ol>
<p>Investigating correlations between AGPAT3 expression levels and
clinical parameters like tumor stage, Gleason score, or patient survival
could provide insights into its potential as a biomarker.</p>
<ol start="5" style="list-style-type: decimal">
<li>Pathway Analysis:</li>
</ol>
<p>Determining which signaling pathways or cellular processes are
affected by AGPAT3 could shed light on its role in prostate cancer
biology. Given its role in lipid metabolism, it might be involved in
cancer-related metabolic changes.</p>
<ol start="6" style="list-style-type: decimal">
<li>Genetic Association Studies:</li>
</ol>
<p>Investigating whether any genetic variants in or near AGPAT3 are
associated with prostate cancer risk or aggressiveness could be
informative.</p>
<p>In conclusion, while there is no specific information about AGPAT3 in
prostate cancer from the provided search results, these suggested
research directions could help elucidate any potential role this gene
might have in prostate cancer development, progression, or as a
biomarker. Further targeted research would be needed to establish any
connection between AGPAT3 and prostate cancer.</p>
<p>Citations: [1] <a href="https://pubmed.ncbi.nlm.nih.gov/30157291/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/30157291/</a> [2] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full</a>
[3] <a
href="https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the"
class="uri">https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the</a>
[4] <a href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [5] <a
href="https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.31746</a>
[6] <a
href="https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in"
class="uri">https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in</a>
[7] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [8]
<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a></p>
</div>
<div id="trim24" class="section level3">
<h3>TRIM24</h3>
<p>Based on the search results, TRIM24 plays a significant role in
prostate cancer. Here are the key points about TRIM24 in prostate
cancer:</p>
<ol style="list-style-type: decimal">
<li>Expression and Function:</li>
</ol>
<ul>
<li><p>TRIM24 is overexpressed in prostate cancer tissues compared to
normal prostate tissue[1][3].</p></li>
<li><p>It functions as an oncogenic transcriptional activator in
prostate cancer[1].</p></li>
<li><p>TRIM24 promotes cell proliferation, particularly under low
androgen conditions[1][3].</p></li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Molecular Mechanisms:</li>
</ol>
<ul>
<li><p>TRIM24 augments androgen receptor (AR) signaling[1][3].</p></li>
<li><p>It binds to gene promoters and activates pathways involved in
both cell proliferation and AR signaling[3].</p></li>
<li><p>The bromodomain and LxxLL motif of TRIM24 are essential for
sustaining castration-resistant prostate cancer (CRPC) cell
proliferation[3].</p></li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Regulation:</li>
</ol>
<ul>
<li><p>TRIM24 is a substrate of the E3 ubiquitin ligase adaptor
SPOP[4].</p></li>
<li><p>Mutations in SPOP, found in about 10% of primary prostate
cancers, stabilize TRIM24 protein, promoting cancer
progression[1][2][4].</p></li>
<li><p>TRIM28 protects TRIM24 from SPOP-mediated degradation, providing
another mechanism for TRIM24 upregulation in SPOP-wildtype prostate
cancers[4].</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Clinical Significance:</li>
</ol>
<ul>
<li><p>TRIM24 serves as an independent prognostic biomarker for prostate
cancer[3].</p></li>
<li><p>Elevated TRIM24 levels are associated with poor prognosis and
increased risk of disease recurrence[1][3].</p></li>
<li><p>The AR/TRIM24 gene signature predicts disease recurrence in
primary tumors[1].</p></li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Therapeutic Implications:</li>
</ol>
<ul>
<li><p>TRIM24 is considered a potential therapeutic target, especially
in SPOP-mutant and CRPC patients[1][2].</p></li>
<li><p>Drugs targeting TRIM24 are currently in development[2].</p></li>
<li><p>Patients with high TRIM28 expression levels might be most
sensitive to TRIM24 inhibitors[2].</p></li>
</ul>
<p>In conclusion, TRIM24 plays a crucial role in prostate cancer
progression, particularly in castration-resistant settings, by enhancing
AR signaling and promoting cell proliferation. Its regulation by SPOP
and TRIM28 provides insights into the mechanisms of its overexpression
in different prostate cancer contexts. The association of TRIM24 with
poor prognosis and its potential as a therapeutic target make it an
important focus for ongoing prostate cancer research.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5124371/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5124371/</a> [2] <a
href="https://news.feinberg.northwestern.edu/2018/12/04/new-therapeutic-target-identified-in-prostate-cancer/"
class="uri">https://news.feinberg.northwestern.edu/2018/12/04/new-therapeutic-target-identified-in-prostate-cancer/</a>
[3] <a
href="https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-024-01289-3"
class="uri">https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-024-01289-3</a>
[4] <a href="https://www.nature.com/articles/s41467-018-07475-5"
class="uri">https://www.nature.com/articles/s41467-018-07475-5</a> [5]
<a
href="https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the"
class="uri">https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the</a>
[6] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [7]
<a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[8] <a
href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a></p>
</div>
<div id="gemin4" class="section level3">
<h3>GEMIN4</h3>
<p>Based on the search results provided, there is no specific
information about the role of GEMIN4 in prostate cancer. The search
results do not contain any direct mentions or studies of GEMIN4 in
relation to prostate cancer.</p>
<p>To provide a meaningful response about GEMIN4 in prostate cancer,
further research would be needed. Here are some general points to
consider for investigating this gene in the context of prostate
cancer:</p>
<ol style="list-style-type: decimal">
<li>Gene Function:</li>
</ol>
<p>GEMIN4 (Gem Nuclear Organelle Associated Protein 4) is part of the
SMN complex, which plays a role in the assembly of small nuclear
ribonucleoproteins (snRNPs), components of the spliceosome. It’s
involved in pre-mRNA splicing.</p>
<ol start="2" style="list-style-type: decimal">
<li>Expression Analysis:</li>
</ol>
<p>A crucial first step would be to analyze the expression of GEMIN4 in
prostate cancer tissues compared to normal prostate tissue. This could
reveal whether the gene is up- or down-regulated in prostate cancer.</p>
<ol start="3" style="list-style-type: decimal">
<li>Functional Studies:</li>
</ol>
<p>If expression differences are found, functional studies in prostate
cancer cell lines could help elucidate the gene’s potential role. This
might involve:</p>
<ul>
<li><p>Overexpression or knockdown experiments</p></li>
<li><p>Analyzing effects on cell proliferation, migration, invasion, or
apoptosis</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Clinical Correlations:</li>
</ol>
<p>Investigating correlations between GEMIN4 expression levels and
clinical parameters like tumor stage, Gleason score, or patient survival
could provide insights into its potential as a biomarker.</p>
<ol start="5" style="list-style-type: decimal">
<li>Pathway Analysis:</li>
</ol>
<p>Determining which signaling pathways or cellular processes are
affected by GEMIN4 could shed light on its role in prostate cancer
biology. Given its role in RNA processing, it might be involved in
alternative splicing events relevant to cancer.</p>
<ol start="6" style="list-style-type: decimal">
<li>Genetic Association Studies:</li>
</ol>
<p>Investigating whether any genetic variants in or near GEMIN4 are
associated with prostate cancer risk or aggressiveness could be
informative.</p>
<p>In conclusion, while there is no specific information about GEMIN4 in
prostate cancer from the provided search results, these suggested
research directions could help elucidate any potential role this gene
might have in prostate cancer development, progression, or as a
biomarker. Further targeted research would be needed to establish any
connection between GEMIN4 and prostate cancer.</p>
<p>Citations: [1] <a
href="https://www.spandidos-publications.com/10.3892/or.2016.4663"
class="uri">https://www.spandidos-publications.com/10.3892/or.2016.4663</a>
[2] <a
href="https://aacrjournals.org/cancerres/article/81/17/4441/670293/A-Wnt-Independent-LGR4-EGFR-Signaling-Axis-in"
class="uri">https://aacrjournals.org/cancerres/article/81/17/4441/670293/A-Wnt-Independent-LGR4-EGFR-Signaling-Axis-in</a>
[3] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [4]
<a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[5] <a href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [6] <a
href="https://news.feinberg.northwestern.edu/2018/12/04/new-therapeutic-target-identified-in-prostate-cancer/"
class="uri">https://news.feinberg.northwestern.edu/2018/12/04/new-therapeutic-target-identified-in-prostate-cancer/</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5124371/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5124371/</a> [8] <a
href="https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-024-01289-3"
class="uri">https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-024-01289-3</a></p>
</div>
<div id="igf1r" class="section level3">
<h3>IGF1R</h3>
<p>Based on the search results, IGF1R (Insulin-like Growth Factor 1
Receptor) plays a significant role in prostate cancer. Here are the key
points about IGF1R in prostate cancer:</p>
<ol style="list-style-type: decimal">
<li>Expression and Regulation:</li>
</ol>
<ul>
<li><p>IGF1R is overexpressed in primary prostate cancer compared to
benign prostatic epithelium[1][3].</p></li>
<li><p>IGF1R expression is higher in higher-grade tumors (primary
Gleason grade 4-5) compared to lower-grade tumors[2].</p></li>
<li><p>About 29% of prostate cancer patients have strong tumor IGF1R
expression[3].</p></li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Subcellular Localization:</li>
</ol>
<ul>
<li><p>IGF1R is found in the plasma membrane, cytoplasm, and nuclei of
prostate cancer cells[2].</p></li>
<li><p>Internalized (nuclear/cytoplasmic) IGF1R is associated with
malignant epithelium and poor outcomes[2][4].</p></li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Role in Cancer Progression:</li>
</ol>
<ul>
<li><p>High IGF1R expression is associated with increased risk of lethal
prostate cancer[3][4].</p></li>
<li><p>IGF1R promotes tumor cell growth, adhesion, and protection from
apoptosis[1].</p></li>
<li><p>IGF1R signaling affects cell survival, renewal, migration, and
resistance to radiation and castration[4].</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Clinical Significance:</li>
</ol>
<ul>
<li><p>High total, cytoplasmic, and internalized IGF1R are associated
with shorter recurrence-free survival after radiotherapy[2].</p></li>
<li><p>Strong IGF1R expression is linked to increased risk of
metastasis[2][3].</p></li>
<li><p>IGF1R expression may be an independent predictor of biochemical
recurrence post-radiotherapy[2].</p></li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Molecular Interactions:</li>
</ol>
<ul>
<li><p>IGF1R expression is higher in ERG-positive tumors, suggesting a
potential interaction with the TMPRSS2:ERG fusion gene[3][4].</p></li>
<li><p>IGF1R signaling can inhibit PTEN expression, enhancing
prosurvival and proliferation signals[4].</p></li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Therapeutic Implications:</li>
</ol>
<ul>
<li><p>Silencing of the IGF1R gene enhances sensitivity to DNA-damaging
agents in prostate cancer cells, even in PTEN-mutant cell
lines[5].</p></li>
<li><p>IGF1R is considered a potential therapeutic target, especially
for advanced prostate cancer[4].</p></li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Biomarker Potential:</li>
</ol>
<ul>
<li>IGF1R expression, particularly internalized IGF1R, may serve as a
biomarker for prostate cancer aggressiveness and prognosis[2][4].</li>
</ul>
<p>In conclusion, IGF1R plays a crucial role in prostate cancer
progression, influencing cell survival, proliferation, and metastasis.
Its overexpression is associated with poor outcomes, making it a
promising target for therapeutic interventions and a potential biomarker
for disease progression.</p>
<p>Citations: [1] <a
href="https://aacrjournals.org/cancerres/article/62/10/2942/508785/Expression-of-the-Type-1-Insulin-like-Growth"
class="uri">https://aacrjournals.org/cancerres/article/62/10/2942/508785/Expression-of-the-Type-1-Insulin-like-Growth</a>
[2] <a href="https://www.nature.com/articles/bjc2017337"
class="uri">https://www.nature.com/articles/bjc2017337</a> [3] <a
href="https://academic.oup.com/carcin/article/39/12/1431/5079148"
class="uri">https://academic.oup.com/carcin/article/39/12/1431/5079148</a>
[4] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9954466/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9954466/</a> [5] <a
href="https://www.nature.com/articles/7700775"
class="uri">https://www.nature.com/articles/7700775</a> [6] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[7] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full</a>
[8] <a
href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a></p>
</div>
<div id="stxbp1" class="section level3">
<h3>STXBP1</h3>
<p>Based on the search results provided, there is no specific
information about the role of STXBP1 in prostate cancer. The search
results do not contain any direct mentions or studies of STXBP1 in
relation to prostate cancer.</p>
<p>To provide a meaningful response about STXBP1 in prostate cancer,
further research would be needed. Here are some general points to
consider for investigating this gene in the context of prostate
cancer:</p>
<ol style="list-style-type: decimal">
<li>Gene Function:</li>
</ol>
<p>STXBP1 (Syntaxin Binding Protein 1) is involved in the release of
neurotransmitters via regulation of syntaxin, a transmembrane protein
involved in the docking of synaptic vesicles with the presynaptic plasma
membrane. While primarily known for its role in neurotransmission, it
could potentially have other functions in different cell types.</p>
<ol start="2" style="list-style-type: decimal">
<li>Expression Analysis:</li>
</ol>
<p>A crucial first step would be to analyze the expression of STXBP1 in
prostate cancer tissues compared to normal prostate tissue. This could
reveal whether the gene is up- or down-regulated in prostate cancer.</p>
<ol start="3" style="list-style-type: decimal">
<li>Functional Studies:</li>
</ol>
<p>If expression differences are found, functional studies in prostate
cancer cell lines could help elucidate the gene’s potential role. This
might involve:</p>
<ul>
<li><p>Overexpression or knockdown experiments</p></li>
<li><p>Analyzing effects on cell proliferation, migration, invasion, or
apoptosis</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Clinical Correlations:</li>
</ol>
<p>Investigating correlations between STXBP1 expression levels and
clinical parameters like tumor stage, Gleason score, or patient survival
could provide insights into its potential as a biomarker.</p>
<ol start="5" style="list-style-type: decimal">
<li>Pathway Analysis:</li>
</ol>
<p>Determining which signaling pathways or cellular processes are
affected by STXBP1 could shed light on its role in prostate cancer
biology. Given its role in vesicle trafficking, it might be involved in
secretion of growth factors or other cancer-related proteins.</p>
<ol start="6" style="list-style-type: decimal">
<li>Genetic Association Studies:</li>
</ol>
<p>Investigating whether any genetic variants in or near STXBP1 are
associated with prostate cancer risk or aggressiveness could be
informative.</p>
<p>In conclusion, while there is no specific information about STXBP1 in
prostate cancer from the provided search results, these suggested
research directions could help elucidate any potential role this gene
might have in prostate cancer development, progression, or as a
biomarker. Further targeted research would be needed to establish any
connection between STXBP1 and prostate cancer.</p>
<p>Citations: [1] <a
href="https://aacrjournals.org/cancerres/article/62/10/2942/508785/Expression-of-the-Type-1-Insulin-like-Growth"
class="uri">https://aacrjournals.org/cancerres/article/62/10/2942/508785/Expression-of-the-Type-1-Insulin-like-Growth</a>
[2] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[3] <a
href="https://news.feinberg.northwestern.edu/2018/12/04/new-therapeutic-target-identified-in-prostate-cancer/"
class="uri">https://news.feinberg.northwestern.edu/2018/12/04/new-therapeutic-target-identified-in-prostate-cancer/</a>
[4] <a
href="https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the"
class="uri">https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the</a>
[5] <a
href="https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-024-01289-3"
class="uri">https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-024-01289-3</a>
[6] <a href="https://www.nature.com/articles/bjc2017337"
class="uri">https://www.nature.com/articles/bjc2017337</a> [7] <a
href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [8]
<a href="https://academic.oup.com/carcin/article/39/12/1431/5079148"
class="uri">https://academic.oup.com/carcin/article/39/12/1431/5079148</a></p>
</div>
<div id="mlph" class="section level3">
<h3>MLPH</h3>
<p>Based on the search results provided, there is no specific
information about the role of MLPH (melanophilin) in prostate cancer.
The search results do not contain any direct mentions or studies of MLPH
in relation to prostate cancer.</p>
<p>To provide a meaningful response about MLPH in prostate cancer,
further research would be needed. Here are some general points to
consider for investigating this gene in the context of prostate
cancer:</p>
<ol style="list-style-type: decimal">
<li>Gene Function:</li>
</ol>
<p>MLPH encodes melanophilin, a protein involved in melanosome transport
in melanocytes. While its primary known function is in pigmentation, it
could potentially have other roles in different cell types.</p>
<ol start="2" style="list-style-type: decimal">
<li>Expression Analysis:</li>
</ol>
<p>A crucial first step would be to analyze the expression of MLPH in
prostate cancer tissues compared to normal prostate tissue. This could
reveal whether the gene is up- or down-regulated in prostate cancer.</p>
<ol start="3" style="list-style-type: decimal">
<li>Functional Studies:</li>
</ol>
<p>If expression differences are found, functional studies in prostate
cancer cell lines could help elucidate the gene’s potential role. This
might involve:</p>
<ul>
<li><p>Overexpression or knockdown experiments</p></li>
<li><p>Analyzing effects on cell proliferation, migration, invasion, or
apoptosis</p></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Clinical Correlations:</li>
</ol>
<p>Investigating correlations between MLPH expression levels and
clinical parameters like tumor stage, Gleason score, or patient survival
could provide insights into its potential as a biomarker.</p>
<ol start="5" style="list-style-type: decimal">
<li>Pathway Analysis:</li>
</ol>
<p>Determining which signaling pathways or cellular processes are
affected by MLPH could shed light on its role in prostate cancer
biology. Given its role in intracellular transport, it might be involved
in trafficking of proteins relevant to cancer progression.</p>
<ol start="6" style="list-style-type: decimal">
<li>Genetic Association Studies:</li>
</ol>
<p>Investigating whether any genetic variants in or near MLPH are
associated with prostate cancer risk or aggressiveness could be
informative.</p>
<p>In conclusion, while there is no specific information about MLPH in
prostate cancer from the provided search results, these suggested
research directions could help elucidate any potential role this gene
might have in prostate cancer development, progression, or as a
biomarker. Further targeted research would be needed to establish any
connection between MLPH and prostate cancer.</p>
<p>Citations: [1] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[2] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full</a>
[3] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [4]
<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a>
[5] <a
href="https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in"
class="uri">https://aacrjournals.org/cancerres/article/83/11_Supplement/A020/726845/Abstract-A020-Unraveling-the-role-of-ANO7-in</a>
[6] <a href="https://www.mdpi.com/2075-4418/11/11/2132"
class="uri">https://www.mdpi.com/2075-4418/11/11/2132</a> [7] <a
href="https://academic.oup.com/carcin/article/39/12/1431/5079148"
class="uri">https://academic.oup.com/carcin/article/39/12/1431/5079148</a>
[8] <a
href="https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the"
class="uri">https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the</a></p>
</div>
<div id="c9orf152" class="section level3">
<h3>C9orf152</h3>
<p>C9orf152 has been identified as a gene of interest in the context of
prostate cancer, particularly regarding its association with biochemical
recurrence (BCR) risk. Here are the key points about C9orf152 in
prostate cancer based on the available information:</p>
<ol style="list-style-type: decimal">
<li><p><strong>Protective Role</strong>: In a study analyzing mRNA
signatures associated with BCR in prostate cancer patients, C9orf152 was
identified as one of the protective mRNAs, with a hazard ratio (HR) of
less than 1. This suggests that higher expression levels of C9orf152 may
be linked to a reduced risk of BCR after radical
prostatectomy[1].</p></li>
<li><p><strong>Risk Stratification</strong>: The study aimed to improve
risk stratification for prostate cancer patients by identifying mRNAs
that could serve as biomarkers for predicting BCR. C9orf152 was part of
a 9-mRNA signature that could help classify patients into high-risk and
low-risk groups for recurrence, indicating its potential utility in
clinical settings[1].</p></li>
<li><p><strong>Biological Significance</strong>: While the specific
biological mechanisms by which C9orf152 influences prostate cancer
progression or recurrence are not detailed in the provided results, its
classification as a protective mRNA implies it may play a role in tumor
biology that warrants further investigation.</p></li>
<li><p><strong>Further Research Directions</strong>: Given its
association with BCR risk, future studies could focus on:</p>
<ul>
<li><p>Analyzing the expression levels of C9orf152 in larger cohorts of
prostate cancer patients.</p></li>
<li><p>Investigating the molecular pathways involved in its protective
effects.</p></li>
<li><p>Exploring potential interactions with other known oncogenic or
tumor suppressor pathways.</p></li>
</ul></li>
</ol>
<p>In conclusion, C9orf152 appears to have a protective role in prostate
cancer concerning biochemical recurrence risk, suggesting it could be a
valuable biomarker for patient stratification and prognosis. Further
research is needed to elucidate its mechanisms and potential
applications in clinical practice.</p>
<p>Citations: [1] <a
href="https://tau.amegroups.org/article/view/56321/html"
class="uri">https://tau.amegroups.org/article/view/56321/html</a> [2] <a
href="https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the"
class="uri">https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the</a>
[3] <a href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [4] <a
href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a>
[5] <a href="https://academic.oup.com/carcin/article/39/12/1431/5079148"
class="uri">https://academic.oup.com/carcin/article/39/12/1431/5079148</a>
[6] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [7]
<a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[8] <a
href="https://news.feinberg.northwestern.edu/2018/12/04/new-therapeutic-target-identified-in-prostate-cancer/"
class="uri">https://news.feinberg.northwestern.edu/2018/12/04/new-therapeutic-target-identified-in-prostate-cancer/</a></p>
</div>
<div id="grhl3" class="section level3">
<h3>GRHL3</h3>
<p>Based on the search results regarding the gene <strong>GRHL3</strong>
(Grainyhead-like 3) in the context of prostate cancer, here are the key
points:</p>
<ol style="list-style-type: decimal">
<li><p><strong>Expression in Cancer</strong>: GRHL3 is part of the
Grainyhead-like gene family, which has been implicated in various
cancers, including prostate cancer. While specific studies on GRHL3 in
prostate cancer are limited, the family members have shown differential
expression patterns in various malignancies.</p></li>
<li><p><strong>Role in Tumor Biology</strong>: The Grainyhead-like
genes, including GRHL3, are known to regulate epithelial characteristics
and can influence processes such as cell migration and invasion. In some
cancers, GRHL3 has been associated with promoting tumor cell migration
by downregulating E-cadherin, a crucial protein for maintaining
epithelial integrity.</p></li>
<li><p><strong>Inverse Relationship with E-cadherin</strong>: Studies
indicate that GRHL3 expression inversely correlates with E-cadherin
levels in certain epithelial tumors. High levels of GRHL3 can lead to
decreased E-cadherin expression, facilitating epithelial-mesenchymal
transition (EMT), which is a critical step in cancer
metastasis.</p></li>
<li><p><strong>Potential as a Biomarker</strong>: Given its involvement
in promoting invasiveness and its regulatory role in epithelial
characteristics, GRHL3 may serve as a potential biomarker for aggressive
forms of prostate cancer. Its expression levels could correlate with
tumor progression and patient outcomes.</p></li>
<li><p><strong>Research Gaps</strong> Although there is some evidence
linking GRHL3 to cancer biology, specific studies directly addressing
its role in prostate cancer progression or prognosis are sparse. Further
research is needed to clarify its functional implications and potential
as a therapeutic target.</p></li>
</ol>
<p>In summary, while GRHL3 is part of a gene family implicated in
various cancers and may influence tumor behavior through mechanisms like
E-cadherin regulation, direct evidence of its role specifically in
prostate cancer remains limited. Further studies are necessary to
elucidate its function and potential clinical relevance in this
context.</p>
<p>Citations: [1] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173839/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173839/</a>
[2] <a href="https://academic.oup.com/abbs/article/48/3/266/2194617"
class="uri">https://academic.oup.com/abbs/article/48/3/266/2194617</a>
[3] <a href="https://academic.oup.com/carcin/article/39/12/1431/5079148"
class="uri">https://academic.oup.com/carcin/article/39/12/1431/5079148</a>
[4] <a
href="https://aacrjournals.org/cancerres/article/62/10/2942/508785/Expression-of-the-Type-1-Insulin-like-Growth"
class="uri">https://aacrjournals.org/cancerres/article/62/10/2942/508785/Expression-of-the-Type-1-Insulin-like-Growth</a>
[5] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [6]
<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a>
[7] <a href="https://www.nature.com/articles/bjc2017337"
class="uri">https://www.nature.com/articles/bjc2017337</a> [8] <a
href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a></p>
</div>
<div id="chmp4c" class="section level3">
<h3>CHMP4C</h3>
<p>Based on the search results, here are the key findings regarding
<strong>CHMP4C</strong> (Charged Multivesicular Body Protein 4C) in
prostate cancer:</p>
<ol style="list-style-type: decimal">
<li><p><strong>High Expression in Prostate Cancer</strong>: CHMP4C is
significantly overexpressed in prostate cancer tissues compared to
benign prostatic hyperplasia. Studies have shown that higher levels of
CHMP4C correlate with poor clinical prognosis and malignant progression
in prostate cancer patients [1][2].</p></li>
<li><p><strong>Role in Cell Proliferation and Metastasis</strong>:
CHMP4C has been implicated in promoting malignant biological behaviors
in prostate cancer cell lines by regulating the cell cycle.
Specifically, it enhances cell proliferation, migration, and invasion
[1][2].</p></li>
<li><p><strong>Prognostic Marker</strong>: The expression level of
CHMP4C is associated with various clinicopathological features,
including Gleason score and lymph node metastasis. Elevated CHMP4C
expression is linked to worse disease-free survival (DFS) and
progression-free survival (PFS) [1][2].</p></li>
<li><p><strong>Subtype Classification</strong>: Based on CHMP4C
expression, researchers have established two new subtypes of prostate
cancer. Low expression of CHMP4C is associated with a better immune
response, whereas high expression indicates a greater sensitivity to
certain chemotherapeutic agents like paclitaxel and 5-fluorouracil
[1].</p></li>
<li><p><strong>Potential for Targeted Therapy</strong>: Given its role
in promoting tumor progression and its correlation with poor prognosis,
CHMP4C may serve as a potential therapeutic target in prostate cancer
treatment. Further research is needed to explore its mechanisms and how
it can be effectively targeted [2].</p></li>
<li><p><strong>Impact on Immune Response</strong>: The study suggests
that varying levels of CHMP4C expression among prostate cancer patients
could influence immune cell infiltration and gene mutation frequency,
indicating its broader implications in tumor microenvironment
interactions [2].</p></li>
</ol>
<p>In conclusion, <strong>CHMP4C</strong> appears to play a significant
role in prostate cancer progression through its involvement in cell
cycle regulation and tumor biology. Its high expression level serves as
a prognostic marker for poor outcomes, making it a candidate for further
research into targeted therapies and personalized treatment strategies
in prostate cancer management.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10301743/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10301743/</a> [2]
<a
href="https://bmcmedgenomics.biomedcentral.com/articles/10.1186/s12920-024-01970-z"
class="uri">https://bmcmedgenomics.biomedcentral.com/articles/10.1186/s12920-024-01970-z</a>
[3] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [4]
<a
href="https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the"
class="uri">https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the</a>
[5] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[6] <a
href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a>
[7] <a href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [8] <a
href="https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-024-01289-3"
class="uri">https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-024-01289-3</a></p>
</div>
<div id="arnt2" class="section level3">
<h3>ARNT2</h3>
<p>Based on the search results regarding <strong>ARNT2</strong> (Aryl
Hydrocarbon Receptor Nuclear Translocator 2) in prostate cancer, here
are the key points:</p>
<ol style="list-style-type: decimal">
<li><p><strong>Expression and Prognosis</strong>: ARNT2 is reported to
be overexpressed in various cancer types, including nasopharyngeal
carcinoma, but specific studies on its expression in prostate cancer are
limited. However, it may play a role in tumor progression and could
serve as a potential prognostic marker.</p></li>
<li><p><strong>Molecular Mechanisms</strong>: ARNT2 functions as a
transcription factor that can form heterodimers with other basic
helix-loop-helix (bHLH) proteins to regulate gene expression under
various physiological conditions. It has been implicated in pathways
related to cancer progression, such as angiogenesis and
metabolism.</p></li>
<li><p><strong>Potential Target Genes</strong>: The gene PTGS2
(prostaglandin-endoperoxide synthase 2) has been identified as a
potential target of ARNT2, suggesting that ARNT2 may influence
inflammatory pathways that are relevant to cancer biology.</p></li>
<li><p><strong>Immune Response Correlation</strong>: In studies
involving other cancers, ARNT2 expression has been correlated with
immune cell infiltration, indicating that it may also play a role in
modulating the tumor microenvironment and immune response.</p></li>
<li><p><strong>Inconsistent Roles Across Cancers</strong>: The role of
ARNT2 appears to vary across different types of cancer. While it has
been associated with tumor promotion in some contexts (e.g.,
glioblastoma), it has also been linked to better prognosis in other
cancers, highlighting its context-dependent effects.</p></li>
<li><p><strong>Further Research Directions</strong>: Given the limited
information specifically linking ARNT2 to prostate cancer, further
studies are warranted to clarify its expression patterns, functional
roles, and potential as a therapeutic target or biomarker in prostate
cancer.</p></li>
</ol>
<p>In conclusion, while ARNT2 is recognized for its involvement in
various cancers and may influence pathways relevant to tumor progression
and immune response, specific studies focusing on its role in prostate
cancer are lacking. More targeted research is needed to elucidate its
significance in this context.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9532129/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9532129/</a> [2] <a
href="https://onlinelibrary.wiley.com/doi/10.1155/2022/9137282"
class="uri">https://onlinelibrary.wiley.com/doi/10.1155/2022/9137282</a>
[3] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.666505/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.666505/full</a>
[4] <a href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [5] <a
href="https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the"
class="uri">https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the</a>
[6] <a
href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a>
[7] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [8]
<a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full</a></p>
</div>
<div id="znf395" class="section level3">
<h3>ZNF395</h3>
<p>The gene <strong>ZNF395</strong> (Zinc Finger Protein 395) has been
implicated in prostate cancer through various studies that assess its
association with disease risk and progression. Here are the key findings
regarding ZNF395 in the context of prostate cancer:</p>
<ol style="list-style-type: decimal">
<li><p><strong>Association with Prostate Cancer Risk</strong>: ZNF395
has been identified in a transcriptome-wide association study (TWAS)
involving a large cohort of men, where it was associated with prostate
cancer risk. This study evaluated 12,014 genes and found that elevated
expression of certain genes, including ZNF395, correlates with increased
risk for prostate cancer.</p></li>
<li><p><strong>Regulatory Mechanisms</strong>: The expression of ZNF395
may be influenced by genetic variants associated with prostate cancer
risk. Understanding how these variants regulate ZNF395 expression could
provide insights into the mechanisms underlying prostate cancer
development.</p></li>
<li><p><strong>Potential Role as a Biomarker</strong>: Given its
association with prostate cancer risk, ZNF395 may serve as a potential
biomarker for early detection or risk stratification in patients.
Further research is needed to validate its utility in clinical
settings.</p></li>
<li><p><strong>Functional Implications</strong>: While specific
functional studies on ZNF395 in prostate cancer are limited, zinc finger
proteins are generally involved in transcriptional regulation and can
influence various cellular processes, including proliferation and
apoptosis. Therefore, ZNF395 may play a role in these pathways within
the context of prostate cancer.</p></li>
<li><p><strong>Need for Further Research</strong>: More detailed studies
are necessary to elucidate the precise role of ZNF395 in prostate cancer
biology, including its mechanisms of action, interactions with other
signaling pathways, and its potential as a therapeutic target.</p></li>
</ol>
<p>In summary, <strong>ZNF395</strong> is associated with prostate
cancer risk and may serve as a potential biomarker for the disease.
However, further research is required to fully understand its functional
implications and regulatory mechanisms within prostate cancer
pathology.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [2]
<a
href="https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the"
class="uri">https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the</a>
[3] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.01030/full</a>
[4] <a
href="https://news.feinberg.northwestern.edu/2018/12/04/new-therapeutic-target-identified-in-prostate-cancer/"
class="uri">https://news.feinberg.northwestern.edu/2018/12/04/new-therapeutic-target-identified-in-prostate-cancer/</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10301743/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10301743/</a> [6]
<a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.666505/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.666505/full</a>
[7] <a href="https://academic.oup.com/carcin/article/39/12/1431/5079148"
class="uri">https://academic.oup.com/carcin/article/39/12/1431/5079148</a>
[8] <a
href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a></p>
</div>
<div id="tgm2" class="section level3">
<h3>TGM2</h3>
<p>The gene <strong>TGM2</strong> (Transglutaminase 2) has been
implicated in prostate cancer through several studies. Here are the key
findings regarding TGM2’s role in this context:</p>
<ol style="list-style-type: decimal">
<li><p><strong>Expression and Activity</strong>: TGM2 is overexpressed
in prostate cancer tissues compared to benign tissues. Its expression
correlates with androgen sensitivity in prostate cancer cell lines,
suggesting a potential role in tumorigenesis and cancer progression.
Elevated levels of TGM2 have been associated with poor survival outcomes
in prostate cancer patients[1].</p></li>
<li><p><strong>Mechanisms of Action</strong>: TGM2 has been shown to
influence the migratory potential and anchorage independence of prostate
cancer cells. Silencing TGM2 expression using CRISPR-Cas9 technology
resulted in reduced migration and altered expression of MUC1, a protein
associated with cancer progression. This indicates that TGM2 may
regulate important pathways involved in the metastatic behavior of
prostate cancer cells[1].</p></li>
<li><p><strong>Role in Androgen Independence</strong>: The truncated
isoform of TGM2 (TGM2_v2) has been identified as significantly
overexpressed in early-stage prostate adenocarcinoma compared to
inflammatory conditions like prostatitis. This truncated form may
contribute to androgen insensitivity, a common feature in advanced
prostate cancer, further complicating treatment options[1].</p></li>
<li><p><strong>Potential as a Biomarker</strong>: Given its increased
expression in prostate cancer and its association with aggressive
disease features, TGM2 may serve as a potential biomarker for prostate
malignancy. Its role in mediating immune evasion and tumor progression
highlights its relevance in the clinical management of prostate
cancer[1].</p></li>
<li><p><strong>Tumor Microenvironment Interaction</strong>: TGM2 is also
involved in modulating the tumor microenvironment by influencing
inflammation and immune cell infiltration, which are critical factors in
cancer progression and metastasis. This suggests that TGM2 not only
affects tumor cells directly but also interacts with the surrounding
tumor microenvironment[4].</p></li>
<li><p><strong>Therapeutic Implications</strong>: Targeting TGM2 or its
pathways could represent a novel therapeutic strategy for managing
prostate cancer, particularly in cases where androgen receptor signaling
is disrupted or ineffective due to advanced disease
states[1][4].</p></li>
</ol>
<p>In conclusion, <strong>TGM2</strong> plays a significant role in
prostate cancer through its involvement in tumor progression, androgen
insensitivity, and interaction with the tumor microenvironment. Its
overexpression and functional implications suggest it could serve as a
valuable biomarker and therapeutic target for aggressive forms of
prostate cancer. Further research is warranted to fully elucidate its
mechanisms and potential clinical applications.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41419-023-05818-9"
class="uri">https://www.nature.com/articles/s41419-023-05818-9</a> [2]
<a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [3]
<a
href="https://assets.researchsquare.com/files/rs-2422188/v1/ff7b3008-4dc7-4150-95bd-dc3c03ea3703.pdf?c=1697491469"
class="uri">https://assets.researchsquare.com/files/rs-2422188/v1/ff7b3008-4dc7-4150-95bd-dc3c03ea3703.pdf?c=1697491469</a>
[4] <a href="https://www.nature.com/articles/s12276-020-0444-7"
class="uri">https://www.nature.com/articles/s12276-020-0444-7</a> [5] <a
href="https://academic.oup.com/carcin/article/39/12/1431/5079148"
class="uri">https://academic.oup.com/carcin/article/39/12/1431/5079148</a>
[6] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[7] <a
href="https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the"
class="uri">https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the</a>
[8] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9532129/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9532129/</a></p>
</div>
<div id="acpp" class="section level3">
<h3>ACPP</h3>
<p>The gene <strong>ACPP</strong> (Acid Phosphatase, Prostate) has been
extensively studied in the context of prostate cancer. Here are the key
findings regarding its role and significance:</p>
<ol style="list-style-type: decimal">
<li><p><strong>Prostate-Specific Function</strong>: ACPP, also known as
prostatic acid phosphatase (PAP), is primarily expressed in the prostate
gland and is secreted by epithelial cells. It has been recognized as a
prostate-specific marker and has been used historically as a diagnostic
tool for prostate cancer, especially before the widespread use of PSA
(prostate-specific antigen) testing [1][2].</p></li>
<li><p><strong>Role in Cancer Etiology</strong>: ACPP plays a critical
role in the etiology of prostate cancer. It is known to inhibit cell
proliferation, making it a potential tumor suppressor. However, its
expression is often downregulated in prostate cancer tissues compared to
benign tissues, despite elevated protein levels being detected in the
serum of patients with advanced disease [1][4].</p></li>
<li><p><strong>Biomarker Potential</strong>: Due to its
prostate-specific expression and association with cancer progression,
ACPP has been suggested as a biomarker for prostate cancer diagnosis and
monitoring. Elevated levels of ACPP in blood can indicate disease
presence or progression, although its utility may be limited compared to
PSA [2][3].</p></li>
<li><p><strong>Genetic Regulation</strong>: The regulation of ACPP
expression can be influenced by genetic factors, including copy number
alterations and mutations in neighboring genes. Studies have shown that
specific genetic variations can affect ACPP mRNA levels, impacting its
role in tumor biology [1][6].</p></li>
<li><p><strong>Spatial Expression Patterns</strong>: Research utilizing
spatial transcriptomics has indicated that ACPP exhibits heterogeneous
expression patterns within prostate tissue sections. It is enriched in
tumor regions but may also show variable expression in non-tumor areas,
highlighting the complexity of its regulation and function within the
tumor microenvironment [4].</p></li>
<li><p><strong>Clinical Implications</strong>: Understanding the
functional implications of ACPP in prostate cancer could lead to
improved diagnostic strategies and therapeutic approaches. Its dual role
as a potential tumor suppressor and a marker for disease progression
makes it a valuable target for further research.</p></li>
</ol>
<p>In summary, <strong>ACPP</strong> is a critical gene associated with
prostate cancer, serving as both a diagnostic marker and a potential
player in tumor suppression. Its expression patterns and regulatory
mechanisms warrant further investigation to fully understand its role in
prostate cancer biology and its potential applications in clinical
practice.</p>
<p>Citations: [1] <a
href="https://genomebiology.biomedcentral.com/articles/10.1186/s13059-020-02188-9"
class="uri">https://genomebiology.biomedcentral.com/articles/10.1186/s13059-020-02188-9</a>
[2] <a href="https://pubmed.ncbi.nlm.nih.gov/8244395/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/8244395/</a> [3] <a
href="https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-016-2787-y"
class="uri">https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-016-2787-y</a>
[4] <a href="https://www.nature.com/articles/s41598-020-60384-w"
class="uri">https://www.nature.com/articles/s41598-020-60384-w</a> [5]
<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988"
class="uri">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35988</a>
[6] <a
href="https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the"
class="uri">https://aacrjournals.org/cancerdiscovery/article/12/12/2838/711191/Prostate-Cancer-Transcriptomic-Regulation-by-the</a>
[7] <a href="http://www.cancerindex.org/geneweb/ACPP.htm"
class="uri">http://www.cancerindex.org/geneweb/ACPP.htm</a> [8] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10301743/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10301743/</a></p>
</div>
<div id="tgfa" class="section level3">
<h3>TGFA</h3>
<p>The gene <strong>TGFA</strong> (Transforming Growth Factor Alpha) has
been studied in the context of prostate cancer, and here are the key
findings related to its role:</p>
<ol style="list-style-type: decimal">
<li><p><strong>Role in Prostate Cancer</strong>: TGFA is a member of the
epidermal growth factor (EGF) family and acts as a potent mitogen for
epithelial cells, including prostate cells. It is involved in
stimulating cell proliferation, differentiation, and survival, which are
critical processes in cancer development.</p></li>
<li><p><strong>Expression Patterns</strong>: Studies have shown that
TGFA expression can be altered in prostate cancer tissues compared to
benign prostate tissues. Increased levels of TGFA have been associated
with more aggressive forms of prostate cancer, indicating its potential
role in tumor progression.</p></li>
<li><p><strong>Interaction with Androgen Receptor Signaling</strong>:
TGFA may influence androgen receptor (AR) signaling pathways, which are
crucial for the growth and survival of prostate cancer cells. The
interaction between TGFA and AR signaling can contribute to the
development of androgen independence, a hallmark of advanced prostate
cancer.</p></li>
<li><p><strong>Prognostic Implications</strong>: Elevated TGFA levels
have been correlated with poor prognosis in prostate cancer patients.
Its expression could serve as a biomarker for disease aggressiveness and
may help in stratifying patients based on their risk of
progression.</p></li>
<li><p><strong>Potential Therapeutic Target</strong>: Given its role in
promoting tumor growth and survival, targeting TGFA or its signaling
pathways may represent a therapeutic strategy for managing prostate
cancer, especially in cases resistant to conventional androgen
deprivation therapies.</p></li>
<li><p><strong>Research Gaps</strong>: While there is evidence
supporting the involvement of TGFA in prostate cancer, further studies
are needed to fully elucidate its mechanisms of action, interaction with
other signaling pathways, and its potential as a therapeutic target or
biomarker.</p></li>
</ol>
<p>In summary, <strong>TGFA</strong> plays a significant role in
prostate cancer by promoting cell proliferation and influencing androgen
receptor signaling, making it a potential target for therapeutic
intervention and a marker for disease progression. Further research is
warranted to explore its full implications in prostate cancer
biology.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41419-023-05818-9"
class="uri">https://www.nature.com/articles/s41419-023-05818-9</a> [2]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148455/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148455/</a>
[3] <a
href="https://www.elsevier.es/en-revista-clinics-22-articulo-tgf-1-expression-as-biomarker-poor-S180759322202004X"
class="uri">https://www.elsevier.es/en-revista-clinics-22-articulo-tgf-1-expression-as-biomarker-poor-S180759322202004X</a>
[4] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [5]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5645057/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5645057/</a> [6] <a
href="https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext"
class="uri">https://academic.oup.com/carcin/article-abstract/22/6/965/2733844?redirectedFrom=fulltext</a>
[7] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.666505/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.666505/full</a>
[8] <a href="https://academic.oup.com/carcin/article/39/12/1431/5079148"
class="uri">https://academic.oup.com/carcin/article/39/12/1431/5079148</a></p>
</div>
<div id="ebf2" class="section level3">
<h3>EBF2</h3>
<p>The gene <strong>EBF2</strong> (Early B-cell Factor 2) has been
studied in various cancer contexts, but specific information regarding
its role in prostate cancer is limited. Here are some relevant points
regarding EBF2 and its potential implications in prostate cancer based
on the available information:</p>
<ol style="list-style-type: decimal">
<li><p><strong>Function and Role</strong>: EBF2 is a transcription
factor that plays a critical role in regulating gene expression during
B-cell development. It is involved in processes such as cell
differentiation and proliferation.</p></li>
<li><p><strong>Potential Implications in Cancer</strong>: While EBF2 is
primarily studied in the context of hematopoietic malignancies, its role
as a transcriptional regulator suggests that it could also influence
tumorigenesis in other cancers, including prostate cancer. However,
specific studies linking EBF2 directly to prostate cancer progression or
biology are not detailed in the provided search results.</p></li>
<li><p><strong>Research Context</strong>: The search results indicate
that EBF2 has been implicated in other cancers, such as pancreatic
cancer, where it cooperates with KMT2D (a histone methyltransferase) to
regulate gene expression critical for tumor suppression.</p></li>
<li><p><strong>Need for Further Research</strong>: Given the limited
direct evidence connecting EBF2 to prostate cancer, further research is
necessary to explore its expression levels, functional roles, and
potential interactions with known pathways involved in prostate cancer
development and progression.</p></li>
<li><p><strong>Potential as a Biomarker or Therapeutic Target</strong>:
If future studies identify significant roles for EBF2 in prostate
cancer, it could serve as a biomarker for disease progression or a
target for therapeutic intervention.</p></li>
</ol>
<p>In summary, while EBF2 plays an important role as a transcription
factor in various biological processes and has implications in other
cancers, specific information about its role in prostate cancer is
currently lacking. Further investigation is needed to clarify its
potential involvement and significance in prostate cancer biology.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5645057/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5645057/</a> [2] <a
href="https://www.nature.com/articles/s41419-023-05818-9"
class="uri">https://www.nature.com/articles/s41419-023-05818-9</a> [3]
<a
href="https://onlinelibrary.wiley.com/doi/full/10.1002/advs.202302037"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/advs.202302037</a>
[4] <a href="https://www.nature.com/articles/s41467-019-10808-7"
class="uri">https://www.nature.com/articles/s41467-019-10808-7</a> [5]
<a href="https://academic.oup.com/carcin/article/39/12/1431/5079148"
class="uri">https://academic.oup.com/carcin/article/39/12/1431/5079148</a>
[6] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.666505/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.666505/full</a>
[7] <a
href="https://www.elsevier.es/en-revista-clinics-22-articulo-tgf-1-expression-as-biomarker-poor-S180759322202004X"
class="uri">https://www.elsevier.es/en-revista-clinics-22-articulo-tgf-1-expression-as-biomarker-poor-S180759322202004X</a>
[8] <a
href="https://aacrjournals.org/mcr/article/7/12/1893/90355/Emerging-Roles-of-the-EBF-Family-of-Transcription"
class="uri">https://aacrjournals.org/mcr/article/7/12/1893/90355/Emerging-Roles-of-the-EBF-Family-of-Transcription</a></p>
</div>
<div id="adgrg1" class="section level3">
<h3>ADGRG1</h3>
<p><strong>Role of ADGRG1 in Prostate Cancer</strong></p>
<p><strong>ADGRG1</strong>, also known as <strong>GPR56</strong>, is an
adhesion G-protein-coupled receptor that has been implicated in various
cancers, including prostate cancer. Its functions and expression
patterns in tumor biology have drawn significant research interest.</p>
<p><strong>Expression Patterns</strong></p>
<p>ADGRG1 is expressed in prostate cancer tissues and has been
associated with tumor progression. Studies indicate that its expression
may vary depending on the tumor microenvironment and the stage of
cancer. The receptor’s role in cell adhesion and signaling suggests it
could influence both tumor growth and metastasis.</p>
<p><strong>Mechanisms of Action</strong></p>
<p>Research has highlighted several mechanisms through which ADGRG1 may
impact prostate cancer:</p>
<ul>
<li><p><strong>Cell-Extracellular Matrix (ECM) Interaction</strong>:
ADGRG1 is involved in regulating cell adhesion to the ECM, which is
crucial for maintaining tissue architecture and influencing cancer cell
behavior. Disruption of this interaction can lead to increased tumor
cell migration and invasion, facilitating metastasis[1][3].</p></li>
<li><p><strong>Inhibition of Metastasis</strong>: In some contexts,
ADGRG1 has been shown to inhibit metastatic growth by modulating ECM
deposition and signaling pathways associated with cell adhesion. For
instance, its re-expression in certain cancer models has resulted in
reduced metastatic potential by affecting fibronectin deposition and
downstream signaling pathways like focal adhesion kinase (FAK)
activation[1][3].</p></li>
<li><p><strong>Tumor Microenvironment Modulation</strong>: ADGRG1 may
also play a role in shaping the tumor microenvironment, potentially
influencing immune responses and the behavior of surrounding stromal
cells. This modulation can affect tumor growth dynamics and the overall
progression of prostate cancer[2][5].</p></li>
</ul>
<p><strong>Clinical Implications</strong></p>
<p>The dual role of ADGRG1 as both a tumor suppressor and promoter in
different contexts suggests that it could serve as a potential biomarker
for prostate cancer prognosis. High expression levels may correlate with
aggressive disease, while its loss could lead to increased metastatic
potential. Understanding the precise role of ADGRG1 in prostate cancer
could open avenues for targeted therapies aimed at modulating its
activity to improve patient outcomes.</p>
<p><strong>Conclusion</strong></p>
<p>ADGRG1 (GPR56) is a significant player in prostate cancer biology,
influencing tumor progression through its effects on cell adhesion, ECM
interactions, and the tumor microenvironment. Further research is
necessary to elucidate its precise mechanisms and therapeutic potential
in managing prostate cancer.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2018.00008/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2018.00008/full</a>
[2] <a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/cas.15150"
class="uri">https://onlinelibrary.wiley.com/doi/abs/10.1111/cas.15150</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8699533/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8699533/</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10750278/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10750278/</a> [5]
<a href="https://www.oncotarget.com/article/2536/text/"
class="uri">https://www.oncotarget.com/article/2536/text/</a> [6] <a
href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADGRG1"
class="uri">https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADGRG1</a>
[7] <a
href="https://www.proteinatlas.org/ENSG00000205336-ADGRG1/pathology"
class="uri">https://www.proteinatlas.org/ENSG00000205336-ADGRG1/pathology</a>
[8] <a href="https://www.mdpi.com/2072-6694/14/8/2001"
class="uri">https://www.mdpi.com/2072-6694/14/8/2001</a></p>
</div>
<div id="sectm1" class="section level3">
<h3>SECTM1</h3>
<p><strong>Overview of SECTM1 in Prostate Cancer</strong></p>
<p><strong>SECTM1 (Selenoprotein K12)</strong> is a gene that has
garnered attention in cancer research, particularly regarding its role
in prostate cancer (PCa). This gene is known to be overexpressed in
various tumors, including melanoma and breast cancer, and it has also
been implicated in the progression of prostate cancer.</p>
<p><strong>Expression and Function</strong></p>
<p>SECTM1 is expressed in prostate cancer cell lines and tissues,
suggesting its involvement in tumor biology. Studies have shown that
SECTM1 can attract human monocytes, which may influence the tumor
microenvironment by promoting inflammation and potentially aiding in
tumor growth through immune modulation[2][4]. The gene’s expression is
associated with various signaling pathways that can affect cancer
progression.</p>
<p><strong>Mechanisms of Action</strong></p>
<p>Research indicates that SECTM1 may function as a costimulatory ligand
for T cells, enhancing their proliferation and cytokine production. This
interaction occurs through CD7-mediated activation of the PI3K pathway,
which is crucial for T cell activation and survival[2][8]. Such
mechanisms might contribute to an immunosuppressive environment that
favors tumor development and metastasis.</p>
<p><strong>Clinical Implications</strong></p>
<p>The overexpression of SECTM1 in prostate cancer is linked to poor
patient outcomes. High levels of SECTM1 have been correlated with
advanced disease states, suggesting that it could serve as a potential
biomarker for disease progression or as a therapeutic target[4][6].
Additionally, its role in attracting immune cells indicates that
targeting SECTM1 might alter the immune landscape of tumors, providing
new avenues for treatment strategies.</p>
<p><strong>Conclusion</strong></p>
<p>In summary, SECTM1 plays a significant role in prostate cancer by
influencing immune cell dynamics and potentially contributing to tumor
growth. Its expression patterns and functional implications make it a
noteworthy candidate for further investigation in both diagnostic and
therapeutic contexts within oncology.</p>
<p>Citations: [1] <a
href="https://www.oncotarget.com/article/2536/text/"
class="uri">https://www.oncotarget.com/article/2536/text/</a> [2] <a
href="https://www.sciencedirect.com/science/article/pii/S0022202X15367191"
class="uri">https://www.sciencedirect.com/science/article/pii/S0022202X15367191</a>
[3] <a href="https://www.mdpi.com/2072-6694/14/8/2001"
class="uri">https://www.mdpi.com/2072-6694/14/8/2001</a> [4] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10750278/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10750278/</a>
[5] <a
href="https://www.sciencedirect.com/science/article/abs/pii/S088875439795151X"
class="uri">https://www.sciencedirect.com/science/article/abs/pii/S088875439795151X</a>
[6] <a
href="https://www.researchgate.net/figure/Bioinformatics-analysis-of-expression-of-the-SECTM1-gene-across-different-human-normal_fig1_51902996"
class="uri">https://www.researchgate.net/figure/Bioinformatics-analysis-of-expression-of-the-SECTM1-gene-across-different-human-normal_fig1_51902996</a>
[7] <a href="https://www.proteinatlas.org/ENSG00000141574-SECTM1/cancer"
class="uri">https://www.proteinatlas.org/ENSG00000141574-SECTM1/cancer</a>
[8] <a
href="https://www.biolegend.com/de-at/products/human-sectm1-fc-chimera-carrier-free-22521"
class="uri">https://www.biolegend.com/de-at/products/human-sectm1-fc-chimera-carrier-free-22521</a></p>
</div>
<div id="ccdc88c" class="section level3">
<h3>CCDC88C</h3>
<p><strong>Role of CCDC88C in Prostate Cancer</strong></p>
<p><strong>CCDC88C</strong>, also known as <strong>Daple</strong>, is a
gene that encodes a protein involved in the regulation of the Wnt
signaling pathway, which plays a critical role in various cellular
processes, including development and cancer progression. Its
implications in prostate cancer have been explored through various
studies.</p>
<p><strong>Mechanisms of Action</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Wnt Signaling Regulation</strong>: CCDC88C interacts with
the dishevelled protein, acting as a negative regulator of the Wnt
signaling pathway. This pathway is crucial for cell proliferation and
differentiation, and its dysregulation is often associated with cancer
progression, including prostate cancer[5].</p></li>
<li><p><strong>Dual Role in Tumorigenesis</strong>: Research indicates
that CCDC88C can have opposing roles during cancer progression.
Initially, it may suppress tumor growth by inhibiting neoplastic
transformation. However, in later stages, it can promote
epithelial-to-mesenchymal transition (EMT), which is associated with
increased invasiveness and metastatic potential of cancer cells[1]. This
duality highlights its complex role in oncogenesis.</p></li>
<li><p><strong>Isoforms and Functionality</strong>: CCDC88C has multiple
isoforms, with distinct functional properties. The full-length isoform
has been shown to trigger EMT and enhance invasion, while other isoforms
may act more effectively as tumor suppressors[1]. The expression levels
of these isoforms can vary significantly between normal and cancerous
tissues.</p></li>
</ol>
<p><strong>Expression in Prostate Cancer</strong></p>
<p>Studies have shown that CCDC88C expression is altered in prostate
cancer tissues compared to normal prostate tissues. Its down-regulation
has been linked to more aggressive forms of prostate cancer, suggesting
that it may serve as a potential biomarker for disease
prognosis[3][5].</p>
<p><strong>Clinical Implications</strong></p>
<p>The expression levels and functional roles of CCDC88C could provide
insights into the aggressiveness of prostate cancer and potential
therapeutic targets. Understanding its mechanisms could lead to novel
strategies for managing prostate cancer by either restoring its
tumor-suppressive functions or inhibiting its pro-metastatic
activities.</p>
<p><strong>Conclusion</strong></p>
<p>CCDC88C plays a significant role in prostate cancer through its
involvement in Wnt signaling and its dual functionality during tumor
progression. Further research is necessary to fully elucidate its
mechanisms and potential as a therapeutic target or biomarker in
prostate cancer management.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41598-019-48420-w"
class="uri">https://www.nature.com/articles/s41598-019-48420-w</a> [2]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [3] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790439/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790439/</a>
[4] <a href="https://www.oncotarget.com/article/2536/text/"
class="uri">https://www.oncotarget.com/article/2536/text/</a> [5] <a
href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCDC88C"
class="uri">https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCDC88C</a>
[6] <a
href="https://journals.plos.org/plosgenetics/article?id=10.1371%2Fjournal.pgen.1003419"
class="uri">https://journals.plos.org/plosgenetics/article?id=10.1371%2Fjournal.pgen.1003419</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8699533/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8699533/</a> [8] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2018.00008/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2018.00008/full</a></p>
</div>
<div id="myo5c" class="section level3">
<h3>MYO5C</h3>
<p><strong>Role of MYO5C in Prostate Cancer</strong></p>
<p><strong>MYO5C</strong>, or Myosin Vc, is a member of the myosin
superfamily of proteins, which are critical for cellular motility and
intracellular transport. Its involvement in prostate cancer is an area
of emerging research, focusing on its potential role in tumor
progression and metastasis.</p>
<p><strong>Mechanisms of Action</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Cell Motility and Invasion</strong>: MYO5C is implicated
in processes that facilitate cell movement and invasion, which are
crucial for cancer metastasis. Myosins, including MYO5C, are known to
interact with actin filaments, contributing to cytoskeletal dynamics
that support cellular migration[2].</p></li>
<li><p><strong>Epithelial-Mesenchymal Transition (EMT)</strong>: The
expression of MYO5C may be associated with the induction of EMT, a
process where epithelial cells acquire migratory and invasive
properties. This transition is often linked to increased aggressiveness
in various cancers, including prostate cancer[2].</p></li>
<li><p><strong>Prognostic Implications</strong>: Some studies suggest
that elevated levels of certain myosins, including MYO5C, could
correlate with poor prognosis in cancer patients. This is due to their
role in enhancing cell motility and facilitating metastatic
spread[2].</p></li>
</ol>
<p><strong>Expression Patterns in Prostate Cancer</strong></p>
<p>Research indicates that the expression of MYO5C may vary between
normal and cancerous prostate tissues. Increased expression levels have
been observed in more aggressive forms of cancer, suggesting that MYO5C
could serve as a potential biomarker for prostate cancer
progression.</p>
<p><strong>Clinical Relevance</strong></p>
<p>Understanding the role of MYO5C in prostate cancer could provide
insights into new therapeutic strategies aimed at inhibiting its
function to reduce metastasis and improve patient outcomes. Targeting
pathways involving MYO5C may help in developing treatments that
specifically address the invasive characteristics of prostate cancer
cells.</p>
<p><strong>Conclusion</strong></p>
<p>MYO5C plays a significant role in the mechanisms underlying prostate
cancer progression, particularly through its influence on cell motility
and potential involvement in EMT. Further research is needed to fully
elucidate its functions and implications for prognosis and therapy in
prostate cancer patients.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3092219/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC3092219/</a> [2] <a
href="https://onlinelibrary.wiley.com/doi/10.1155/2022/5501476"
class="uri">https://onlinelibrary.wiley.com/doi/10.1155/2022/5501476</a>
[3] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [4] <a
href="https://journals.plos.org/plosgenetics/article?id=10.1371%2Fjournal.pgen.1003419"
class="uri">https://journals.plos.org/plosgenetics/article?id=10.1371%2Fjournal.pgen.1003419</a>
[5] <a href="https://www.oncotarget.com/article/2536/text/"
class="uri">https://www.oncotarget.com/article/2536/text/</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8699533/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8699533/</a> [7] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2018.00008/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2018.00008/full</a>
[8] <a href="https://www.nature.com/articles/s41598-019-48420-w"
class="uri">https://www.nature.com/articles/s41598-019-48420-w</a></p>
</div>
<div id="fmn1" class="section level3">
<h3>FMN1</h3>
<p><strong>FMN1 and Its Role in Prostate Cancer</strong></p>
<p><strong>FMN1</strong> (Formin 1) is a gene located on chromosome 15,
which has garnered attention in the context of prostate cancer due to
its expression patterns and potential involvement in tumorigenesis.</p>
<p><strong>Expression and Linkage Studies</strong></p>
<p>Research has indicated that FMN1 is <strong>highly expressed in the
prostate</strong>, suggesting a possible functional role in this tissue.
A notable study highlighted a <strong>linkage peak at 15q14</strong>,
where FMN1 resides, indicating that genetic variations in this region
may contribute to hereditary prostate cancer susceptibility. This
linkage was supported by evidence from multiple family studies, which
showed suggestive associations between FMN1 and prostate cancer
phenotypes, particularly in families with multiple cases of the
disease[1].</p>
<p><strong>Biological Functions</strong></p>
<p>FMN1 is part of the <strong>formin family of proteins</strong>, which
are known to regulate cytoskeletal dynamics and are essential for cell
division and polarity. The role of FMN1 in these processes suggests it
may influence tumor cell behavior, including proliferation and
migration, which are critical factors in cancer progression. Although
direct links between FMN1 and prostate cancer have not been extensively
documented, its involvement in cellular organization could imply a role
in the invasive characteristics of prostate cancer cells[1].</p>
<p><strong>Genetic Interactions</strong></p>
<p>Recent studies have explored genetic interactions involving FMN1,
particularly its association with other genes within the same locus,
such as GREM1. These interactions may provide insights into how
environmental factors, like body mass index (BMI), could modulate cancer
risk through genetic pathways. While this research primarily focuses on
colorectal cancer, it highlights the importance of understanding
gene-environment interactions that could be relevant for prostate cancer
as well[2].</p>
<p><strong>Conclusion</strong></p>
<p>FMN1 represents a promising candidate gene for further investigation
in prostate cancer research. Its high expression in prostate tissue,
coupled with linkage evidence suggesting its potential role in
hereditary prostate cancer susceptibility, positions it as an important
focus for understanding the genetic underpinnings of this disease.
Future studies should aim to clarify the mechanisms by which FMN1
contributes to prostate cancer progression and explore its potential as
a biomarker or therapeutic target.</p>
<p>Citations: [1] <a href="https://www.nature.com/articles/ejhg201049"
class="uri">https://www.nature.com/articles/ejhg201049</a> [2] <a
href="https://aacrjournals.org/cancerres/article/83/15/2572/728086/A-Genetic-Locus-within-the-FMN1-GREM1-Gene-Region"
class="uri">https://aacrjournals.org/cancerres/article/83/15/2572/728086/A-Genetic-Locus-within-the-FMN1-GREM1-Gene-Region</a>
[3] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3092219/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC3092219/</a> [5] <a
href="https://journals.plos.org/plosgenetics/article?id=10.1371%2Fjournal.pgen.1003419"
class="uri">https://journals.plos.org/plosgenetics/article?id=10.1371%2Fjournal.pgen.1003419</a>
[6] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2018.00008/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2018.00008/full</a>
[7] <a href="https://www.oncotarget.com/article/2536/text/"
class="uri">https://www.oncotarget.com/article/2536/text/</a> [8] <a
href="https://onlinelibrary.wiley.com/doi/10.1155/2022/5501476"
class="uri">https://onlinelibrary.wiley.com/doi/10.1155/2022/5501476</a></p>
</div>
<div id="ube2e2" class="section level3">
<h3>UBE2E2</h3>
<p><strong>UBE2E2 and Its Role in Prostate Cancer</strong></p>
<p><strong>UBE2E2</strong> (Ubiquitin Conjugating Enzyme E2 E2) is part
of the ubiquitin-conjugating enzyme family, which plays a crucial role
in the ubiquitination process—a post-translational modification that
regulates protein degradation, signaling, and cellular processes. While
the specific effects of UBE2E2 in prostate cancer (PCa) are not
thoroughly understood, emerging evidence suggests its potential
involvement in tumor biology.</p>
<p><strong>Expression Patterns in Prostate Cancer</strong></p>
<p>Research indicates that <strong>UBE2E2 is downregulated in tumor
samples compared to normal tissues</strong>, which may imply a loss of
function that could contribute to cancer progression. This
downregulation has been observed alongside other ubiquitin-related
genes, suggesting a broader alteration in the ubiquitination landscape
within prostate tumors[2].</p>
<p><strong>Potential Mechanisms and Implications</strong></p>
<p>The role of UBE2E2 in cancer is still being elucidated, but it is
hypothesized that its function as an E2 enzyme may influence the
stability and degradation of oncogenic proteins. Disruption in the
ubiquitination pathways can lead to the accumulation of proteins that
promote tumor growth and resistance to therapies. For instance,
aberrations in ubiquitin-mediated degradation processes are linked to
resistance against antiandrogen therapies in prostate cancer,
highlighting the importance of this pathway in managing disease
outcomes[1].</p>
<p><strong>Future Directions for Research</strong></p>
<p>Given the potential implications of UBE2E2 in prostate cancer,
further studies are warranted to clarify its specific roles and
mechanisms. Investigating how UBE2E2 interacts with other proteins
involved in the ubiquitination process could provide insights into its
contribution to tumorigenesis and therapeutic resistance. Understanding
these mechanisms may also open avenues for targeted therapies aimed at
restoring normal ubiquitination processes or exploiting vulnerabilities
associated with UBE2E2 dysregulation.</p>
<p><strong>Conclusion</strong></p>
<p>UBE2E2 appears to be an important player in the complex network of
protein regulation within prostate cancer. Its downregulation in tumors
suggests a potential role in disease progression, although more research
is needed to fully understand its functions and therapeutic
implications. As studies continue to unveil the intricacies of ubiquitin
signaling pathways, UBE2E2 may emerge as a significant factor in
prostate cancer biology and treatment strategies.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41388-023-02890-5"
class="uri">https://www.nature.com/articles/s41388-023-02890-5</a> [2]
<a href="https://tcr.amegroups.org/article/view/67645/html"
class="uri">https://tcr.amegroups.org/article/view/67645/html</a> [3] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [4] <a
href="https://www.oncotarget.com/article/2536/text/"
class="uri">https://www.oncotarget.com/article/2536/text/</a> [5] <a
href="https://journals.plos.org/plosgenetics/article?id=10.1371%2Fjournal.pgen.1003419"
class="uri">https://journals.plos.org/plosgenetics/article?id=10.1371%2Fjournal.pgen.1003419</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3092219/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC3092219/</a> [7] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2019.00235/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2019.00235/full</a>
[8] <a href="https://www.nature.com/articles/ejhg201049"
class="uri">https://www.nature.com/articles/ejhg201049</a></p>
</div>
<div id="bcl2l14" class="section level3">
<h3>BCL2L14</h3>
<p><strong>BCL2L14 and Its Role in Prostate Cancer</strong></p>
<p><strong>BCL2L14</strong>, also known as BCL-G, is a member of the
BCL-2 family of proteins, which are primarily involved in regulating
apoptosis (programmed cell death). The role of BCL2L14 in prostate
cancer is complex and has been the subject of various studies exploring
its expression patterns and functional implications.</p>
<p><strong>Expression and Genetic Alterations</strong></p>
<p>Research indicates that <strong>BCL2L14 expression can be altered in
prostate cancer</strong>, with reports of both gene deletions and
amplifications. These genetic changes may influence the protein’s
function and its involvement in apoptotic processes within cancer cells.
Specifically, the expression of BCL2L14 has been shown to be regulated
by several transcription factors, including p53, which is crucial for
maintaining cellular homeostasis and responding to stress
signals[2].</p>
<p><strong>Implications for Tumor Progression</strong></p>
<p>The expression levels of BCL2L14 have been associated with tumor
progression. Elevated levels of anti-apoptotic proteins like those from
the BCL-2 family can lead to increased cell survival, contributing to
cancer development and resistance to therapies. In prostate cancer, high
expression of BCL2L14 may correlate with more aggressive disease
characteristics and poorer patient outcomes, particularly in the context
of treatment resistance[1][4].</p>
<p><strong>Interaction with Other Proteins</strong></p>
<p>BCL2L14 interacts with other members of the BCL-2 family, which can
modulate its pro-apoptotic or anti-apoptotic functions. For instance,
studies suggest that the balance between pro-apoptotic proteins (like
Bax) and anti-apoptotic proteins (like BCL2L14) is critical for
determining cell fate in response to therapy[3][5]. This balance may
influence how prostate cancer cells respond to treatments such as
hormone therapy or chemotherapy.</p>
<p><strong>Research Directions</strong></p>
<p>Future research on BCL2L14 could focus on:</p>
<ul>
<li><p><strong>Therapeutic Targeting</strong>: Investigating whether
targeting BCL2L14 or its pathways could enhance treatment efficacy in
prostate cancer.</p></li>
<li><p><strong>Biomarker Potential</strong>: Assessing whether BCL2L14
expression levels can serve as a prognostic marker for disease
progression or treatment response.</p></li>
<li><p><strong>Mechanistic Studies</strong>: Exploring the specific
mechanisms through which BCL2L14 influences apoptosis and interacts with
other signaling pathways in prostate cancer cells.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>BCL2L14 plays a significant role in the apoptosis regulation
landscape within prostate cancer. Its altered expression may contribute
to tumor progression and treatment resistance, highlighting its
potential as a therapeutic target or biomarker. Continued investigation
into its functions and interactions will be essential for developing
more effective strategies against prostate cancer.</p>
<p>Citations: [1] <a
href="https://www.drugtargetreview.com/news/153270/bcl2-protein-linked-to-metastatic-castration-resistant-prostate-cancer/"
class="uri">https://www.drugtargetreview.com/news/153270/bcl2-protein-linked-to-metastatic-castration-resistant-prostate-cancer/</a>
[2] <a href="https://www.nature.com/articles/s41418-023-01158-5"
class="uri">https://www.nature.com/articles/s41418-023-01158-5</a> [3]
<a href="https://www.nature.com/articles/cr200712"
class="uri">https://www.nature.com/articles/cr200712</a> [4] <a
href="https://www.clinicsinoncology.com/open-access/the-expression-profile-of-bcl-2-protein-in-prostate-cancernbsp-7439.pdf"
class="uri">https://www.clinicsinoncology.com/open-access/the-expression-profile-of-bcl-2-protein-in-prostate-cancernbsp-7439.pdf</a>
[5] <a href="https://pubmed.ncbi.nlm.nih.gov/7671257/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/7671257/</a> [6] <a
href="https://www.nature.com/articles/ejhg201049"
class="uri">https://www.nature.com/articles/ejhg201049</a> [7] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [8] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355002/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355002/</a></p>
</div>
<div id="slc39a8" class="section level3">
<h3>SLC39A8</h3>
<p><strong>SLC39A8 and Its Role in Prostate Cancer</strong></p>
<p><strong>SLC39A8</strong>, also known as ZIP8, is a member of the
solute carrier family of zinc transporters. Its role in prostate cancer
has garnered attention due to its implications in zinc homeostasis and
cancer biology.</p>
<p><strong>Expression Patterns in Prostate Cancer</strong></p>
<p>Research has demonstrated that <strong>SLC39A8 is upregulated in
various prostate cancer cell lines</strong>, such as DU145, LNCaP, and
C4-2B, compared to normal prostate epithelial cells. This suggests that
SLC39A8 may play a significant role in the altered zinc metabolism
observed in prostate cancer, which is crucial for tumor growth and
progression[1][4].</p>
<p><strong>Prognostic Implications</strong></p>
<p>The expression levels of SLC39A8 have been associated with clinical
outcomes in prostate cancer. In pan-cancer analyses, including studies
on prostate cancer, higher expression of SLC39A8 has been linked to
poorer overall survival rates. This indicates that SLC39A8 may serve as
a potential prognostic biomarker for patients with prostate
cancer[2][4].</p>
<p><strong>Mechanistic Insights</strong></p>
<p>Zinc transporters, including SLC39A8, are involved in the regulation
of cellular zinc levels, which can influence various cellular processes
such as apoptosis, proliferation, and oxidative stress response.
Dysregulation of zinc homeostasis due to altered expression of SLC39A8
may contribute to the malignant transformation and progression of
prostate cancer cells[1][4].</p>
<p><strong>Future Research Directions</strong></p>
<p>Further investigations are warranted to explore:</p>
<ul>
<li><p><strong>Therapeutic Targeting</strong>: The potential of
targeting SLC39A8 to modify zinc levels in prostate cancer cells and
evaluate its impact on tumor growth and treatment response.</p></li>
<li><p><strong>Mechanistic Studies</strong>: Understanding the specific
pathways through which SLC39A8 influences prostate cancer biology could
provide insights into novel therapeutic strategies.</p></li>
<li><p><strong>Clinical Validation</strong>: Assessing the utility of
SLC39A8 as a biomarker for disease prognosis and treatment
stratification in clinical settings.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>SLC39A8 is implicated in the pathology of prostate cancer through its
role as a zinc transporter. Its upregulation correlates with adverse
clinical outcomes, highlighting its potential as a biomarker and
therapeutic target. Continued research into its function and mechanisms
will be essential for advancing our understanding of prostate cancer
biology.</p>
<p>Citations: [1] <a href="https://www.jcancer.org/v15p0939.htm"
class="uri">https://www.jcancer.org/v15p0939.htm</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8675640/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8675640/</a> [3] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [4] <a
href="https://www.mdpi.com/2072-6643/16/13/2026"
class="uri">https://www.mdpi.com/2072-6643/16/13/2026</a> [5] <a
href="https://www.nature.com/articles/cr200712"
class="uri">https://www.nature.com/articles/cr200712</a> [6] <a
href="https://www.nature.com/articles/ejhg201049"
class="uri">https://www.nature.com/articles/ejhg201049</a> [7] <a
href="https://www.clinicsinoncology.com/open-access/the-expression-profile-of-bcl-2-protein-in-prostate-cancernbsp-7439.pdf"
class="uri">https://www.clinicsinoncology.com/open-access/the-expression-profile-of-bcl-2-protein-in-prostate-cancernbsp-7439.pdf</a>
[8] <a href="https://pubmed.ncbi.nlm.nih.gov/7671257/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/7671257/</a></p>
</div>
<div id="tbx1" class="section level3">
<h3>TBX1</h3>
<p><strong>TBX1 and Its Role in Prostate Cancer</strong></p>
<p><strong>TBX1</strong>, a member of the T-box family of transcription
factors, has been implicated in various biological processes, including
embryonic development and tumorigenesis. Although specific studies on
TBX1 in prostate cancer are limited, its potential roles can be inferred
from its functions in other cancers and related pathways.</p>
<p><strong>Expression and Function</strong></p>
<p>TBX1 is known to regulate a variety of genes through epigenetic
modifications, influencing cell proliferation and differentiation. In
the context of cancer, members of the T-box family, including TBX1, have
been associated with tumorigenesis. Research indicates that
abnormalities in TBX1 expression may contribute to the development and
progression of tumors in various tissues, although direct evidence
linking TBX1 specifically to prostate cancer remains sparse[1][2].</p>
<p><strong>Implications in Tumorigenesis</strong></p>
<p>While TBX1 itself has not been extensively studied in prostate
cancer, its involvement in other cancers suggests that it may play a
role in similar pathways:</p>
<ul>
<li><p><strong>Transcriptional Regulation</strong>: TBX1 is not a strong
activator or repressor but regulates gene expression through
interactions with chromatin remodeling complexes. This suggests it could
influence key oncogenic pathways[1].</p></li>
<li><p><strong>Cell Cycle Regulation</strong>: Studies have shown that
silencing TBX1 can lead to cell cycle arrest, which might impact tumor
growth dynamics[1].</p></li>
</ul>
<p><strong>Potential Mechanisms</strong></p>
<p>The mechanisms by which TBX1 might influence prostate cancer could
include:</p>
<ul>
<li><p><strong>Gene Regulation</strong>: By modulating the expression of
genes involved in cell proliferation and apoptosis.</p></li>
<li><p><strong>Interaction with Other Pathways</strong>: TBX1 could
interact with signaling pathways that are critical for prostate cancer
progression, such as WNT or p53 pathways, although specific interactions
in prostate cancer need further exploration[2].</p></li>
</ul>
<p><strong>Future Research Directions</strong></p>
<p>To elucidate the role of TBX1 in prostate cancer, future studies
should focus on:</p>
<ul>
<li><p><strong>Expression Analysis</strong>: Investigating TBX1
expression levels in prostate cancer tissues versus normal
tissues.</p></li>
<li><p><strong>Functional Studies</strong>: Exploring the effects of
TBX1 knockdown or overexpression on prostate cancer cell lines and tumor
models.</p></li>
<li><p><strong>Pathway Interactions</strong>: Identifying specific
pathways affected by TBX1 to understand its role in tumor
progression.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While direct evidence linking TBX1 to prostate cancer is limited, its
established roles in other cancers and cellular processes suggest it may
have significant implications for understanding prostate cancer biology.
Further research is necessary to clarify its specific contributions and
potential as a therapeutic target.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/labinvest201788"
class="uri">https://www.nature.com/articles/labinvest201788</a> [2] <a
href="https://www.spandidos-publications.com/10.3892/ol.2016.5296"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2016.5296</a>
[3] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [4] <a
href="https://www.nature.com/articles/cr200712"
class="uri">https://www.nature.com/articles/cr200712</a> [5] <a
href="https://www.mdpi.com/2072-6643/16/13/2026"
class="uri">https://www.mdpi.com/2072-6643/16/13/2026</a> [6] <a
href="https://www.jcancer.org/v15p0939.htm"
class="uri">https://www.jcancer.org/v15p0939.htm</a> [7] <a
href="https://www.nature.com/articles/ejhg201049"
class="uri">https://www.nature.com/articles/ejhg201049</a> [8] <a
href="https://www.clinicsinoncology.com/open-access/the-expression-profile-of-bcl-2-protein-in-prostate-cancernbsp-7439.pdf"
class="uri">https://www.clinicsinoncology.com/open-access/the-expression-profile-of-bcl-2-protein-in-prostate-cancernbsp-7439.pdf</a></p>
</div>
<div id="pwwp2a" class="section level3">
<h3>PWWP2A</h3>
<p><strong>PWWP2A and Its Role in Prostate Cancer</strong></p>
<p><strong>PWWP2A</strong> is a chromatin-binding protein that plays a
significant role in regulating gene expression and chromatin structure.
Its involvement in prostate cancer, while not extensively studied, can
be inferred from its biological functions and interactions with
chromatin.</p>
<p><strong>Function of PWWP2A</strong></p>
<p>PWWP2A is known to bind to specific histone modifications and
nucleosome variants, particularly H2A.Z. It is involved in mitotic
progression and the regulation of chromatin dynamics. By interacting
with the NuRD complex, PWWP2A helps regulate histone acetylation levels,
which are crucial for gene expression modulation[2]. This regulation of
chromatin structure suggests that PWWP2A could influence the expression
of genes involved in cancer progression, including those relevant to
prostate cancer.</p>
<p><strong>Implications in Prostate Cancer</strong></p>
<p>While direct evidence linking PWWP2A to prostate cancer is limited,
several aspects suggest its potential involvement:</p>
<ul>
<li><p><strong>Chromatin Regulation</strong>: Given that prostate cancer
is influenced by epigenetic changes, PWWP2A’s role in chromatin
remodeling could be critical. Alterations in chromatin structure can
affect the expression of oncogenes and tumor suppressor genes,
potentially contributing to tumorigenesis.</p></li>
<li><p><strong>Androgen Receptor Signaling</strong>: Prostate cancer
growth is heavily influenced by androgens and their receptors. The
interaction of PWWP2A with chromatin may impact the transcriptional
activity of androgen-responsive genes, although specific studies on this
interaction in prostate cancer are lacking[3].</p></li>
</ul>
<p><strong>Future Research Directions</strong></p>
<p>To better understand the role of PWWP2A in prostate cancer, future
research should focus on:</p>
<ul>
<li><p><strong>Expression Studies</strong>: Investigating the expression
levels of PWWP2A in prostate cancer tissues compared to normal
tissues.</p></li>
<li><p><strong>Functional Analysis</strong>: Conducting experiments to
determine how PWWP2A affects the proliferation and survival of prostate
cancer cells.</p></li>
<li><p><strong>Pathway Interactions</strong>: Exploring how PWWP2A
interacts with androgen receptor signaling pathways and other oncogenic
pathways relevant to prostate cancer.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While the direct impact of PWWP2A on prostate cancer remains to be
fully elucidated, its established functions in chromatin regulation and
potential interactions with key signaling pathways suggest it may play a
significant role in the disease’s biology. Further studies are necessary
to clarify its contributions and potential as a therapeutic target in
prostate cancer management.</p>
<p>Citations: [1] <a href="https://www.nature.com/articles/cr200712"
class="uri">https://www.nature.com/articles/cr200712</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6191444/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC6191444/</a> [3] <a
href="https://ar.iiarjournals.org/content/40/5/2559"
class="uri">https://ar.iiarjournals.org/content/40/5/2559</a> [4] <a
href="https://www.clinicsinoncology.com/open-access/the-expression-profile-of-bcl-2-protein-in-prostate-cancernbsp-7439.pdf"
class="uri">https://www.clinicsinoncology.com/open-access/the-expression-profile-of-bcl-2-protein-in-prostate-cancernbsp-7439.pdf</a>
[5] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [6] <a
href="https://www.nature.com/articles/ejhg201049"
class="uri">https://www.nature.com/articles/ejhg201049</a> [7] <a
href="https://www.nature.com/articles/s41467-020-20820-x"
class="uri">https://www.nature.com/articles/s41467-020-20820-x</a> [8]
<a href="https://www.mdpi.com/2072-6643/16/13/2026"
class="uri">https://www.mdpi.com/2072-6643/16/13/2026</a></p>
</div>
<div id="rps6kl1" class="section level3">
<h3>RPS6KL1</h3>
<p><strong>RPS6KL1 and Its Potential Role in Prostate
Cancer</strong></p>
<p><strong>RPS6KL1</strong> (Ribosomal Protein S6 Kinase-Like 1) is a
gene that encodes a protein involved in the regulation of cell growth
and proliferation. Its specific role in prostate cancer is not
extensively documented, but there are several avenues through which it
may influence cancer biology.</p>
<p><strong>Biological Functions of RPS6KL1</strong></p>
<p>RPS6KL1 is part of the ribosomal protein family, which plays a
crucial role in protein synthesis. The protein encoded by RPS6KL1 is
thought to be involved in:</p>
<ul>
<li><p><strong>Cell Growth Regulation</strong>: It may participate in
signaling pathways that control cell proliferation and
survival.</p></li>
<li><p><strong>Response to Stress</strong>: RPS6KL1 has been implicated
in cellular responses to stress, which can affect tumor progression and
response to therapy.</p></li>
</ul>
<p><strong>Implications in Prostate Cancer</strong></p>
<p>While direct studies linking RPS6KL1 to prostate cancer are scarce,
several factors suggest its potential involvement:</p>
<ul>
<li><p><strong>Cell Proliferation</strong>: Given its role in cell
growth, alterations in RPS6KL1 expression could impact prostate cancer
cell proliferation. Increased proliferation is a hallmark of cancer
progression.</p></li>
<li><p><strong>Genetic Alterations</strong>: Research into various
genetic alterations associated with prostate cancer may reveal mutations
or expression changes involving RPS6KL1, potentially linking it to
tumorigenesis.</p></li>
</ul>
<p><strong>Future Research Directions</strong></p>
<p>To better understand the implications of RPS6KL1 in prostate cancer,
future studies could focus on:</p>
<ul>
<li><p><strong>Expression Analysis</strong>: Investigating RPS6KL1
expression levels in prostate cancer tissues compared to normal
tissues.</p></li>
<li><p><strong>Functional Studies</strong>: Conducting experiments to
assess the impact of RPS6KL1 knockdown or overexpression on prostate
cancer cell lines.</p></li>
<li><p><strong>Pathway Exploration</strong>: Exploring how RPS6KL1
interacts with known oncogenic pathways involved in prostate cancer
development and progression.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While the direct association of RPS6KL1 with prostate cancer remains
to be fully established, its fundamental roles in cell growth and
response to stress suggest it could play a significant part in the
disease’s biology. Further research is necessary to elucidate its
specific contributions and potential as a therapeutic target.</p>
<p>Citations: [1] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [2] <a
href="https://www.nature.com/articles/ejhg201049"
class="uri">https://www.nature.com/articles/ejhg201049</a> [3] <a
href="https://www.nature.com/articles/s41467-020-20820-x"
class="uri">https://www.nature.com/articles/s41467-020-20820-x</a> [4]
<a href="https://www.nature.com/articles/cr200712"
class="uri">https://www.nature.com/articles/cr200712</a> [5] <a
href="https://ar.iiarjournals.org/content/40/5/2559"
class="uri">https://ar.iiarjournals.org/content/40/5/2559</a> [6] <a
href="https://www.mdpi.com/2072-6643/16/13/2026"
class="uri">https://www.mdpi.com/2072-6643/16/13/2026</a> [7] <a
href="https://www.clinicsinoncology.com/open-access/the-expression-profile-of-bcl-2-protein-in-prostate-cancernbsp-7439.pdf"
class="uri">https://www.clinicsinoncology.com/open-access/the-expression-profile-of-bcl-2-protein-in-prostate-cancernbsp-7439.pdf</a>
[8] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6191444/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC6191444/</a></p>
</div>
<div id="tacc1" class="section level3">
<h3>TACC1</h3>
<p><strong>TACC1 and Its Role in Prostate Cancer</strong></p>
<p><strong>TACC1</strong> (Transforming Acidic Coiled-Coil 1) is a gene
that encodes a protein involved in various cellular processes, including
cell growth and differentiation. Research has indicated that TACC1 may
play a significant role in the progression of prostate cancer,
particularly in the transition from androgen-dependent to
androgen-independent stages.</p>
<p><strong>Association with Prostate Cancer Progression</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Expression Levels</strong>: Studies have shown that TACC1
expression levels are associated with advanced stages of prostate
cancer. In a study using DNA microarrays, TACC1 was found to be
overexpressed in androgen-independent prostate adenocarcinomas compared
to androgen-dependent stages. This suggests that TACC1 may contribute to
the aggressive behavior of prostate tumors as they progress to more
advanced forms[1].</p></li>
<li><p><strong>Interaction with Signaling Pathways</strong>: TACC1 has
been implicated in various signaling pathways that are crucial for
cancer development. It interacts with nuclear receptors, influencing
transcriptional regulation, which can affect tumor growth and response
to therapies[2]. Specifically, TACC1 is part of a network involving
other factors like RARγ and miR-96, which have been linked to aggressive
prostate cancer phenotypes[4].</p></li>
<li><p><strong>Potential as a Biomarker</strong>: Given its association
with advanced disease stages, TACC1 may serve as a potential biomarker
for predicting disease progression in prostate cancer patients. Its
expression levels could help stratify patients based on their risk of
developing aggressive forms of the disease[1][4].</p></li>
</ol>
<p><strong>Mechanistic Insights</strong></p>
<ul>
<li><p><strong>Role in Transcriptional Regulation</strong>: TACC1 acts
as a cofactor for several nuclear receptors, enhancing their
transcriptional activity. This function suggests that alterations in
TACC1 expression could significantly impact the gene expression
landscape within prostate cancer cells, potentially leading to enhanced
tumor growth and survival[2].</p></li>
<li><p><strong>Impact on Androgen Receptor Signaling</strong>: The
interplay between TACC1 and androgen receptor signaling pathways is
particularly noteworthy. As prostate cancer progresses, the ability of
tumors to grow independently of androgen signaling becomes critical, and
TACC1’s involvement in these pathways may facilitate this
transition[4].</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>TACC1 appears to play a multifaceted role in prostate cancer
progression, particularly in the transition to androgen independence.
Its overexpression in advanced stages of the disease and its involvement
in critical signaling pathways highlight its potential as both a
biomarker and a therapeutic target. Further research is needed to
elucidate the precise mechanisms by which TACC1 influences prostate
cancer biology and to explore its potential utility in clinical
settings.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [2] <a
href="https://bmcmolbiol.biomedcentral.com/articles/10.1186/1471-2199-11-3"
class="uri">https://bmcmolbiol.biomedcentral.com/articles/10.1186/1471-2199-11-3</a>
[3] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [4] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336686/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336686/</a>
[5] <a href="https://www.mdpi.com/2072-6643/16/13/2026"
class="uri">https://www.mdpi.com/2072-6643/16/13/2026</a> [6] <a
href="https://www.nature.com/articles/ejhg201049"
class="uri">https://www.nature.com/articles/ejhg201049</a> [7] <a
href="https://www.nature.com/articles/s41467-020-20820-x"
class="uri">https://www.nature.com/articles/s41467-020-20820-x</a> [8]
<a href="https://www.nature.com/articles/cr200712"
class="uri">https://www.nature.com/articles/cr200712</a></p>
</div>
<div id="pik3c2b" class="section level3">
<h3>PIK3C2B</h3>
<p><strong>PIK3C2B and Its Role in Prostate Cancer</strong></p>
<p><strong>PIK3C2B</strong> (Phosphoinositide 3-kinase, class 2, beta)
is a member of the phosphoinositide 3-kinase (PI3K) family, which plays
a crucial role in various cellular processes, including cell growth,
proliferation, and survival. Recent studies have begun to elucidate the
specific implications of PIK3C2B in prostate cancer, highlighting its
potential as a biomarker and therapeutic target.</p>
<p><strong>Genetic Associations with Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Single Nucleotide Polymorphisms (SNPs)</strong>: Research
has identified significant associations between SNPs in the PIK3C2B gene
and prostate cancer risk. Notably, SNP rs7556371 has been linked to an
increased risk of developing prostate cancer, with odds ratios
suggesting a heightened susceptibility among certain populations,
particularly younger men and those with a family history of the
disease[4][5]. This indicates that genetic variations in PIK3C2B may
contribute to the etiology of prostate cancer.</p></li>
<li><p><strong>Expression Patterns</strong>: Studies have shown that
PIK3C2B is overexpressed in certain prostate cancer cell lines,
particularly those lacking the tumor suppressor PTEN. This
overexpression correlates with aggressive cancer phenotypes and may
influence tumor behavior by modulating signaling pathways involved in
cell migration and invasion[2][5].</p></li>
</ol>
<p><strong>Functional Role in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Cell Migration and Invasion</strong>: PIK3C2B has been
implicated in regulating key signaling pathways that affect prostate
cancer cell migration and invasion. It has been shown to activate the
MEK/ERK pathway, which is necessary for these processes but does not
significantly impact cell proliferation[2]. This suggests that PIK3C2B
may facilitate metastatic potential rather than tumor growth
directly.</p></li>
<li><p><strong>Therapeutic Target</strong>: Given its role in promoting
invasive characteristics of prostate cancer cells, PIK3C2B presents a
novel target for therapeutic intervention. Inhibition of PIK3C2B
activity has been shown to impair cancer cell survival and proliferation
in various malignancies, indicating that similar strategies could be
beneficial in treating prostate cancer[5].</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>PIK3C2B plays a significant role in the pathogenesis of prostate
cancer through its involvement in genetic susceptibility and functional
contributions to cell migration and invasion. The identification of SNPs
associated with increased risk highlights its potential as a biomarker
for early detection and risk assessment. Furthermore, targeting PIK3C2B
may offer new avenues for therapeutic strategies aimed at managing
aggressive forms of prostate cancer. Continued research into its
mechanisms will be crucial for developing effective interventions.</p>
<p>Citations: [1] <a
href="https://aacrjournals.org/cancerdiscovery/article/8/6/764/10187/Identification-of-Pik3ca-Mutation-as-a-Genetic"
class="uri">https://aacrjournals.org/cancerdiscovery/article/8/6/764/10187/Identification-of-Pik3ca-Mutation-as-a-Genetic</a>
[2] <a href="https://www.nature.com/articles/srep23277"
class="uri">https://www.nature.com/articles/srep23277</a> [3] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [4]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840184/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840184/</a>
[5] <a href="https://ar.iiarjournals.org/content/32/8/3015"
class="uri">https://ar.iiarjournals.org/content/32/8/3015</a> [6] <a
href="https://www.nature.com/articles/cr200712"
class="uri">https://www.nature.com/articles/cr200712</a> [7] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [8] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a></p>
</div>
<div id="smad2" class="section level3">
<h3>SMAD2</h3>
<p><strong>SMAD2 and Its Role in Prostate Cancer</strong></p>
<p><strong>SMAD2</strong> is a key protein involved in the transforming
growth factor-beta (TGF-β) signaling pathway, which plays a critical
role in regulating cell growth, differentiation, and apoptosis. In the
context of prostate cancer, SMAD2 has been studied for its potential
tumor suppressive functions and its involvement in the progression of
the disease.</p>
<p><strong>Tumor Suppression Mechanisms</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>TGF-β Signaling</strong>: TGF-β functions as a tumor
suppressor in prostate cancer primarily through its ability to induce
apoptosis and inhibit cell proliferation. While SMAD3 has been
identified as the primary mediator of TGF-β responses, recent studies
suggest that SMAD2 also plays a crucial role in TGF-β-induced apoptosis
and gene expression. Silencing SMAD2 has been shown to cause malignant
transformation in non-tumorigenic prostate cells, indicating its
importance as a tumor suppressor [1].</p></li>
<li><p><strong>Castration and Apoptosis</strong>: Research indicates
that after castration, there is an increase in phosphorylated SMAD2
(P-SMAD2) levels in prostate epithelial cells, suggesting that the TGF-β
signaling pathway is activated during this process. This activation is
associated with increased apoptosis in both normal and tumorigenic
prostate cells [2]. The presence of P-SMAD2 correlates with apoptotic
markers, emphasizing its role in mediating cell death under certain
conditions.</p></li>
</ol>
<p><strong>Expression Patterns in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Altered Expression</strong>: In various studies, SMAD2
expression has been reported to be lower in androgen-independent
prostate cancer cells compared to androgen-dependent cells. This
reduction may contribute to the cancer’s progression towards a more
aggressive phenotype, as the loss of TGF-β signaling can lead to
unchecked cellular proliferation [3][4].</p></li>
<li><p><strong>Interaction with Other Proteins</strong>: The interaction
between SMAD2 and other proteins, such as PIAS1 (Protein Inhibitor of
Activated STAT), has been shown to influence the transcriptional
activity of SMAD complexes. These interactions can affect the response
of prostate cancer cells to apoptotic signals, highlighting a complex
regulatory network that may impact tumor behavior [5].</p></li>
</ol>
<p><strong>Implications for Treatment</strong></p>
<p>The understanding of SMAD2’s role in prostate cancer suggests
potential therapeutic strategies that could involve restoring or
enhancing TGF-β signaling pathways. By targeting the mechanisms through
which SMAD2 operates, it may be possible to develop treatments that
reinstate its tumor-suppressive functions or inhibit pathways that lead
to cancer progression.</p>
<p><strong>Conclusion</strong></p>
<p>SMAD2 is integral to the TGF-β signaling pathway and exhibits
significant roles in apoptosis and tumor suppression within prostate
cancer biology. Its altered expression and functionality during disease
progression underscore its potential as a biomarker for disease state
and a target for therapeutic intervention. Further research into the
specific mechanisms of SMAD2 could provide insights into novel treatment
strategies for prostate cancer patients.</p>
<p>Citations: [1] <a href="https://pubmed.ncbi.nlm.nih.gov/19276350/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/19276350/</a> [2] <a
href="https://aacrjournals.org/cancerres/article/59/11/2731/505158/Increased-Smad-Expression-and-Activation-Are"
class="uri">https://aacrjournals.org/cancerres/article/59/11/2731/505158/Increased-Smad-Expression-and-Activation-Are</a>
[3] <a href="https://www.nature.com/articles/cr200712"
class="uri">https://www.nature.com/articles/cr200712</a> [4] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [5]
<a href="https://www.nature.com/articles/cddis2013333"
class="uri">https://www.nature.com/articles/cddis2013333</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [7] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [8] <a
href="https://www.nature.com/articles/srep23277"
class="uri">https://www.nature.com/articles/srep23277</a></p>
</div>
<div id="loc283070" class="section level3">
<h3>LOC283070</h3>
<p><strong>LOC283070 and Its Role in Prostate Cancer</strong></p>
<p><strong>LOC283070</strong> is a long non-coding RNA (lncRNA) that has
been implicated in various cancers, including prostate cancer. Although
specific research directly linking LOC283070 to prostate cancer is
limited, its expression patterns and potential roles in tumor biology
suggest it may influence cancer progression.</p>
<p><strong>Expression and Function</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Differential Expression</strong>: Studies have indicated
that lncRNAs, including LOC283070, can exhibit altered expression levels
in cancerous tissues compared to normal tissues. This dysregulation can
impact cellular processes such as proliferation, apoptosis, and
metastasis, which are critical in the context of prostate cancer
.</p></li>
<li><p><strong>Potential Mechanisms</strong>: Long non-coding RNAs like
LOC283070 may function by interacting with proteins or other RNA
molecules to modulate gene expression. They can influence signaling
pathways that are crucial for tumor growth and progression, although
specific mechanisms involving LOC283070 in prostate cancer remain to be
fully elucidated.</p></li>
</ol>
<p><strong>Implications for Prognosis</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Biomarker Potential</strong>: The expression levels of
certain lncRNAs have been explored as potential biomarkers for cancer
prognosis. If LOC283070 is found to be significantly upregulated or
downregulated in prostate cancer patients, it could serve as a
prognostic indicator or therapeutic target.</p></li>
<li><p><strong>Association with Tumor Characteristics</strong>: Research
into lncRNAs often focuses on their correlation with tumor
characteristics such as grade, stage, and response to treatment. Further
investigation into LOC283070 may reveal its association with aggressive
forms of prostate cancer or resistance to therapies.</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>While direct evidence linking LOC283070 to prostate cancer
specifically is scarce, its classification as a long non-coding RNA
suggests it may play a role in the disease’s biology. Future studies are
necessary to clarify its functions, expression patterns in prostate
cancer tissues, and potential as a therapeutic target or biomarker for
disease progression. Understanding the role of lncRNAs like LOC283070
could contribute to more personalized approaches in prostate cancer
treatment and management.</p>
<p>Citations: [1] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [3] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [4]
<a href="https://www.nature.com/articles/cr200712"
class="uri">https://www.nature.com/articles/cr200712</a> [5] <a
href="https://www.nature.com/articles/cddis2013333"
class="uri">https://www.nature.com/articles/cddis2013333</a> [6] <a
href="https://pubmed.ncbi.nlm.nih.gov/19276350/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/19276350/</a> [7] <a
href="https://aacrjournals.org/cancerres/article/59/11/2731/505158/Increased-Smad-Expression-and-Activation-Are"
class="uri">https://aacrjournals.org/cancerres/article/59/11/2731/505158/Increased-Smad-Expression-and-Activation-Are</a>
[8] <a href="https://www.nature.com/articles/srep23277"
class="uri">https://www.nature.com/articles/srep23277</a></p>
</div>
<div id="fbxo38" class="section level3">
<h3>FBXO38</h3>
<p><strong>FBXO38 and Its Role in Prostate Cancer</strong></p>
<p><strong>FBXO38</strong> is an E3 ubiquitin ligase that has garnered
attention for its role in modulating immune responses, particularly in
the context of cancer. Recent studies have highlighted its potential
implications in prostate cancer through its effects on natural killer
(NK) cells and tumor-infiltrating T cells.</p>
<p><strong>Mechanisms of Action</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Regulation of Immune Cells</strong>: FBXO38 is known to
enhance the function of NK cells by maintaining the signaling strength
of interleukin-15 (IL-15), which is crucial for NK cell proliferation
and survival. In prostate cancer, lower expression levels of FBXO38 have
been observed in tumor-infiltrating NK cells compared to their
peritumoral counterparts, suggesting a role in immune evasion by
tumors[1].</p></li>
<li><p><strong>Impact on Tumor Growth</strong>: Conditional knockout
studies in mice have demonstrated that the absence of FBXO38 leads to
accelerated tumor growth and increased metastasis. This suggests that
FBXO38 plays a protective role against tumor progression by sustaining
the antitumor functions of NK cells[1].</p></li>
<li><p><strong>Influence on T Cell Function</strong>: FBXO38 also
facilitates the degradation of PD-1, a checkpoint protein that inhibits
T cell activity. By promoting PD-1 degradation, FBXO38 enhances the
cytotoxic functions of tumor-infiltrating T cells, which may be
particularly relevant in the immunotherapy landscape for prostate
cancer[3].</p></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Potential Biomarker</strong>: Given its correlation with
immune cell proliferation and function, FBXO38 may serve as a potential
biomarker for assessing immune responses in prostate cancer patients.
Its expression levels could indicate the status of antitumor immunity
within the tumor microenvironment.</p></li>
<li><p><strong>Therapeutic Target</strong>: The ability of FBXO38 to
modulate immune responses opens avenues for therapeutic strategies aimed
at enhancing its expression or function. This could improve the efficacy
of existing immunotherapies by boosting NK and T cell responses against
prostate tumors[1][3].</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>FBXO38 appears to play a significant role in regulating immune
responses in prostate cancer, particularly through its effects on NK and
T cells. Its downregulation in tumor-infiltrating immune cells may
contribute to tumor progression and immune evasion, making it a
promising candidate for further research as both a biomarker and a
therapeutic target in prostate cancer management. Further studies are
needed to fully elucidate its mechanisms and potential clinical
applications.</p>
<p>Citations: [1] <a
href="https://aacrjournals.org/cancerimmunolres/article-abstract/12/10/1438/748724/The-E3-Ubiquitin-Ligase-FBXO38-Maintains-the?redirectedFrom=fulltext"
class="uri">https://aacrjournals.org/cancerimmunolres/article-abstract/12/10/1438/748724/The-E3-Ubiquitin-Ligase-FBXO38-Maintains-the?redirectedFrom=fulltext</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [3] <a
href="https://www.sciencedirect.com/science/article/pii/S1525001621002173"
class="uri">https://www.sciencedirect.com/science/article/pii/S1525001621002173</a>
[4] <a href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [5]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [6] <a
href="https://tcr.amegroups.org/article/view/36190/html"
class="uri">https://tcr.amegroups.org/article/view/36190/html</a> [7] <a
href="https://pubmed.ncbi.nlm.nih.gov/19276350/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/19276350/</a> [8] <a
href="https://aacrjournals.org/cancerres/article/59/11/2731/505158/Increased-Smad-Expression-and-Activation-Are"
class="uri">https://aacrjournals.org/cancerres/article/59/11/2731/505158/Increased-Smad-Expression-and-Activation-Are</a></p>
</div>
<div id="capn9" class="section level3">
<h3>CAPN9</h3>
<p><strong>CAPN9 and Its Role in Prostate Cancer</strong></p>
<p><strong>Calpain-9 (CAPN9)</strong> is a member of the calpain family
of calcium-dependent cysteine proteases. Recent research has begun to
elucidate its potential role in prostate cancer (PCa), particularly
regarding its expression patterns and implications for tumor progression
and prognosis.</p>
<p><strong>Expression Patterns in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Downregulation in Tumor Tissues</strong>: Studies have
shown that CAPN9 is significantly downregulated in prostate cancer
tissues compared to normal prostate tissues. This decrease in expression
is associated with various cancer types, including gastric cancer, where
low levels of CAPN9 correlate with poor prognosis[1][2]. Similarly, the
downregulation of CAPN9 in prostate cancer may suggest a loss of its
tumor suppressor functions.</p></li>
<li><p><strong>Prognostic Implications</strong>: The expression levels
of CAPN9 have been linked to clinical outcomes in cancer patients. In
gastric cancer, low CAPN9 expression was identified as an independent
prognostic factor for unfavorable outcomes[2]. While specific studies on
CAPN9’s prognostic value in prostate cancer are limited, the trend of
decreased expression suggests it may also serve as a potential biomarker
for disease progression.</p></li>
</ol>
<p><strong>Mechanistic Insights</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Tumor Suppressor Functions</strong>: CAPN9 has been
characterized as a tumor suppressor in other malignancies. It is
involved in processes such as cell cycle regulation and apoptosis,
indicating that its loss may contribute to uncontrolled cell growth and
survival of malignant cells[2]. The mechanisms through which CAPN9
exerts its effects could potentially involve modulation of signaling
pathways related to cell proliferation and survival.</p></li>
<li><p><strong>Interaction with Other Proteins</strong>: Calpains,
including CAPN9, can modulate key signaling molecules involved in
tumorigenesis, such as focal adhesion kinase and hypoxia-inducible
factor 1[1]. This suggests that CAPN9 may influence not only tumor cell
behavior but also the tumor microenvironment, potentially affecting
immune cell infiltration and response.</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>The downregulation of CAPN9 in prostate cancer tissues indicates its
potential role as a tumor suppressor and prognostic marker. Further
research is necessary to clarify its specific functions within prostate
cancer biology and to explore its utility as a therapeutic target or
biomarker for patient stratification. Understanding the mechanisms
governing CAPN9’s involvement in tumorigenesis could provide insights
into novel treatment strategies for prostate cancer patients.</p>
<p>Citations: [1] <a
href="https://jgo.amegroups.org/article/view/59749/html"
class="uri">https://jgo.amegroups.org/article/view/59749/html</a> [2] <a
href="https://www.nature.com/articles/srep29604"
class="uri">https://www.nature.com/articles/srep29604</a> [3] <a
href="https://tcr.amegroups.org/article/view/36190/html"
class="uri">https://tcr.amegroups.org/article/view/36190/html</a> [4] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [5]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [7] <a
href="https://aacrjournals.org/cancerres/article/59/11/2731/505158/Increased-Smad-Expression-and-Activation-Are"
class="uri">https://aacrjournals.org/cancerres/article/59/11/2731/505158/Increased-Smad-Expression-and-Activation-Are</a>
[8] <a
href="https://www.sciencedirect.com/science/article/pii/S1525001621002173"
class="uri">https://www.sciencedirect.com/science/article/pii/S1525001621002173</a></p>
</div>
<div id="tomm7" class="section level3">
<h3>TOMM7</h3>
<p><strong>TOMM7 and Its Role in Prostate Cancer</strong></p>
<p><strong>Translocase of the Outer Mitochondrial Membrane 7
(TOMM7)</strong> is a gene that encodes a protein involved in
mitochondrial function and has been implicated in various cancer types,
including prostate cancer (PCa). While specific studies directly linking
TOMM7 to prostate cancer are limited, emerging research highlights its
potential relevance in the context of cancer biology.</p>
<p><strong>Functional Overview of TOMM7</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Mitochondrial Function</strong>: TOMM7 is part of the
translocase complex that facilitates the import of proteins into
mitochondria. This function is critical for maintaining mitochondrial
integrity and energy metabolism, both of which are essential for
cellular health and proliferation.</p></li>
<li><p><strong>Association with Cancer</strong>: Alterations in
mitochondrial function have been linked to tumorigenesis. Mitochondria
play a crucial role in apoptosis, metabolism, and reactive oxygen
species (ROS) production, all of which can influence cancer development
and progression.</p></li>
</ol>
<p><strong>Potential Implications in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Gene Expression Changes</strong>: In prostate cancer,
changes in the expression levels of mitochondrial genes, including
TOMM7, may correlate with tumor progression. Although direct evidence
specifically highlighting TOMM7’s role in PCa is sparse, its involvement
in mitochondrial dynamics suggests it could impact cancer cell
metabolism and survival.</p></li>
<li><p><strong>Interaction with Signaling Pathways</strong>:
Mitochondrial proteins like TOMM7 may interact with key signaling
pathways that are often dysregulated in cancers, such as the PI3K/AKT
pathway. This pathway is known for its role in promoting cell growth and
survival, making it a critical area of study for understanding cancer
biology.</p></li>
<li><p><strong>Potential as a Biomarker</strong>: Given the importance
of mitochondrial function in cancer, TOMM7 could serve as a potential
biomarker for prostate cancer progression or response to therapy.
Further research is needed to evaluate its expression patterns in
clinical samples and its predictive value regarding patient
outcomes.</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>While current research does not provide extensive direct evidence
linking TOMM7 specifically to prostate cancer, its role in mitochondrial
function and potential interactions with critical signaling pathways
suggest it may have implications for tumor biology. Future studies
focusing on the expression and functional roles of TOMM7 in prostate
cancer could help clarify its significance and potential as a
therapeutic target or biomarker.</p>
<p>Citations: [1] <a
href="https://aacrjournals.org/cancerres/article/59/11/2731/505158/Increased-Smad-Expression-and-Activation-Are"
class="uri">https://aacrjournals.org/cancerres/article/59/11/2731/505158/Increased-Smad-Expression-and-Activation-Are</a>
[2] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [3] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [4]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143958/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143958/</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [6] <a
href="https://www.sciencedirect.com/science/article/pii/S1525001621002173"
class="uri">https://www.sciencedirect.com/science/article/pii/S1525001621002173</a>
[7] <a href="https://tcr.amegroups.org/article/view/36190/html"
class="uri">https://tcr.amegroups.org/article/view/36190/html</a> [8] <a
href="https://www.nature.com/articles/srep29604"
class="uri">https://www.nature.com/articles/srep29604</a></p>
</div>
<div id="wnt2" class="section level3">
<h3>WNT2</h3>
<p><strong>WNT2 and Its Role in Prostate Cancer</strong></p>
<p>The <strong>WNT2 gene</strong> is part of the Wnt signaling pathway,
which plays a crucial role in various biological processes, including
cell proliferation, differentiation, and migration. In the context of
prostate cancer (PCa), WNT signaling has garnered attention due to its
involvement in tumorigenesis and disease progression.</p>
<p><strong>Overview of WNT Signaling in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><strong>Canonical vs. Non-Canonical Pathways</strong>: The Wnt
signaling pathway is generally divided into two categories:
<ul>
<li><strong>Canonical Wnt Pathway</strong>: Involves β-catenin and is
often associated with oncogenic activity in various cancers, including
prostate cancer.</li>
<li><strong>Non-Canonical Wnt Pathway</strong>: Includes pathways such
as Wnt5a, which can have both tumor-suppressive and oncogenic roles
depending on the context.</li>
</ul></li>
<li><strong>WNT2 Expression</strong>: While specific studies focusing
solely on WNT2 in prostate cancer are limited, it is known that aberrant
expression of Wnt genes, including WNT2, can contribute to the disease.
Increased expression of certain Wnt ligands has been associated with
advanced disease states and poor prognosis.</li>
</ol>
<p><strong>Implications of WNT2 in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Tumor Progression</strong>: Research indicates that
activation of the Wnt pathway can facilitate tumor formation and
progression in prostate cancer. For instance, the canonical Wnt
pathway’s activation leads to increased β-catenin accumulation, which
can promote cell proliferation and survival of cancer
cells[4][5].</p></li>
<li><p><strong>Androgen Receptor Interaction</strong>: The interaction
between Wnt signaling and androgen receptor (AR) pathways is significant
in prostate cancer. Studies have shown that β-catenin can act as a
co-regulator for AR, influencing the progression to androgen
independence—a critical factor in advanced prostate
cancer[2][4].</p></li>
<li><p><strong>Potential as a Therapeutic Target</strong>: Given its
role in promoting tumor growth and progression, targeting the Wnt
signaling pathway, including components like WNT2, presents a potential
therapeutic strategy. Inhibitors that block Wnt ligand secretion or
disrupt β-catenin activity are being explored as possible treatments for
aggressive forms of prostate cancer[3][5].</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>While direct evidence linking WNT2 specifically to prostate cancer
remains limited, its involvement in the broader context of Wnt signaling
suggests it may play a role in tumorigenesis and disease progression.
Further research is needed to clarify its specific contributions and
potential as a biomarker or therapeutic target in prostate cancer
management.</p>
<p>Citations: [1] <a
href="https://www.oncotarget.com/article/14161/text/"
class="uri">https://www.oncotarget.com/article/14161/text/</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8777554/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8777554/</a> [3] <a
href="https://www.mdpi.com/2218-273X/12/2/309"
class="uri">https://www.mdpi.com/2218-273X/12/2/309</a> [4] <a
href="https://aacrjournals.org/cancerres/article/64/21/7918/511993/Analysis-of-Wnt-Gene-Expression-in-Prostate"
class="uri">https://aacrjournals.org/cancerres/article/64/21/7918/511993/Analysis-of-Wnt-Gene-Expression-in-Prostate</a>
[5] <a href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [6]
<a
href="https://aacrjournals.org/cancerres/article/59/11/2731/505158/Increased-Smad-Expression-and-Activation-Are"
class="uri">https://aacrjournals.org/cancerres/article/59/11/2731/505158/Increased-Smad-Expression-and-Activation-Are</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [8] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a></p>
</div>
<div id="foxj1" class="section level3">
<h3>FOXJ1</h3>
<p><strong>FOXJ1 in Prostate Cancer</strong></p>
<p>The <strong>FOXJ1</strong> gene, part of the forkhead box family of
transcription factors, has been studied for its role in various cancers,
including prostate cancer (PCa). Research indicates that FOXJ1 may have
significant implications for tumor behavior and potential diagnostic
utility.</p>
<p><strong>Expression Levels in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Down-Regulation in Tumor Tissues</strong>: Studies have
shown that FOXJ1 mRNA levels are significantly lower in prostate cancer
tissues compared to adjacent non-cancerous tissues. This down-regulation
is associated with advanced pathological features, such as higher TNM
stage and tumor volume, as well as lymphatic metastasis[1].</p></li>
<li><p><strong>Correlation with Clinical Features</strong>: Increased
expression of FOXJ1 has been linked to better clinical outcomes.
Specifically, its expression is negatively correlated with the Gleason
score and clinical stage, suggesting that higher levels of FOXJ1 may
inhibit tumor progression[2].</p></li>
</ol>
<p><strong>Functional Role of FOXJ1</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Inhibition of Tumor Cell Proliferation and
Invasion</strong>: Experimental studies involving the DU145 prostate
cancer cell line demonstrated that overexpression of FOXJ1 inhibits cell
proliferation and invasion. This effect is mediated through a reduction
in matrix metalloproteinases (MMP-2 and MMP-9), which are critical for
cancer cell invasion and metastasis[1].</p></li>
<li><p><strong>Potential as a Diagnostic Marker</strong>: Given its
expression patterns and correlation with disease severity, FOXJ1 may
serve as a valuable biomarker for diagnosing prostate cancer. Its
diagnostic accuracy was found to be high, with a sensitivity of 86.3%
and specificity of 82.7%[3].</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>FOXJ1 appears to play a dual role in prostate cancer by acting as a
tumor suppressor and a potential diagnostic marker. Its down-regulation
in cancerous tissues correlates with more aggressive disease
characteristics, while its overexpression can inhibit critical processes
involved in tumor progression. Further research may solidify its role in
clinical applications for prostate cancer diagnosis and treatment
strategies.</p>
<p>Citations: [1] <a
href="https://e-century.us/files/ijcem/10/1/ijcem0037325.pdf"
class="uri">https://e-century.us/files/ijcem/10/1/ijcem0037325.pdf</a>
[2] <a href="https://pubmed.ncbi.nlm.nih.gov/28952222/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/28952222/</a> [3] <a
href="https://jbuon.com/archive/22-4-1017.pdf"
class="uri">https://jbuon.com/archive/22-4-1017.pdf</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [5] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [6] <a
href="https://en.wikipedia.org/wiki/FOXJ1"
class="uri">https://en.wikipedia.org/wiki/FOXJ1</a> [7] <a
href="https://aacrjournals.org/cancerres/article/82/12_Supplement/2350/701819/Abstract-2350-Foxj1-is-a-new-master-regulator-of"
class="uri">https://aacrjournals.org/cancerres/article/82/12_Supplement/2350/701819/Abstract-2350-Foxj1-is-a-new-master-regulator-of</a>
[8] <a href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a></p>
</div>
<div id="zdhhc7" class="section level3">
<h3>ZDHHC7</h3>
<p><strong>ZDHHC7 in Prostate Cancer</strong></p>
<p>The <strong>ZDHHC7</strong> gene, a member of the ZDHHC family of
palmitoyl acyltransferases, has emerged as a significant factor in the
context of prostate cancer (PCa). Recent studies highlight its role in
modulating androgen receptor (AR) signaling and its potential
implications for cancer progression.</p>
<p><strong>Role in Androgen Receptor Regulation</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Inhibition of Androgen Receptor Activity</strong>: ZDHHC7
has been identified as an inhibitor of the androgen receptor, a critical
regulator of prostate cancer development and progression. Research
indicates that ZDHHC7 negatively regulates AR gene transcription,
leading to decreased AR protein levels and diminished AR signaling in
prostate cancer cells[1]. This suggests that ZDHHC7 plays a crucial role
in controlling the hormonal signaling pathways that drive prostate
cancer.</p></li>
<li><p><strong>Impact on Cell Proliferation and Invasion</strong>: The
depletion of ZDHHC7 enhances the oncogenic properties of prostate cancer
cells, promoting increased proliferation and invasion. Conversely,
restoring ZDHHC7 expression has been shown to suppress these aggressive
characteristics both in vitro and in vivo, indicating its potential as a
therapeutic target[1].</p></li>
</ol>
<p><strong>Expression Patterns and Clinical Implications</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Downregulation in Prostate Cancer</strong>: ZDHHC7 is
significantly downregulated in prostate cancer tissues compared to
benign adjacent tissues. This loss of expression is associated with more
aggressive disease features and worse clinical outcomes, suggesting that
ZDHHC7 could serve as a biomarker for aggressive prostate
cancer[1].</p></li>
<li><p><strong>Potential as a Therapeutic Target</strong>: Given its
role in inhibiting AR signaling and its association with tumor
progression, ZDHHC7 presents a promising target for therapeutic
intervention. Strategies aimed at restoring or enhancing ZDHHC7 function
may provide new avenues for treating advanced prostate
cancer[1].</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>ZDHHC7 is an important regulator of androgen receptor activity and
plays a significant role in the progression of prostate cancer. Its
downregulation correlates with more aggressive disease, making it a
potential biomarker and therapeutic target for managing prostate cancer.
Further research into ZDHHC7’s mechanisms may enhance our understanding
of its role in prostate cancer biology and treatment strategies.</p>
<p>Citations: [1] <a href="https://pubmed.ncbi.nlm.nih.gov/37198397/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/37198397/</a> [2] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [3] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [5] <a
href="https://e-century.us/files/ijcem/10/1/ijcem0037325.pdf"
class="uri">https://e-century.us/files/ijcem/10/1/ijcem0037325.pdf</a>
[6] <a href="https://pubmed.ncbi.nlm.nih.gov/28952222/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/28952222/</a> [7] <a
href="https://www.nature.com/articles/srep45300"
class="uri">https://www.nature.com/articles/srep45300</a> [8] <a
href="https://jbuon.com/archive/22-4-1017.pdf"
class="uri">https://jbuon.com/archive/22-4-1017.pdf</a></p>
</div>
<div id="zbtb38" class="section level3">
<h3>ZBTB38</h3>
<p><strong>ZBTB38 in Prostate Cancer</strong></p>
<p>The <strong>ZBTB38</strong> gene, a member of the zinc finger and BTB
domain-containing family, has been implicated in the regulation of
prostate cancer (PCa) progression. Research indicates that ZBTB38 plays
a dual role in cancer biology, acting as a suppressor of cell
proliferation and migration.</p>
<p><strong>Expression and Prognostic Significance</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Reduced Expression in Cancer</strong>: Studies have
consistently shown that ZBTB38 expression is significantly lower in
prostate cancer tissues compared to benign prostatic tissues. This
downregulation correlates with advanced disease features, such as higher
Gleason scores and poorer patient prognosis[1][3]. Specifically,
patients exhibiting lower levels of ZBTB38 expression tend to have worse
outcomes, suggesting its potential utility as a prognostic
biomarker.</p></li>
<li><p><strong>Mechanism of Action</strong>: ZBTB38 functions primarily
by promoting the expression of <strong>DKK1</strong> (Dickkopf WNT
signaling pathway inhibitor 1), which is known to inhibit Wnt signaling
pathways that are often activated in cancer progression. By enhancing
DKK1 expression, ZBTB38 can repress the proliferation and migration of
prostate cancer cells, highlighting its role as a tumor
suppressor[1][2].</p></li>
</ol>
<p><strong>Functional Studies</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Inhibition of Proliferation and Migration</strong>:
Experimental overexpression of ZBTB38 in prostate cancer cell lines,
such as LNCaP and DU145, has demonstrated a significant reduction in
cell proliferation and migratory capacity. This suggests that restoring
ZBTB38 levels could counteract aggressive cancer
behaviors[1][3].</p></li>
<li><p><strong>Interaction with Other Proteins</strong>: ZBTB38 has been
shown to interact with proteins like <strong>PRKDC</strong>, which may
modulate its suppressive effects on cancer cell behavior. The inhibition
of PRKDC enhances the tumor-suppressive function of ZBTB38, further
supporting its role in regulating prostate cancer
progression[1].</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>ZBTB38 emerges as a critical regulator in prostate cancer, with its
downregulation associated with more aggressive disease and poorer
patient outcomes. Its ability to inhibit cell proliferation and
migration through mechanisms involving DKK1 suggests that ZBTB38 could
serve both as a prognostic marker and a potential therapeutic target for
managing prostate cancer. Further research into its regulatory pathways
may provide deeper insights into its role in cancer biology.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [2]
<a href="https://www.spandidos-publications.com/10.3892/or.2018.6937"
class="uri">https://www.spandidos-publications.com/10.3892/or.2018.6937</a>
[3] <a
href="https://academic.oup.com/jes/article/6/3/bvac006/6511003?login=false"
class="uri">https://academic.oup.com/jes/article/6/3/bvac006/6511003?login=false</a>
[4] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [5] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [6]
<a href="https://pubmed.ncbi.nlm.nih.gov/37198397/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/37198397/</a> [7] <a
href="https://jbuon.com/archive/22-4-1017.pdf"
class="uri">https://jbuon.com/archive/22-4-1017.pdf</a> [8] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a></p>
</div>
<div id="pxmp4" class="section level3">
<h3>PXMP4</h3>
<p><strong>PXMP4 in Prostate Cancer</strong></p>
<p>The <strong>PXMP4</strong> gene, known for encoding a peroxisome
membrane protein, has been studied for its role in various cancers,
including prostate cancer. Research indicates that PXMP4 expression is
significantly silenced in prostate cancer due to DNA methylation,
particularly involving intronic CpG dinucleotides.</p>
<p><strong>Expression and Methylation</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Silencing Mechanism</strong>: In prostate cancer tissues,
the expression of PXMP4 is largely suppressed, primarily attributed to
<strong>DNA methylation</strong>. This silencing mechanism involves the
methylation of specific regions within the gene, which prevents its
transcription and subsequent protein production[1][2].</p></li>
<li><p><strong>Correlation with Other Cancers</strong>: While studies
have highlighted the downregulation of PXMP4 in prostate cancer, it is
also noted that high levels of PXMP4 expression are observed in other
cancers, such as hepatocellular carcinoma (HCC), where its expression
correlates with tumor progression and poor prognosis[1]. This suggests a
complex role for PXMP4 across different cancer types.</p></li>
</ol>
<p><strong>Functional Implications</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Potential Tumor Suppressor Role</strong>: The loss of
PXMP4 expression in prostate cancer may contribute to tumorigenesis by
removing its regulatory effects on cellular processes. In other
contexts, such as colorectal cancer, PXMP4 has been implicated in
promoting cell proliferation and invasion, indicating that its function
can vary significantly depending on the cancer type[1].</p></li>
<li><p><strong>Clinical Significance</strong>: The inverse relationship
between PXMP4 expression and DNA methylation levels suggests that
monitoring PXMP4 could have diagnostic and prognostic implications for
prostate cancer patients. Restoration of PXMP4 expression through
demethylating agents may represent a potential therapeutic
strategy[1][2].</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>Overall, the role of PXMP4 in prostate cancer is characterized by its
silenced expression due to DNA methylation, suggesting a potential tumor
suppressive function that is lost during cancer progression. Further
research is needed to fully elucidate its mechanisms and implications
for treatment strategies in prostate cancer.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11077113/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC11077113/</a> [2]
<a href="https://www.nature.com/articles/s41598-022-06479-y"
class="uri">https://www.nature.com/articles/s41598-022-06479-y</a> [3]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [4] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [5]
<a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [6]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [7] <a
href="https://jbuon.com/archive/22-4-1017.pdf"
class="uri">https://jbuon.com/archive/22-4-1017.pdf</a> [8] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7103649/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7103649/</a></p>
</div>
<div id="mbnl1" class="section level3">
<h3>MBNL1</h3>
<p><strong>MBNL1 in Prostate Cancer</strong></p>
<p>The <strong>MBNL1</strong> gene, which encodes the Muscleblind-like 1
protein, is increasingly recognized for its role in cancer biology,
including prostate cancer. MBNL1 is primarily known as an RNA-binding
protein that regulates pre-mRNA splicing, and its expression and
function can significantly impact tumor behavior.</p>
<p><strong>Expression Patterns and Functional Role</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Downregulation in Cancer</strong>: MBNL1 is generally
downregulated in various cancer types, including prostate cancer. This
reduction in expression has been correlated with poorer prognoses,
suggesting that MBNL1 may function as a tumor suppressor[2][4]. Notably,
studies indicate that MBNL1 is involved in maintaining normal splicing
patterns; its absence can lead to alternative splicing events that
promote tumorigenesis.</p></li>
<li><p><strong>Alternative Splicing Isoforms</strong>: The activity of
MBNL1 is influenced by alternative splicing, particularly the inclusion
or exclusion of specific exons. Isoforms lacking exon 7 (Δex7) have been
shown to act as antisurvival factors, while those retaining this exon
(MBNL1 +ex7) are associated with pro-survival functions[2]. This
splicing switch appears to be a mechanism through which cancer cells
manipulate MBNL1 activity to favor their survival and
proliferation.</p></li>
</ol>
<p><strong>Tumor Suppressive Effects</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Inhibition of Prostate Cancer Cell Migration and
Invasion</strong>: Research has demonstrated that MBNL1 can inhibit the
migration and invasion of prostate cancer cells, suggesting its role as
a suppressor of aggressive tumor behavior[4]. Overexpression of MBNL1
has been linked to reduced glycolysis and proliferation in cancer cells,
indicating its potential as a therapeutic target[4].</p></li>
<li><p><strong>Impact on Glycolysis</strong>: The MBNL1/circNTRK2/PAX5
pathway has been identified as crucial in regulating aerobic glycolysis
in tumors. By promoting circNTRK2 expression, MBNL1 can inhibit
metabolic pathways that are often upregulated in cancer cells,
contributing to its tumor-suppressive effects[4].</p></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<p>The downregulation of MBNL1 and the resulting shift towards
pro-tumorigenic isoforms may provide insights into the mechanisms
underlying prostate cancer progression. Understanding these dynamics
could lead to novel therapeutic strategies aimed at restoring MBNL1
function or correcting splicing aberrations associated with prostate
cancer.</p>
<p><strong>Conclusion</strong></p>
<p>MBNL1 plays a multifaceted role in prostate cancer through its
regulation of RNA splicing and cellular metabolism. Its downregulation
is associated with aggressive tumor characteristics, while its
overexpression can inhibit key processes like cell migration and
glycolysis. Future research focusing on the modulation of MBNL1 activity
may offer new avenues for treatment in prostate cancer patients.</p>
<p>Citations: [1] <a
href="https://aacrjournals.org/cancerres/article/80/21/4681/645802/The-Alternative-Splicing-Factor-MBNL1-Inhibits"
class="uri">https://aacrjournals.org/cancerres/article/80/21/4681/645802/The-Alternative-Splicing-Factor-MBNL1-Inhibits</a>
[2] <a
href="https://www.life-science-alliance.org/content/1/5/e201800157"
class="uri">https://www.life-science-alliance.org/content/1/5/e201800157</a>
[3] <a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [4]
<a href="https://www.nature.com/articles/s41419-022-05219-4"
class="uri">https://www.nature.com/articles/s41419-022-05219-4</a> [5]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [6] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [7] <a
href="https://jbuon.com/archive/22-4-1017.pdf"
class="uri">https://jbuon.com/archive/22-4-1017.pdf</a> [8] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a></p>
</div>
<div id="arap1" class="section level3">
<h3>ARAP1</h3>
<p><strong>ARAP1 in Prostate Cancer</strong></p>
<p>The <strong>ARAP1</strong> gene, which encodes a protein involved in
various cellular processes, has been implicated in cancer biology,
including prostate cancer. While specific studies on ARAP1’s role in
prostate cancer are limited, there are insights into its potential
functions and associations with tumor progression.</p>
<p><strong>Role of ARAP1</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Cellular Functions</strong>: ARAP1 (ArfGAP with RhoGAP
domain, ANK repeat, and PH domain 1) is known to participate in the
regulation of cellular signaling pathways, particularly those involving
Rho GTPases. These pathways are crucial for cell migration, adhesion,
and proliferation, all of which are significant in cancer
progression.</p></li>
<li><p><strong>Long Non-Coding RNA Association</strong>: A related study
identified a long non-coding RNA known as <strong>ARAP1-AS1</strong>,
which is associated with various cancers, including cervical cancer.
Although this study does not directly address prostate cancer, it
underscores the potential oncogenic role of ARAP1-related transcripts.
The upregulation of ARAP1-AS1 was shown to enhance cell viability and
invasion by modulating microRNA expressions that affect target gene
regulation[1].</p></li>
</ol>
<p><strong>Potential Implications in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Gene Expression and Cancer Progression</strong>: While
specific data on ARAP1 expression levels in prostate cancer tissues are
scarce, the gene’s involvement in pathways that govern cell behavior
suggests it may play a role in the transition from androgen-dependent to
androgen-independent prostate cancer. This transition is critical as it
often correlates with more aggressive disease and poorer
prognosis.</p></li>
<li><p><strong>Fusion Genes and Cancer Recurrence</strong>: Research has
identified various fusion genes associated with progressive prostate
cancer. Although ARAP1 itself was not highlighted among these fusion
events, understanding its interactions within cellular pathways could
provide insights into mechanisms of disease progression and potential
therapeutic targets[4].</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>While direct evidence linking ARAP1 specifically to prostate cancer
is limited, its involvement in critical cellular processes and
associations with long non-coding RNAs suggest it may play a role in the
disease’s progression. Further research is needed to elucidate the
specific mechanisms by which ARAP1 influences prostate cancer biology
and to explore its potential as a therapeutic target or biomarker for
disease progression.</p>
<p>Citations: [1] <a
href="https://karger.com/pat/article/88/4/301/266469/Long-Non-Coding-RNA-ARAP1-AS1-Facilitates-the"
class="uri">https://karger.com/pat/article/88/4/301/266469/Long-Non-Coding-RNA-ARAP1-AS1-Facilitates-the</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [3] <a
href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [4]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [5] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [6]
<a href="https://jbuon.com/archive/22-4-1017.pdf"
class="uri">https://jbuon.com/archive/22-4-1017.pdf</a> [7] <a
href="https://www.life-science-alliance.org/content/1/5/e201800157"
class="uri">https://www.life-science-alliance.org/content/1/5/e201800157</a>
[8] <a href="https://www.nature.com/articles/s41419-022-05219-4"
class="uri">https://www.nature.com/articles/s41419-022-05219-4</a></p>
</div>
<div id="rp11-77h9.1" class="section level3">
<h3>RP11-77H9.1</h3>
<p><strong>RP11-77H9.1 in Prostate Cancer</strong></p>
<p>The <strong>RP11-77H9.1</strong> gene, a long non-coding RNA
(lncRNA), has gained attention in the context of prostate cancer due to
its potential roles in tumorigenesis and disease progression.</p>
<p><strong>Characteristics of RP11-77H9.1</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Long Non-Coding RNA</strong>: RP11-77H9.1 is classified
as a long non-coding RNA, which means it does not encode proteins but
may play regulatory roles in gene expression and cellular
processes.</p></li>
<li><p><strong>Expression Patterns</strong>: Research indicates that
lncRNAs like RP11-77H9.1 can exhibit differential expression in
cancerous tissues compared to normal tissues, which may correlate with
tumor characteristics and patient outcomes.</p></li>
</ol>
<p><strong>Implications in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Association with Tumor Progression</strong>: Although
specific studies focusing solely on RP11-77H9.1 in prostate cancer are
limited, lncRNAs have been implicated in various aspects of cancer
biology, including cell proliferation, migration, and metastasis. For
example, changes in lncRNA expression profiles have been associated with
the transition from androgen-dependent to androgen-independent prostate
cancer, a critical factor in disease progression.</p></li>
<li><p><strong>Potential as a Biomarker</strong>: Given the role of
lncRNAs in regulating gene networks involved in cancer, RP11-77H9.1 may
serve as a potential biomarker for prostate cancer diagnosis or
prognosis, although further research is necessary to establish its
clinical relevance.</p></li>
<li><p><strong>Fusion Genes Context</strong>: In the broader context of
prostate cancer research, some studies have identified fusion genes that
involve lncRNAs, indicating that alterations in these genes might
contribute to cancer progression. While RP11-77H9.1 has not been
directly linked to known fusion events in prostate cancer, the
exploration of lncRNA fusions remains an important area of
investigation.</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>The role of RP11-77H9.1 in prostate cancer is still under
investigation, with its potential involvement in tumor biology
suggesting it could be significant for understanding disease mechanisms
and developing therapeutic strategies. Further studies are needed to
clarify its specific functions and implications for patient management
in prostate cancer contexts.</p>
<p>Citations: [1] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6425931/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC6425931/</a> [3] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [4] <a
href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [5]
<a href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [6]
<a href="https://www.life-science-alliance.org/content/1/5/e201800157"
class="uri">https://www.life-science-alliance.org/content/1/5/e201800157</a>
[7] <a href="https://jbuon.com/archive/22-4-1017.pdf"
class="uri">https://jbuon.com/archive/22-4-1017.pdf</a> [8] <a
href="https://karger.com/pat/article/88/4/301/266469/Long-Non-Coding-RNA-ARAP1-AS1-Facilitates-the"
class="uri">https://karger.com/pat/article/88/4/301/266469/Long-Non-Coding-RNA-ARAP1-AS1-Facilitates-the</a></p>
</div>
<div id="col2a1" class="section level3">
<h3>COL2A1</h3>
<p><strong>COL2A1 in Prostate Cancer</strong></p>
<p>The <strong>COL2A1</strong> gene encodes the pro-alpha1(II) chain of
type II collagen, a crucial component of cartilage and other connective
tissues. While its primary associations are with skeletal disorders,
emerging research suggests that alterations in COL2A1 may also play a
role in cancer biology, including prostate cancer.</p>
<p><strong>Genetic Alterations and Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Alteration Frequency</strong>: Although COL2A1 is not
traditionally linked to prostate cancer, studies indicate that it may
exhibit mutations or structural alterations in certain cases. For
instance, COL2A1 has been identified as frequently altered in other
tumor types, such as chondrosarcoma, which raises questions about its
potential involvement in prostate cancer as well[1].</p></li>
<li><p><strong>Expression Patterns</strong>: Research has shown that
changes in the expression of collagen genes, including COL2A1, can
influence tumor microenvironments and may be associated with cancer
progression. The extracellular matrix (ECM), where type II collagen is a
significant component, plays a critical role in tumor growth and
metastasis[4].</p></li>
<li><p><strong>Potential Mechanisms</strong>: The potential mechanisms
by which COL2A1 might influence prostate cancer include:</p>
<ul>
<li><strong>Tumor Microenvironment Modulation</strong>: Alterations in
collagen composition can affect cell signaling pathways that regulate
tumor growth and invasion.</li>
<li><strong>Interaction with Other Genes</strong>: COL2A1 may interact
with other genes involved in prostate cancer progression, although
specific interactions remain to be fully elucidated.</li>
</ul></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<ul>
<li><strong>Biomarker Potential</strong>: Given the role of collagen in
tissue architecture and tumor biology, variations in COL2A1 expression
could potentially serve as biomarkers for disease progression or
response to therapy in prostate cancer patients.</li>
<li><strong>Research Directions</strong>: Further studies are needed to
clarify the specific roles of COL2A1 mutations or expression changes in
prostate cancer and to investigate its potential as a therapeutic target
or prognostic marker.</li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While the direct implications of COL2A1 in prostate cancer are not
yet fully understood, its role as a structural protein in the ECM and
its alterations observed in other malignancies suggest that it warrants
further investigation. Understanding the relationship between COL2A1 and
prostate cancer could provide insights into tumor biology and lead to
new therapeutic strategies.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4158757/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4158757/</a> [2] <a
href="https://karger.com/pat/article/88/4/301/266469/Long-Non-Coding-RNA-ARAP1-AS1-Facilitates-the"
class="uri">https://karger.com/pat/article/88/4/301/266469/Long-Non-Coding-RNA-ARAP1-AS1-Facilitates-the</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [4] <a
href="https://medlineplus.gov/genetics/gene/col2a1/"
class="uri">https://medlineplus.gov/genetics/gene/col2a1/</a> [5] <a
href="https://www.nature.com/articles/s41388-021-02013-y"
class="uri">https://www.nature.com/articles/s41388-021-02013-y</a> [6]
<a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [7]
<a href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [8]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a></p>
</div>
<div id="znf236" class="section level3">
<h3>ZNF236</h3>
<p><strong>ZNF236 in Prostate Cancer</strong></p>
<p>The <strong>ZNF236</strong> gene, a member of the zinc finger protein
family, has been implicated in various biological processes, including
transcriptional regulation. While specific studies directly linking
ZNF236 to prostate cancer are limited, its broader role in cancer
biology and potential implications in prostate cancer warrant
examination.</p>
<p><strong>Potential Role in Cancer Biology</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Zinc Finger Proteins</strong>: Zinc finger proteins like
ZNF236 are known to play crucial roles in regulating gene expression and
cellular processes. They can act as transcription factors, influencing
pathways that may contribute to tumorigenesis.</p></li>
<li><p><strong>Gene Regulation</strong>: Research has shown that
alterations in the expression of zinc finger genes can affect cell
proliferation, apoptosis, and differentiation—all critical factors in
cancer development. Although direct evidence connecting ZNF236
specifically to prostate cancer is sparse, its involvement in these
regulatory mechanisms suggests it could have a role.</p></li>
</ol>
<p><strong>Indirect Associations</strong></p>
<ul>
<li><p><strong>Related Genes</strong>: Other zinc finger proteins, such
as ZNF217, have been studied more extensively in the context of prostate
cancer. For instance, ZNF217 has been shown to promote tumor growth by
regulating iron metabolism through the inhibition of ferroportin (FPN)
expression[1]. This highlights a potential pathway where similar zinc
finger proteins might influence prostate cancer progression.</p></li>
<li><p><strong>Expression Studies</strong>: While specific studies on
ZNF236’s expression in prostate cancer tissues are lacking, the general
trend of altered expression of zinc finger proteins in various cancers
points to a possible involvement of ZNF236 in the disease.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>The current understanding of ZNF236’s role in prostate cancer is
limited and primarily speculative based on its classification as a zinc
finger protein and its known functions. Further research is necessary to
elucidate any direct connections between ZNF236 and prostate cancer,
including its expression patterns in tumor tissues and its functional
role within oncogenic pathways. As the field advances, ZNF236 may emerge
as a relevant factor worth investigating for its potential contributions
to prostate cancer biology.</p>
<p>Citations: [1] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356707/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356707/</a>
[2] <a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [3]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [4] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [5]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4158757/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4158757/</a> [7] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6606384/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC6606384/</a> [8] <a
href="https://aacrjournals.org/cancerres/article/79/13/3192/638326/Identification-of-Novel-Susceptibility-Loci-and"
class="uri">https://aacrjournals.org/cancerres/article/79/13/3192/638326/Identification-of-Novel-Susceptibility-Loci-and</a></p>
</div>
<div id="haus6" class="section level3">
<h3>HAUS6</h3>
<p><strong>HAUS6 in Prostate Cancer</strong></p>
<p>The <strong>HAUS6</strong> gene is part of the Augmin complex, which
is essential for microtubule nucleation during cell division. While
specific studies directly investigating HAUS6’s role in prostate cancer
are limited, insights can be drawn from its function and associations
with other cancers.</p>
<p><strong>Role of HAUS6</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Microtubule Nucleation</strong>: HAUS6 is involved in the
assembly of the Augmin complex, which recruits γ-tubulin to microtubule
organizing centers, facilitating spindle formation during mitosis. This
process is critical for proper cell division, and disruptions can lead
to genomic instability, a hallmark of cancer.</p></li>
<li><p><strong>Expression Patterns</strong>: Research indicates that
members of the Augmin family, including HAUS6, show variable expression
in different cancers. For example, while HAUS6 expression was noted to
be low in gliomas, other members like HAUS1 and HAUS3 were associated
with poor prognosis in various tumor types[2].</p></li>
</ol>
<p><strong>Implications for Prostate Cancer</strong></p>
<ul>
<li><p><strong>Potential Involvement</strong>: Although direct evidence
linking HAUS6 to prostate cancer progression is not well-documented, its
role in cell division suggests that alterations in its expression or
function could contribute to tumorigenesis. Disruption of mitotic
processes due to dysfunctional microtubule dynamics could lead to
chromosomal abnormalities often observed in cancer cells.</p></li>
<li><p><strong>Related Gene Studies</strong>: Other genes within the
Augmin complex have been implicated in tumor growth and progression
across different cancers. For instance, studies on the Augmin family
have shown that mutations or altered expressions can affect cellular
behavior and tumor characteristics[2].</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While specific research on HAUS6 in prostate cancer remains sparse,
its fundamental role in cell division and associations with other
malignancies suggest it may play a role worth investigating further.
Understanding its expression patterns and functional implications could
provide insights into its potential contribution to prostate cancer
biology and progression. Further studies are needed to clarify these
relationships and establish any direct links between HAUS6 and prostate
cancer outcomes.</p>
<p>Citations: [1] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904742/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904742/</a>
[2] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170088/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170088/</a>
[3] <a href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [5] <a
href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [6]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [7] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6606384/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC6606384/</a> [8] <a
href="https://aacrjournals.org/cancerres/article/79/13/3192/638326/Identification-of-Novel-Susceptibility-Loci-and"
class="uri">https://aacrjournals.org/cancerres/article/79/13/3192/638326/Identification-of-Novel-Susceptibility-Loci-and</a></p>
</div>
<div id="mapkbp1" class="section level3">
<h3>MAPKBP1</h3>
<p><strong>MAPKBP1 in Prostate Cancer</strong></p>
<p>The <strong>MAPKBP1</strong> gene, also known as <strong>MAPK binding
protein 1</strong>, has been studied in the context of various cancers,
including prostate cancer. Although specific research directly linking
MAPKBP1 to prostate cancer is limited, its role in cellular signaling
pathways and potential implications for cancer progression warrant
attention.</p>
<p><strong>Function and Mechanism</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Role in Signaling Pathways</strong>: MAPKBP1 is involved
in the mitogen-activated protein kinase (MAPK) signaling pathway, which
regulates various cellular processes, including proliferation,
differentiation, and apoptosis. This pathway is critical in cancer
biology, as dysregulation can lead to uncontrolled cell growth.</p></li>
<li><p><strong>Interaction with Other Proteins</strong>: MAPKBP1
functions as a scaffold protein that interacts with several kinases and
other signaling molecules. This interaction is essential for the proper
transmission of signals within the MAPK pathway, influencing cellular
responses to external stimuli.</p></li>
</ol>
<p><strong>Implications for Prostate Cancer</strong></p>
<ul>
<li><p><strong>Expression Levels</strong>: While specific studies on
MAPKBP1 expression in prostate cancer tissues are not extensively
documented, alterations in related MAPK pathway components have been
observed in prostate cancer cases. For instance, genes like MAPK8IP2 (a
related scaffold protein) have shown significant upregulation in
prostate cancer and are correlated with disease progression and patient
survival outcomes[1].</p></li>
<li><p><strong>Potential Biomarker</strong>: Given its involvement in
critical signaling pathways associated with cell growth and survival,
MAPKBP1 could potentially serve as a biomarker for prostate cancer
progression. Further studies are needed to evaluate its expression
levels in prostate tissues and its correlation with clinical
outcomes.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While direct evidence linking MAPKBP1 specifically to prostate cancer
is still emerging, its role within the MAPK signaling pathway suggests
it may contribute to the disease’s biology. Future research focusing on
its expression patterns and functional implications in prostate cancer
could provide valuable insights into its potential as a therapeutic
target or prognostic marker.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [2]
<a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [3]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [4] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [5] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6904742/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC6904742/</a> [7] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6606384/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC6606384/</a> [8] <a
href="https://aacrjournals.org/cancerres/article/79/13/3192/638326/Identification-of-Novel-Susceptibility-Loci-and"
class="uri">https://aacrjournals.org/cancerres/article/79/13/3192/638326/Identification-of-Novel-Susceptibility-Loci-and</a></p>
</div>
<div id="klf7" class="section level3">
<h3>KLF7</h3>
<p><strong>KLF7 in Prostate Cancer</strong></p>
<p><strong>KLF7</strong>, or Krüppel-like factor 7, is a member of the
Krüppel-like factor family of transcription factors, which play crucial
roles in various cellular processes, including proliferation,
differentiation, and apoptosis. Recent studies have highlighted its
involvement in cancer biology, including prostate cancer.</p>
<p><strong>Expression and Role in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Abnormal Expression</strong>: KLF7 has been reported to
be abnormally expressed in several cancers, including prostate cancer.
Its overexpression is associated with aggressive tumor characteristics,
suggesting a potential role in promoting tumor growth and
metastasis[1][5].</p></li>
<li><p><strong>Mechanistic Insights</strong>: KLF7 functions as a
transcriptional activator that can influence various signaling pathways
critical for cancer progression. It has been implicated in enhancing the
expression of genes associated with cell proliferation and survival,
which could contribute to the malignant phenotype observed in prostate
cancer[1][5].</p></li>
<li><p><strong>Impact on Tumor Microenvironment</strong>: The
dysregulation of KLF7 may also affect the tumor microenvironment by
modulating inflammation and angiogenesis, further supporting tumor
growth and metastasis[5].</p></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<ul>
<li><p><strong>Prognostic Marker</strong>: The expression levels of KLF7
could potentially serve as a prognostic marker for prostate cancer.
Higher levels of KLF7 have been correlated with advanced disease stages
and poorer clinical outcomes[1][5].</p></li>
<li><p><strong>Therapeutic Target</strong>: Given its role in promoting
tumorigenesis, targeting KLF7 or its downstream signaling pathways may
offer new therapeutic avenues for treating prostate cancer. Inhibiting
KLF7 function could disrupt the pathways it regulates, potentially
leading to reduced tumor growth and improved patient
outcomes[1][5].</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>KLF7 plays a significant role in prostate cancer progression through
its regulatory effects on gene expression and signaling pathways. Its
abnormal expression is linked to aggressive tumor behavior, making it a
potential biomarker and therapeutic target in the management of prostate
cancer. Further research is needed to fully elucidate its mechanisms and
validate its clinical utility.</p>
<p>Citations: [1] <a href="https://www.ijbs.com/v20p0387.htm"
class="uri">https://www.ijbs.com/v20p0387.htm</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [3]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [4] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [5]
<a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1080720/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1080720/full</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC1698935/</a> [7] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6904742/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC6904742/</a> [8] <a
href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a></p>
</div>
<div id="bbc3" class="section level3">
<h3>BBC3</h3>
<p><strong>BBC3 in Prostate Cancer</strong></p>
<p><strong>BBC3</strong>, also known as <strong>PUMA</strong> (p53
upregulated modulator of apoptosis), is a pro-apoptotic protein
belonging to the BCL-2 family. It plays a crucial role in the regulation
of apoptosis, particularly in response to cellular stress and damage.
The gene is located on chromosome 19q13.32 and is recognized for its
ability to induce mitochondrial outer membrane permeabilization, leading
to apoptosis.</p>
<p><strong>Role in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Pro-Apoptotic Function</strong>: BBC3/PUMA is primarily
involved in promoting apoptosis, especially in cancer cells where the
apoptotic pathways are often disrupted. In prostate cancer, the
expression of BBC3 has been linked to the induction of cell death in
response to various stimuli, including DNA damage and oncogenic
stress[1][5].</p></li>
<li><p><strong>Expression Patterns</strong>: Studies have shown that
BBC3 expression can be altered in prostate cancer tissues compared to
normal tissues. The protein’s levels may correlate with tumor
aggressiveness and patient prognosis, making it a potential biomarker
for disease progression[3][4].</p></li>
<li><p><strong>Mechanistic Insights</strong>: BBC3 functions
independently of p53 in some contexts, suggesting that it may provide a
therapeutic target even in tumors with p53 mutations, which are common
in advanced prostate cancer[5]. Its ability to displace anti-apoptotic
proteins from pro-apoptotic factors allows for the activation of
apoptotic signaling cascades, which can be crucial for eliminating
cancer cells.</p></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<ul>
<li><p><strong>Potential Therapeutic Target</strong>: Given its role in
apoptosis, targeting BBC3 may offer a novel approach for cancer therapy.
Enhancing BBC3 activity could sensitize prostate cancer cells to
treatments that induce apoptosis, thereby improving therapeutic
outcomes[1][5].</p></li>
<li><p><strong>Biomarker Potential</strong>: The expression levels of
BBC3 might serve as a prognostic marker in prostate cancer, helping to
stratify patients based on their risk profiles and guiding treatment
decisions[3][4].</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>BBC3 plays a significant role in the apoptotic processes relevant to
prostate cancer biology. Its function as a pro-apoptotic factor
positions it as both a potential therapeutic target and a biomarker for
assessing disease progression and treatment response. Further research
into its regulatory mechanisms and expression patterns could provide
valuable insights into its utility in clinical settings.</p>
<p>Citations: [1] <a href="http://www.cancerindex.org/geneweb/BBC3.htm"
class="uri">http://www.cancerindex.org/geneweb/BBC3.htm</a> [2] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [3]
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=BBC3"
class="uri">https://www.genecards.org/cgi-bin/carddisp.pl?gene=BBC3</a>
[4] <a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [5]
<a href="https://www.spandidos-publications.com/10.3892/ol.2017.5657"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2017.5657</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [7]
<a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1080720/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1080720/full</a>
[8] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a></p>
</div>
<div id="ube2r2" class="section level3">
<h3>UBE2R2</h3>
<p><strong>UBE2R2 in Prostate Cancer</strong></p>
<p><strong>UBE2R2</strong> is a member of the ubiquitin-conjugating
enzyme family, which plays a critical role in the ubiquitin-proteasome
system that regulates protein degradation, cell cycle progression, and
various cellular processes. Its involvement in cancer, particularly
prostate cancer, has been a subject of investigation.</p>
<p><strong>Role and Mechanism</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Ubiquitination Process</strong>: UBE2R2 participates in
the ubiquitination pathway, where it conjugates ubiquitin to target
proteins for degradation. This process is crucial for maintaining
cellular homeostasis and regulating various signaling pathways that can
influence cancer progression.</p></li>
<li><p><strong>Gene Expression in Tumors</strong>: Recent studies
indicate that UBE2R2 is significantly upregulated in various tumor
types, including prostate cancer. The overexpression of UBE2R2 may
contribute to tumorigenesis by promoting the degradation of tumor
suppressor proteins or enhancing the stability of oncogenic
proteins[2][4].</p></li>
<li><p><strong>Prognostic Implications</strong>: Elevated levels of
UBE2R2 have been associated with poor prognosis in several cancers,
suggesting that it may serve as a potential biomarker for disease
progression and therapeutic response in prostate cancer
patients[3].</p></li>
</ol>
<p><strong>Clinical Relevance</strong></p>
<ul>
<li><p><strong>Potential Therapeutic Target</strong>: Given its role in
regulating protein degradation pathways that are often hijacked in
cancer, targeting UBE2R2 could provide a novel therapeutic strategy.
Inhibitors that disrupt its function might restore the levels of tumor
suppressors or destabilize oncogenic proteins, thereby inhibiting cancer
cell proliferation.</p></li>
<li><p><strong>Research Directions</strong>: Further studies are needed
to elucidate the specific targets of UBE2R2 in prostate cancer and to
explore its interactions within the ubiquitin-proteasome system to
better understand its contribution to cancer biology.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>UBE2R2 is implicated in the progression of prostate cancer through
its role in protein ubiquitination. Its upregulation may correlate with
adverse clinical outcomes, positioning it as a potential biomarker and
therapeutic target. Continued research into its mechanisms and effects
on tumor biology will be essential for developing effective strategies
for managing prostate cancer.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41388-024-03028-x"
class="uri">https://www.nature.com/articles/s41388-024-03028-x</a> [2]
<a href="https://tcr.amegroups.org/article/view/67645/html"
class="uri">https://tcr.amegroups.org/article/view/67645/html</a> [3] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [4]
<a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [5]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [6] <a
href="https://www.spandidos-publications.com/10.3892/ol.2017.5657"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2017.5657</a>
[7] <a href="http://www.cancerindex.org/geneweb/BBC3.htm"
class="uri">http://www.cancerindex.org/geneweb/BBC3.htm</a> [8] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1080720/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1080720/full</a></p>
</div>
<div id="grhl1" class="section level3">
<h3>GRHL1</h3>
<p><strong>GRHL1 in Prostate Cancer</strong></p>
<p><strong>GRHL1 (Grainyhead-like 1)</strong> is a transcription factor
that belongs to the Grainyhead-like family, which plays significant
roles in various biological processes, including epithelial development
and differentiation. Its involvement in cancer, particularly prostate
cancer, has been increasingly recognized.</p>
<p><strong>Expression and Function</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Expression Levels</strong>: Studies have indicated that
GRHL1 is expressed in various tissues, including prostate tissue.
However, the specific expression patterns of GRHL1 in prostate cancer
compared to normal prostate tissue require further
investigation.</p></li>
<li><p><strong>Potential Tumor Suppressor Role</strong>: GRHL1 has been
implicated as a tumor suppressor in several contexts. For instance, it
has been shown to regulate pathways involved in cell proliferation and
differentiation. In colorectal cancer, higher levels of GRHL1 were
associated with poor disease-free survival, suggesting a complex role in
tumor biology that may also apply to prostate cancer[2].</p></li>
<li><p><strong>Mechanistic Insights</strong>: The mechanism by which
GRHL1 may influence prostate cancer progression is not fully elucidated.
It is suggested that GRHL1 could interact with other signaling pathways
and transcription factors that are crucial for maintaining epithelial
integrity and preventing epithelial-to-mesenchymal transition (EMT), a
process often associated with increased metastatic potential in
cancers.</p></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<ul>
<li><p><strong>Biomarker Potential</strong>: Given its role in tumor
suppression and the regulation of epithelial characteristics, GRHL1
could serve as a potential biomarker for prostate cancer prognosis. The
correlation between its expression levels and clinical outcomes in
prostate cancer patients remains an area for further research.</p></li>
<li><p><strong>Therapeutic Target</strong>: Targeting GRHL1 or its
downstream pathways might offer new therapeutic strategies for managing
prostate cancer, particularly in cases where EMT and metastasis are
prominent.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>GRHL1 appears to play a multifaceted role in the context of prostate
cancer, potentially acting as a tumor suppressor by maintaining
epithelial characteristics and regulating cell growth. Further studies
are needed to clarify its expression patterns, functional mechanisms,
and clinical relevance as a biomarker or therapeutic target in prostate
cancer management.</p>
<p>Citations: [1] <a
href="https://academic.oup.com/endo/article/160/5/1275/5428132?login=false"
class="uri">https://academic.oup.com/endo/article/160/5/1275/5428132?login=false</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7173839/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7173839/</a> [3] <a
href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [4]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [5] <a
href="https://www.nature.com/articles/s41467-021-27732-4"
class="uri">https://www.nature.com/articles/s41467-021-27732-4</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [7]
<a
href="https://biosignaling.biomedcentral.com/articles/10.1186/s12964-022-01029-5"
class="uri">https://biosignaling.biomedcentral.com/articles/10.1186/s12964-022-01029-5</a>
[8] <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRHL1"
class="uri">https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRHL1</a></p>
</div>
<div id="dnase2b" class="section level3">
<h3>DNASE2B</h3>
<p><strong>DNASE2B in Prostate Cancer</strong></p>
<p><strong>DNASE2B</strong> is a member of the deoxyribonuclease (DNase)
family, which plays a crucial role in DNA degradation and has
implications in various biological processes, including immune responses
and cancer progression. Recent studies have begun to explore the role of
DNASE2B in the context of prostate cancer.</p>
<p><strong>Expression and Role</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Expression Patterns</strong>: DNASE2B is expressed in
various tissues, including human salivary glands and lungs. In the
context of tumors, its expression levels can vary significantly. A
pan-cancer analysis indicated that while some DNase family members are
upregulated in tumors, DNASE2B expression was notably lower compared to
other DNases like DNASE1L1 and DNASE1L3[3].</p></li>
<li><p><strong>Potential Tumor Microenvironment Influence</strong>: The
expression of DNASE2B has been associated with the tumor
microenvironment, particularly regarding immune cell infiltration and
the overall immune landscape of tumors. This suggests that DNASE2B may
play a role in modulating immune responses within the prostate cancer
microenvironment[3].</p></li>
<li><p><strong>Implications for Cancer Progression</strong>: Although
specific studies directly linking DNASE2B to prostate cancer progression
are limited, its involvement in DNA degradation processes indicates a
potential role in tumor biology. The enzyme’s activity could influence
how cancer cells interact with their environment, particularly regarding
apoptosis and immune evasion mechanisms.</p></li>
</ol>
<p><strong>Clinical Relevance</strong></p>
<ul>
<li><p><strong>Survival Correlations</strong>: The expression levels of
DNASE family members, including DNASE2B, have been correlated with
overall survival rates across various cancers. Understanding these
correlations in prostate cancer specifically could provide insights into
its prognostic significance[3].</p></li>
<li><p><strong>Therapeutic Potential</strong>: Given its role in DNA
degradation and potential effects on immune modulation, targeting
DNASE2B or manipulating its expression could offer new therapeutic
avenues for prostate cancer treatment.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While research on DNASE2B specifically within prostate cancer is
still emerging, its expression patterns and functional implications
suggest it may play a role in tumor biology and the immune landscape of
prostate tumors. Further studies are needed to clarify its specific
contributions to prostate cancer progression and its potential as a
biomarker or therapeutic target.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [2]
<a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [3]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926046/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926046/</a>
[4] <a
href="https://biosignaling.biomedcentral.com/articles/10.1186/s12964-022-01029-5"
class="uri">https://biosignaling.biomedcentral.com/articles/10.1186/s12964-022-01029-5</a>
[5] <a
href="https://academic.oup.com/endo/article/160/5/1275/5428132?login=false"
class="uri">https://academic.oup.com/endo/article/160/5/1275/5428132?login=false</a>
[6] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [7] <a
href="https://aacrjournals.org/cancerres/article/83/16/2763/728334/The-Genomic-and-Epigenomic-Landscape-of-Double"
class="uri">https://aacrjournals.org/cancerres/article/83/16/2763/728334/The-Genomic-and-Epigenomic-Landscape-of-Double</a>
[8] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7173839/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7173839/</a></p>
</div>
<div id="fam162a" class="section level3">
<h3>FAM162A</h3>
<p><strong>FAM162A in Prostate Cancer</strong></p>
<p><strong>FAM162A</strong> (Family with Sequence Similarity 162 Member
A) is a gene that has recently garnered attention in cancer research,
particularly concerning its potential implications in prostate
cancer.</p>
<p><strong>Expression and Function</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Gene Characteristics</strong>: FAM162A is located on
chromosome 10 and encodes a protein that is believed to play a role in
cellular processes, although its exact function remains less
well-defined compared to other genes involved in cancer.</p></li>
<li><p><strong>Prostate Cancer Association</strong>: Recent studies have
suggested that FAM162A may be involved in the progression of prostate
cancer. It has been observed that alterations in the expression of
FAM162A can correlate with disease progression and patient outcomes,
indicating its potential as a biomarker for prostate cancer.</p></li>
<li><p><strong>Molecular Mechanisms</strong>: While specific mechanisms
of action for FAM162A in prostate cancer are still under investigation,
it is hypothesized that it may interact with various signaling pathways
that are critical for tumor growth and metastasis. This includes
potential interactions with androgen receptor signaling, which is a
significant pathway in prostate cancer biology.</p></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<ul>
<li><p><strong>Prognostic Marker Potential</strong>: The expression
levels of FAM162A could serve as a prognostic marker for prostate
cancer, helping to stratify patients based on their risk of disease
progression or recurrence after treatment.</p></li>
<li><p><strong>Therapeutic Targeting</strong>: Understanding the role of
FAM162A in prostate cancer could lead to new therapeutic strategies
aimed at modulating its expression or function, potentially improving
treatment outcomes for patients.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>FAM162A appears to be an emerging player in the landscape of prostate
cancer research. While more detailed studies are needed to elucidate its
precise role and mechanisms, its association with disease progression
highlights its potential as both a biomarker and a therapeutic target in
prostate cancer management. Further research will clarify how FAM162A
can be effectively integrated into clinical practice for better patient
outcomes.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [2]
<a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [3]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [4] <a
href="https://biosignaling.biomedcentral.com/articles/10.1186/s12964-022-01029-5"
class="uri">https://biosignaling.biomedcentral.com/articles/10.1186/s12964-022-01029-5</a>
[5] <a
href="https://academic.oup.com/endo/article/160/5/1275/5428132?login=false"
class="uri">https://academic.oup.com/endo/article/160/5/1275/5428132?login=false</a>
[6] <a
href="https://aacrjournals.org/cancerres/article/83/16/2763/728334/The-Genomic-and-Epigenomic-Landscape-of-Double"
class="uri">https://aacrjournals.org/cancerres/article/83/16/2763/728334/The-Genomic-and-Epigenomic-Landscape-of-Double</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7173839/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7173839/</a> [8] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926046/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926046/</a></p>
</div>
<div id="efhd1" class="section level3">
<h3>EFHD1</h3>
<p><strong>EFHD1 in Prostate Cancer</strong></p>
<p><strong>EFHD1</strong> (EF-hand domain family member D1) is a gene
that has been investigated in the context of various cancers, including
its potential role in prostate cancer. However, specific studies
focusing on EFHD1’s involvement in prostate cancer are limited.</p>
<p><strong>Expression and Function</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Calcium Regulation</strong>: EFHD1 is primarily known for
its function in regulating calcium levels within mitochondria. It
interacts with the mitochondrial calcium uniporter (MCU), which is
crucial for calcium uptake into mitochondria. This interaction
influences various signaling pathways, including the Hippo/YAP pathway,
which is involved in cell growth and proliferation[2].</p></li>
<li><p><strong>Tumor Metastasis</strong>: While much of the research on
EFHD1 has centered on its role in clear cell renal cell carcinoma
(ccRCC), where it has been shown to suppress cell migration and
invasion, its specific effects in prostate cancer remain underexplored.
The expression of EFHD1 has been correlated with clinical outcomes in
ccRCC, suggesting that it may also have prognostic implications in other
cancers, including prostate cancer[2].</p></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<ul>
<li><p><strong>Potential Biomarker</strong>: Although direct evidence
linking EFHD1 to prostate cancer progression is sparse, its role as a
regulator of mitochondrial function and calcium homeostasis positions it
as a potential biomarker for cancer prognosis. Further research could
elucidate whether altered EFHD1 expression correlates with disease
severity or patient outcomes in prostate cancer.</p></li>
<li><p><strong>Therapeutic Targeting</strong>: Understanding the
molecular mechanisms by which EFHD1 operates could open avenues for
therapeutic interventions aimed at modulating its activity or
expression, potentially impacting tumor behavior.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>Currently, the role of EFHD1 specifically in prostate cancer is not
well-defined, with more research needed to clarify its expression
patterns and functional significance within this context. Its
established roles in other cancers suggest that investigating EFHD1
could yield valuable insights into the mechanisms of prostate cancer
progression and potential therapeutic strategies.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [2]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154798/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154798/</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [4]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [5] <a
href="https://academic.oup.com/endo/article/160/5/1275/5428132?login=false"
class="uri">https://academic.oup.com/endo/article/160/5/1275/5428132?login=false</a>
[6] <a href="https://www.nature.com/articles/s41467-024-47664-z"
class="uri">https://www.nature.com/articles/s41467-024-47664-z</a> [7]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7173839/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7173839/</a> [8] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9092641/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9092641/</a></p>
</div>
<div id="satb1" class="section level3">
<h3>SATB1</h3>
<p><strong>SATB1 in Prostate Cancer</strong></p>
<p><strong>SATB1</strong> (Special AT-rich sequence-binding protein 1)
is a nuclear factor that plays a critical role in chromatin organization
and gene expression regulation. Its involvement in cancer, particularly
prostate cancer, has garnered attention due to its potential as an
oncogene.</p>
<p><strong>Role in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Overexpression in Metastatic Prostate Cancer</strong>:
Studies have indicated that SATB1 is overexpressed in metastatic
prostate cancer, suggesting a correlation with tumor aggressiveness and
poor patient outcomes. This overexpression is believed to promote cancer
cell growth and invasion, making SATB1 a significant player in the
progression of prostate cancer [1][2].</p></li>
<li><p><strong>Mechanisms of Action</strong>: SATB1 functions as a
global chromatin organizer, influencing the expression of various
oncogenes and tumor suppressor genes. It has been shown to recruit
histone-modifying enzymes that either activate or repress gene
expression, thereby affecting cellular processes such as proliferation
and apoptosis [2].</p></li>
<li><p><strong>Experimental Evidence</strong>: Research involving short
hairpin RNA (shRNA) targeting SATB1 demonstrated a reduction in tumor
growth in xenograft models of prostate cancer. The study revealed that
inhibiting SATB1 expression significantly decreased tumor size,
indicating its role in promoting tumorigenesis [1].</p></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<ul>
<li><p><strong>Prognostic Marker</strong>: Given its association with
aggressive cancer phenotypes, SATB1 may serve as a prognostic marker for
patients with prostate cancer. Elevated levels of SATB1 could indicate a
higher risk of metastasis and poorer survival rates [2].</p></li>
<li><p><strong>Therapeutic Target</strong>: The modulation of SATB1
expression presents a potential therapeutic avenue. Targeting SATB1 to
inhibit its function could be explored as a strategy to suppress
prostate cancer progression and improve patient outcomes [2].</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>SATB1 is implicated as an important factor in the malignancy of
prostate cancer through its roles in chromatin organization and gene
regulation. Its overexpression correlates with aggressive disease
characteristics, making it a candidate for further research as both a
prognostic marker and a therapeutic target in prostate cancer
management. Further studies are needed to fully elucidate its mechanisms
and potential applications in clinical settings.</p>
<p>Citations: [1] <a
href="https://www.spandidos-publications.com/10.3892/ol.2017.7006"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2017.7006</a>
[2] <a href="https://www.nature.com/articles/s41388-018-0541-4"
class="uri">https://www.nature.com/articles/s41388-018-0541-4</a> [3] <a
href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [5]
<a href="https://www.nature.com/articles/s41467-024-47664-z"
class="uri">https://www.nature.com/articles/s41467-024-47664-z</a> [6]
<a
href="https://academic.oup.com/endo/article/160/5/1275/5428132?login=false"
class="uri">https://academic.oup.com/endo/article/160/5/1275/5428132?login=false</a>
[7] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [8] <a
href="http://www.cancerindex.org/geneweb/SATB1.htm"
class="uri">http://www.cancerindex.org/geneweb/SATB1.htm</a></p>
</div>
<div id="btbd2" class="section level3">
<h3>BTBD2</h3>
<p><strong>BTBD2 in Prostate Cancer</strong></p>
<p><strong>BTBD2</strong> (BTB Domain Containing 2) is a gene that has
been studied for its potential implications in various cancers,
including prostate cancer. While specific studies directly linking BTBD2
to prostate cancer are limited, there are several insights regarding its
role and significance in cancer biology.</p>
<p><strong>Potential Role in Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Gene Function</strong>: BTBD2 is involved in the
regulation of protein interactions and may play a role in cellular
signaling pathways that are critical for cell proliferation and
differentiation. Its function as a BTB (Broad Complex, Tramtrack, and
Bric-a-brac) domain-containing protein suggests it may be involved in
transcriptional regulation and the modulation of cellular responses to
various stimuli.</p></li>
<li><p><strong>Expression Patterns</strong>: Some research indicates
that changes in the expression levels of BTBD2 may correlate with cancer
progression. For example, alterations in the expression of genes
involved in cell cycle regulation, such as BTBD2, have been implicated
in tumorigenesis and metastasis across different cancer types, including
prostate cancer .</p></li>
<li><p><strong>Association with Other Genes</strong>: BTBD2 may interact
with other oncogenes or tumor suppressor genes, influencing pathways
that regulate cancer cell behavior. Understanding these interactions
could provide insights into the mechanisms underlying prostate cancer
development and progression.</p></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<ul>
<li><p><strong>Prognostic Marker</strong>: Although direct evidence
linking BTBD2 to prostate cancer prognosis is sparse, the gene’s
involvement in critical cellular processes suggests that it could serve
as a potential biomarker for disease progression or response to therapy
if further validated through research.</p></li>
<li><p><strong>Therapeutic Target</strong>: Given its regulatory roles,
targeting BTBD2 or its pathways could offer new therapeutic strategies
for managing prostate cancer, particularly in cases where traditional
therapies are ineffective.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While specific studies on BTBD2 in prostate cancer are limited, its
role as a regulatory protein suggests it may influence tumor biology
through various mechanisms. Further research is necessary to elucidate
its specific functions and potential as a biomarker or therapeutic
target in prostate cancer management. Understanding the broader context
of BTBD2’s interactions within cellular networks will be crucial for
determining its relevance in prostate cancer progression.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [2]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [3]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [4] <a
href="https://academic.oup.com/endo/article/160/5/1275/5428132?login=false"
class="uri">https://academic.oup.com/endo/article/160/5/1275/5428132?login=false</a>
[5] <a href="https://www.nature.com/articles/s41388-018-0541-4"
class="uri">https://www.nature.com/articles/s41388-018-0541-4</a> [6] <a
href="https://www.nature.com/articles/s41467-024-47664-z"
class="uri">https://www.nature.com/articles/s41467-024-47664-z</a> [7]
<a href="https://www.spandidos-publications.com/10.3892/ol.2017.7006"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2017.7006</a>
[8] <a href="http://www.cancerindex.org/geneweb/SATB1.htm"
class="uri">http://www.cancerindex.org/geneweb/SATB1.htm</a></p>
</div>
<div id="hmgcs1" class="section level3">
<h3>HMGCS1</h3>
<p><strong>HMGCS1 in Prostate Cancer</strong></p>
<p><strong>HMGCS1</strong> (3-hydroxy-3-methylglutaryl-CoA synthase 1)
has emerged as a significant player in the context of prostate cancer,
particularly through its involvement in the mevalonate pathway, which is
crucial for lipid biosynthesis and cellular signaling.</p>
<p><strong>Oncogenic Role</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Expression and Prognosis</strong>: Studies have shown
that HMGCS1 is often overexpressed in prostate cancer tissues,
especially in the stroma surrounding tumors. This overexpression is
associated with poor prognosis, as higher levels of HMGCS1 correlate
negatively with patient survival outcomes[1][2].</p></li>
<li><p><strong>Mechanisms of Action</strong>: The role of HMGCS1 in
promoting prostate cancer cell growth has been demonstrated through
various mechanisms:</p>
<ul>
<li><strong>Autocrine/Paracrine Signaling</strong>: Research indicates
that both prostate cancer cells and stromal cells can stimulate each
other’s growth via HMGCS1. Overexpression of HMGCS1 in these cells leads
to increased viability and proliferation, suggesting a cooperative
interaction that enhances tumor growth[2][3].</li>
<li><strong>Stromal Influence</strong>: The tumor microenvironment,
particularly the cancer-associated fibroblasts (CAFs), plays a critical
role in cancer progression. HMGCS1 expression is linked to the
differentiation of normal stromal cells into CAFs, which can promote
tumor invasion and metastasis[2][4].</li>
</ul></li>
<li><p><strong>Pathway Involvement</strong>: HMGCS1 is part of the
mevalonate pathway, which is essential for synthesizing cholesterol and
other lipids. This pathway has been implicated in various cancer
processes, including cell proliferation and survival. The upregulation
of HMGCS1 suggests that it may contribute to the metabolic reprogramming
observed in cancer cells, facilitating their growth and resistance to
therapies[1][2].</p></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<ul>
<li><p><strong>Potential Therapeutic Target</strong>: Given its role in
promoting prostate cancer cell growth and its association with poor
outcomes, HMGCS1 presents a potential target for therapeutic
intervention. Inhibitors of the mevalonate pathway could be explored as
treatment options for patients with high HMGCS1
expression[1][2].</p></li>
<li><p><strong>Biomarker for Disease Progression</strong>: The
expression levels of HMGCS1 could serve as a biomarker for assessing
disease progression and guiding treatment strategies, particularly in
distinguishing aggressive forms of prostate cancer from indolent
ones[3][4].</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>HMGCS1 plays a crucial oncogenic role in prostate cancer through its
involvement in autocrine and paracrine signaling within the tumor
microenvironment. Its overexpression correlates with adverse clinical
outcomes, making it a promising target for future research aimed at
developing novel therapeutic strategies and improving patient
prognostication. Further studies are necessary to fully elucidate its
mechanisms and potential as a biomarker or therapeutic target in
prostate cancer management.</p>
<p>Citations: [1] <a
href="https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1562"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1562</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5686443/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5686443/</a> [3] <a
href="https://www.spandidos-publications.com/10.3892/ol.2017.7025/abstract"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2017.7025/abstract</a>
[4] <a
href="https://aacrjournals.org/cancerres/article/78/13_Supplement/79/630829/Abstract-79-Stromal-regulation-of-prostate-cancer"
class="uri">https://aacrjournals.org/cancerres/article/78/13_Supplement/79/630829/Abstract-79-Stromal-regulation-of-prostate-cancer</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [6]
<a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [7]
<a href="https://www.spandidos-publications.com/10.3892/ol.2017.7006"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2017.7006</a>
[8] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a></p>
</div>
<div id="hla-dpb1" class="section level3">
<h3>HLA-DPB1</h3>
<p><strong>HLA-DPB1 in Prostate Cancer</strong></p>
<p><strong>HLA-DPB1</strong> (Human Leukocyte Antigen DP Beta 1) is a
gene that encodes a protein involved in the immune response and has been
implicated in various cancers, including prostate cancer. Although
specific studies directly linking HLA-DPB1 to prostate cancer are
limited, its role in tumor immunology offers insights into potential
mechanisms of cancer progression and treatment responses.</p>
<p><strong>Immune Response and Tumor Microenvironment</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Antigen Presentation</strong>: HLA-DPB1 is part of the
major histocompatibility complex (MHC) class II, which presents
processed antigens to CD4+ T cells. This function is crucial for
initiating immune responses against tumors. Alterations in HLA-DPB1
expression can affect how effectively the immune system recognizes and
attacks prostate cancer cells.</p></li>
<li><p><strong>Association with Immune Escape</strong>: Tumors often
develop mechanisms to evade immune detection, which may involve
downregulation or alteration of HLA molecules, including HLA-DPB1. This
immune evasion can contribute to tumor progression and resistance to
therapies, such as immunotherapy.</p></li>
</ol>
<p><strong>Genetic Variants and Prognosis</strong></p>
<ul>
<li><p><strong>Polymorphisms</strong>: Variants in the HLA-DPB1 gene may
influence individual susceptibility to prostate cancer and affect
disease outcomes. Some studies suggest that specific alleles of HLA
genes can be associated with either increased risk or protection against
prostate cancer.</p></li>
<li><p><strong>Prognostic Value</strong>: The expression levels of
HLA-DPB1 may correlate with clinical outcomes in prostate cancer
patients. Higher expression levels could indicate a more active immune
response against the tumor, potentially leading to better
prognosis.</p></li>
</ul>
<p><strong>Therapeutic Implications</strong></p>
<ul>
<li><p><strong>Immunotherapy</strong>: Understanding the role of
HLA-DPB1 in prostate cancer could enhance the development of
immunotherapeutic strategies. Targeting pathways that modulate HLA
expression or enhancing antigen presentation may improve the efficacy of
treatments such as checkpoint inhibitors.</p></li>
<li><p><strong>Vaccine Development</strong>: Given its role in antigen
presentation, HLA-DPB1 could be a target for therapeutic vaccines
designed to elicit a stronger immune response against prostate cancer
cells.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While direct evidence linking HLA-DPB1 specifically to prostate
cancer is still emerging, its established role in immune response and
potential implications for tumor progression and treatment responses
underscore its importance in oncological research. Further studies are
needed to elucidate the precise mechanisms by which HLA-DPB1 influences
prostate cancer biology and patient outcomes.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [2]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [3]
<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1562"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1562</a>
[4] <a
href="https://www.spandidos-publications.com/10.3892/ol.2017.7006"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2017.7006</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5686443/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5686443/</a> [6] <a
href="https://aacrjournals.org/cancerres/article/78/13_Supplement/79/630829/Abstract-79-Stromal-regulation-of-prostate-cancer"
class="uri">https://aacrjournals.org/cancerres/article/78/13_Supplement/79/630829/Abstract-79-Stromal-regulation-of-prostate-cancer</a>
[7] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [8] <a
href="https://www.spandidos-publications.com/10.3892/ol.2017.7025/abstract"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2017.7025/abstract</a></p>
</div>
<div id="fam118a" class="section level3">
<h3>FAM118A</h3>
<p><strong>FAM118A in Prostate Cancer</strong></p>
<p><strong>FAM118A</strong> (Family with Sequence Similarity 118 Member
A) is a gene that has recently been implicated in prostate cancer
research. Although the specific role of FAM118A in prostate cancer is
still being elucidated, emerging studies suggest it may be involved in
the disease’s progression and risk assessment.</p>
<p><strong>Gene Expression and Prostate Cancer Risk</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Expression Patterns</strong>: Research indicates that
FAM118A is part of a broader gene expression signature associated with
prostate cancer. A study highlighted its expression in relation to other
genes, suggesting it may contribute to the molecular landscape of
prostate cancer and differentiate between cancerous and non-cancerous
tissues[5].</p></li>
<li><p><strong>Prognostic Potential</strong>: The expression levels of
FAM118A, along with other genes, have been analyzed to identify
biomarkers that could predict prostate cancer risk and progression. Its
association with glycosylating enzymes suggests a potential role in
tumor biology and metabolic pathways relevant to cancer
development[5].</p></li>
</ol>
<p><strong>Implications for Treatment</strong></p>
<ul>
<li><strong>Target for Therapeutics</strong>: Given its involvement in
gene expression profiles linked to prostate cancer, FAM118A could serve
as a target for future therapeutic strategies. Understanding its
function may provide insights into novel treatment approaches or improve
existing ones by tailoring therapies based on genetic profiles.</li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While the direct mechanisms by which FAM118A influences prostate
cancer are still under investigation, its emerging role in gene
expression patterns related to the disease highlights its potential
significance in understanding prostate cancer biology and improving
prognostic assessments. Further research is necessary to clarify its
specific functions and implications for patient management.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [2]
<a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [3]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [4] <a
href="https://aacrjournals.org/cancerres/article/78/13_Supplement/79/630829/Abstract-79-Stromal-regulation-of-prostate-cancer"
class="uri">https://aacrjournals.org/cancerres/article/78/13_Supplement/79/630829/Abstract-79-Stromal-regulation-of-prostate-cancer</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5686443/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5686443/</a> [7] <a
href="https://www.spandidos-publications.com/10.3892/ol.2017.7025/abstract"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2017.7025/abstract</a>
[8] <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1562"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1562</a></p>
</div>
<div id="gigyf2" class="section level3">
<h3>GIGYF2</h3>
<p><strong>GIGYF2 in Prostate Cancer</strong></p>
<p><strong>GIGYF2</strong> (Grb10-Interacting GYF Protein 2) is a gene
located on chromosome 2q36.1 and has been associated with various
biological processes, including its role as an RNA-binding protein.
Recent research has begun to explore its implications in prostate
cancer, shedding light on its potential involvement in tumor biology and
progression.</p>
<p><strong>Role in Cancer Biology</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Expression and Function</strong>: GIGYF2 is known to
interact with several signaling pathways, including the mTORC1 pathway,
which is crucial for cell growth and proliferation. Aberrant expression
of GIGYF2 has been observed in various cellular contexts, suggesting it
may play a role in cellular senescence and dysfunction[1]. This
dysregulation can contribute to the pathogenesis of cancer, including
prostate cancer.</p></li>
<li><p><strong>Association with Prostate Cancer Progression</strong>:
Although specific studies directly linking GIGYF2 to prostate cancer are
limited, its involvement in signaling pathways that regulate cell growth
implies a potential role in cancer progression. For instance, GIGYF2’s
interaction with mTORC1 could influence the growth of prostate cancer
cells, as mTORC1 is often activated in malignancies[1].</p></li>
<li><p><strong>Potential as a Therapeutic Target</strong>: Given its
role in regulating mRNA stability and translation repression, GIGYF2 may
represent a novel target for therapeutic intervention. Disruption of
GIGYF2’s function could potentially affect the viability and
proliferation of prostate cancer cells, making it a candidate for
further investigation in treatment strategies[1].</p></li>
</ol>
<p><strong>Summary</strong></p>
<p>While the direct implications of GIGYF2 in prostate cancer are still
being elucidated, its involvement in critical signaling pathways and
cellular processes suggests it may play a significant role in the
disease’s biology. Ongoing research is necessary to clarify the exact
mechanisms by which GIGYF2 influences prostate cancer progression and to
explore its potential as a therapeutic target.</p>
<p>Citations: [1] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400931/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400931/</a>
[2] <a
href="https://www.michiganmedicine.org/health-lab/researchers-identify-factor-drives-prostate-cancer-causing-genes"
class="uri">https://www.michiganmedicine.org/health-lab/researchers-identify-factor-drives-prostate-cancer-causing-genes</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [4]
<a href="https://www.spandidos-publications.com/10.3892/br.2014.324"
class="uri">https://www.spandidos-publications.com/10.3892/br.2014.324</a>
[5] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/</a> [7]
<a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [8]
<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1562"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1562</a></p>
</div>
<div id="znf568" class="section level3">
<h3>ZNF568</h3>
<p><strong>ZNF568 in Prostate Cancer</strong></p>
<p><strong>ZNF568</strong> (Zinc Finger Protein 568) is a gene that has
recently gained attention in the context of prostate cancer research.
Its expression levels and functional role in cancer progression have
been investigated, highlighting its potential significance in the
disease.</p>
<p><strong>Expression and Prognostic Value</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Association with Mortality</strong>: Studies have
indicated that high expression levels of ZNF568 correlate with increased
mortality in prostate cancer patients. Specifically, research has shown
that elevated expression of ZNF568, along with several other genes, is
linked to poorer survival outcomes, suggesting its role as a potential
prognostic biomarker for the disease [5].</p></li>
<li><p><strong>Gene Characterization</strong>: ZNF568 is part of a
larger group of zinc finger proteins, which are known to be involved in
various cellular processes, including transcription regulation. The
specific mechanisms by which ZNF568 influences prostate cancer
progression are still being explored, but its association with mortality
rates underscores its relevance in clinical outcomes [5].</p></li>
</ol>
<p><strong>Potential Mechanisms</strong></p>
<ul>
<li><strong>Regulatory Role</strong>: As a zinc finger protein, ZNF568
may play a role in regulating gene expression and cellular signaling
pathways that are critical for tumor growth and metastasis.
Understanding how ZNF568 interacts with other molecular pathways in
prostate cancer could provide insights into its function and therapeutic
targeting [5].</li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While the exact mechanisms by which ZNF568 contributes to prostate
cancer progression require further investigation, its association with
increased mortality highlights its potential as a prognostic marker.
Continued research into the functional roles of ZNF568 and its
interactions within cancer-related pathways will be essential for
elucidating its significance in prostate cancer biology.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [2]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [3] <a
href="https://www.michiganmedicine.org/health-lab/researchers-identify-factor-drives-prostate-cancer-causing-genes"
class="uri">https://www.michiganmedicine.org/health-lab/researchers-identify-factor-drives-prostate-cancer-causing-genes</a>
[4] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [5]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476269/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476269/</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7380489/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7380489/</a> [7] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/</a> [8]
<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1562"
class="uri">https://onlinelibrary.wiley.com/doi/full/10.1002/cnr2.1562</a></p>
</div>
<div id="c9orf64" class="section level3">
<h3>C9orf64</h3>
<p><strong>C9orf64 in Prostate Cancer</strong></p>
<p><strong>C9orf64</strong> (Chromosome 9 open reading frame 64) is a
gene located on chromosome 9 that encodes the queuosine salvage protein,
which is involved in the processing and recycling of tRNA. While there
is limited direct research specifically linking C9orf64 to prostate
cancer, understanding its biological functions provides insights into
its potential implications in cancer biology.</p>
<p><strong>Gene Function and Characteristics</strong></p>
<ul>
<li><p><strong>Protein Function</strong>: The queuosine salvage protein
encoded by C9orf64 functions as a queuosine-nucleotide
N-glycosylase/hydrolase (QNG1), which is essential for the release of
queuine from Q-5’-monophosphate. This activity is crucial for the
recycling of queuosine, a modified nucleoside found in certain tRNAs,
which may play roles in cellular metabolism and translation
efficiency[1].</p></li>
<li><p><strong>Expression Patterns</strong>: C9orf64 shows high
expression levels in the duodenum and small intestine, with presence in
various other tissues as well. Its expression may be relevant in tissues
where metabolic processes are critical, potentially influencing tumor
biology indirectly[1].</p></li>
</ul>
<p><strong>Potential Implications in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Lack of Direct Evidence</strong>: Currently, there is no
substantial direct evidence linking C9orf64 to prostate cancer
progression or outcomes. However, its role in tRNA processing suggests
that it could influence protein synthesis and cellular responses to
stress, which are important factors in cancer development.</p></li>
<li><p><strong>Gene Variants and Disease Associations</strong>: Variants
of C9orf64 have been associated with other health conditions, such as
developmental delays and seizures, but specific associations with
prostate cancer have not been established in the literature
reviewed[1].</p></li>
<li><p><strong>Research Opportunities</strong>: Given the increasing
interest in the role of non-coding regions and uncharacterized genes in
cancer biology, further research could explore whether variations or
expression levels of C9orf64 correlate with prostate cancer risk or
prognosis.</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>While C9orf64 is primarily characterized for its role in tRNA
processing and has implications in various cellular functions, its
direct involvement in prostate cancer remains largely unexplored. Future
studies may clarify any potential connections between C9orf64 expression
or genetic variants and prostate cancer outcomes.</p>
<p>Citations: [1] <a href="https://en.wikipedia.org/wiki/C9orf64"
class="uri">https://en.wikipedia.org/wiki/C9orf64</a> [2] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [3] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [4]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298883/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298883/</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/</a> [6]
<a
href="https://www.michiganmedicine.org/health-lab/researchers-identify-factor-drives-prostate-cancer-causing-genes"
class="uri">https://www.michiganmedicine.org/health-lab/researchers-identify-factor-drives-prostate-cancer-causing-genes</a>
[7] <a href="https://www.nature.com/articles/s41419-021-04278-3"
class="uri">https://www.nature.com/articles/s41419-021-04278-3</a> [8]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7476269/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7476269/</a></p>
</div>
<div id="senp5" class="section level3">
<h3>SENP5</h3>
<p><strong>SENP5 in Prostate Cancer</strong></p>
<p><strong>SENP5</strong> (Sentrin-specific protease 5) is a member of
the SUMO-specific protease family, which plays a crucial role in the
post-translational modification of proteins through deSUMOylation. This
process is important for regulating various cellular functions,
including transcription, cell cycle progression, and apoptosis. The
involvement of SENP5 in cancer, including prostate cancer, has been a
subject of interest due to its potential role in tumorigenesis.</p>
<p><strong>Role of SENP5 in Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Oncogenic Properties</strong>: SENP5 has been implicated
as an oncogene in several cancer types. Studies have shown that
overexpression of SENP5 can promote cell proliferation and inhibit
apoptosis, contributing to tumor growth and survival. For instance, in
gastric cancer, SENP5 was found to be significantly upregulated in tumor
tissues compared to normal tissues, suggesting a similar potential role
in other cancers, including prostate cancer[1][2].</p></li>
<li><p><strong>SUMOylation Regulation</strong>: SENP5 is involved in the
regulation of SUMOylation, a process that modifies proteins and
influences their function and stability. This modification is
particularly relevant for the androgen receptor (AR), which is critical
in prostate cancer. Although specific studies directly linking SENP5 to
AR activity in prostate cancer are limited, its role as a SUMO-specific
protease suggests it may influence AR-mediated transcriptional activity
by modulating the SUMOylation state of AR[3].</p></li>
<li><p><strong>Cell Cycle and Apoptosis</strong>: Research indicates
that SENP5 is essential for maintaining mitochondrial function and
cytokinesis, which are vital for cell division and survival. Knockdown
studies have demonstrated that reducing SENP5 levels can lead to
increased SUMO conjugates and defects in cell morphology, ultimately
affecting cell growth and promoting apoptosis[2]. These effects could be
particularly significant in the context of prostate cancer, where cell
proliferation and survival are critical for tumor progression.</p></li>
</ol>
<p><strong>Implications for Prostate Cancer Research</strong></p>
<ul>
<li><p><strong>Potential Biomarker</strong>: Given its role in cell
growth and survival, SENP5 could serve as a potential biomarker for
aggressive prostate cancer or as a therapeutic target. Its expression
levels may correlate with disease progression or response to
therapies.</p></li>
<li><p><strong>Target for Therapy</strong>: Targeting SENP5 or its
pathways could provide new avenues for treatment strategies aimed at
inhibiting tumor growth or enhancing the efficacy of existing
therapies.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While direct evidence linking SENP5 specifically to prostate cancer
remains limited, its established roles in other cancers and its
regulatory functions related to the androgen receptor suggest that it
may play a significant role in prostate cancer biology. Further research
is needed to clarify its specific contributions and potential as a
therapeutic target or biomarker within this context.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41467-024-53493-x"
class="uri">https://www.nature.com/articles/s41467-024-53493-x</a> [2]
<a href="https://www.spandidos-publications.com/10.3892/etm.2014.1644"
class="uri">https://www.spandidos-publications.com/10.3892/etm.2014.1644</a>
[3] <a
href="https://academic.oup.com/mend/article/23/3/292/2660991?login=false"
class="uri">https://academic.oup.com/mend/article/23/3/292/2660991?login=false</a>
[4] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [5]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [6] <a
href="https://www.mdpi.com/2072-6694/13/9/2059"
class="uri">https://www.mdpi.com/2072-6694/13/9/2059</a> [7] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/</a> [8]
<a
href="https://www.michiganmedicine.org/health-lab/researchers-identify-factor-drives-prostate-cancer-causing-genes"
class="uri">https://www.michiganmedicine.org/health-lab/researchers-identify-factor-drives-prostate-cancer-causing-genes</a></p>
</div>
<div id="slc38a1" class="section level3">
<h3>SLC38A1</h3>
<p><strong>SLC38A1 in Prostate Cancer</strong></p>
<p><strong>SLC38A1</strong> (Solute Carrier Family 38 Member 1) is a
gene that encodes a sodium-dependent neutral amino acid transporter. Its
role in prostate cancer has been explored in the context of tumor
biology and progression, although specific studies focusing solely on
SLC38A1 in prostate cancer are limited.</p>
<p><strong>Expression and Function</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Amino Acid Transport</strong>: SLC38A1 is primarily
involved in the transport of amino acids across cell membranes, which is
crucial for various cellular processes, including protein synthesis and
energy metabolism. In cancer cells, altered amino acid metabolism is
often observed, supporting rapid growth and proliferation.</p></li>
<li><p><strong>Potential Role in Tumorigenesis</strong>: While direct
evidence linking SLC38A1 to prostate cancer progression is sparse, its
involvement in amino acid transport suggests it may play a role in the
metabolic adaptations of prostate cancer cells. Tumors often exhibit
increased reliance on specific nutrients, including amino acids, to
sustain their growth.</p></li>
</ol>
<p><strong>Clinical Relevance</strong></p>
<ul>
<li><p><strong>Fusion Genes and Prognosis</strong>: In a broader context
of prostate cancer research, certain fusion genes have been identified
that correlate with disease progression. For instance, studies have
shown that patients with specific gene fusions, including those
involving SLC45A2 and AMACR, have a higher risk of recurrence and
metastasis after treatment[1]. Although SLC38A1 itself is not mentioned
as a fusion gene, understanding its expression dynamics could provide
insights into metabolic vulnerabilities in prostate cancer.</p></li>
<li><p><strong>Biomarker Potential</strong>: Given its function in amino
acid transport, SLC38A1 could potentially serve as a biomarker for
assessing metabolic changes in prostate cancer. Alterations in its
expression might reflect the aggressive nature of tumors or their
response to therapies.</p></li>
</ul>
<p><strong>Conclusion</strong></p>
<p>While research specifically targeting SLC38A1’s role in prostate
cancer is limited, its function as an amino acid transporter positions
it as a potentially important player in the metabolic landscape of
tumors. Further investigation into its expression patterns and
functional implications could enhance our understanding of prostate
cancer biology and contribute to the development of novel therapeutic
strategies.</p>
<p>Citations: [1] <a
href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [3]
<a
href="https://academic.oup.com/mend/article/23/3/292/2660991?login=false"
class="uri">https://academic.oup.com/mend/article/23/3/292/2660991?login=false</a>
[4] <a href="https://www.nature.com/articles/s41467-024-53493-x"
class="uri">https://www.nature.com/articles/s41467-024-53493-x</a> [5]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9954451/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9954451/</a> [7] <a
href="https://www.michiganmedicine.org/health-lab/researchers-identify-factor-drives-prostate-cancer-causing-genes"
class="uri">https://www.michiganmedicine.org/health-lab/researchers-identify-factor-drives-prostate-cancer-causing-genes</a>
[8] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139225/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139225/</a></p>
</div>
<div id="rccd1" class="section level3">
<h3>RCCD1</h3>
<p><strong>RCCD1 in Prostate Cancer</strong></p>
<p><strong>RCCD1</strong> (Regulator of Chromosome Condensation 1) is a
gene that has been implicated in various cellular processes, including
cell cycle regulation and chromosomal stability. Its specific role in
prostate cancer is still being elucidated, but emerging evidence
suggests it may contribute to tumorigenesis and cancer progression.</p>
<p><strong>Expression and Potential Role</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Cell Cycle Regulation</strong>: RCCD1 is known to play a
role in the regulation of the cell cycle and chromosomal organization.
Dysregulation of these processes can lead to genomic instability, a
hallmark of cancer, including prostate cancer.</p></li>
<li><p><strong>Association with Tumor Characteristics</strong>: While
direct studies linking RCCD1 expression to prostate cancer outcomes are
limited, genes involved in chromosomal stability often correlate with
aggressive tumor characteristics. This suggests that RCCD1 may be
involved in the progression of prostate cancer or its response to
therapies.</p></li>
</ol>
<p><strong>Genetic Studies</strong></p>
<ul>
<li><strong>Genome-Wide Association Studies (GWAS)</strong>: Recent
large-scale GWAS have identified numerous risk variants associated with
prostate cancer, some of which may involve pathways related to RCCD1.
Although RCCD1 itself was not specifically highlighted in these studies,
the broader context of chromosomal regulation indicates its potential
relevance in prostate cancer susceptibility and progression.</li>
</ul>
<p><strong>Clinical Implications</strong></p>
<ul>
<li><strong>Biomarker Potential</strong>: Given its involvement in cell
cycle regulation, RCCD1 could serve as a potential biomarker for
assessing tumor aggressiveness or predicting treatment responses in
prostate cancer patients. Further research is necessary to validate this
potential.</li>
</ul>
<p><strong>Conclusion</strong></p>
<p>RCCD1’s role in prostate cancer remains an area of active
investigation. Its involvement in cell cycle regulation and chromosomal
stability suggests it could play a significant part in the biology of
prostate tumors. Ongoing research may clarify its specific contributions
and potential as a therapeutic target or biomarker in prostate cancer
management.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [2]
<a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [3] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10841479/</a> [4]
<a href="https://www.nature.com/articles/s41467-024-53493-x"
class="uri">https://www.nature.com/articles/s41467-024-53493-x</a> [5]
<a
href="https://www.michiganmedicine.org/health-lab/researchers-identify-factor-drives-prostate-cancer-causing-genes"
class="uri">https://www.michiganmedicine.org/health-lab/researchers-identify-factor-drives-prostate-cancer-causing-genes</a>
[6] <a
href="https://academic.oup.com/mend/article/23/3/292/2660991?login=false"
class="uri">https://academic.oup.com/mend/article/23/3/292/2660991?login=false</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9139225/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9139225/</a> [8] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9954451/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9954451/</a></p>
</div>
<div id="chd3" class="section level3">
<h3>CHD3</h3>
<p><strong>CHD3 in Prostate Cancer</strong></p>
<p><strong>CHD3</strong> (Chromodomain Helicase DNA Binding Protein 3)
is a member of the CHD family of proteins, which are involved in
chromatin remodeling and gene regulation. While specific studies
focusing solely on CHD3 in prostate cancer are limited, insights can be
drawn from its general role within the CHD family and its potential
implications in cancer biology.</p>
<p><strong>Role in Chromatin Remodeling</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Nucleosome Remodeling</strong>: CHD3 is part of the NuRD
(nucleosome remodeling and deacetylase) complex, which plays a critical
role in chromatin remodeling by altering nucleosome positioning and
modifying histones. This function is essential for regulating gene
expression, particularly in processes related to cell proliferation and
differentiation[2][4].</p></li>
<li><p><strong>Tumorigenesis</strong>: The NuRD complex, including CHD3,
has been implicated in various cancers through its involvement in
epithelial-to-mesenchymal transition (EMT) and metastasis. Such
processes are crucial for cancer progression, including prostate
cancer[2].</p></li>
</ol>
<p><strong>Implications in Prostate Cancer</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Oncogenic Potential</strong>: Although direct evidence
linking CHD3 to prostate cancer specifically is sparse, its role as a
chromatin remodeler suggests that it may influence pathways relevant to
oncogenesis. For instance, aberrations in chromatin remodeling can lead
to the activation of oncogenes or silencing of tumor suppressor genes,
contributing to cancer development[4][5].</p></li>
<li><p><strong>Expression Patterns</strong>: Bioinformatics analyses
have shown that members of the CHD family, including CHD3, exhibit
distinct expression patterns across various cancer types. While higher
expression levels of some CHD proteins correlate with poor prognosis in
certain cancers, the specific relationship between CHD3 expression and
clinical outcomes in prostate cancer requires further
investigation[4].</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>The role of CHD3 in prostate cancer remains an area needing more
focused research. Its involvement in chromatin remodeling through the
NuRD complex indicates potential pathways through which it could affect
tumorigenesis and cancer progression. Understanding the functional
dynamics of CHD3 could provide valuable insights into its contributions
to prostate cancer biology and potential therapeutic targets.</p>
<p>Citations: [1] <a
href="https://academic.oup.com/nar/article/50/21/12186/6835365?login=false"
class="uri">https://academic.oup.com/nar/article/50/21/12186/6835365?login=false</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4233650/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4233650/</a> [3] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [4]
<a href="https://www.nature.com/articles/s41598-024-68644-9"
class="uri">https://www.nature.com/articles/s41598-024-68644-9</a> [5]
<a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1123362/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1123362/full</a>
[6] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [7] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9954451/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9954451/</a> [8] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069695/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069695/</a></p>
</div>
<div id="armc1" class="section level3">
<h3>ARMC1</h3>
<p><strong>ARMC1 in Prostate Cancer</strong></p>
<p><strong>ARMC1</strong> (Armadillo Repeat Containing 1) is a gene that
has been studied primarily in the context of various cancers, including
breast cancer, but its specific role in prostate cancer is less
well-defined. Here are some insights regarding ARMC1’s potential
implications in prostate cancer based on available research:</p>
<p><strong>Expression and Prognostic Significance</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Expression Levels</strong>: While direct studies on ARMC1
expression in prostate cancer are limited, it is known that ARMC1
expression is often elevated in various tumor types compared to normal
tissues. This pattern suggests that ARMC1 may also be overexpressed in
prostate cancer, similar to its behavior in other malignancies like
breast cancer[1].</p></li>
<li><p><strong>Prognostic Marker</strong>: In breast cancer, higher
levels of ARMC1 have been associated with poorer survival outcomes,
indicating its potential as a prognostic marker. Although specific data
for prostate cancer are not extensively documented, the trend of
increased expression correlating with adverse clinical outcomes could
imply a similar role in prostate cancer[1].</p></li>
</ol>
<p><strong>Potential Mechanisms</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Cell Cycle Regulation</strong>: Functional enrichment
analyses indicate that ARMC1 may be involved in regulating the cell
cycle, which is a critical aspect of cancer progression. Dysregulation
of cell cycle proteins can lead to uncontrolled cell proliferation, a
hallmark of cancer[1].</p></li>
<li><p><strong>Chromatin Regulation and Signaling Pathways</strong>: The
role of ARMC1 in chromatin remodeling and its interactions with various
signaling pathways could influence prostate cancer development and
progression. Chromatin modifications are crucial for the regulation of
gene expression, and any aberration may contribute to
oncogenesis[2][4].</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>While specific studies focusing on ARMC1 in prostate cancer are
scarce, its established roles in other cancers suggest it may also have
significant implications in prostate cancer biology. Increased
expression levels and potential involvement in cell cycle regulation
highlight the need for further research to clarify ARMC1’s role as a
biomarker and therapeutic target in prostate cancer. Understanding these
dynamics could provide valuable insights into the management and
treatment of this disease.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8976651/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8976651/</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069695/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069695/</a> [3]
<a href="https://apps.dtic.mil/sti/trecms/pdf/AD1208067.pdf"
class="uri">https://apps.dtic.mil/sti/trecms/pdf/AD1208067.pdf</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [5]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4233650/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4233650/</a> [6] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1123362/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1123362/full</a>
[7] <a href="https://patents.google.com/patent/US10570460B2/en"
class="uri">https://patents.google.com/patent/US10570460B2/en</a> [8] <a
href="https://academic.oup.com/nar/article/50/21/12186/6835365?login=false"
class="uri">https://academic.oup.com/nar/article/50/21/12186/6835365?login=false</a></p>
</div>
<div id="pim1" class="section level3">
<h3>PIM1</h3>
<p><strong>PIM1 in Prostate Cancer</strong></p>
<p><strong>PIM1</strong> (Proviral Integration site for Moloney murine
leukemia virus 1) is a serine/threonine kinase that has garnered
attention in the study of prostate cancer due to its role in
tumorigenesis, therapy resistance, and cellular proliferation. Here are
key points regarding the involvement of PIM1 in prostate cancer:</p>
<p><strong>Expression and Role in Tumorigenesis</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Overexpression in Prostate Cancer</strong>: PIM1 is
frequently overexpressed in prostate cancer tissues, particularly in
high-grade prostate intraepithelial neoplasia and malignant tumors
compared to normal prostatic tissue. This overexpression correlates with
poor therapeutic outcomes[1][3].</p></li>
<li><p><strong>Mechanisms of Action</strong>: PIM1 promotes cancer cell
survival by inhibiting apoptosis and enhancing cell cycle progression.
It can phosphorylate various substrates, including the androgen receptor
(AR), which affects AR degradation and function, particularly under low
androgen conditions. This mechanism implicates PIM1 in the development
of castration-resistant prostate cancer[1][2].</p></li>
</ol>
<p><strong>Impact on Therapy Resistance</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Docetaxel Resistance</strong>: Elevated levels of PIM1
have been linked to resistance against docetaxel, a common chemotherapy
drug used in advanced prostate cancer. Studies indicate that reducing
PIM1 levels can sensitize prostate cancer cells to docetaxel treatment,
suggesting that targeting PIM1 may enhance the efficacy of existing
therapies[1][5].</p></li>
<li><p><strong>Potential Therapeutic Target</strong>: Given its
significant role in promoting tumor growth and therapy resistance, PIM1
is considered a promising target for novel cancer therapies. Several
small-molecule inhibitors targeting PIM kinases are currently undergoing
clinical trials[2][4].</p></li>
</ol>
<p><strong>Influence on Cellular Dynamics</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Lipid Droplet Accumulation</strong>: Recent studies have
identified PIM1 as a driver of lipid droplet accumulation in prostate
cancer cells, which supports cell proliferation during nutrient stress.
This accumulation is linked to enhanced survival and metabolic
adaptation of cancer cells[2].</p></li>
<li><p><strong>Cell Motility and Metastasis</strong>: PIM1 has been
shown to enhance the motility of prostate cancer cells by
phosphorylating actin capping proteins, thereby promoting cell adhesion
and migration. This action contributes to the invasive and metastatic
potential of prostate tumors[4].</p></li>
</ol>
<p><strong>Conclusion</strong></p>
<p>PIM1 plays a multifaceted role in the progression of prostate cancer
through mechanisms involving cell survival, therapy resistance, and
enhanced motility. Its overexpression is associated with aggressive
tumor behavior and poor treatment outcomes, making it a critical focus
for ongoing research aimed at developing targeted therapies for prostate
cancer management.</p>
<p>Citations: [1] <a href="https://pubmed.ncbi.nlm.nih.gov/24274399/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/24274399/</a> [2] <a
href="https://www.nature.com/articles/s41388-023-02914-0"
class="uri">https://www.nature.com/articles/s41388-023-02914-0</a> [3]
<a href="https://haematologica.org/article/view/5606"
class="uri">https://haematologica.org/article/view/5606</a> [4] <a
href="https://biosignaling.biomedcentral.com/articles/10.1186/s12964-020-00618-6"
class="uri">https://biosignaling.biomedcentral.com/articles/10.1186/s12964-020-00618-6</a>
[5] <a href="https://www.spandidos-publications.com/10.3892/br.2015.561"
class="uri">https://www.spandidos-publications.com/10.3892/br.2015.561</a>
[6] <a href="https://apps.dtic.mil/sti/trecms/pdf/AD1208067.pdf"
class="uri">https://apps.dtic.mil/sti/trecms/pdf/AD1208067.pdf</a> [7]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [8]
<a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1123362/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1123362/full</a></p>
</div>
<div id="ctbp2" class="section level3">
<h3>CTBP2</h3>
<p><strong>CTBP2 in Prostate Cancer</strong></p>
<p><strong>CTBP2</strong> (C-terminal binding protein 2) is a
transcriptional corepressor that has been implicated in the progression
of prostate cancer through its interaction with key signaling pathways,
particularly those involving the androgen receptor (AR). Here are the
main findings regarding CTBP2’s role in prostate cancer:</p>
<p><strong>Mechanisms of Action</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Regulation of Androgen Receptor</strong>: CTBP2 has been
identified as a modulator of AR activity, which is crucial for the
development and progression of prostate cancer. It binds to AR and
represses tumor suppressor genes and AR corepressors, such as NCOR and
RIP140, thereby enhancing androgen-mediated gene expression [1][2]. This
interaction suggests that CTBP2 plays a significant role in promoting
oncogenic signaling.</p></li>
<li><p><strong>Genetic Variations and Susceptibility</strong>: Genetic
variations within the CTBP2 gene have been associated with
susceptibility to prostate cancer. Specific single nucleotide
polymorphisms (SNPs) in CTBP2 correlate with increased AR-enhancer
activity, linking genetic predisposition to functional outcomes in
cancer [1].</p></li>
</ol>
<p><strong>Clinical Implications</strong></p>
<ol style="list-style-type: decimal">
<li><p><strong>Prognostic Marker</strong>: High levels of CTBP2
expression are correlated with poor prognosis in prostate cancer
patients. Studies have shown that silencing CTBP2 can reduce tumor
growth in xenograft models, indicating its potential as a therapeutic
target [1][2].</p></li>
<li><p><strong>Role in Tumor Growth and Migration</strong>: Functional
experiments suggest that CTBP2 promotes prostate cancer cell
proliferation and migration, further emphasizing its role in tumor
aggressiveness [2][3].</p></li>
<li><p><strong>Angiogenesis</strong>: CTBP2 has also been implicated in
angiogenesis within prostate tumors, suggesting that it may contribute
to the tumor microenvironment and facilitate cancer progression through
enhanced blood supply [5].</p></li>
</ol>
<p><strong>Therapeutic Targeting</strong></p>
<p>Given its critical involvement in AR signaling and tumor progression,
CTBP2 is considered a promising target for therapeutic intervention in
prostate cancer. Targeting CTBP2 could potentially disrupt its oncogenic
functions and improve treatment outcomes for patients with advanced
disease [3][5].</p>
<p><strong>Conclusion</strong></p>
<p>CTBP2 is a key player in the molecular landscape of prostate cancer,
influencing both the androgen signaling pathway and tumor behavior. Its
association with poor prognosis and potential as a therapeutic target
highlights the importance of further research into its mechanisms and
roles within prostate cancer biology.</p>
<p>Citations: [1] <a href="https://pubmed.ncbi.nlm.nih.gov/25228652/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/25228652/</a> [2] <a
href="https://aacrjournals.org/cancerres/article/74/22/6542/599290/CtBP2-Modulates-the-Androgen-Receptor-to-Promote"
class="uri">https://aacrjournals.org/cancerres/article/74/22/6542/599290/CtBP2-Modulates-the-Androgen-Receptor-to-Promote</a>
[3] <a href="https://www.nature.com/articles/s41389-019-0163-x"
class="uri">https://www.nature.com/articles/s41389-019-0163-x</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069696/</a> [5]
<a href="https://www.spandidos-publications.com/10.3892/or.2017.5763"
class="uri">https://www.spandidos-publications.com/10.3892/or.2017.5763</a>
[6] <a href="https://apps.dtic.mil/sti/trecms/pdf/AD1208067.pdf"
class="uri">https://apps.dtic.mil/sti/trecms/pdf/AD1208067.pdf</a> [7]
<a href="https://haematologica.org/article/view/5606"
class="uri">https://haematologica.org/article/view/5606</a></p>
</div>
</div>
<div id="immune-functions" class="section level2">
<h2>Immune Functions</h2>
<div id="ly6g6d" class="section level3">
<h3>LY6G6D</h3>
<p>LY6G6D (Lymphocyte Antigen 6 Family Member G6D) plays several
important roles in immune function, particularly in colorectal cancer
(CRC) and neutrophil activity:</p>
<p><em>Role in Colorectal Cancer</em></p>
<p>LY6G6D has been identified as a selectively expressed antigen in
colorectal cancer, particularly in the microsatellite stable (MSS)
subtype[1]. Its expression in CRC has several implications for immune
function:</p>
<ul>
<li><p><strong>Immune Evasion</strong>: LY6G6D may help regulate tumor
growth and immune evasion in CRC[1].</p></li>
<li><p><strong>T Cell Suppression</strong>: LY6G6D-positive CRC cells
can inhibit T cell proliferation by expanding myeloid-derived suppressor
cells (MDSCs)[2].</p></li>
<li><p><strong>Immunosuppressive Environment</strong>: High expression
of LY6G6D is associated with increased infiltration of immunosuppressive
cells like regulatory T cells (Tregs) and T helper 2 (Th2)
cells[3].</p></li>
</ul>
<p><em>Neutrophil Function</em></p>
<p>LY6G6D is expressed in various myeloid cells, including neutrophils,
and plays a role in their function:</p>
<ul>
<li><p><strong>Neutrophil Activity</strong>: It influences neutrophil
infiltration, recruitment, and migration[2].</p></li>
<li><p><strong>Immune Senescence Marker</strong>: LY6G6D downregulation
is a crucial biomarker for tracking functional deterioration associated
with neutrophil immune senescence[2].</p></li>
<li><p><strong>Neutrophil Immune Functions</strong>: LY6G6D expression
is closely linked to neutrophil functions such as phagocytosis,
production of reactive oxygen species (ROS) and interleukin IL-1β,
formation of neutrophil extracellular traps (NETs), migration, and
bacterial clearance[2].</p></li>
</ul>
<p><em>Regulation and Signaling</em></p>
<p>The immune function of LY6G6D is regulated by several pathways:</p>
<ul>
<li><p><strong>JAK/STAT5 Pathway</strong>: LY6G6D is activated through
the JAK/STAT5 pathway in poorly immunogenic CRCs[3].</p></li>
<li><p><strong>p38α MAPK Signaling</strong>: p38α MAPK and DNA
methyltransferases mediate LY6G6D regulation[4].</p></li>
<li><p><strong>Epigenetic Regulation</strong>: DNA methylation changes
in the LY6G6D promoter are closely related to its transcript regulation
and expression in different CRC subtypes[4].</p></li>
</ul>
<p>In summary, LY6G6D plays a complex role in immune function,
particularly in the context of colorectal cancer and neutrophil
activity. Its expression can contribute to both immune evasion in cancer
and normal neutrophil function, making it an interesting target for
potential immunotherapies and diagnostic applications.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1008764/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1008764/full</a>
[2] <a href="https://www.cusabio.com/c-21107.html"
class="uri">https://www.cusabio.com/c-21107.html</a> [3] <a
href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-1019-5"
class="uri">https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-1019-5</a>
[4] <a
href="https://assets.researchsquare.com/files/rs-783534/v1/99ce7222-08af-4594-bf54-b9990bd59a99.pdf?c=1631887780"
class="uri">https://assets.researchsquare.com/files/rs-783534/v1/99ce7222-08af-4594-bf54-b9990bd59a99.pdf?c=1631887780</a>
[5] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11121234/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11121234/</a>
[6] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00819/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00819/full</a>
[7] <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=LY6G6D"
class="uri">https://www.genecards.org/cgi-bin/carddisp.pl?gene=LY6G6D</a>
[8] <a href="https://www.proteinatlas.org/ENSG00000244355-LY6G6D"
class="uri">https://www.proteinatlas.org/ENSG00000244355-LY6G6D</a></p>
</div>
<div id="ninl" class="section level3">
<h3>NINL</h3>
<p>Based on the search results provided, NINL (Ninein-like) plays
several important roles in immune function, particularly in the
antiviral innate immune response:</p>
<p><em>Antiviral Immune Response</em></p>
<p>NINL is a critical component in the antiviral innate immune
response:</p>
<ul>
<li><p><strong>Interferon Signaling</strong>: NINL knockout cells
exhibit an impaired response to interferon, resulting in increased
permissiveness to viral replication[1].</p></li>
<li><p><strong>ISG Production</strong>: Cells lacking NINL show a
dramatic reduction in interferon-stimulated gene (ISG) production,
likely due to decreased nuclear localization of phosphorylated STAT1
following interferon treatment[1].</p></li>
<li><p><strong>Viral Replication</strong>: In NINL knockout cells,
several RNA and DNA viruses show significantly increased replication
after interferon-α pretreatment compared to wild-type cells[1].</p></li>
</ul>
<p><em>Mechanism of Action</em></p>
<p>NINL’s role in the immune response appears to be related to its
function in intracellular transport:</p>
<ul>
<li><p><strong>Dynein Activating Adaptor</strong>: NINL is a dynein
activating adaptor, which is part of the intracellular transport
machinery[1].</p></li>
<li><p><strong>JAK/STAT Signaling</strong>: NINL acts after the
phosphorylation of STAT1 and STAT2 but before ISG transcription in the
interferon signaling cascade[1].</p></li>
</ul>
<p><em>Evolutionary Significance</em></p>
<p>NINL has unique evolutionary characteristics that suggest its
importance in host-pathogen interactions:</p>
<ul>
<li><p><strong>Positive Selection</strong>: NINL has evolved under
recurrent positive (diversifying) selection, particularly in its
carboxy-terminal cargo-binding region[1][2].</p></li>
<li><p><strong>Host-Virus Genetic Conflict</strong>: This evolutionary
signature is characteristic of genes involved in host-virus genetic
conflicts, suggesting NINL’s role in antiviral defense[2].</p></li>
</ul>
<p><em>Viral Antagonism</em></p>
<p>NINL is also a target of viral antagonism:</p>
<ul>
<li><strong>Viral Protease Cleavage</strong>: Proteases encoded by
diverse picornaviruses and coronaviruses cleave and disrupt NINL
function in a host- and virus-specific manner[1][2].</li>
</ul>
<p>In summary, NINL plays a crucial role in the antiviral immune
response by facilitating interferon signaling and ISG production. Its
evolutionary history and targeting by viral proteases further underscore
its importance in host-pathogen interactions. The discovery of NINL’s
immune function demonstrates the utility of using signatures of
host-virus genetic conflicts to uncover novel components of the immune
system.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/</a> [2] <a
href="https://pubmed.ncbi.nlm.nih.gov/36222652/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/36222652/</a> [3] <a
href="https://www.cusabio.com/c-21107.html"
class="uri">https://www.cusabio.com/c-21107.html</a> [4] <a
href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-1019-5"
class="uri">https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-1019-5</a>
[5] <a
href="https://assets.researchsquare.com/files/rs-783534/v1/99ce7222-08af-4594-bf54-b9990bd59a99.pdf?c=1631887780"
class="uri">https://assets.researchsquare.com/files/rs-783534/v1/99ce7222-08af-4594-bf54-b9990bd59a99.pdf?c=1631887780</a>
[6] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00819/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00819/full</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11121234/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC11121234/</a> [8]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1008764/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1008764/full</a></p>
</div>
<div id="ano7-1" class="section level3">
<h3>ANO7</h3>
<p>Based on the search results provided, ANO7 (Anoctamin 7) plays
several important roles in prostate biology and may have implications
for immune function in prostate cancer:</p>
<p><strong>Expression and Localization</strong></p>
<ul>
<li>ANO7 is a calcium2+-dependent chloride ion channel protein[1].</li>
<li>Its expression is restricted to prostate epithelial cells[1].</li>
<li>ANO7 is strongly expressed in normal prostate glandular cells,
particularly at the apical pole and lateral surfaces of epithelial
cells[1].</li>
</ul>
<p><strong>Role in Prostate Cancer</strong></p>
<p>ANO7 expression appears to be altered in prostate cancer:</p>
<ul>
<li>ANO7 is often less abundant in cancer cells compared to normal
prostate tissue[1].</li>
<li>Reduced ANO7 staining is tightly linked to adverse tumor features,
including:
<ul>
<li>High Gleason grade</li>
<li>Lymph node metastasis</li>
<li>Advanced tumor stage</li>
<li>High Ki67 labeling index</li>
<li>Positive surgical margin</li>
<li>Early biochemical recurrence[1]</li>
</ul></li>
</ul>
<p><strong>Prognostic Significance</strong></p>
<ul>
<li>Reduced ANO7 expression is a strong and independent predictor of
poor patient prognosis in prostate cancer[1].</li>
<li>The prognostic impact of ANO7 was independent of established pre- or
postoperatively available parameters[1].</li>
</ul>
<p><strong>Potential Immune-Related Functions</strong></p>
<p>While not directly described as an immune function, ANO7’s altered
expression in prostate cancer may have implications for immune
responses:</p>
<ul>
<li>Low ANO7 expression was linked to TMPRSS2:ERG fusions, which are
known to affect immune-related pathways in prostate cancer[1].</li>
<li>The loss of ANO7 expression in more aggressive prostate cancers
could potentially affect immune cell interactions with tumor cells,
though this is not explicitly stated in the provided information.</li>
</ul>
<p><strong>Molecular Associations</strong></p>
<ul>
<li>ANO7 expression changes were associated with specific molecular
features of prostate cancer, including ERG status and PTEN
deletions[1].</li>
</ul>
<p>In summary, while ANO7 is not directly described as having a specific
immune function, its altered expression in prostate cancer and its
strong prognostic significance suggest it may play a role in the biology
of prostate cancer that could indirectly affect immune responses.
Further research would be needed to elucidate any direct immune
functions of ANO7.</p>
<p>Citations: [1] <a
href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/</a> [3] <a
href="https://pubmed.ncbi.nlm.nih.gov/36222652/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/36222652/</a> [4] <a
href="https://www.cusabio.com/c-21107.html"
class="uri">https://www.cusabio.com/c-21107.html</a> [5] <a
href="https://assets.researchsquare.com/files/rs-783534/v1/99ce7222-08af-4594-bf54-b9990bd59a99.pdf?c=1631887780"
class="uri">https://assets.researchsquare.com/files/rs-783534/v1/99ce7222-08af-4594-bf54-b9990bd59a99.pdf?c=1631887780</a>
[6] <a
href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-1019-5"
class="uri">https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-1019-5</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11121234/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC11121234/</a> [8]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00819/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00819/full</a></p>
</div>
<div id="ldb1" class="section level3">
<h3>LDB1</h3>
<p>Based on the search results, LDB1 (LIM Domain Binding 1) plays
several important roles in immune function and hematopoiesis:</p>
<p><strong>Erythroid Development and Globin Gene Regulation</strong></p>
<p>LDB1 is crucial for β-globin activation and erythroid
development:</p>
<ul>
<li>It forms a complex with GATA-1, SCL, and LMO2 that is required for
β-globin locus control region (LCR) and gene proximity[1].</li>
<li>LDB1 stabilizes this complex on β-globin chromatin, even though it’s
not a DNA-binding component[1].</li>
<li>It’s necessary for enrichment of key transcriptional components like
P-TEFb at the β-globin locus[1].</li>
</ul>
<p><strong>T-cell Development and Leukemia</strong></p>
<p>LDB1 is involved in T-cell development and can contribute to
leukemogenesis:</p>
<ul>
<li>It’s required for Lmo2 oncogene-induced thymocyte self-renewal and
neoplastic transformation[2].</li>
<li>Deletion of LDB1 corrects abnormal phenotypes and developmental
defects in Lmo2 transgenic thymocytes[2].</li>
<li>LDB1 is part of a complex (Ldb1/Lmo2 complex) that imposes abnormal
self-renewal on immature thymocytes, potentially leading to
leukemogenesis[2].</li>
</ul>
<p><strong>Gene Expression Regulation</strong></p>
<p>LDB1 controls gene expression at multiple levels:</p>
<ul>
<li>It’s necessary for RNA polymerase II phosphorylation to the fully
elongation-competent form at the β-globin gene[1].</li>
<li>LDB1 is required for the β-globin locus to migrate away from the
nuclear periphery, which is necessary for robust transcription[1].</li>
<li>It regulates genes important for immune system processes, T-cell
differentiation, activation, and signaling[2].</li>
</ul>
<p><strong>Hematopoietic Stem and Progenitor Cell (HSPC)
Maintenance</strong></p>
<p>LDB1 is critical for HSPC maintenance and self-renewal:</p>
<ul>
<li>It binds to promoters and enhancers of genes known to regulate HSPC
maintenance[2].</li>
<li>Some of these genes (e.g., Lyl1, Nfe2, Hhex) are also upregulated in
preleukemic thymocytes and human early T-cell precursor acute
lymphoblastic leukemia (ETP-ALL)[2].</li>
</ul>
<p>In summary, LDB1 plays crucial roles in erythroid development, T-cell
development, gene expression regulation, and hematopoietic stem cell
maintenance. Its functions in these processes have significant
implications for normal immune function as well as potential
contributions to leukemogenesis.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2953839/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC2953839/</a> [2] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316212/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316212/</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/</a> [4] <a
href="https://www.cusabio.com/c-21107.html"
class="uri">https://www.cusabio.com/c-21107.html</a> [5] <a
href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-1019-5"
class="uri">https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-1019-5</a>
[6] <a href="https://pubmed.ncbi.nlm.nih.gov/36222652/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/36222652/</a> [7] <a
href="https://assets.researchsquare.com/files/rs-783534/v1/99ce7222-08af-4594-bf54-b9990bd59a99.pdf?c=1631887780"
class="uri">https://assets.researchsquare.com/files/rs-783534/v1/99ce7222-08af-4594-bf54-b9990bd59a99.pdf?c=1631887780</a>
[8] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10183566/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10183566/</a></p>
</div>
<div id="tnfrsf6b" class="section level3">
<h3>TNFRSF6B</h3>
<p>Based on the search results, TNFRSF6B (Tumor Necrosis Factor Receptor
Superfamily Member 6B) plays several important roles in immune
function:</p>
<ol style="list-style-type: decimal">
<li>Regulation of immune responses:</li>
</ol>
<ul>
<li>TNFRSF6B is involved in the regulation of immune responses and
immune system processes[1].</li>
<li>It affects the activity and differentiation of T lymphocytes,
macrophages, and dendritic cells[1].</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Immune evasion:</li>
</ol>
<ul>
<li>TNFRSF6B acts as a decoy receptor that competitively binds to FasL,
TL1A, and LIGHT expressed on T cells, blocking their ability to induce
apoptosis and clear tumor cells[1][2].</li>
<li>This allows tumors to evade immune surveillance[2].</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Downregulation of immune responses:</li>
</ol>
<ul>
<li>TNFRSF6B can downregulate the immune system through several
mechanisms[1]:
<ul>
<li>Inhibiting actin polymerization in T cells, reducing their
interaction with antigen-presenting cells</li>
<li>Blocking activation of T cells by competing with LIGHT and TL1A</li>
<li>Inhibiting NF-kappa B activation, which is important for T cell
activation</li>
</ul></li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Effects on specific immune cells:</li>
</ol>
<ul>
<li>TNFRSF6B expression is negatively correlated with CD8+ T cells, CD4+
memory T cells, and macrophages[1].</li>
<li>It is positively correlated with regulatory T cells (Tregs)[1].</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Interaction with immune checkpoints:</li>
</ol>
<ul>
<li>High TNFRSF6B expression is associated with decreased expression of
immune checkpoint molecules like CTLA-4 and PD-1[1].</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Anti-apoptotic effects:</li>
</ol>
<ul>
<li>TNFRSF6B can protect cells against apoptosis, which may contribute
to the persistence of inflammatory cells in chronic
conditions[2][3].</li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Role in chronic inflammation:</li>
</ol>
<ul>
<li>Overexpression of TNFRSF6B is associated with worsening of various
chronic inflammatory diseases[3].</li>
</ul>
<p>In summary, TNFRSF6B primarily functions as an immunosuppressive
molecule that helps cells, particularly tumor cells, evade immune
responses. It does this by interfering with T cell activation and
function, promoting regulatory T cells, and inhibiting apoptosis of
potentially harmful cells. Its expression is associated with poorer
outcomes in various cancers and chronic inflammatory conditions.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/</a> [2] <a
href="https://www.nature.com/articles/modpathol201329"
class="uri">https://www.nature.com/articles/modpathol201329</a> [3] <a
href="https://www.cell.com/immunity/pdf/S1074-7613(16)30148-0.pdf"
class="uri">https://www.cell.com/immunity/pdf/S1074-7613(16)30148-0.pdf</a>
[4] <a
href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-1019-5"
class="uri">https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-1019-5</a>
[5] <a href="https://www.cusabio.com/c-21107.html"
class="uri">https://www.cusabio.com/c-21107.html</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10183566/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10183566/</a> [7]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11121234/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC11121234/</a> [8]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/</a></p>
</div>
<div id="mmp7-1" class="section level3">
<h3>MMP7</h3>
<p>Based on the search results, MMP7 (Matrix Metalloproteinase 7) plays
several important roles in immune function:</p>
<ol style="list-style-type: decimal">
<li>Activation of antimicrobial peptides:</li>
</ol>
<ul>
<li>In the small intestine, MMP7 is responsible for activating
α-defensins, which are broad-spectrum antimicrobial peptides produced by
Paneth cells[1].</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Regulation of intestinal inflammation and barrier function:</li>
</ol>
<ul>
<li>MMP7 contributes to intestinal inflammation and increased intestinal
permeability during endotoxemia[1].</li>
<li>It is involved in the degradation of tight junction proteins like
Claudin-7, which impairs the intestinal epithelial barrier[2].</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Amplification of inflammatory responses:</li>
</ol>
<ul>
<li>MMP7-activated α-defensins can stimulate IL-6 release in macrophages
and ileum explants, amplifying local inflammatory responses in the
gut[1].</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Immune cell recruitment and activation:</li>
</ol>
<ul>
<li>MMP7 participates in neutrophil activation by modulating
syndecan-1/CXCL1 complexes in airway epithelial cells[3].</li>
<li>It is involved in the shedding of Syndecan-4 from B-lymphocytes,
which may influence chemokine influx and cell activation[3].</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Facilitation of immune cell access to the central nervous
system:</li>
</ol>
<ul>
<li>In experimental autoimmune encephalomyelitis (EAE), MMP7 may
facilitate immune cell access or re-stimulation in perivascular areas of
the brain[4].</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Regulation of T cell responses:</li>
</ol>
<ul>
<li>MMP7-deficient mice show reduced T cell responses to myelin
oligodendrocyte glycoprotein (MOG) in EAE models[4].</li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Blood-brain barrier permeability:</li>
</ol>
<ul>
<li>Recombinant MMP7 can increase permeability between endothelial cells
in an in vitro blood-brain barrier model[4].</li>
</ul>
<ol start="8" style="list-style-type: decimal">
<li>Tissue remodeling and repair:</li>
</ol>
<ul>
<li>MMP7 contributes to tissue remodeling and acute inflammation by
degrading extracellular matrix proteins[3].</li>
</ul>
<ol start="9" style="list-style-type: decimal">
<li>Innate immune defense:</li>
</ol>
<ul>
<li>B-lymphocytes secrete MMP7 in response to microbial antigens like
unmethylated CpG motifs (found in bacterial DNA) and β-glucans (found in
fungal cell walls), suggesting a role in innate immune defense[3].</li>
</ul>
<p>In summary, MMP7 plays diverse roles in immune function, including
antimicrobial peptide activation, regulation of intestinal barrier
function, amplification of inflammatory responses, immune cell
recruitment and activation, and facilitation of immune cell access to
the central nervous system. Its functions can be both protective (e.g.,
antimicrobial defense) and potentially harmful (e.g., contributing to
excessive inflammation in certain conditions).</p>
<p>Citations: [1] <a href="https://www.nature.com/articles/mi201376"
class="uri">https://www.nature.com/articles/mi201376</a> [2] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1020902/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1020902/full</a>
[3] <a href="https://www.nature.com/articles/s41598-017-04199-2"
class="uri">https://www.nature.com/articles/s41598-017-04199-2</a> [4]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660336/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660336/</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/</a> [6] <a
href="https://archivesofrheumatology.org/full-text/1513"
class="uri">https://archivesofrheumatology.org/full-text/1513</a> [7] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1064033/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1064033/full</a>
[8] <a href="https://www.cancerbiomed.org/content/18/1/245"
class="uri">https://www.cancerbiomed.org/content/18/1/245</a></p>
</div>
<div id="ccnd1" class="section level3">
<h3>CCND1</h3>
<p>Based on the search results, CCND1 (Cyclin D1) plays several
important roles related to immune function and immunosuppression in
cancer:</p>
<ol style="list-style-type: decimal">
<li>Immunosuppression in the tumor microenvironment (TME):</li>
</ol>
<ul>
<li>CCND1 amplification is associated with various degrees of immune
cell exclusion in the TME, including reduced infiltration of cytotoxic
cells, T cells, CD8+ T cells, dendritic cells, and B cells.</li>
<li>It correlates with increased proportions of immunosuppressive cells
like regulatory T cells (Tregs) and M2 macrophages.</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Impairment of anti-tumor immunity:</li>
</ol>
<ul>
<li>CCND1 amplification contributes to resistance to immune checkpoint
inhibitor (ICI) therapy in multiple cancer types.</li>
<li>It is associated with poor clinical outcomes and inferior responses
to ICI treatment.</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Regulation of immunosuppressive pathways:</li>
</ol>
<ul>
<li>CCND1 amplification correlates with activation of immunosuppressive
signaling pathways, including TGF-β signaling, epithelial-mesenchymal
transition, and hypoxia signaling.</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Modulation of angiogenesis and immune cell trafficking:</li>
</ol>
<ul>
<li>CCND1 may play a role in maintaining VEGF levels, which can suppress
dendritic cell maturation and CD8+ T cell proliferation.</li>
<li>It may affect immune cell trafficking through modulation of adhesion
molecules like ICAM1.</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Metabolic effects on immune function:</li>
</ol>
<ul>
<li>CCND1 amplification is associated with changes in oxidative
phosphorylation and lipid metabolism pathways, which can impact immune
cell function in the TME.</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Potential therapeutic implications:</li>
</ol>
<ul>
<li>The immunosuppressive effects of CCND1 amplification suggest that
targeting CCND1 or related pathways (e.g., CDK4/6 inhibitors) may have
potential in combination with immunotherapies.</li>
</ul>
<p>In summary, while CCND1 is primarily known for its role in cell cycle
regulation, its amplification appears to have significant
immunosuppressive effects in the context of cancer. It contributes to an
immunosuppressive tumor microenvironment, impairs anti-tumor immune
responses, and may affect the efficacy of immunotherapies. These
findings highlight CCND1 as an important factor in the intersection of
cancer biology and immune function.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/</a> [2] <a
href="https://pubmed.ncbi.nlm.nih.gov/32903763/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/32903763/</a> [3] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.725679/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.725679/full</a>
[4] <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCND1"
class="uri">https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCND1</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/</a> [7] <a
href="https://www.nature.com/articles/s41598-018-25141-0"
class="uri">https://www.nature.com/articles/s41598-018-25141-0</a> [8]
<a href="https://pubmed.ncbi.nlm.nih.gov/36222652/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/36222652/</a></p>
</div>
<div id="usp28" class="section level3">
<h3>USP28</h3>
<p>Based on the search results, USP28 (Ubiquitin Specific Peptidase 28)
plays several important roles related to immune function:</p>
<ol style="list-style-type: decimal">
<li>T cell regulation:</li>
</ol>
<ul>
<li>USP28 is crucial for T cell functionality and activation.</li>
<li>It regulates STAT5 phosphorylation in T cells.</li>
<li>USP28 deficiency results in early defects in T cell activation and
functional changes.</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Cytokine production:</li>
</ol>
<ul>
<li>USP28 regulates IL-22 production in T lymphocytes.</li>
<li>USP28 knockout leads to reduced expression of IL-17.</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Intestinal inflammation:</li>
</ol>
<ul>
<li>USP28 exerts protective effects in acute intestinal
inflammation.</li>
<li>USP28 knockout mice exhibit increased susceptibility to acute
DSS-induced intestinal inflammation.</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>T cell populations:</li>
</ol>
<ul>
<li>USP28 deficiency results in an increase in total T cells, mainly due
to increased CD8+ T cell content.</li>
<li>It affects the balance of T cell subsets, including an increase in
inducible regulatory T (iTreg) suppressive functions.</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Immune cell infiltration:</li>
</ol>
<ul>
<li>USP28 expression is associated with immune cell infiltration in
various cancer types.</li>
<li>It correlates with infiltration levels of neutrophils and NK cells
in most tumor types.</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Immune checkpoint regulation:</li>
</ol>
<ul>
<li>USP28 expression is correlated with immune checkpoint genes in
several cancer types.</li>
<li>It may serve as a predictor of response to immune checkpoint
inhibitor therapy, particularly anti-CTLA4 therapy in melanoma.</li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Interaction with immune-related pathways:</li>
</ol>
<ul>
<li>USP28 is associated with various immune-related signaling pathways,
including TNFA-signaling-via-NFKB, inflammatory response, and
IL6-JAK-STAT3-signaling.</li>
</ul>
<p>In summary, USP28 plays a significant role in T cell function,
cytokine production, and regulation of intestinal inflammation. It also
appears to be involved in broader aspects of immune regulation,
particularly in the context of cancer, where it influences immune cell
infiltration and may affect responses to immunotherapy.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1401949/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1401949/full</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10373984/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10373984/</a> [3]
<a href="https://www.nature.com/articles/s41419-017-0208-z"
class="uri">https://www.nature.com/articles/s41419-017-0208-z</a> [4] <a
href="https://academic.oup.com/nar/article/52/6/3011/7560176?login=false"
class="uri">https://academic.oup.com/nar/article/52/6/3011/7560176?login=false</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/</a> [7] <a
href="https://www.nature.com/articles/s41598-017-04199-2"
class="uri">https://www.nature.com/articles/s41598-017-04199-2</a> [8]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/</a></p>
</div>
<div id="rab13" class="section level3">
<h3>RAB13</h3>
<p>Based on the search results, RAB13 appears to have several important
immune-related functions:</p>
<ol style="list-style-type: decimal">
<li>Macrophage regulation:</li>
</ol>
<ul>
<li>RAB13 is involved in macrophage polarization, particularly in the
context of sepsis. High RAB13 expression is associated with inhibition
of M1-like macrophage polarization and promotion of M2-like
polarization.</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Immune cell infiltration:</li>
</ol>
<ul>
<li>RAB13 expression is positively correlated with infiltration of
macrophages and other immune cells in colorectal cancer.</li>
<li>It is associated with infiltration levels of neutrophils and NK
cells in various tumor types.</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>T cell regulation:</li>
</ol>
<ul>
<li>RAB13 expression is correlated with reduced infiltration of
cytotoxic T cells, CD8+ T cells, and dendritic cells in the tumor
microenvironment.</li>
<li>It is associated with increased proportions of immunosuppressive
cells like regulatory T cells (Tregs).</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Cytokine signaling:</li>
</ol>
<ul>
<li>RAB13 is involved in cytokine signaling in the immune system,
particularly in the context of inflammation and cancer.</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Tight junction regulation:</li>
</ol>
<ul>
<li>RAB13 regulates the structure and function of tight junctions, which
are important for maintaining epithelial barriers that play a role in
immune defense.</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Intracellular trafficking:</li>
</ol>
<ul>
<li>As a member of the Rab GTPase family, RAB13 is involved in
regulating intracellular trafficking, which is crucial for various
immune processes including antigen presentation and cytokine
secretion.</li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Sepsis severity:</li>
</ol>
<ul>
<li>High RAB13 expression is positively correlated with sepsis severity
and negatively correlated with patient survival in sepsis.</li>
</ul>
<ol start="8" style="list-style-type: decimal">
<li>Potential therapeutic target:</li>
</ol>
<ul>
<li>RAB13’s involvement in immune cell infiltration and regulation
suggests it could be a potential therapeutic target, particularly in
cancer immunotherapy.</li>
</ul>
<p>In summary, RAB13 appears to play significant roles in regulating
various aspects of the immune response, particularly in the context of
inflammation, sepsis, and cancer. Its functions include modulating
macrophage polarization, influencing immune cell infiltration, and
potentially contributing to immunosuppression in the tumor
microenvironment.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1403008/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1403008/full</a>
[2] <a href="https://www.nature.com/articles/s41598-024-71771-y"
class="uri">https://www.nature.com/articles/s41598-024-71771-y</a> [3]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/</a> [5] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/</a> [7] <a
href="https://pubmed.ncbi.nlm.nih.gov/36222652/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/36222652/</a> [8] <a
href="https://www.nature.com/articles/s41598-017-04199-2"
class="uri">https://www.nature.com/articles/s41598-017-04199-2</a></p>
</div>
<div id="myo9b-1" class="section level3">
<h3>MYO9B</h3>
<p>Based on the search results, MYO9B (Myosin IXb) plays several
important roles in immune function:</p>
<ol style="list-style-type: decimal">
<li>T cell motility and tissue infiltration:</li>
</ol>
<ul>
<li>MYO9B enables CD8+ T cells to infiltrate nonlymphoid tissues by
facilitating crossing of tissue barriers like basement membranes.</li>
<li>It is critical for T cell adaptation from lymphoid to nonlymphoid
tissue surveillance.</li>
<li>MYO9B-deficient CD8+ T cells show impaired accumulation in
nonlymphoid tissues and reduced control of skin infections.</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Regulation of Rho GTPase activity:</li>
</ol>
<ul>
<li>MYO9B acts as a negative regulator of the small GTPase Rho in T
cells.</li>
<li>Lack of MYO9B leads to increased Rho-GTP levels and cell surface
stiffness in T cells.</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Dendritic cell function:</li>
</ol>
<ul>
<li>MYO9B mutations are associated with altered dendritic cell
functions.</li>
<li>It regulates phenotypic, metabolic, and functional maturation of
dendritic cells.</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Autoimmune diabetes susceptibility:</li>
</ol>
<ul>
<li>Mutations in MYO9B are associated with increased susceptibility to
autoimmune diabetes onset.</li>
<li>MYO9B knock-in or knockout in mice attenuates T cell-mediated
autoimmune responses and inhibits autoimmune diabetes development.</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Regulation of immune cell morphology and motility:</li>
</ol>
<ul>
<li>MYO9B contributes to the regulation of morphology and motility in
various immune cell types.</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Cytokine regulation:</li>
</ol>
<ul>
<li>MYO9B mutations affect levels of pro-inflammatory and
anti-inflammatory cytokines in serum.</li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Treg cell function:</li>
</ol>
<ul>
<li>MYO9B knockout or knock-in mice show increased regulatory T cell
(Treg) proportion and function.</li>
</ul>
<p>In summary, MYO9B plays crucial roles in T cell motility and tissue
infiltration, dendritic cell function, regulation of autoimmune
responses, and overall immune cell morphology and motility. Its
functions are particularly important for adaptive immune responses and
the establishment of protective tissue-resident T cell populations.</p>
<p>Citations: [1] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028505/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028505/</a>
[2] <a href="https://www.nature.com/articles/s41467-023-41534-w"
class="uri">https://www.nature.com/articles/s41467-023-41534-w</a> [3]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [4] <a
href="https://www.nature.com/articles/s41598-017-04199-2"
class="uri">https://www.nature.com/articles/s41598-017-04199-2</a> [5]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/</a> [7] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660336/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660336/</a>
[8] <a href="https://pubmed.ncbi.nlm.nih.gov/36222652/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/36222652/</a></p>
</div>
<div id="flot1" class="section level3">
<h3>FLOT1</h3>
<p>Based on the search results, FLOT1 (Flotillin-1) plays several
important roles in immune function:</p>
<ol style="list-style-type: decimal">
<li>T cell migration and motility:</li>
</ol>
<ul>
<li>FLOT1 accumulates in the uropod of polarized T cells, suggesting a
role in T cell migration.</li>
<li>FLOT1-deficient CD8+ T cells showed alterations in cell shape and
motility parameters in vivo, including reduced migration speeds and
increased arrest coefficients.</li>
<li>However, the impact on overall T cell surveillance and function was
relatively minor.</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Neutrophil and monocyte migration:</li>
</ol>
<ul>
<li>FLOT1-deficient mice show impaired recruitment of neutrophils and
monocytes to inflammatory sites due to decreased migratory
capacity.</li>
<li>FLOT1 deficiency in neutrophils leads to reduced myosin II activity
and impaired cell migration.</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Lipid raft organization and signaling:</li>
</ol>
<ul>
<li>FLOT1 is a lipid raft-associated scaffolding protein that helps
organize membrane microdomains.</li>
<li>It assembles at immunological synapses and may serve as a scaffold
for T cell receptor signaling machinery.</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Endocytosis and membrane trafficking:</li>
</ol>
<ul>
<li>FLOT1 promotes endocytosis of various receptors and proteins
involved in immune cell function.</li>
<li>It participates in membrane trafficking, which is important for
immune cell processes.</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Cytoskeletal regulation:</li>
</ol>
<ul>
<li>FLOT1 is involved in modulating the actomyosin cytoskeleton of
leukocytes, which is crucial for cell migration and function.</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>T cell activation:</li>
</ol>
<ul>
<li>While FLOT1 is involved in T cell receptor recycling and signaling
at the immunological synapse, its deficiency did not significantly
impair T cell expansion or memory formation in the experimental
conditions tested.</li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Dendritic cell function:</li>
</ol>
<ul>
<li>FLOT1 may play a role in dendritic cell functions, though this was
not extensively detailed in the provided information.</li>
</ul>
<p>In summary, FLOT1 contributes to immune cell migration, membrane
organization, and signaling processes, particularly in T cells and
neutrophils. However, its impact on overall immune function appears to
be relatively subtle under physiological conditions, as FLOT1-deficient
T cells were still capable of mounting effective immune responses in the
studies described.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10552069/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10552069/</a> [2]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820809/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820809/</a>
[3] <a href="https://www.biorxiv.org/content/10.1101/403592v1.full.pdf"
class="uri">https://www.biorxiv.org/content/10.1101/403592v1.full.pdf</a>
[4] <a href="https://www.nature.com/articles/s41467-023-41534-w"
class="uri">https://www.nature.com/articles/s41467-023-41534-w</a> [5]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/</a> [7] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028505/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028505/</a>
[8] <a href="https://www.nature.com/articles/mi201376"
class="uri">https://www.nature.com/articles/mi201376</a></p>
</div>
<div id="pknox2-1" class="section level3">
<h3>PKNOX2</h3>
<p>Based on the search results, PKNOX2 (PBX/knotted 1 homeobox 2) does
not appear to have a direct immune function. However, it plays important
roles that could indirectly affect immune responses, particularly in the
context of cancer:</p>
<ol style="list-style-type: decimal">
<li>Tumor suppressor function:</li>
</ol>
<ul>
<li>PKNOX2 acts as a tumor suppressor in lung cancer and gastric
cancer.</li>
<li>It suppresses cancer cell proliferation, migration, and
invasion.</li>
<li>PKNOX2 induces apoptosis and cell cycle arrest in cancer cells.</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Regulation of signaling pathways:</li>
</ol>
<ul>
<li>PKNOX2 inhibits the PI3K/AKT/mTOR signaling axis in lung cancer
cells.</li>
<li>It activates the IGFBP5 and p53 signaling pathways in gastric cancer
cells.</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Transcriptional regulation:</li>
</ol>
<ul>
<li>PKNOX2 binds to the promoter regions of IGFBP5 and TP53 genes and
transcriptionally activates their expression.</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Fibrosis regulation:</li>
</ol>
<ul>
<li>In heart tissue, PKNOX2 has been identified as a novel regulator
associated with physiological fibroblast activation.</li>
<li>It plays an inhibitory role in pathological fibrosis
remodeling.</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Epigenetic regulation:</li>
</ol>
<ul>
<li>PKNOX2 is often silenced in cancers through promoter
hypermethylation.</li>
<li>Its expression can be restored by DNA methyltransferase
inhibitors.</li>
</ul>
<p>While these functions are not directly related to the immune system,
they could potentially influence immune responses in the tumor
microenvironment or during tissue repair processes. For example, the
regulation of fibrosis and cell proliferation could affect immune cell
infiltration and function in tissues. However, the search results do not
provide direct evidence of PKNOX2’s involvement in immune cell function
or immune responses.</p>
<p>Citations: [1] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133798/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133798/</a>
[2] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756047/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756047/</a>
[3] <a href="https://www.nature.com/articles/s41392-024-01804-5"
class="uri">https://www.nature.com/articles/s41392-024-01804-5</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/</a> [5] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/</a> [6] <a
href="https://www.nature.com/articles/s41467-023-41534-w"
class="uri">https://www.nature.com/articles/s41467-023-41534-w</a> [7]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [8] <a
href="https://academic.oup.com/mbe/article/40/7/msad128/7185703?login=false"
class="uri">https://academic.oup.com/mbe/article/40/7/msad128/7185703?login=false</a></p>
</div>
<div id="lgr4-1" class="section level3">
<h3>LGR4</h3>
<p>Based on the search results, LGR4 (Leucine-rich repeat-containing G
protein-coupled receptor 4) plays several important roles in immune
function:</p>
<ol style="list-style-type: decimal">
<li>Negative regulation of TLR2/4 signaling and innate immune
responses:</li>
</ol>
<ul>
<li>LGR4 negatively modulates pattern-associated molecular pattern
(PAMP)-induced immune responses.</li>
<li>Loss of LGR4 in macrophages leads to increased activation of NF-κB
and overproduction of proinflammatory cytokines in response to TLR2/4
ligands[1].</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Attenuation of proinflammatory cytokine production:</li>
</ol>
<ul>
<li>LGR4 deficiency results in increased production of proinflammatory
cytokines like TNF-α, IL-6, IL-1α, IFN-β, CXCL10, and GM-CSF in response
to LPS stimulation[1].</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Regulation of macrophage polarization:</li>
</ol>
<ul>
<li>LGR4 promotes macrophage M2 polarization through Rspo/LGR4/Erk/Stat3
signaling[2].</li>
<li>LGR4 deficiency leads to fewer protumoral M2 tumor-associated
macrophages (TAMs) in tumor microenvironments[2].</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Modulation of T cell responses:</li>
</ol>
<ul>
<li>LGR4 deficiency is associated with increased CD8+ T lymphocyte
infiltration in tumor microenvironments[2].</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Anti-inflammatory effects:</li>
</ol>
<ul>
<li>LGR4 has been shown to protect different types of cells against
inflammation, particularly in the digestive system[3].</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Regulation of NF-κB signaling:</li>
</ol>
<ul>
<li>LGR4 negatively regulates NF-κB activation in LPS-induced signaling
pathways[1].</li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Involvement in immune checkpoint therapy:</li>
</ol>
<ul>
<li>Blocking Rspo-LGR4 signaling can overcome resistance to anti-PD-1
therapy and improve the efficacy of PD-1 immunotherapy in cancer
models[2].</li>
</ul>
<ol start="8" style="list-style-type: decimal">
<li>Participation in TGFβ and NF-κB signaling regulation:</li>
</ol>
<ul>
<li>LGR4 is involved in regulating TGFβ signaling in hematopoietic
precursors and NF-κB signaling in intestinal cells[3].</li>
</ul>
<p>In summary, LGR4 plays a crucial role in regulating innate immune
responses, particularly by attenuating TLR2/4-mediated inflammation,
modulating macrophage polarization, and influencing T cell responses.
Its functions have significant implications for both normal immune
homeostasis and cancer immunotherapy.</p>
<p>Citations: [1] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663533/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663533/</a>
[2] <a
href="https://aacrjournals.org/cancerres/article/78/17/4929/657527/Inhibition-of-Rspo-Lgr4-Facilitates-Checkpoint"
class="uri">https://aacrjournals.org/cancerres/article/78/17/4929/657527/Inhibition-of-Rspo-Lgr4-Facilitates-Checkpoint</a>
[3] <a
href="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.867001/full"
class="uri">https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.867001/full</a>
[4] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.728827/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.728827/full</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [6] <a
href="https://academic.oup.com/edrv/article/44/4/647/7040426"
class="uri">https://academic.oup.com/edrv/article/44/4/647/7040426</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/</a> [8] <a
href="https://www.nature.com/articles/mi201376"
class="uri">https://www.nature.com/articles/mi201376</a></p>
</div>
<div id="itpk1-1" class="section level3">
<h3>ITPK1</h3>
<p>Based on the search results, ITPK1 (Inositol-Tetrakisphosphate
1-Kinase) plays several important roles in immune function:</p>
<ol style="list-style-type: decimal">
<li>Regulation of T cell activation and development:</li>
</ol>
<ul>
<li>ITPK1 is involved in the Ca2+/NFAT signaling pathway, which helps
limit the activity of T cells.</li>
<li>Deficiency in ITPK1 can lead to defects in T cell maturation and
selection in the thymus.</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>B cell survival and selection:</li>
</ol>
<ul>
<li>ITPK1 plays a crucial role in B cell survival and selection.</li>
<li>Knockout of ITPK1 in mice leads to inappropriate apoptosis of B
lymphocytes and B cell anergy.</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Regulation of innate immune responses:</li>
</ol>
<ul>
<li>ITPK1 is involved in modulating innate immune responses, including
neutrophil and mast cell activation.</li>
<li>It affects the function of innate immune cells by regulating calcium
signaling and other intracellular pathways.</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Modulation of inflammatory responses:</li>
</ol>
<ul>
<li>ITPK1 helps regulate inflammatory responses by controlling the
production of cytokines and other inflammatory mediators.</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Calcium signaling regulation:</li>
</ol>
<ul>
<li>ITPK1 is involved in the production of inositol
1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4), which regulates calcium
signaling in immune cells.</li>
<li>This regulation of calcium signaling is crucial for various immune
cell functions, including activation, proliferation, and cytokine
production.</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Potential role in autoimmune disorders:</li>
</ol>
<ul>
<li>Variations in ITPK1 have been associated with increased risk of
autoimmune disorders like Kawasaki disease, suggesting a role in
maintaining immune tolerance.</li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Interaction with other signaling pathways:</li>
</ol>
<ul>
<li>ITPK1 interacts with other important signaling pathways in immune
cells, such as the PI3K/AKT pathway, potentially influencing various
aspects of immune cell function.</li>
</ul>
<p>In summary, ITPK1 plays a critical role in regulating both innate and
adaptive immune responses, primarily through its effects on calcium
signaling, T and B cell development and function, and modulation of
inflammatory responses. Its involvement in these processes makes it an
important factor in maintaining proper immune function and preventing
autoimmune disorders.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11115942/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC11115942/</a> [2]
<a href="https://medlineplus.gov/genetics/gene/itpkc/"
class="uri">https://medlineplus.gov/genetics/gene/itpkc/</a> [3] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7601042/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7601042/</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [5] <a
href="https://ashpublications.org/bloodadvances/article/7/14/3710/495307/Deciphering-the-genetic-basis-of-immune"
class="uri">https://ashpublications.org/bloodadvances/article/7/14/3710/495307/Deciphering-the-genetic-basis-of-immune</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/</a> [7] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/</a> [8] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663533/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663533/</a></p>
</div>
<div id="gdf7-1" class="section level3">
<h3>GDF7</h3>
<p>Based on the search results, GDF7 (Growth Differentiation Factor 7)
appears to have several important immune-related functions:</p>
<ol style="list-style-type: decimal">
<li>Anti-inflammatory effects:</li>
</ol>
<ul>
<li>GDF7 prevents LPS-induced inflammatory responses in acute lung
injury (ALI) models.</li>
<li>It inhibits inflammation and oxidative stress in ALI mice,
protecting against pulmonary injury and dysfunction.</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Regulation of oxidative stress:</li>
</ol>
<ul>
<li>GDF7 treatment significantly reduces oxidative stress in LPS-induced
ALI.</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Modulation of signaling pathways:</li>
</ol>
<ul>
<li>GDF7 activates AMP-activated protein kinase (AMPK), which is crucial
for its anti-inflammatory and antioxidant effects.</li>
<li>It regulates the STING/AMPK pathway, downregulating the stimulator
of interferon genes (STING) to activate AMPK.</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Potential therapeutic role:</li>
</ol>
<ul>
<li>GDF7 has been identified as a potential agent for the treatment of
sepsis-induced ALI.</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Involvement in TGF-β superfamily signaling:</li>
</ol>
<ul>
<li>As a member of the TGF-β superfamily, GDF7 likely plays roles in
development, differentiation, homeostasis, and disease processes related
to immune function.</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Possible role in innate immunity:</li>
</ol>
<ul>
<li>While not directly stated, GDF7’s involvement in preventing
LPS-induced responses suggests a role in innate immune regulation.</li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Interaction with other immune-related factors:</li>
</ol>
<ul>
<li>GDF7 may interact with other members of the TGF-β superfamily that
are known to regulate various aspects of immune function.</li>
</ul>
<p>In summary, GDF7 appears to have significant anti-inflammatory and
antioxidant properties, particularly in the context of acute lung injury
and sepsis. Its ability to modulate key signaling pathways like AMPK and
STING suggests a broader role in regulating immune responses and
protecting against inflammatory damage.</p>
<p>Citations: [1] <a
href="https://onlinelibrary.wiley.com/doi/10.1155/2022/3676444"
class="uri">https://onlinelibrary.wiley.com/doi/10.1155/2022/3676444</a>
[2] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507863/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507863/</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/</a> [4] <a
href="https://www.nature.com/articles/mi201376"
class="uri">https://www.nature.com/articles/mi201376</a> [5] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [6] <a
href="https://www.nature.com/articles/s41467-023-41534-w"
class="uri">https://www.nature.com/articles/s41467-023-41534-w</a> [7]
<a href="https://www.nature.com/articles/s41467-023-38994-5"
class="uri">https://www.nature.com/articles/s41467-023-38994-5</a> [8]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3663533/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC3663533/</a></p>
</div>
<div id="trim24-1" class="section level3">
<h3>TRIM24</h3>
<p>The immune function of the gene <strong>TRIM24</strong> (Tripartite
Motif Containing 24) is significant in various aspects of immune
response, particularly in antiviral immunity and T cell function:</p>
<ol style="list-style-type: decimal">
<li><strong>Antiviral Immunity</strong>:
<ul>
<li>TRIM24 acts as a <strong>positive regulator</strong> of antiviral
signaling. It facilitates the activation of <strong>IRF3</strong>, a key
transcription factor in the induction of type I interferons (IFN-I)
during viral infections. This is crucial for mounting an effective
antiviral response against RNA viruses, such as the vesicular stomatitis
virus (VSV) [1][4].</li>
<li>Upon viral infection, TRIM24 translocates to the mitochondria, where
it interacts with <strong>TRAF3</strong> and mediates its K63-linked
ubiquitination. This modification promotes TRAF3’s association with MAVS
and TBK1, leading to the activation of downstream antiviral signaling
pathways [1][4].</li>
</ul></li>
<li><strong>Regulation of T Cell Responses</strong>:
<ul>
<li>TRIM24 is essential for T-helper 2 (TH2) cell-mediated immune
responses, particularly in airway allergy and antihelminth immunity.
TRIM24-deficient T cells exhibit reduced expression of IL-1 receptor
(IL-1R), which impairs their activation in response to IL-1β, a critical
cytokine for TH2 cell activation [2][3].</li>
<li>The absence of TRIM24 in T cells leads to diminished expression of
various TH2 cytokines and chemokines, indicating its role in promoting
TH2-associated immune functions [2].</li>
</ul></li>
<li><strong>Feedback Regulation</strong>:
<ul>
<li>Interestingly, TRIM24 is also subject to transcriptional suppression
by activated IRF3, forming a negative feedback loop that helps prevent
overactivation of antiviral signaling [1]. This regulatory mechanism
ensures a balanced immune response during viral infections.</li>
</ul></li>
<li><strong>Impact on HIV-1 Transcription</strong>:
<ul>
<li>TRIM24 has been implicated in the regulation of latent HIV-1
expression by enhancing transcriptional elongation from the HIV-1
promoter in response to T-cell activation signals. This indicates its
role in both HIV pathogenesis and T cell signaling [3].</li>
</ul></li>
</ol>
<p>In summary, TRIM24 plays a critical role in enhancing antiviral
immunity through its regulation of interferon signaling and T cell
responses. It is essential for effective TH2-mediated immunity and
serves as a regulatory checkpoint to maintain balance in immune
activation during viral infections.</p>
<p>Citations: [1] <a
href="https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through"
class="uri">https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4747735/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4747735/</a> [3] <a
href="https://www.nature.com/articles/s42003-023-04484-z"
class="uri">https://www.nature.com/articles/s42003-023-04484-z</a> [4]
<a href="https://pubmed.ncbi.nlm.nih.gov/32324863/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/32324863/</a> [5] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/</a> [6] <a
href="https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-024-01289-3"
class="uri">https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-024-01289-3</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3663533/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC3663533/</a> [8] <a
href="https://www.nature.com/articles/s41416-022-01853-z"
class="uri">https://www.nature.com/articles/s41416-022-01853-z</a></p>
</div>
<div id="zdhhc7-1" class="section level3">
<h3>ZDHHC7</h3>
<p>The immune function of the gene <strong>ZDHHC7</strong> (Zinc Finger
DHHC-Type Containing 7) is primarily linked to its role in the
regulation of the <strong>NLRP3 inflammasome</strong>, a critical
component of the innate immune response:</p>
<ol style="list-style-type: decimal">
<li><strong>Palmitoylation of NLRP3</strong>:
<ul>
<li>ZDHHC7 is identified as a palmitoyl-acyltransferase that
specifically palmitoylates the NLRP3 protein at cysteine residue Cys126.
This post-translational modification is essential for NLRP3 activation
in macrophages, which is crucial for the assembly and activation of the
inflammasome.</li>
</ul></li>
<li><strong>Inflammasome Activation</strong>:
<ul>
<li>The palmitoylation of NLRP3 by ZDHHC7 promotes its localization and
oligomerization, which are necessary steps for recruiting the adaptor
protein ASC (apoptosis-associated speck-like protein containing a CARD)
and forming the inflammasome complex. This process ultimately leads to
the activation of caspase-1 and the secretion of pro-inflammatory
cytokines such as IL-1β and IL-18.</li>
</ul></li>
<li><strong>Impact on Inflammation</strong>:
<ul>
<li>Disruption of ZDHHC7 function, through knockout or pharmacological
inhibition, results in diminished NLRP3 activation, reduced cytokine
secretion, and protection against inflammation-induced conditions such
as LPS-induced endotoxic shock and monosodium urate-induced peritonitis
in mouse models.</li>
</ul></li>
<li><strong>Regulatory Mechanism</strong>:
<ul>
<li>The study highlights that ZDHHC7-mediated palmitoylation is vital
for NLRP3’s resting localization on the trans-Golgi network (TGN) and
its activation upon inflammatory stimuli. This suggests that ZDHHC7
plays a significant role in regulating inflammatory responses,
particularly in macrophages.</li>
</ul></li>
</ol>
<p>In summary, ZDHHC7 functions as a critical regulator of the NLRP3
inflammasome through its role in palmitoylating NLRP3, thereby
facilitating its activation and subsequent inflammatory responses. This
makes ZDHHC7 a potential target for therapeutic strategies aimed at
treating chronic inflammatory diseases associated with NLRP3
hyperactivation.</p>
<p>Citations: [1] <a
href="https://www.biorxiv.org/content/10.1101/2023.11.07.566005v1.full"
class="uri">https://www.biorxiv.org/content/10.1101/2023.11.07.566005v1.full</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4076735/</a> [3] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4990496/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4990496/</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [5]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [6] <a
href="https://www.nature.com/articles/s41467-023-41534-w"
class="uri">https://www.nature.com/articles/s41467-023-41534-w</a> [7]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3663533/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC3663533/</a> [8] <a
href="https://www.nature.com/articles/s41588-023-01421-y"
class="uri">https://www.nature.com/articles/s41588-023-01421-y</a></p>
</div>
<div id="arnt2-1" class="section level3">
<h3>ARNT2</h3>
<p>The immune function of the gene <strong>ARNT2</strong> (Aryl
Hydrocarbon Receptor Nuclear Translocator 2) is linked to its role in
regulating immune responses, particularly in the context of cancer and
inflammation:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Cell Infiltration</strong>:
<ul>
<li>ARNT2 expression is correlated with the infiltration of various
immune cells in nasopharyngeal carcinoma (NPC). High levels of ARNT2 are
associated with increased infiltration of CD4+ T cells, macrophages, and
dendritic cells, while negatively correlating with B cells and mast
cells. This suggests that ARNT2 may influence the immune landscape
within tumors, potentially affecting tumor progression and immune
evasion [1].</li>
</ul></li>
<li><strong>Interaction with Prostaglandin Pathways</strong>:
<ul>
<li>ARNT2 is implicated in the transcriptional regulation of
<strong>PTGS2</strong> (prostaglandin-endoperoxide synthase 2), an
enzyme involved in the inflammatory response. The regulation of PTGS2 by
ARNT2 may contribute to inflammatory processes and the modulation of
immune responses in cancer [1].</li>
</ul></li>
<li><strong>Inflammatory Response in Multiple Sclerosis</strong>:
<ul>
<li>In models of multiple sclerosis (MS), ARNT2 expression is altered,
indicating its potential role in neuroinflammation. The expression
levels of ARNT2 decline during peak disease stages, suggesting a
relationship between ARNT2 and immune responses in the central nervous
system [2].</li>
</ul></li>
<li><strong>Potential Immunosuppressive Role</strong>:
<ul>
<li>The presence of resting dendritic cells, which are often associated
with immunosuppressive states, was found to be higher in NPC samples
with elevated ARNT2 expression. This indicates that ARNT2 may play a
role in promoting an immunosuppressive microenvironment that could
facilitate tumor progression [1].</li>
</ul></li>
<li><strong>Regulatory Mechanisms</strong>:
<ul>
<li>As a transcription factor, ARNT2 regulates various target genes
involved in immune responses. Its dysregulation can lead to alterations
in immune signaling pathways, potentially impacting how immune cells
respond to tumors or inflammatory stimuli [1][2].</li>
</ul></li>
</ol>
<p>In summary, ARNT2 appears to play a multifaceted role in immune
function, particularly in cancer and inflammation. It influences immune
cell infiltration, regulates inflammatory mediators like PTGS2, and may
contribute to immunosuppressive environments within tumors. Further
research could clarify its specific mechanisms and potential therapeutic
implications in immune-related diseases.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9532129/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9532129/</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7251514/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7251514/</a> [3] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8421915/</a> [4] <a
href="https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through"
class="uri">https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4747735/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4747735/</a> [7] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9651953/</a> [8] <a
href="https://www.nature.com/articles/s41467-023-41534-w"
class="uri">https://www.nature.com/articles/s41467-023-41534-w</a></p>
</div>
<div id="rtel1" class="section level3">
<h3>RTEL1</h3>
<p>The immune function of the gene <strong>RTEL1</strong> (Regulator of
Telomere Length 1) is primarily associated with its role in maintaining
genomic stability, which indirectly impacts immune responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Telomere Maintenance</strong>:
<ul>
<li>RTEL1 is essential for proper telomere replication and stability. It
helps disassemble telomere loops (T-loops) and facilitates the
replication of telomeres, preventing telomere shortening and
dysfunction, which can lead to genomic instability and cellular
senescence. This stability is crucial for the normal functioning of
immune cells, particularly T cells and B cells, which require intact
telomeres for proliferation and function [1][2].</li>
</ul></li>
<li><strong>Immune Deficiencies</strong>:
<ul>
<li>Mutations in RTEL1 are linked to immunodeficiency conditions such as
dyskeratosis congenita and aplastic anemia. Individuals with biallelic
mutations in RTEL1 often exhibit short telomeres, leading to impaired
hematopoiesis and increased susceptibility to infections due to
compromised immune cell production [1]. This highlights RTEL1’s critical
role in sustaining a functional immune system.</li>
</ul></li>
<li><strong>Influence on Immune Cell Function</strong>:
<ul>
<li>The integrity of telomeres maintained by RTEL1 is vital for the
lifespan and functionality of immune cells. Shortened telomeres can lead
to premature senescence or apoptosis of T and B lymphocytes, thereby
reducing the adaptive immune response [2].</li>
</ul></li>
<li><strong>Regulation of RNA Processing</strong>:
<ul>
<li>RTEL1 also plays a role in RNA processing and trafficking, affecting
the localization of certain RNAs within cells. This function may
influence the expression of genes involved in immune responses, although
specific mechanisms remain to be fully elucidated [2].</li>
</ul></li>
<li><strong>Potential Role in Cancer Immunology</strong>:
<ul>
<li>Given that RTEL1 is involved in maintaining genomic integrity, its
dysfunction can contribute to tumorigenesis. Tumors often exploit
mechanisms to evade immune detection, and understanding how RTEL1
influences this process could provide insights into cancer immunotherapy
strategies [2].</li>
</ul></li>
</ol>
<p>In summary, RTEL1 is crucial for maintaining telomere stability and
genomic integrity, which are essential for proper immune cell function
and overall immune health. Its mutations are associated with
immunodeficiency syndromes, underscoring its importance in the immune
system’s ability to respond effectively to pathogens.</p>
<p>Citations: [1] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744058/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744058/</a>
[2] <a href="https://www.nature.com/articles/s41467-021-23299-2"
class="uri">https://www.nature.com/articles/s41467-021-23299-2</a> [3]
<a
href="https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through"
class="uri">https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through</a>
[4] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/</a> [5] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [7] <a
href="https://www.nature.com/articles/s41467-023-41534-w"
class="uri">https://www.nature.com/articles/s41467-023-41534-w</a> [8]
<a href="https://erj.ersjournals.com/content/46/2/474"
class="uri">https://erj.ersjournals.com/content/46/2/474</a></p>
</div>
<div id="igf1r-1" class="section level3">
<h3>IGF1R</h3>
<p>The immune function of the gene <strong>IGF1R</strong> (Insulin-like
Growth Factor 1 Receptor) is multifaceted, influencing various aspects
of immune responses, particularly in the context of cancer and
inflammation:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Cell Activation</strong>:
<ul>
<li>IGF1R signaling plays a crucial role in the activation and
proliferation of T cells. It enhances the proliferation and chemotaxis
of activated T cells, indicating that IGF1R is important for T cell
responses during immune activation [3][4].</li>
</ul></li>
<li><strong>Influence on T Regulatory Cells</strong>:
<ul>
<li>IGF1R is involved in the modulation of T regulatory (Treg) cells,
which are critical for maintaining immune tolerance and preventing
autoimmunity. Activation of IGF1R promotes Treg proliferation and
immunosuppressive functions, potentially contributing to an
immunosuppressive tumor microenvironment [3][4].</li>
</ul></li>
<li><strong>Impact on Tumor Immunology</strong>:
<ul>
<li>In the context of cancer, IGF1R promotes an immunosuppressive
environment by enhancing the recruitment and activity of
immunosuppressive cells such as M2 macrophages and myeloid-derived
suppressor cells (MDSCs). This can impair anti-tumor immunity by
inhibiting the activation of cytotoxic CD8+ T cells and natural killer
(NK) cells [3][4].</li>
</ul></li>
<li><strong>CNS Inflammation Modulation</strong>:
<ul>
<li>IGF1R signaling in central nervous system (CNS) macrophages
regulates their morphology and function, influencing autoimmune CNS
inflammation. Deletion of IGF1R in these cells results in increased
severity of autoimmune conditions, suggesting a protective role against
inflammation [2].</li>
</ul></li>
<li><strong>Cytokine Production</strong>:
<ul>
<li>IGF1R influences cytokine production by immune cells, which can
modulate inflammatory responses. For example, it has been shown to
affect the production of IL-10, an anti-inflammatory cytokine,
indicating its role in balancing immune responses [1][3].</li>
</ul></li>
<li><strong>Tumor Microenvironment Dynamics</strong>:
<ul>
<li>In tumor models, IGF1R deficiency leads to reduced tumor growth and
inflammation, as well as increased infiltration of effector T cells.
This suggests that IGF1R signaling contributes to maintaining an
immunosuppressive tumor microenvironment that favors tumor progression
[4].</li>
</ul></li>
</ol>
<p>In summary, IGF1R plays a significant role in regulating immune
responses through its effects on T cell activation, modulation of Treg
function, and influence on the tumor microenvironment. Its signaling
pathways are critical for both promoting and inhibiting various aspects
of immunity, particularly in cancer contexts where it can contribute to
immune evasion and tumor progression.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2879913/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC2879913/</a> [2] <a
href="https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-023-01535-8"
class="uri">https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-023-01535-8</a>
[3] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1356321/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1356321/full</a>
[4] <a href="https://www.nature.com/articles/s41388-022-02376-w"
class="uri">https://www.nature.com/articles/s41388-022-02376-w</a> [5]
<a href="https://www.nature.com/articles/s41598-024-53209-7"
class="uri">https://www.nature.com/articles/s41598-024-53209-7</a> [6]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/</a>
[7] <a
href="https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through"
class="uri">https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through</a>
[8] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/</a></p>
</div>
<div id="wtap" class="section level3">
<h3>WTAP</h3>
<p>The immune function of the gene <strong>WTAP</strong> (Wilms Tumor
1-Associated Protein) is multifaceted, particularly in the context of
inflammation and cancer:</p>
<ol style="list-style-type: decimal">
<li><strong>Role in m6A RNA Methylation</strong>:
<ul>
<li>WTAP is a key component of the m6A methyltransferase complex, which
adds N6-methyladenosine (m6A) modifications to RNA. This modification
influences various biological processes, including gene expression
regulation and RNA stability, which are crucial for immune
responses.</li>
</ul></li>
<li><strong>Regulation of Inflammatory Responses</strong>:
<ul>
<li>WTAP expression is significantly upregulated in response to
inflammatory stimuli, such as lipopolysaccharides (LPS) and cytokines.
It enhances the synthesis of pro-inflammatory cytokines by facilitating
the m6A modification of their mRNA, thereby promoting inflammation. This
suggests that WTAP plays a role in amplifying inflammatory responses
during immune activation.</li>
</ul></li>
<li><strong>Impact on Immune Cell Infiltration</strong>:
<ul>
<li>High levels of WTAP expression correlate with increased infiltration
of various immune cells, including CD4+ T cells, CD8+ T cells,
macrophages, and dendritic cells in tumors. This indicates that WTAP may
influence the tumor microenvironment by modulating immune cell dynamics
and potentially affecting tumor progression.</li>
</ul></li>
<li><strong>Antiviral Response Regulation</strong>:
<ul>
<li>WTAP is involved in antiviral immunity by maintaining the expression
of key components in the type I interferon signaling pathway. During
viral infections, its degradation can restrict antiviral responses,
highlighting its dual role in immune regulation.</li>
</ul></li>
<li><strong>Prognostic Marker in Cancer</strong>:
<ul>
<li>In various cancers, including hepatocellular carcinoma (HCC) and
esophageal carcinoma (ESCA), WTAP has been identified as a prognostic
marker associated with poor outcomes. Its expression levels are linked
to immune cell infiltration patterns, suggesting that it may serve as a
biomarker for tumor immunogenicity.</li>
</ul></li>
<li><strong>Potential Therapeutic Target</strong>:
<ul>
<li>Given its role in regulating inflammatory responses and immune cell
dynamics, targeting WTAP could be a potential therapeutic strategy for
managing excessive inflammation or enhancing anti-tumor immunity.</li>
</ul></li>
</ol>
<p>In summary, WTAP plays a significant role in regulating immune
responses through its involvement in m6A RNA methylation, modulation of
inflammatory signaling pathways, and influencing immune cell
infiltration within tumors. Its expression levels have implications for
cancer prognosis and therapeutic strategies aimed at modulating immune
responses.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.852000/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.852000/full</a>
[2] <a href="https://www.nature.com/articles/s41419-022-05268-9"
class="uri">https://www.nature.com/articles/s41419-022-05268-9</a> [3]
<a
href="https://www.biorxiv.org/content/10.1101/2023.10.30.564747v1.full"
class="uri">https://www.biorxiv.org/content/10.1101/2023.10.30.564747v1.full</a>
[4] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.1007696/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.1007696/full</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [6] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252703/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252703/</a>
[7] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/</a>
[8] <a
href="https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through"
class="uri">https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through</a></p>
</div>
<div id="stxbp1-1" class="section level3">
<h3>STXBP1</h3>
<p>The immune function of the gene <strong>STXBP1</strong> (Syntaxin
Binding Protein 1) is primarily associated with its role in regulating
immune cell cytotoxicity, particularly in natural killer (NK) cells and
cytotoxic T cells:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Cytotoxic Activity</strong>:
<ul>
<li>STXBP1 is crucial for the granule exocytosis pathway in NK and CD8+
T cells. It has been shown to be responsible for approximately 50% of
the cytotoxic activity of these immune cells when stimulated with
interleukin-2 (IL-2) [4]. This suggests that STXBP1 plays a significant
role in the ability of these cells to kill target cells
effectively.</li>
</ul></li>
<li><strong>Granule Exocytosis</strong>:
<ul>
<li>The protein is involved in the docking and fusion of cytotoxic
granules with the plasma membrane of immune cells, which is essential
for releasing perforin and granzymes—key molecules that mediate cell
lysis [4]. This process is vital for the immune response against
infected or malignant cells.</li>
</ul></li>
<li><strong>Functional Redundancy with Other Proteins</strong>:
<ul>
<li>While STXBP1 contributes significantly to NK and T cell function, it
operates alongside other proteins like STXBP2. Although there may be
some redundancy, STXBP1 has distinct roles that are critical for
effective immune responses [4].</li>
</ul></li>
<li><strong>Mast Cell Function</strong>:
<ul>
<li>Although STXBP1 was investigated in the context of mast cell
activation, studies indicate that it is not required for IgE-mediated
mast cell degranulation or allergic inflammation [1]. This suggests that
while STXBP1 plays a role in some immune cells, its functions can vary
widely across different cell types.</li>
</ul></li>
<li><strong>Implications in Immune Disorders</strong>:
<ul>
<li>Given its critical role in cytotoxicity, mutations or deficiencies
in STXBP1 can lead to impaired immune responses, which may contribute to
increased susceptibility to infections or malignancies.</li>
</ul></li>
</ol>
<p>In summary, STXBP1 is essential for the cytotoxic functions of NK and
CD8+ T cells by facilitating granule exocytosis. Its role underscores
the importance of precise regulation in immune cell functionality,
particularly in the context of adaptive immunity and responses to
pathogens or tumors.</p>
<p>Citations: [1] <a
href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0058560"
class="uri">https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0058560</a>
[2] <a
href="https://www.stxbp1disorders.org/stxbp1-critical-for-neuronal-development"
class="uri">https://www.stxbp1disorders.org/stxbp1-critical-for-neuronal-development</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7056272/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7056272/</a> [4] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862791/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862791/</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [6]
<a href="https://www.nature.com/articles/s41416-022-01853-z"
class="uri">https://www.nature.com/articles/s41416-022-01853-z</a> [7]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1356321/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1356321/full</a>
[8] <a
href="https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through"
class="uri">https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through</a></p>
</div>
<div id="znf395-1" class="section level3">
<h3>ZNF395</h3>
<p>The immune function of the gene <strong>ZNF395</strong> (Zinc Finger
Protein 395) is primarily associated with its role in regulating the
expression of interferon-stimulated genes (ISGs) and pro-inflammatory
cytokines, particularly in the context of antiviral responses and
inflammation:</p>
<ol style="list-style-type: decimal">
<li><strong>Activation of Interferon-Stimulated Genes</strong>:
<ul>
<li>ZNF395 acts as a transcription factor that enhances the expression
of a subset of ISGs, including chemokines such as
<strong>CXCL10</strong> and <strong>CXCL11</strong>. These chemokines
are critical for attracting immune cells to sites of infection or
inflammation, thereby playing a vital role in the antiviral immune
response [1][2].</li>
</ul></li>
<li><strong>Independence from Interferon</strong>:
<ul>
<li>While ZNF395 enhances the expression of ISGs, it operates
independently of interferon signaling pathways. It can amplify the
effects of interferon on ISG expression, indicating its importance in
modulating the innate immune response [1].</li>
</ul></li>
<li><strong>Regulation by IKK Signaling</strong>:
<ul>
<li>The transcriptional activity of ZNF395 is regulated by IκB kinase
(IKK) signaling, which is necessary for its activation and also promotes
its degradation. This regulation ensures that ZNF395’s activity is
tightly controlled, allowing for a balanced immune response [2][4].</li>
</ul></li>
<li><strong>Role in Hypoxia-Induced Inflammation</strong>:
<ul>
<li>ZNF395 is implicated in hypoxia-associated inflammation by
superactivating pro-inflammatory cytokines such as
<strong>IL-1β</strong>, <strong>IL-6</strong>, and <strong>IL-8</strong>
under low oxygen conditions. This suggests that ZNF395 may contribute to
inflammatory processes in tumor microenvironments, linking it to both
immune responses and cancer progression [3][4].</li>
</ul></li>
<li><strong>Impact on Immune Cell Function</strong>:
<ul>
<li>In studies involving glioma, ZNF395 has been shown to influence
macrophage polarization, promoting M2 macrophage characteristics that
are associated with tumor progression and immunosuppression. This
highlights its role in shaping the immune microenvironment in cancer
[3].</li>
</ul></li>
<li><strong>Antiviral Response</strong>:
<ul>
<li>ZNF395 has been found to be downregulated during high viral loads
(e.g., HIV and CMV), suggesting that it may play a protective role in
antiviral immunity by regulating the expression of genes involved in
combating viral infections [1].</li>
</ul></li>
</ol>
<p>In summary, ZNF395 is an important regulator of the innate immune
response, particularly through its activation of ISGs and
pro-inflammatory cytokines. Its roles extend to influencing macrophage
polarization and modulating responses to hypoxia, making it a
significant factor in both immune regulation and cancer biology.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5339479/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5339479/</a> [2] <a
href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0074911"
class="uri">https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0074911</a>
[3] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548007/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548007/</a>
[4] <a href="https://onlinelibrary.wiley.com/doi/10.1155/2015/804264"
class="uri">https://onlinelibrary.wiley.com/doi/10.1155/2015/804264</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [6] <a
href="https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through"
class="uri">https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through</a>
[7] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1356321/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1356321/full</a>
[8] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/</a></p>
</div>
<div id="sept2" class="section level3">
<h3>SEPT2</h3>
<p>The immune function of the gene <strong>SEPT2</strong> (Septin 2) is
primarily associated with its role in the cytoskeleton and its
involvement in immune responses, particularly in phagocytosis and host
defense mechanisms:</p>
<ol style="list-style-type: decimal">
<li><strong>Cytoskeletal Role</strong>:
<ul>
<li>SEPT2 is part of the septin family of proteins, which are known to
contribute to the organization of the cytoskeleton. This structural role
is crucial for various cellular processes, including cytokinesis, cell
motility, and the formation of membrane structures.</li>
</ul></li>
<li><strong>Phagocytosis</strong>:
<ul>
<li>SEPT2 has been shown to play a significant role in phagocytosis, a
process by which immune cells engulf and eliminate pathogens. Studies
indicate that silencing SEPT2 can inhibit antibody-mediated phagocytosis
by 50-70%, highlighting its importance in the function of phagocytic
cells like macrophages and neutrophils.</li>
</ul></li>
<li><strong>Host Defense Against Infections</strong>:
<ul>
<li>Septins, including SEPT2, are implicated in the host’s defense
against various pathogens, including bacteria and viruses. They may
participate in forming structures around intracellular pathogens,
thereby aiding in their degradation and preventing their
replication.</li>
</ul></li>
<li><strong>Regulation of Immune Responses</strong>:
<ul>
<li>SEPT2 is involved in the recruitment of multiprotein complexes
necessary for the formation of phagosomes, which are essential for
processing and presenting antigens to T cells. This process is vital for
initiating adaptive immune responses.</li>
</ul></li>
<li><strong>Pathogen Sensing</strong>:
<ul>
<li>The septin cytoskeleton can sense pathogenic microbes and trigger
host defense mechanisms. This includes rearranging to form protective
structures that can sequester pathogens within immune cells.</li>
</ul></li>
<li><strong>Involvement in Inflammation</strong>:
<ul>
<li>By participating in the organization of immune cell structures and
facilitating phagocytosis, SEPT2 indirectly influences inflammatory
responses, which are critical for combating infections.</li>
</ul></li>
</ol>
<p>In summary, SEPT2 plays a crucial role in immune function by
supporting phagocytosis, contributing to host defense mechanisms against
infections, and participating in the organization of cytoskeletal
structures necessary for effective immune responses. Its involvement in
these processes underscores the importance of septins in maintaining
immune system integrity and functionality.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [2]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001386/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001386/</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [4] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/</a>
[5] <a
href="https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through"
class="uri">https://rupress.org/jem/article/217/7/e20192083/151700/TRIM24-facilitates-antiviral-immunity-through</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [7]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5339479/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5339479/</a> [8] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1356321/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1356321/full</a></p>
</div>
<div id="tgfa-1" class="section level3">
<h3>TGFA</h3>
<p>The immune function of the gene <strong>TGFA</strong> (Transforming
Growth Factor Alpha) is primarily linked to its role as a cytokine that
influences various immune responses, particularly in the context of
inflammation and tissue repair:</p>
<ol style="list-style-type: decimal">
<li><strong>Cytokine Activity</strong>:
<ul>
<li>TGFA is a member of the transforming growth factor (TGF) family and
functions similarly to TGF-β in regulating immune responses. It plays a
role in promoting cellular proliferation, differentiation, and survival,
particularly in epithelial cells and some immune cells.</li>
</ul></li>
<li><strong>Regulation of Immune Cell Function</strong>:
<ul>
<li>TGFA has been shown to influence the behavior of various immune
cells, including T cells and macrophages. It can modulate T cell
activation and differentiation, potentially impacting the balance
between pro-inflammatory and anti-inflammatory responses.</li>
</ul></li>
<li><strong>Promotion of Inflammation</strong>:
<ul>
<li>TGFA is involved in inflammatory processes, acting as a
pro-inflammatory cytokine that can enhance the recruitment and
activation of immune cells at sites of injury or infection. This
function is critical for initiating and sustaining immune
responses.</li>
</ul></li>
<li><strong>Influence on Tumor Microenvironment</strong>:
<ul>
<li>In cancer, TGFA can contribute to the creation of an
immunosuppressive tumor microenvironment by promoting the
differentiation of regulatory T cells (Tregs) and inhibiting cytotoxic T
cell functions. This can facilitate tumor growth and metastasis by
evading immune surveillance.</li>
</ul></li>
<li><strong>Role in Tissue Repair</strong>:
<ul>
<li>Beyond its immune functions, TGFA is also involved in tissue repair
processes. It can promote wound healing by stimulating cell
proliferation and migration, which are essential for tissue regeneration
following injury.</li>
</ul></li>
<li><strong>Interaction with Other Cytokines</strong>:
<ul>
<li>TGFA may interact with other cytokines and signaling pathways to
fine-tune immune responses. For instance, it can cooperate with TGF-β to
regulate various aspects of immunity, including the differentiation of B
cells and the production of immunoglobulins.</li>
</ul></li>
</ol>
<p>In summary, TGFA plays a significant role in modulating immune
responses through its effects on inflammation, immune cell function, and
tissue repair. Its dual role as both a promoter of inflammation and a
contributor to immunosuppression in tumors highlights its importance in
maintaining immune balance under different physiological conditions.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/</a> [2] <a
href="https://aacrjournals.org/clincancerres/article/13/18/5262/194359/Transforming-Growth-Factor-and-the-Immune-Response"
class="uri">https://aacrjournals.org/clincancerres/article/13/18/5262/194359/Transforming-Growth-Factor-and-the-Immune-Response</a>
[3] <a
href="https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737"
class="uri">https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737</a>
[4] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.891268/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.891268/full</a>
[5] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1066375/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1066375/full</a>
[6] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [8]
<a href="https://www.cell.com/immunity/pdf/S1074-7613(19)30141-4.pdf"
class="uri">https://www.cell.com/immunity/pdf/S1074-7613(19)30141-4.pdf</a></p>
</div>
<div id="cdca7l" class="section level3">
<h3>CDCA7L</h3>
<p>The immune function of the gene <strong>CDCA7L</strong> (Cell
Division Cycle Associated 7 Like) is primarily associated with its role
in regulating immune responses, particularly in the context of cancer
and lymphoid malignancies:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Cell Function</strong>:
<ul>
<li>CDCA7L has been implicated in the modulation of immune cell
activities, particularly in lymphocytes. It may influence T cell
apoptosis, which is crucial for maintaining immune homeostasis and
preventing autoimmunity. This suggests a potential role in regulating
the survival and function of T cells during immune responses.</li>
</ul></li>
<li><strong>Association with Tumor Immunity</strong>:
<ul>
<li>In various cancers, including lymphomas, CDCA7L is overexpressed,
indicating its involvement in tumorigenesis. Its expression levels are
correlated with the proliferation of tumor cells, which can impact the
immune landscape within tumors. High expression may contribute to an
immunosuppressive environment that favors tumor growth.</li>
</ul></li>
<li><strong>Impact on Immune Infiltration</strong>:
<ul>
<li>The expression of CDCA7L is associated with changes in immune cell
infiltration within tumors. For instance, lower methylation levels of
related genes have been linked to increased immune cell infiltration,
suggesting that CDCA7L may play a role in shaping the tumor
microenvironment and influencing how immune cells interact with cancer
cells.</li>
</ul></li>
<li><strong>Potential as a Therapeutic Target</strong>:
<ul>
<li>Given its role in lymphomagenesis and tumor progression, CDCA7L
could be considered a potential target for therapeutic interventions
aimed at enhancing anti-tumor immunity or inhibiting tumor growth.</li>
</ul></li>
<li><strong>Cytoskeletal Dynamics</strong>:
<ul>
<li>CDCA7L is involved in cytoskeletal dynamics, which are essential for
processes like cell migration and invasion. This function can impact how
immune cells move and respond to signals within the tumor
microenvironment.</li>
</ul></li>
</ol>
<p>In summary, CDCA7L plays a significant role in regulating immune
responses, particularly through its effects on T cell function and its
involvement in cancer biology. Its expression influences immune cell
dynamics and could serve as a potential target for therapies aimed at
modulating immune responses in cancer. Further research is needed to
fully elucidate its mechanisms and implications in various immune
contexts.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.566183/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.566183/full</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6165795/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC6165795/</a> [3] <a
href="https://haematologica.org/article/view/9291"
class="uri">https://haematologica.org/article/view/9291</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/</a> [5] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/</a> [7] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [8]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5339479/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5339479/</a></p>
</div>
<div id="egf" class="section level3">
<h3>EGF</h3>
<p>The immune function of the gene <strong>EGF</strong> (Epidermal
Growth Factor) is primarily related to its role as a signaling molecule
that influences various immune processes, particularly in inflammation
and tissue repair:</p>
<ol style="list-style-type: decimal">
<li><strong>Cytokine Activity</strong>:
<ul>
<li>EGF is a potent mitogen that stimulates cell proliferation,
differentiation, and survival. It plays a crucial role in wound healing
and tissue regeneration, which are essential processes in immune
responses following injury or infection.</li>
</ul></li>
<li><strong>Regulation of Inflammatory Responses</strong>:
<ul>
<li>EGF can modulate inflammatory responses by influencing the activity
of immune cells. It has been shown to promote the activation and
migration of macrophages, which are key players in the immune system
responsible for phagocytosing pathogens and secreting pro-inflammatory
cytokines.</li>
</ul></li>
<li><strong>Impact on Dendritic Cells</strong>:
<ul>
<li>EGF affects dendritic cell function, enhancing their ability to
present antigens and activate T cells. This interaction is critical for
initiating adaptive immune responses, linking innate and adaptive
immunity.</li>
</ul></li>
<li><strong>Role in Tumor Immunology</strong>:
<ul>
<li>In the context of cancer, EGF signaling can contribute to an
immunosuppressive tumor microenvironment. Tumors often exploit EGF
pathways to evade immune detection, promoting the proliferation of tumor
cells while inhibiting effective anti-tumor immune responses.</li>
</ul></li>
<li><strong>Interaction with Other Cytokines</strong>:
<ul>
<li>EGF can interact with other cytokines and growth factors to modulate
immune responses further. For example, it may work in conjunction with
transforming growth factor-beta (TGF-β) to regulate the balance between
pro-inflammatory and anti-inflammatory signals.</li>
</ul></li>
<li><strong>Potential Therapeutic Target</strong>:
<ul>
<li>Given its role in inflammation and tissue repair, EGF signaling
pathways are being explored as potential therapeutic targets for various
inflammatory diseases and cancer treatments.</li>
</ul></li>
</ol>
<p>In summary, EGF plays a significant role in regulating immune
functions through its effects on inflammation, cell proliferation, and
interactions with various immune cells. Its involvement in both tissue
repair and tumor biology highlights its importance in maintaining immune
homeostasis and responding to pathological conditions.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [2] <a
href="https://www.cell.com/immunity/pdf/S1074-7613(19)30141-4.pdf"
class="uri">https://www.cell.com/immunity/pdf/S1074-7613(19)30141-4.pdf</a>
[3] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/</a>
[4] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/</a> [5] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5339479/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5339479/</a> [7] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.891268/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.891268/full</a>
[8] <a
href="https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737"
class="uri">https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737</a></p>
</div>
<div id="agpat3-1" class="section level3">
<h3>AGPAT3</h3>
<p>The immune function of the gene <strong>AGPAT3</strong>
(1-Acylglycerol-3-Phosphate O-Acyltransferase 3) is associated with its
role in lipid metabolism and its implications in immune responses,
particularly in the context of inflammation and cancer:</p>
<ol style="list-style-type: decimal">
<li><strong>Lipid Metabolism</strong>:
<ul>
<li>AGPAT3 is involved in the synthesis of phosphatidic acid (PA) from
lysophosphatidic acid (LPA), which is a key lipid mediator that
influences various cellular processes, including cell proliferation,
migration, and survival. This metabolic pathway is crucial for
maintaining cellular homeostasis and supporting immune cell
functions.</li>
</ul></li>
<li><strong>Regulation of Inflammatory Responses</strong>:
<ul>
<li>The products of AGPAT3 activity, particularly PA and LPA, are known
to play significant roles in regulating inflammatory responses. LPA can
act on its receptors to promote macrophage activation and polarization,
influencing the overall inflammatory environment.</li>
</ul></li>
<li><strong>Impact on Immune Cell Function</strong>:
<ul>
<li>AGPAT3 has been shown to favor the synthesis of polyunsaturated
fatty acid (PUFA)-containing phospholipids, which are important for
maintaining membrane integrity and fluidity in immune cells. This can
affect the functionality of T cells and macrophages during immune
responses.</li>
</ul></li>
<li><strong>Cancer Immunology</strong>:
<ul>
<li>In cancer contexts, AGPAT3 may influence tumor progression and the
immune microenvironment. For instance, its activity can affect the
infiltration and activation of immune cells within tumors, potentially
impacting anti-tumor immunity. Changes in lipid metabolism mediated by
AGPAT3 can alter how immune cells interact with tumor cells.</li>
</ul></li>
<li><strong>Potential as a Therapeutic Target</strong>:
<ul>
<li>Given its role in lipid metabolism and inflammation, AGPAT3 may
represent a potential target for therapeutic interventions aimed at
modulating immune responses in inflammatory diseases or cancer.</li>
</ul></li>
<li><strong>Tissue-Specific Functions</strong>:
<ul>
<li>AGPAT3’s functions are also tissue-specific; for example, it plays a
role in the synthesis of DHA-containing phospholipids in the brain and
eyes, which may have implications for neuroinflammation and retinal
health.</li>
</ul></li>
</ol>
<p>In summary, AGPAT3 is involved in lipid metabolism with significant
implications for immune function through its regulation of inflammatory
processes and interactions with immune cells. Its role in cancer biology
further underscores its importance in modulating the immune landscape
within tumors.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8750616/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8750616/</a> [3] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/</a>
[4] <a href="https://www.nature.com/articles/s41392-020-0117-y"
class="uri">https://www.nature.com/articles/s41392-020-0117-y</a> [5] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/</a> [7] <a
href="https://www.cell.com/immunity/pdf/S1074-7613(19)30141-4.pdf"
class="uri">https://www.cell.com/immunity/pdf/S1074-7613(19)30141-4.pdf</a>
[8] <a
href="https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737"
class="uri">https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737</a></p>
</div>
<div id="evi5" class="section level3">
<h3>EVI5</h3>
<p>The immune function of the gene <strong>EVI5</strong> (Ecotropic
Viral Integration Site 5) is primarily linked to its roles in
hematopoiesis, immune cell regulation, and its implications in
cancer:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Hematopoietic Stem Cells</strong>:
<ul>
<li>EVI5 is involved in the regulation of hematopoietic stem cells
(HSCs), influencing their proliferation and differentiation. This is
crucial for maintaining a healthy immune system, as HSCs give rise to
various immune cell types.</li>
</ul></li>
<li><strong>Impact on Immune Cell Function</strong>:
<ul>
<li>EVI5 has been shown to play a role in the differentiation and
function of specific immune cells, including T cells. Its expression can
affect the development and activation of these cells, which are
essential for adaptive immunity.</li>
</ul></li>
<li><strong>Association with Cancer Immunology</strong>:
<ul>
<li>In the context of acute myeloid leukemia (AML), EVI5 is implicated
in promoting an immunosuppressive tumor microenvironment. It can
influence the expression of genes associated with immune evasion,
potentially leading to poor outcomes in patients with
EVI5-overexpressing tumors.</li>
</ul></li>
<li><strong>Interaction with Cytokine Signaling</strong>:
<ul>
<li>EVI5 may interact with pathways involving cytokines such as
interferon-gamma (IFN-γ), which is known to play a role in shaping
immune responses and promoting an immunosuppressive environment in
tumors. This interaction suggests that EVI5 could modulate the immune
landscape within cancers.</li>
</ul></li>
<li><strong>Potential for Therapeutic Targeting</strong>:
<ul>
<li>Given its role in both hematopoiesis and cancer immunology, EVI5
presents potential as a therapeutic target for enhancing anti-tumor
immunity or improving outcomes in hematological malignancies.</li>
</ul></li>
</ol>
<p>In summary, EVI5 plays a significant role in regulating immune cell
development and function, particularly within the context of
hematopoiesis and cancer. Its influence on immune responses and tumor
microenvironments highlights its importance in both normal immune
function and disease processes.</p>
<p>Citations: [1] <a
href="https://ashpublications.org/bloodadvances/article/7/8/1577/486860/EVI1-exerts-distinct-roles-in-AML-via-ERG-and"
class="uri">https://ashpublications.org/bloodadvances/article/7/8/1577/486860/EVI1-exerts-distinct-roles-in-AML-via-ERG-and</a>
[2] <a href="https://www.nature.com/articles/s41577-022-00763-8"
class="uri">https://www.nature.com/articles/s41577-022-00763-8</a> [3]
<a href="https://www.nature.com/articles/s41408-021-00457-9"
class="uri">https://www.nature.com/articles/s41408-021-00457-9</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7438829/</a> [5] <a
href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0074911"
class="uri">https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0074911</a>
[6] <a href="https://en.wikipedia.org/wiki/MECOM"
class="uri">https://en.wikipedia.org/wiki/MECOM</a> [7] <a
href="https://link.springer.com/article/10.1007/s00277-024-05779-9"
class="uri">https://link.springer.com/article/10.1007/s00277-024-05779-9</a>
[8] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a></p>
</div>
<div id="irx3" class="section level3">
<h3>IRX3</h3>
<p>The immune function of the gene <strong>IRX3</strong> (Iroquois
Homeobox 3) is associated with its role in regulating hematopoiesis and
influencing immune cell differentiation:</p>
<ol style="list-style-type: decimal">
<li><strong>Role in Hematopoiesis</strong>:
<ul>
<li>IRX3 is part of the Iroquois homeobox gene family, which plays
critical roles in the development and differentiation of hematopoietic
cells. It has been implicated in the regulation of hematopoietic
progenitor cells, influencing their differentiation into various immune
cell lineages.</li>
</ul></li>
<li><strong>Influence on Lymphocyte Development</strong>:
<ul>
<li>Studies suggest that IRX3 may be involved in the development of
lymphocytes, particularly B cells. Its expression patterns during
hematopoiesis indicate a potential role in early lymphoid development,
which is crucial for generating functional immune cells.</li>
</ul></li>
<li><strong>Aberrant Expression in Hematologic Malignancies</strong>:
<ul>
<li>Dysregulation of IRX3 has been observed in various hematologic
malignancies, including acute lymphoblastic leukemia (ALL). This
aberrant expression can disrupt normal immune cell differentiation and
contribute to the pathogenesis of these diseases.</li>
</ul></li>
<li><strong>Transcriptional Regulation</strong>:
<ul>
<li>As a transcription factor, IRX3 can regulate the expression of genes
involved in immune cell development and function. This regulatory
capacity suggests that it plays a significant role in shaping the immune
landscape during both normal development and pathological
conditions.</li>
</ul></li>
<li><strong>Potential Impact on Immune Responses</strong>:
<ul>
<li>By influencing the differentiation and function of immune cells,
IRX3 may indirectly affect immune responses to infections and tumors.
Its role in maintaining proper hematopoietic function underscores its
importance in overall immune system health.</li>
</ul></li>
</ol>
<p>In summary, IRX3 plays a significant role in the regulation of
hematopoiesis and lymphocyte development, with implications for immune
function and responses. Its involvement in hematologic malignancies
further highlights its importance in both normal and pathological immune
processes.</p>
<p>Citations: [1] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957183/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957183/</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11160718/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC11160718/</a> [3]
<a
href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0074911"
class="uri">https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0074911</a>
[4] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [5] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/</a> [6] <a
href="https://www.nature.com/articles/srep20254"
class="uri">https://www.nature.com/articles/srep20254</a> [7] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [8]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/</a></p>
</div>
<div id="rhod" class="section level3">
<h3>RHOD</h3>
<p>The immune function of the gene <strong>RHOD</strong> (Rho D) is
primarily associated with its role in regulating the cytoskeleton and
influencing immune cell behavior, particularly in the context of cell
migration, activation, and signaling:</p>
<ol style="list-style-type: decimal">
<li><strong>Cytoskeletal Dynamics</strong>:
<ul>
<li>RHOD is a member of the Rho family of small GTPases, which are
critical regulators of the cytoskeleton. By controlling actin filament
organization, RHOD influences various cellular processes including cell
shape, motility, and adhesion, all of which are essential for immune
cell function.</li>
</ul></li>
<li><strong>Regulation of Immune Cell Migration</strong>:
<ul>
<li>RHOD plays a significant role in the migration of immune cells to
sites of infection or inflammation. Its activity can enhance the ability
of immune cells to navigate through tissues, facilitating their
recruitment to areas where they are needed to mount an immune
response.</li>
</ul></li>
<li><strong>Impact on T Cell Activation</strong>:
<ul>
<li>Studies indicate that RHOD may be involved in T cell activation
processes. It can influence the formation of the immunological synapse,
which is crucial for effective T cell signaling and activation upon
encountering antigens.</li>
</ul></li>
<li><strong>Role in Cytokine Secretion</strong>:
<ul>
<li>By regulating cytoskeletal rearrangements, RHOD may also impact the
secretion of cytokines from immune cells. Proper cytokine release is
essential for coordinating immune responses and communicating between
different immune cell types.</li>
</ul></li>
<li><strong>Involvement in Phagocytosis</strong>:
<ul>
<li>RHOD has been implicated in phagocytosis, the process by which
immune cells engulf and digest pathogens. Its regulation of actin
dynamics is vital for the formation of membrane extensions that surround
and internalize pathogens.</li>
</ul></li>
<li><strong>Potential Implications in Disease</strong>:
<ul>
<li>Dysregulation of RHOD function can lead to impaired immune
responses, contributing to various diseases including autoimmune
disorders and infections. Understanding its role could provide insights
into therapeutic strategies aimed at enhancing immune function or
correcting defects.</li>
</ul></li>
</ol>
<p>In summary, RHOD is an important regulator of cytoskeletal dynamics
that influences various aspects of immune cell function, including
migration, activation, cytokine secretion, and phagocytosis. Its role
underscores the importance of cytoskeletal regulation in maintaining
effective immune responses.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [2] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.845064/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.845064/full</a>
[3] <a
href="https://journals.aai.org/jimmunol/article/171/1/96/75059/Rho-Kinase-Promotes-Alloimmune-Responses-by"
class="uri">https://journals.aai.org/jimmunol/article/171/1/96/75059/Rho-Kinase-Promotes-Alloimmune-Responses-by</a>
[4] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/</a> [6] <a
href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0074911"
class="uri">https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0074911</a>
[7] <a
href="https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2014.00522/full"
class="uri">https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2014.00522/full</a>
[8] <a
href="https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737"
class="uri">https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737</a></p>
</div>
<div id="foxj1-1" class="section level3">
<h3>FOXJ1</h3>
<p>The immune function of the gene <strong>FOXJ1</strong> (Forkhead Box
J1) is primarily associated with its role in regulating cilia formation
and function, which has implications for immune responses, particularly
in mucosal immunity and inflammation:</p>
<ol style="list-style-type: decimal">
<li><strong>Cilia Formation and Function</strong>:
<ul>
<li>FOXJ1 is a transcription factor that plays a critical role in the
development of motile cilia. These cilia are essential for clearing
mucus and pathogens from epithelial surfaces, particularly in the
respiratory tract. Effective ciliary function is crucial for maintaining
airway homeostasis and preventing infections.</li>
</ul></li>
<li><strong>Mucosal Immunity</strong>:
<ul>
<li>By promoting cilia formation, FOXJ1 contributes to mucosal immunity.
Ciliated epithelial cells help to trap and expel pathogens and debris,
thus playing a protective role against respiratory infections. This
function is vital for the innate immune response in the airways.</li>
</ul></li>
<li><strong>Regulation of Inflammatory Responses</strong>:
<ul>
<li>FOXJ1 may also influence inflammatory responses in the lungs. The
presence of functional cilia can modulate the local immune environment
by affecting the recruitment and activity of immune cells, such as
macrophages and neutrophils, which are involved in responding to
infections.</li>
</ul></li>
<li><strong>Role in Chronic Respiratory Diseases</strong>:
<ul>
<li>Dysregulation of FOXJ1 expression has been linked to chronic
respiratory diseases, such as asthma and chronic obstructive pulmonary
disease (COPD). In these conditions, impaired ciliary function can lead
to increased mucus accumulation and inflammation, exacerbating disease
symptoms.</li>
</ul></li>
<li><strong>Potential Impact on Autoimmunity</strong>:
<ul>
<li>There is emerging evidence that FOXJ1 may play a role in autoimmune
processes by influencing the behavior of immune cells at mucosal
surfaces. Its involvement in regulating epithelial cell responses could
affect how the immune system interacts with environmental antigens.</li>
</ul></li>
<li><strong>Therapeutic Implications</strong>:
<ul>
<li>Understanding the role of FOXJ1 in ciliary function and mucosal
immunity may have therapeutic implications for treating respiratory
diseases and enhancing mucosal defenses against infections.</li>
</ul></li>
</ol>
<p>In summary, FOXJ1 is crucial for the formation and function of motile
cilia, which are essential for mucosal immunity and maintaining airway
health. Its role in regulating inflammatory responses underscores its
importance in both protective immunity and the pathogenesis of
respiratory diseases.</p>
<p>Citations: [1] <a
href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0074911"
class="uri">https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0074911</a>
[2] <a
href="https://www.cell.com/immunity/pdf/S1074-7613(19)30141-4.pdf"
class="uri">https://www.cell.com/immunity/pdf/S1074-7613(19)30141-4.pdf</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [4] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[5] <a
href="https://journals.aai.org/jimmunol/article/171/4/1623/35732/FOXO-Transcription-Factors-as-Regulators-of-Immune"
class="uri">https://journals.aai.org/jimmunol/article/171/4/1623/35732/FOXO-Transcription-Factors-as-Regulators-of-Immune</a>
[6] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.971045/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.971045/full</a>
[7] <a
href="https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737"
class="uri">https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737</a>
[8] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/</a></p>
</div>
<div id="adgrg1-1" class="section level3">
<h3>ADGRG1</h3>
<p>The immune function of the gene <strong>ADGRG1</strong> (Adhesion G
Protein-Coupled Receptor G1), also known as <strong>GPR56</strong>, is
primarily associated with its roles in immune cell regulation,
particularly in the context of lymphocyte development and immune
responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Lymphocyte Development</strong>:
<ul>
<li>ADGRG1 is expressed in various immune cells, including T cells and B
cells. It plays a significant role in the development and
differentiation of these lymphocytes, influencing their fate decisions
during immune responses. Specifically, it has been implicated in B cell
fate decisions, which are crucial for effective humoral immunity.</li>
</ul></li>
<li><strong>Modulation of Immune Cell Activation</strong>:
<ul>
<li>ADGRG1 is involved in modulating the activation and function of
immune cells. For example, its expression can affect T cell activation
and the production of cytokines, thereby influencing the adaptive immune
response. This modulation is essential for maintaining a balanced immune
response and preventing excessive inflammation.</li>
</ul></li>
<li><strong>Impact on Immune Surveillance</strong>:
<ul>
<li>The receptor has been shown to play a role in the surveillance
functions of immune cells. By regulating the migration and adhesion of
lymphocytes to tissues, ADGRG1 contributes to the ability of these cells
to respond to infections and other immune challenges effectively.</li>
</ul></li>
<li><strong>Involvement in Inflammation</strong>:
<ul>
<li>ADGRG1 has been linked to inflammatory processes. Its activation can
influence the behavior of granulocytes (such as neutrophils), enhancing
their antimicrobial activity and promoting the production of reactive
oxygen species (ROS). This suggests that ADGRG1 plays a role in innate
immunity by modulating the inflammatory response during infections.</li>
</ul></li>
<li><strong>Potential Role in Autoimmunity</strong>:
<ul>
<li>Dysregulation of ADGRG1 expression or function may contribute to
autoimmune conditions by affecting lymphocyte behavior and leading to
inappropriate immune activation or tolerance breakdown.</li>
</ul></li>
<li><strong>Therapeutic Implications</strong>:
<ul>
<li>Given its roles in regulating lymphocyte function and inflammation,
ADGRG1 may represent a potential therapeutic target for modulating
immune responses in various diseases, including autoimmune disorders and
cancers.</li>
</ul></li>
</ol>
<p>In summary, ADGRG1 is an important regulator of immune cell
development and function, influencing both adaptive and innate immune
responses. Its involvement in lymphocyte differentiation, activation,
and inflammatory processes underscores its significance in maintaining
immune homeostasis and responding to pathological conditions.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/</a> [2]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [3] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.02830/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.02830/full</a>
[4] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078727/</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/</a> [6] <a
href="https://www.cell.com/immunity/pdf/S1074-7613(19)30141-4.pdf"
class="uri">https://www.cell.com/immunity/pdf/S1074-7613(19)30141-4.pdf</a>
[7] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[8] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.845064/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.845064/full</a></p>
</div>
<div id="satb1-1" class="section level3">
<h3>SATB1</h3>
<p>The immune function of the gene <strong>SATB1</strong> (Special
AT-rich Sequence-Binding Protein 1) is multifaceted, playing critical
roles in T cell development, regulation, and immune responses:</p>
<ol style="list-style-type: decimal">
<li><strong>T Cell Development</strong>:
<ul>
<li>SATB1 is essential for normal T cell development in the thymus. It
influences the differentiation of T cells by regulating the expression
of genes involved in T cell maturation and function, particularly during
the transition from double-positive to single-positive thymocytes.</li>
</ul></li>
<li><strong>Regulation of T Cell Activation</strong>:
<ul>
<li>SATB1 is involved in the activation of cytotoxic T lymphocytes
(CTLs). It helps coordinate the expression of genes necessary for CTL
activation and effector functions, contributing to effective immune
responses against tumors and infections.</li>
</ul></li>
<li><strong>Influence on T Regulatory Cells</strong>:
<ul>
<li>SATB1 expression is downregulated in regulatory T cells (Tregs),
suggesting that it plays a role in maintaining the balance between
effector T cells and Tregs. This balance is crucial for preventing
excessive immune responses and maintaining self-tolerance.</li>
</ul></li>
<li><strong>Tumor Immunology</strong>:
<ul>
<li>SATB1 has been implicated in tumor immunology, where its expression
can affect the behavior of immune cells within the tumor
microenvironment. Increased SATB1 expression in tumor-infiltrating Tregs
and dendritic cells can lead to an immunosuppressive phenotype,
promoting tumor growth and progression.</li>
</ul></li>
<li><strong>Prevention of T Cell Exhaustion</strong>:
<ul>
<li>SATB1 has been shown to help avoid T cell exhaustion, a state where
T cells lose their ability to respond effectively to antigens. Its
presence is associated with enhanced anti-tumor immunity, as it
maintains a more functional state in activated T cells.</li>
</ul></li>
<li><strong>Role in Inflammation</strong>:
<ul>
<li>By modulating the expression of various cytokines and chemokines,
SATB1 can influence inflammatory responses. Its regulation of immune
cell interactions within inflamed tissues underscores its importance in
both protective immunity and pathological inflammation.</li>
</ul></li>
<li><strong>Epigenetic Regulation</strong>:
<ul>
<li>SATB1 acts as an epigenetic regulator, shaping the chromatin
landscape of immune cells. This regulation allows for the coordinated
expression of multiple genes involved in immune function, facilitating
rapid responses during immune challenges.</li>
</ul></li>
</ol>
<p>In summary, SATB1 is a crucial regulator of immune function,
influencing T cell development, activation, and differentiation while
also playing significant roles in tumor immunology and inflammatory
responses. Its ability to modulate gene expression patterns makes it a
key player in maintaining immune homeostasis and responding effectively
to pathogens and tumors.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41388-018-0541-4"
class="uri">https://www.nature.com/articles/s41388-018-0541-4</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [3] <a
href="https://www.cell.com/immunity/pdf/S1074-7613(19)30141-4.pdf"
class="uri">https://www.cell.com/immunity/pdf/S1074-7613(19)30141-4.pdf</a>
[4] <a
href="https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737"
class="uri">https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/</a> [6] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [7]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [8]
<a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a></p>
</div>
<div id="hla-dpb1-1" class="section level3">
<h3>HLA-DPB1</h3>
<p>The immune function of the gene <strong>HLA-DPB1</strong> (Major
Histocompatibility Complex, Class II, DP Beta 1) is crucial for the
adaptive immune response, particularly in the context of antigen
presentation:</p>
<ol style="list-style-type: decimal">
<li><strong>Antigen Presentation</strong>:
<ul>
<li>HLA-DPB1 is a part of the human leukocyte antigen (HLA) complex and
encodes a protein that forms a heterodimer with another protein called
HLA-DPA1. This complex is expressed on the surface of antigen-presenting
cells (APCs), such as B cells, dendritic cells, and macrophages.
HLA-DPB1 presents peptides derived from extracellular proteins to CD4+ T
cells, facilitating their activation and proliferation in response to
foreign antigens, such as those from pathogens or tumors [2][3].</li>
</ul></li>
<li><strong>Role in Immune Responses</strong>:
<ul>
<li>The binding of peptide fragments to HLA-DPB1 allows the immune
system to distinguish between self and non-self proteins. This is
critical for initiating appropriate immune responses against infections
and for activating helper T cells, which in turn stimulate B cells to
produce antibodies [2][3][4].</li>
</ul></li>
<li><strong>Genetic Variability and Immune Response</strong>:
<ul>
<li>HLA-DPB1 exhibits significant polymorphism, meaning there are many
different alleles that can affect how well certain peptides bind to the
molecule. This variability can influence individual immune responses to
infections and vaccines. For example, specific alleles of HLA-DPB1 have
been associated with varying levels of antibody responses to vaccines
like the Japanese encephalitis vaccine [4].</li>
</ul></li>
<li><strong>Association with Autoimmune Diseases</strong>:
<ul>
<li>Variants of the HLA-DPB1 gene have been linked to autoimmune
conditions such as granulomatosis with polyangiitis and chronic
beryllium disease. These associations suggest that certain alleles may
predispose individuals to inappropriate immune responses against their
own tissues [2][3].</li>
</ul></li>
<li><strong>Tumor Immunology</strong>:
<ul>
<li>In cancer contexts, HLA-DPB1 expression is associated with
tumor-infiltrating lymphocytes (TILs). High levels of HLA-DPB1 may
correlate with increased immune infiltration by CD8+ T cells and other
immune cell types, which can enhance anti-tumor immunity [1][4].</li>
</ul></li>
</ol>
<p>In summary, HLA-DPB1 plays a vital role in the immune system by
facilitating the presentation of antigens to T cells, thereby initiating
and regulating adaptive immune responses. Its genetic variability can
influence individual susceptibility to infections, vaccine responses,
and autoimmune diseases, highlighting its importance in immunology.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01245/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01245/full</a>
[2] <a
href="https://medlineplus.gov/download/genetics/gene/hla-dpb1.pdf"
class="uri">https://medlineplus.gov/download/genetics/gene/hla-dpb1.pdf</a>
[3] <a
href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=HLA-DPB1"
class="uri">https://www.genecards.org/cgi-bin/carddisp.pl?gene=HLA-DPB1</a>
[4] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00428/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00428/full</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [6]
<a
href="https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737"
class="uri">https://www.annualreviews.org/content/journals/10.1146/annurev.immunol.24.021605.090737</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5453394/</a> [8] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a></p>
</div>
<div id="sipa1l3" class="section level3">
<h3>SIPA1L3</h3>
<p>The immune function of the gene <strong>SIPA1L3</strong>
(Signal-Induced Proliferation-Associated 1-Like 3) is primarily linked
to its role in regulating immune cell trafficking and signaling,
particularly through its involvement with the Rap1 GTPase pathway:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Lymphocyte Trafficking</strong>:
<ul>
<li>SIPA1L3 is known to act as a GTPase-activating protein (GAP) for
Rap1, a small GTPase that plays a critical role in the regulation of
integrins and cell adhesion. By inactivating Rap1, SIPA1L3 helps
modulate the adhesion and migration of lymphocytes, which is essential
for their proper trafficking to sites of inflammation or infection
[2].</li>
</ul></li>
<li><strong>Impact on T Cell Function</strong>:
<ul>
<li>In T cells, SIPA1L3 deficiency has been shown to lead to increased
activation of Rap1, resulting in enhanced adhesion and altered migration
patterns. This can affect how T cells respond to chemokines and navigate
through tissues, which is crucial for effective immune surveillance and
response [2].</li>
</ul></li>
<li><strong>Influence on Immune Responses</strong>:
<ul>
<li>The regulation of lymphocyte trafficking by SIPA1L3 is vital for
maintaining immune homeostasis. Proper function of this gene ensures
that T cells can effectively enter lymph nodes and exit back into
circulation, which is necessary for mounting appropriate immune
responses [2].</li>
</ul></li>
<li><strong>Role in Autoimmunity</strong>:
<ul>
<li>Mice deficient in SIPA1L3 have been observed to develop late-onset
autoimmune diseases, suggesting that proper regulation of this gene is
important for preventing inappropriate immune activation and maintaining
tolerance [2][4].</li>
</ul></li>
<li><strong>Potential Implications in Cancer</strong>:
<ul>
<li>Alterations in SIPA1L3 expression may also have implications in
cancer biology, particularly regarding how tumor-infiltrating
lymphocytes interact with the tumor microenvironment. Dysregulated
trafficking could affect the ability of immune cells to target tumors
effectively [4].</li>
</ul></li>
<li><strong>Interplay with Other Immune Mechanisms</strong>:
<ul>
<li>The interaction between SIPA1L3 and other signaling pathways
highlights its role as a critical regulator within the broader context
of immune cell dynamics. For example, its effects on integrin-mediated
adhesion can influence how immune cells respond to various stimuli
during an immune challenge [2].</li>
</ul></li>
</ol>
<p>In summary, SIPA1L3 plays a significant role in regulating lymphocyte
trafficking and signaling through its action on the Rap1 pathway. Its
function is crucial for maintaining effective immune responses and
preventing autoimmune conditions, making it an important player in the
immune system’s ability to respond to pathogens and maintain
homeostasis.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41388-023-02787-3"
class="uri">https://www.nature.com/articles/s41388-023-02787-3</a> [2]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1234747/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1234747/full</a>
[3] <a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [4]
<a href="https://www.nature.com/articles/s41467-018-03307-8"
class="uri">https://www.nature.com/articles/s41467-018-03307-8</a> [5]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [7]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [8] <a
href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0074911"
class="uri">https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0074911</a></p>
</div>
<div id="pdlim5-1" class="section level3">
<h3>PDLIM5</h3>
<p>The immune function of the gene <strong>PDLIM5</strong> (PDZ and LIM
Domain 5) is primarily associated with its role in regulating immune
cell signaling and inflammatory responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of NF-κB Signaling</strong>:
<ul>
<li>PDLIM5 is involved in the modulation of the NF-κB signaling pathway,
which is critical for the activation of immune responses. By interacting
with components of this pathway, PDLIM5 can influence the transcription
of pro-inflammatory cytokines and chemokines, thereby affecting the
overall inflammatory response in immune cells.</li>
</ul></li>
<li><strong>Impact on Cytokine Production</strong>:
<ul>
<li>Similar to other members of the PDZ-LIM protein family, PDLIM5 may
act as a negative regulator of NF-κB-mediated signaling. This regulation
helps prevent excessive inflammation, which can lead to tissue damage
and chronic inflammatory diseases. Increased expression of PDLIM5 has
been associated with reduced production of pro-inflammatory cytokines,
indicating its role in controlling inflammatory responses.</li>
</ul></li>
<li><strong>Role in Immune Cell Function</strong>:
<ul>
<li>PDLIM5 is expressed in various immune cells, including T cells and
dendritic cells. Its presence in these cells suggests it may play a role
in their activation, differentiation, and migration, which are essential
for effective immune surveillance and response.</li>
</ul></li>
<li><strong>Potential Implications in Autoimmunity and Cancer</strong>:
<ul>
<li>Dysregulation of PDLIM5 may contribute to autoimmune conditions by
failing to adequately control inflammatory responses. In cancer,
alterations in PDLIM5 expression could influence tumor progression by
modulating the immune microenvironment, potentially affecting how tumors
evade immune detection.</li>
</ul></li>
<li><strong>Interplay with Other Proteins</strong>:
<ul>
<li>PDLIM5 interacts with various signaling molecules and cytoskeletal
components, facilitating the formation of protein complexes that
regulate cellular responses to external stimuli. This interaction is
crucial for maintaining proper immune cell function and
communication.</li>
</ul></li>
</ol>
<p>In summary, PDLIM5 plays a significant role in regulating immune
responses through its involvement in NF-κB signaling and cytokine
production. Its functions in immune cell activation and migration
underscore its importance in maintaining immune homeostasis and
responding to pathological conditions. Further research into PDLIM5
could provide insights into its potential as a therapeutic target for
inflammatory diseases and cancer.</p>
<p>Citations: [1] <a href="https://www.nature.com/articles/srep18327"
class="uri">https://www.nature.com/articles/srep18327</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8335553/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8335553/</a> [3] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01559/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01559/full</a>
[4] <a href="https://onlinelibrary.wiley.com/doi/10.1155/2022/2922832"
class="uri">https://onlinelibrary.wiley.com/doi/10.1155/2022/2922832</a>
[5] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[6] <a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [7]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [8]
<a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01245/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01245/full</a></p>
</div>
<div id="bcl2l14-1" class="section level3">
<h3>BCL2L14</h3>
<p>The immune function of the gene <strong>BCL2L14</strong> (BCL2-like
14) is primarily associated with its role in regulating apoptosis and
influencing immune cell survival and function:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Apoptosis</strong>:
<ul>
<li>BCL2L14 is part of the Bcl-2 family of proteins, which are critical
regulators of the apoptotic pathway. Specifically, BCL2L14 functions as
a pro-apoptotic protein, promoting programmed cell death in certain
contexts. This regulation is essential for maintaining immune
homeostasis by controlling the lifespan of immune cells, such as T and B
lymphocytes.</li>
</ul></li>
<li><strong>Influence on Lymphocyte Development</strong>:
<ul>
<li>By modulating apoptosis, BCL2L14 plays a role in lymphocyte
development. Proper regulation of cell death during immune cell
maturation ensures that only functional and appropriately activated
cells survive, which is crucial for effective immune responses.</li>
</ul></li>
<li><strong>Impact on Immune Responses</strong>:
<ul>
<li>The expression levels of BCL2L14 can influence the activation and
proliferation of immune cells. For instance, in activated T cells,
increased levels of BCL2L14 can promote apoptosis, thereby regulating
the expansion of T cell populations after an immune response has been
mounted.</li>
</ul></li>
<li><strong>Role in Autoimmunity</strong>:
<ul>
<li>Dysregulation of BCL2L14 may contribute to autoimmune diseases by
affecting the survival and activation of autoreactive lymphocytes. If
apoptotic pathways are not properly regulated, this can lead to an
accumulation of potentially harmful immune cells that attack
self-tissues.</li>
</ul></li>
<li><strong>Cancer Immunology</strong>:
<ul>
<li>In cancer contexts, BCL2L14 may influence tumor immunity by
regulating the survival of tumor-infiltrating lymphocytes (TILs). The
balance between pro-apoptotic and anti-apoptotic signals can affect how
well these immune cells can persist within the tumor microenvironment
and exert their anti-tumor effects.</li>
</ul></li>
<li><strong>Interactions with Other Proteins</strong>:
<ul>
<li>BCL2L14 interacts with other members of the Bcl-2 family to modulate
apoptotic signaling pathways. These interactions are critical for
determining whether a cell will undergo apoptosis or survive under
various conditions, including stress or infection.</li>
</ul></li>
</ol>
<p>In summary, BCL2L14 plays a significant role in regulating apoptosis
within the immune system, influencing lymphocyte development,
activation, and survival. Its functions are crucial for maintaining
immune homeostasis and preventing autoimmune responses while also
impacting tumor immunity. Understanding its role could provide insights
into therapeutic strategies for autoimmune diseases and cancer
immunotherapy.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/</a> [2]
<a href="https://en.wikipedia.org/wiki/BCL2-like_1"
class="uri">https://en.wikipedia.org/wiki/BCL2-like_1</a> [3] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3663908/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC3663908/</a> [4] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01245/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01245/full</a>
[5] <a
href="https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2016.00135/full"
class="uri">https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2016.00135/full</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [7]
<a href="https://www.nature.com/articles/srep18327"
class="uri">https://www.nature.com/articles/srep18327</a> [8] <a
href="https://www.nature.com/articles/s41467-018-03307-8"
class="uri">https://www.nature.com/articles/s41467-018-03307-8</a></p>
</div>
<div id="ube2e2-1" class="section level3">
<h3>UBE2E2</h3>
<p>The immune function of the gene <strong>UBE2E2</strong> (Ubiquitin
Conjugating Enzyme E2 E2) is primarily associated with its role in the
ubiquitination process, which is critical for regulating various immune
responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Ubiquitination and Immune Signaling</strong>:
<ul>
<li>UBE2E2 is involved in the ubiquitination of proteins, a
post-translational modification that can alter protein stability,
localization, and activity. This process is essential for regulating
immune signaling pathways, including those involved in the activation of
immune cells and the modulation of inflammatory responses.</li>
</ul></li>
<li><strong>Regulation of NF-κB Pathway</strong>:
<ul>
<li>UBE2E2 has been implicated in the regulation of the NF-κB signaling
pathway, which plays a crucial role in mediating immune responses and
inflammation. By facilitating the ubiquitination of specific substrates,
UBE2E2 can influence NF-κB activation and its downstream effects on
cytokine production and immune cell activation.</li>
</ul></li>
<li><strong>Impact on Cytokine Production</strong>:
<ul>
<li>Through its role in ubiquitination, UBE2E2 can affect the production
of pro-inflammatory cytokines. This regulation is vital for coordinating
immune responses to infections and other immune challenges.</li>
</ul></li>
<li><strong>Influence on Immune Cell Survival and
Proliferation</strong>:
<ul>
<li>UBE2E2 may also play a role in regulating the survival and
proliferation of immune cells. By modulating the degradation of proteins
involved in cell cycle regulation and apoptosis, it contributes to
maintaining appropriate levels of immune cell populations during an
immune response.</li>
</ul></li>
<li><strong>Potential Role in Autoimmunity and Cancer</strong>:
<ul>
<li>Dysregulation of UBE2E2 expression or function can lead to altered
immune responses, contributing to autoimmune diseases or impacting tumor
immunity. For example, improper regulation of cytokine signaling
pathways can result in chronic inflammation or ineffective anti-tumor
immunity.</li>
</ul></li>
<li><strong>Interplay with Other Ubiquitin Ligases</strong>:
<ul>
<li>UBE2E2 often works in conjunction with E3 ubiquitin ligases to
target specific proteins for ubiquitination. This collaboration is
crucial for fine-tuning immune signaling pathways and ensuring that
immune responses are appropriately activated or suppressed.</li>
</ul></li>
</ol>
<p>In summary, UBE2E2 plays a significant role in regulating immune
functions through its involvement in ubiquitination processes that
modulate signaling pathways, cytokine production, and immune cell
dynamics. Its importance in maintaining immune homeostasis highlights
its potential as a target for therapeutic interventions in autoimmune
diseases and cancer.</p>
<p>Citations: [1] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10723344/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10723344/</a>
[2] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.793610/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.793610/full</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3663908/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC3663908/</a> [5] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01245/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01245/full</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [7] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[8] <a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a></p>
</div>
<div id="lmo4-1" class="section level3">
<h3>LMO4</h3>
<p>The immune function of the gene <strong>LMO4</strong> (LIM Domain
Only 4) is primarily associated with its role in enhancing CD8+ T cell
responses and promoting T cell memory formation:</p>
<ol style="list-style-type: decimal">
<li><strong>Enhancement of CD8+ T Cell Stemness</strong>:
<ul>
<li>LMO4 has been shown to boost the stem-like properties of CD8+ T
cells, which are crucial for long-term immunity. By promoting the
generation and maintenance of stem-like memory T cells, LMO4 enhances
the ability of these cells to respond to subsequent infections or tumor
challenges.</li>
</ul></li>
<li><strong>Modulation of Cytokine Signaling</strong>:
<ul>
<li>LMO4 interacts with signaling pathways, notably potentiating STAT3
signaling in response to interleukin-21 (IL-21). This interaction
promotes the expression of genes important for memory T cell development
and function, thereby enhancing the overall immune response.</li>
</ul></li>
<li><strong>Promotion of Antitumor Immunity</strong>:
<ul>
<li>In preclinical models, overexpression of LMO4 in CD8+ T cells has
been linked to improved antitumor immunity. This results in increased
tumor regression and enhanced persistence of T cells in the tumor
microenvironment, suggesting that LMO4 can be a valuable target for
improving cancer immunotherapies.</li>
</ul></li>
<li><strong>Increased Polyfunctionality</strong>:
<ul>
<li>CD8+ T cells overexpressing LMO4 exhibit increased polyfunctional
capabilities, meaning they can produce multiple cytokines
simultaneously. This polyfunctionality is critical for effective immune
responses, as it enhances the ability of T cells to combat infections
and tumors.</li>
</ul></li>
<li><strong>Impact on Memory T Cell Formation</strong>:
<ul>
<li>LMO4 helps maintain a balance between effector and memory T cell
populations by curbing terminal differentiation. This ensures that a
reservoir of memory T cells is available for rapid response upon
re-exposure to antigens.</li>
</ul></li>
<li><strong>Potential Therapeutic Applications</strong>:
<ul>
<li>Given its role in enhancing T cell function and memory formation,
LMO4 could be targeted in therapeutic strategies aimed at improving
vaccine efficacy or developing more effective adoptive T cell therapies
for cancer treatment.</li>
</ul></li>
</ol>
<p>In summary, LMO4 plays a significant role in regulating CD8+ T cell
immunity by enhancing their stem-like properties, modulating cytokine
signaling, promoting antitumor responses, and increasing the formation
of polyfunctional memory T cells. Its functions make it a promising
candidate for applications in immunotherapy and vaccine development.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41392-024-01915-z"
class="uri">https://www.nature.com/articles/s41392-024-01915-z</a> [2]
<a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [5]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/</a> [6]
<a href="https://www.nature.com/articles/srep18327"
class="uri">https://www.nature.com/articles/srep18327</a> [7] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01245/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01245/full</a>
[8] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4632508/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4632508/</a></p>
</div>
<div id="ppp1r14a-1" class="section level3">
<h3>PPP1R14A</h3>
<p>The immune function of the gene <strong>PPP1R14A</strong> (Protein
Phosphatase 1 Regulatory Inhibitor Subunit 14A) is primarily associated
with its regulatory role in immune cell signaling and its influence on
tumor immunity:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Cell Infiltration</strong>:
<ul>
<li>PPP1R14A has been shown to correlate with the levels of various
infiltrating immune cells across multiple cancer types. Its expression
is significantly associated with the abundance of immune cells such as B
cells, CD4+ T cells, CD8+ T cells, macrophages, and dendritic cells.
This suggests that PPP1R14A may play a role in modulating the immune
landscape within tumors, impacting how immune cells infiltrate and
respond to cancer cells [1].</li>
</ul></li>
<li><strong>Relationship with Immune Checkpoint Molecules</strong>:
<ul>
<li>The expression of PPP1R14A is linked to immune checkpoint molecules
(ICMs), which are critical for regulating immune responses and
preventing excessive inflammation. In certain cancers, high levels of
PPP1R14A expression have been associated with a negative relationship
with ICMs, indicating that it might influence the effectiveness of
immunotherapy by affecting how immune checkpoints regulate T cell
activity [1].</li>
</ul></li>
<li><strong>Impact on Tumor Microenvironment</strong>:
<ul>
<li>Studies have indicated that PPP1R14A expression can affect the tumor
microenvironment by altering the balance of immune cell types present.
For instance, in some cancers, high PPP1R14A levels were correlated with
increased infiltration of specific immune cell types while showing a
negative correlation with others, suggesting a complex role in shaping
the immune response to tumors [1].</li>
</ul></li>
<li><strong>Potential as a Prognostic Biomarker</strong>:
<ul>
<li>Given its association with immune cell infiltration and checkpoint
regulation, PPP1R14A may serve as a prognostic biomarker in cancer. Its
expression levels could help predict patient outcomes and responses to
immunotherapy, particularly in tumors where immune evasion is a concern
[1].</li>
</ul></li>
<li><strong>Role in Cancer Progression</strong>:
<ul>
<li>By influencing both immune cell dynamics and signaling pathways
involved in tumorigenesis, PPP1R14A may play a dual role in promoting
cancer progression while also modulating the host’s immune response
against tumors [2].</li>
</ul></li>
</ol>
<p>In summary, PPP1R14A is an important regulator of immune responses in
the context of cancer, influencing immune cell infiltration, checkpoint
regulation, and potentially serving as a prognostic biomarker for
treatment outcomes. Its role in shaping the tumor microenvironment
highlights its significance in both tumor biology and immunology.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9152294/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9152294/</a> [2] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631915/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631915/</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [4]
<a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [5]
<a href="https://onlinelibrary.wiley.com/doi/10.1111/jcmm.17697"
class="uri">https://onlinelibrary.wiley.com/doi/10.1111/jcmm.17697</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [7] <a
href="https://www.nature.com/articles/s41392-024-01915-z"
class="uri">https://www.nature.com/articles/s41392-024-01915-z</a> [8]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/</a></p>
</div>
<div id="tbx5-1" class="section level3">
<h3>TBX5</h3>
<p>The immune function of the gene <strong>TBX5</strong> (T-box 5) is
primarily associated with its role in the development and regulation of
immune cells, particularly in the context of T cell differentiation and
function:</p>
<ol style="list-style-type: decimal">
<li><strong>Role in T Cell Development</strong>:
<ul>
<li>TBX5 is a member of the T-box family of transcription factors, which
are crucial for various developmental processes, including the
development of immune cells. It is involved in the differentiation of T
cells, particularly influencing their maturation and functional
capabilities.</li>
</ul></li>
<li><strong>Influence on Th Cell Differentiation</strong>:
<ul>
<li>While TBX5 is not as extensively studied as other T-box genes like
TBX21 (T-bet), it may still play a role in modulating the balance
between different T helper (Th) cell subsets. For example, it could
influence the differentiation of Th1 and Th2 cells, impacting the
overall immune response to infections and allergens.</li>
</ul></li>
<li><strong>Potential Role in Cardiac Immunity</strong>:
<ul>
<li>TBX5 has been implicated in cardiac development, but its expression
in immune cells suggests a potential role in cardiac immunity. It may
influence how immune cells interact with cardiac tissues, especially
during inflammatory responses or in conditions like myocarditis.</li>
</ul></li>
<li><strong>Regulation of Cytokine Production</strong>:
<ul>
<li>As a transcription factor, TBX5 may regulate genes involved in
cytokine production, thereby influencing the inflammatory response. This
regulation is essential for coordinating the immune response during
infections or tissue damage.</li>
</ul></li>
<li><strong>Impact on Autoimmunity</strong>:
<ul>
<li>Alterations in TBX5 expression or function could potentially
contribute to autoimmune conditions by affecting T cell differentiation
and function. Dysregulation of T cell responses can lead to
inappropriate immune activation against self-antigens.</li>
</ul></li>
<li><strong>Interplay with Other Immune Regulators</strong>:
<ul>
<li>TBX5 may interact with other transcription factors and signaling
pathways that regulate immune responses, contributing to a complex
network that governs T cell behavior and overall immunity.</li>
</ul></li>
</ol>
<p>In summary, TBX5 plays a significant role in regulating T cell
development and function within the immune system. Its involvement in
cytokine regulation and potential impact on autoimmunity highlight its
importance in maintaining immune homeostasis and responding effectively
to pathogens. Further research is needed to fully elucidate its specific
roles and mechanisms within the immune context.</p>
<p>Citations: [1] <a
href="https://www.spandidos-publications.com/10.3892/ol.2016.5296"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2016.5296</a>
[2] <a href="https://en.wikipedia.org/wiki/TBX21"
class="uri">https://en.wikipedia.org/wiki/TBX21</a> [3] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [5] <a
href="https://medlineplus.gov/genetics/gene/tbx1/"
class="uri">https://medlineplus.gov/genetics/gene/tbx1/</a> [6] <a
href="https://www.nature.com/articles/srep18327"
class="uri">https://www.nature.com/articles/srep18327</a> [7] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01559/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01559/full</a>
[8] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/</a></p>
</div>
<div id="ddx52" class="section level3">
<h3>DDX52</h3>
<p>The immune function of the gene <strong>DDX52</strong> (DEAD-box
helicase 52) is primarily associated with its regulatory role in innate
immunity, particularly in response to viral infections:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Antiviral Responses</strong>:
<ul>
<li>DDX52 has been identified as a negative regulator of the antiviral
innate immune response. It influences the production of type I
interferons (IFNs), which are crucial for initiating antiviral defenses.
Overexpression of DDX52 can inhibit IFN production, thereby facilitating
viral replication and impairing the host’s ability to mount an effective
immune response against viral pathogens [1][2].</li>
</ul></li>
<li><strong>Interaction with Signaling Pathways</strong>:
<ul>
<li>DDX52 interacts with key components of the RLR (RIG-I-like receptor)
signaling pathway, such as TBK1 (TANK-binding kinase 1). By promoting
the degradation of TBK1, DDX52 disrupts the formation of the TBK1-TRAF3
complex, which is essential for activating downstream signaling that
leads to IFN production. This action further dampens the antiviral
response [2].</li>
</ul></li>
<li><strong>Influence on Cytokine Production</strong>:
<ul>
<li>In addition to its effects on IFN production, DDX52 has been shown
to regulate other cytokines involved in the immune response. For
example, it can inhibit the expression of pro-inflammatory cytokines
like IL-6, which are critical for coordinating immune responses during
infections [1].</li>
</ul></li>
<li><strong>Role in Viral Propagation</strong>:
<ul>
<li>By inhibiting key antiviral pathways and promoting viral
replication, DDX52 plays a dual role in both supporting viral life
cycles and modulating host immune responses. This makes it a target of
interest in understanding viral pathogenesis and developing antiviral
therapies [3].</li>
</ul></li>
<li><strong>Potential as a Therapeutic Target</strong>:
<ul>
<li>Given its role as a negative regulator of innate immunity, targeting
DDX52 may offer therapeutic avenues for enhancing antiviral responses in
infected individuals or for developing strategies against viruses that
exploit this pathway for replication [4].</li>
</ul></li>
</ol>
<p>In summary, DDX52 functions as a critical regulator of innate
immunity by negatively influencing antiviral responses through its
interactions with key signaling pathways and cytokine production. Its
role in promoting viral propagation highlights its significance in both
immunology and virology.</p>
<p>Citations: [1] <a
href="https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530"
class="uri">https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530</a>
[2] <a
href="https://link.springer.com/article/10.1007/s00018-023-04860-2"
class="uri">https://link.springer.com/article/10.1007/s00018-023-04860-2</a>
[3] <a href="https://atm.amegroups.org/article/view/97397/html"
class="uri">https://atm.amegroups.org/article/view/97397/html</a> [4] <a
href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.1039440/full"
class="uri">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.1039440/full</a>
[5] <a
href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-023-02787-x"
class="uri">https://jeccr.biomedcentral.com/articles/10.1186/s13046-023-02787-x</a>
[6] <a
href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.943032/full"
class="uri">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.943032/full</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/</a> [8]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a></p>
</div>
<div id="iqgap1" class="section level3">
<h3>IQGAP1</h3>
<p>The immune function of the gene <strong>IQGAP1</strong> (IQ Motif
Containing GTPase Activating Protein 1) is multifaceted and plays a
critical role in regulating various immune cell functions through its
involvement in signaling pathways and cytoskeletal dynamics:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Cell Function</strong>:
<ul>
<li>IQGAP1 acts as a scaffolding protein that organizes signaling
molecules within immune cells. It is involved in processes such as
phagocytosis in macrophages and cell migration in neutrophils,
facilitating effective immune responses to pathogens[1][3].</li>
</ul></li>
<li><strong>Natural Killer (NK) Cell Activity</strong>:
<ul>
<li>IQGAP1 is essential for NK cell homeostasis and function. It helps
regulate NK cell motility and their ability to produce inflammatory
cytokines upon activation through natural killer receptors (NKRs). In
the absence of IQGAP1, NK cells exhibit reduced motility and impaired
antitumor immunity, indicating its crucial role in NK cell-mediated
responses[1][3].</li>
</ul></li>
<li><strong>T Cell Receptor Signaling</strong>:
<ul>
<li>In T cells, IQGAP1 negatively regulates T cell receptor (TCR)
signaling and the dynamics of filamentous actin at the immunological
synapse. This regulation can influence cytokine secretion, such as IL-2
and IFN-γ, highlighting its role in modulating T cell
activation[3][4].</li>
</ul></li>
<li><strong>Cytokine Production</strong>:
<ul>
<li>IQGAP1 has been shown to influence the production of type I
interferons (IFNs) in response to cytosolic nucleic acids. Knockdown of
IQGAP1 leads to increased IFN-β production, suggesting that it acts as a
negative regulator of this pathway, thereby modulating the immune
response to viral infections[4].</li>
</ul></li>
<li><strong>Phagocytosis and Inflammatory Responses</strong>:
<ul>
<li>In macrophages, IQGAP1 facilitates phagocytosis and the secretion of
pro-inflammatory cytokines like IL-1β. Its interaction with
actin-nucleating proteins is crucial for forming phagocytic cups during
engulfment processes[3][4].</li>
</ul></li>
<li><strong>Interaction with Other Signaling Molecules</strong>:
<ul>
<li>IQGAP1 interacts with various proteins involved in immune signaling,
including NLRC3, which also plays a role in regulating type I IFN
responses. This interaction suggests a complex network where IQGAP1 may
help fine-tune immune signaling pathways[4].</li>
</ul></li>
</ol>
<p>In summary, IQGAP1 is a critical regulator of immune functions
through its roles in modulating NK cell activity, T cell signaling,
phagocytosis, and cytokine production. Its ability to act as a scaffold
for signaling molecules underscores its importance in maintaining
effective immune responses and homeostasis within the immune system.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [3] <a
href="https://journals.aai.org/jimmunol/article/199/8/2896/106428/The-Scaffolding-Protein-IQGAP1-Interacts-with"
class="uri">https://journals.aai.org/jimmunol/article/199/8/2896/106428/The-Scaffolding-Protein-IQGAP1-Interacts-with</a>
[4] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5714304/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5714304/</a> [5] <a
href="https://journals.aai.org/jimmunol/article/188/5/2057/83300/IQGAP1-A-Regulator-of-Intracellular-Spacetime"
class="uri">https://journals.aai.org/jimmunol/article/188/5/2057/83300/IQGAP1-A-Regulator-of-Intracellular-Spacetime</a>
[6] <a
href="https://rupress.org/jcb/article/222/6/e202205062/214044/The-IQGAP-scaffolds-Critical-nodes-bridging"
class="uri">https://rupress.org/jcb/article/222/6/e202205062/214044/The-IQGAP-scaffolds-Critical-nodes-bridging</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4480615/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4480615/</a> [8] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a></p>
</div>
<div id="ccdc88c-1" class="section level3">
<h3>CCDC88C</h3>
<p>The immune function of the gene <strong>CCDC88C</strong> (Coiled-Coil
Domain Containing Protein 88C) is primarily associated with its roles in
immune cell signaling, particularly in the context of T cell activation
and dendritic cell (DC) function:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of T Cell Activation</strong>:
<ul>
<li>CCDC88C is implicated in the activation and proliferation of CD4+ T
cells. Its expression levels correlate with CD4+ T cell activation,
suggesting that it plays a role in enhancing T cell responses during
immune challenges, such as infections or tumors. This regulation is
essential for effective adaptive immune responses.</li>
</ul></li>
<li><strong>Influence on Dendritic Cell Function</strong>:
<ul>
<li>CCDC88C is critical for the migration and function of dendritic
cells. Studies indicate that CCDC88C-deficient dendritic cells show
impaired migration to draining lymph nodes upon inflammatory stimuli
(e.g., LPS). This defect leads to reduced recruitment and activation of
antigen-specific T cells, highlighting CCDC88C’s role in coordinating
the immune response through DCs.</li>
</ul></li>
<li><strong>Impact on Cytokine Production</strong>:
<ul>
<li>The absence of CCDC88C affects the production of pro-inflammatory
cytokines in response to various stimuli. This suggests that CCDC88C is
involved in regulating the inflammatory response, which is crucial for
orchestrating immune reactions.</li>
</ul></li>
<li><strong>Association with Inflammatory Diseases</strong>:
<ul>
<li>Variants in the CCDC88C gene have been associated with
susceptibility to several inflammatory and autoimmune diseases in
humans. This connection underscores its importance in maintaining immune
homeostasis and preventing excessive inflammation.</li>
</ul></li>
<li><strong>Role in Immune Cell Migration</strong>:
<ul>
<li>CCDC88C facilitates the motility of immune cells, particularly
dendritic cells, which is vital for their ability to survey tissues and
present antigens to T cells. Impaired migration due to CCDC88C
deficiency can lead to diminished immune surveillance and
responses.</li>
</ul></li>
<li><strong>Potential Therapeutic Target</strong>:
<ul>
<li>Given its critical role in regulating T cell and dendritic cell
functions, targeting CCDC88C may offer therapeutic avenues for enhancing
immune responses in vaccines or improving immunotherapy outcomes in
cancer treatment.</li>
</ul></li>
</ol>
<p>In summary, CCDC88C plays a significant role in regulating T cell
activation and dendritic cell function, influencing cytokine production
and immune cell migration. Its involvement in inflammatory diseases
highlights its importance in maintaining immune balance and responding
effectively to pathogens.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4267237/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4267237/</a> [2] <a
href="https://pubmed.ncbi.nlm.nih.gov/32480428/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/32480428/</a> [3] <a
href="https://atm.amegroups.org/article/view/26384/html"
class="uri">https://atm.amegroups.org/article/view/26384/html</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/</a> [5]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [7] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [8]
<a href="https://link.springer.com/article/10.1007/s00018-023-04860-2"
class="uri">https://link.springer.com/article/10.1007/s00018-023-04860-2</a></p>
</div>
<div id="chmp4c-1" class="section level3">
<h3>CHMP4C</h3>
<p>The immune function of the gene <strong>CHMP4C</strong> (Charged
Multivesicular Body Protein 4C) is primarily associated with its role in
the <strong>Endosomal Sorting Complex Required for Transport
(ESCRT)</strong> pathway, which is crucial for various cellular
processes, including immune responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Role in Viral Budding</strong>:
<ul>
<li>CHMP4C is a key component of the ESCRT-III complex, which is
involved in the budding and release of enveloped viruses, including HIV
and herpes simplex virus (HSV). By facilitating the final stages of
viral budding, CHMP4C plays a critical role in controlling viral
replication and dissemination, thereby influencing the host’s immune
response to viral infections [1][2].</li>
</ul></li>
<li><strong>Regulation of Cytokine Secretion</strong>:
<ul>
<li>The ESCRT machinery, including CHMP4C, is also involved in the
secretion of cytokines and other signaling molecules from immune cells.
This regulation is essential for coordinating immune responses, as
cytokines play a pivotal role in mediating communication between immune
cells and orchestrating inflammatory responses.</li>
</ul></li>
<li><strong>Antigen Presentation</strong>:
<ul>
<li>CHMP4C may influence the processing and presentation of antigens by
regulating the trafficking of major histocompatibility complex (MHC)
molecules. Proper functioning of the ESCRT pathway is crucial for
maintaining the integrity of antigen presentation processes, which are
vital for T cell activation and adaptive immunity [4].</li>
</ul></li>
<li><strong>Innate Immune Responses</strong>:
<ul>
<li>CHMP4C has been implicated in innate immune signaling pathways,
particularly those involving pattern recognition receptors (PRRs). By
participating in the endosomal trafficking of these receptors, CHMP4C
can modulate the activation of downstream signaling cascades that lead
to the production of type I interferons and other pro-inflammatory
cytokines [1].</li>
</ul></li>
<li><strong>Impact on Immune Cell Dynamics</strong>:
<ul>
<li>Beyond its roles in viral budding and cytokine secretion, CHMP4C
contributes to the overall dynamics of immune cells by regulating
membrane remodeling processes that are essential for cell migration and
interaction with other immune cells.</li>
</ul></li>
<li><strong>Potential Therapeutic Target</strong>:
<ul>
<li>Given its involvement in viral pathogenesis and immune regulation,
targeting CHMP4C or related ESCRT components may offer therapeutic
strategies for enhancing antiviral immunity or modulating inflammatory
responses in various diseases.</li>
</ul></li>
</ol>
<p>In summary, CHMP4C is a critical player in the ESCRT pathway with
significant implications for viral budding, cytokine secretion, antigen
presentation, and overall immune cell function. Its roles underscore its
importance in both innate and adaptive immunity, particularly in
response to viral infections.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3302528/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC3302528/</a> [2] <a
href="https://www.nature.com/articles/s41467-018-05889-9"
class="uri">https://www.nature.com/articles/s41467-018-05889-9</a> [3]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [5] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/</a> [6]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10587442/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10587442/</a> [8]
<a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a></p>
</div>
<div id="znf217" class="section level3">
<h3>ZNF217</h3>
<p>The immune function of the gene <strong>ZNF217</strong> (Zinc Finger
Protein 217) is primarily associated with its roles in regulating immune
responses, particularly in the context of inflammation and cancer:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Cell Function</strong>:
<ul>
<li>ZNF217 has been implicated in modulating the function of various
immune cells, including T cells and macrophages. It can influence the
differentiation and activation of these cells, thereby impacting overall
immune responses.</li>
</ul></li>
<li><strong>Influence on Inflammatory Responses</strong>:
<ul>
<li>ZNF217 is involved in the regulation of inflammatory cytokines. Its
expression can affect the production of pro-inflammatory cytokines,
which are crucial for coordinating immune responses during infections or
tissue damage. This suggests that ZNF217 may play a role in maintaining
the balance between pro-inflammatory and anti-inflammatory signals.</li>
</ul></li>
<li><strong>Role in Cancer Immunology</strong>:
<ul>
<li>ZNF217 has been associated with cancer progression and immune
evasion. It can promote tumor cell survival and proliferation while
suppressing anti-tumor immune responses. By influencing the expression
of genes involved in immune regulation, ZNF217 may help tumors escape
detection and destruction by the immune system.</li>
</ul></li>
<li><strong>Potential as a Therapeutic Target</strong>:
<ul>
<li>Given its involvement in both inflammation and cancer, ZNF217 may
represent a potential therapeutic target for enhancing anti-tumor
immunity or modulating inflammatory diseases. Targeting ZNF217 could
help restore effective immune responses against tumors or reduce
excessive inflammation in autoimmune conditions.</li>
</ul></li>
<li><strong>Interplay with Other Transcription Factors</strong>:
<ul>
<li>ZNF217 may interact with other transcription factors and signaling
pathways that regulate immune responses, contributing to a complex
network that governs how immune cells respond to various stimuli.</li>
</ul></li>
</ol>
<p>In summary, ZNF217 plays a significant role in regulating immune
functions by influencing the activation and differentiation of immune
cells, modulating inflammatory responses, and impacting tumor immunity.
Its functions highlight its importance in maintaining immune homeostasis
and responding effectively to pathological conditions. Further research
into ZNF217 could provide insights into its potential as a target for
therapeutic interventions in cancer and inflammatory diseases.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.02907/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.02907/full</a>
[2] <a
href="https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-021-00345-1"
class="uri">https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-021-00345-1</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [5] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10055975/</a> [7]
<a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [8]
<a
href="https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530"
class="uri">https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530</a></p>
</div>
<div id="txn" class="section level3">
<h3>TXN</h3>
<p>The immune function of the gene <strong>TXN</strong> (Thioredoxin) is
primarily associated with its role in redox regulation, which is crucial
for maintaining cellular homeostasis and modulating immune
responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Redox Regulation</strong>:
<ul>
<li>TXN functions as an antioxidant by catalyzing the reduction of
disulfide bonds in proteins, thereby protecting cells from oxidative
stress. This redox activity is vital for the proper functioning of
immune cells, as oxidative stress can impair their function and
viability.</li>
</ul></li>
<li><strong>Modulation of Immune Responses</strong>:
<ul>
<li>TXN has been shown to influence the activation and proliferation of
various immune cells, including T cells and macrophages. By regulating
the redox state within these cells, TXN can modulate their responses to
cytokines and other signaling molecules, affecting overall immune
function.</li>
</ul></li>
<li><strong>Cytokine Production</strong>:
<ul>
<li>TXN plays a role in the production of cytokines, which are critical
for communication between immune cells. For instance, it can enhance the
secretion of pro-inflammatory cytokines in response to pathogens or
inflammatory stimuli, thereby promoting an effective immune
response.</li>
</ul></li>
<li><strong>Regulation of Inflammation</strong>:
<ul>
<li>By influencing the balance between oxidative and reductive states,
TXN can help regulate inflammatory processes. Its activity is essential
for preventing excessive inflammation that could lead to tissue damage
and chronic inflammatory diseases.</li>
</ul></li>
<li><strong>Role in Cellular Senescence and Inflammaging</strong>:
<ul>
<li>TXN is involved in cellular senescence and the senescence-associated
secretory phenotype (SASP), which contributes to chronic inflammation
associated with aging (inflammaging). This suggests that TXN may play a
dual role in both promoting immune responses and contributing to
age-related inflammation.</li>
</ul></li>
<li><strong>Implications in Disease</strong>:
<ul>
<li>Dysregulation of TXN has been linked to various diseases, including
autoimmune disorders and cancer. Its role in modulating oxidative stress
and inflammatory responses makes it a potential target for therapeutic
interventions aimed at restoring normal immune function.</li>
</ul></li>
</ol>
<p>In summary, TXN is a critical regulator of immune function through
its roles in redox regulation, modulation of cytokine production, and
control of inflammatory responses. Its importance in maintaining
cellular homeostasis highlights its significance in both innate and
adaptive immunity.</p>
<p>Citations: [1] <a href="https://pubmed.ncbi.nlm.nih.gov/38267705/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/38267705/</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [3]
<a
href="https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530"
class="uri">https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530</a>
[4] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/</a> [5] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [6] <a
href="https://news.uthscsa.edu/scientists-create-first-mouse-model-with-complete-functional-human-immune-system/"
class="uri">https://news.uthscsa.edu/scientists-create-first-mouse-model-with-complete-functional-human-immune-system/</a>
[7] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[8] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6431610/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC6431610/</a></p>
</div>
<div id="tbx1-1" class="section level3">
<h3>TBX1</h3>
<p>The immune function of the gene <strong>TBX1</strong> (T-box 1) is
primarily associated with its critical roles in immune system
development and function, particularly in the context of T cell
maturation and the regulation of immune responses:</p>
<ol style="list-style-type: decimal">
<li><strong>T Cell Development</strong>:
<ul>
<li>TBX1 is essential for the proper development of T cells in the
thymus. It plays a pivotal role in the differentiation of thymocytes
into functional T cells, influencing their maturation and selection
processes. This is crucial for establishing a competent adaptive immune
response.</li>
</ul></li>
<li><strong>Regulation of Thymic Function</strong>:
<ul>
<li>TBX1 is involved in the development of thymic epithelial cells,
which are essential for T cell maturation. Proper functioning of TBX1
ensures that these cells can support the positive and negative selection
processes that are vital for producing self-tolerant T cells.</li>
</ul></li>
<li><strong>Influence on Immune Responses</strong>:
<ul>
<li>Beyond T cell development, TBX1 has been implicated in regulating
various aspects of immune responses. It can influence the expression of
cytokines and other signaling molecules that modulate immune activation
and inflammation.</li>
</ul></li>
<li><strong>Role in Congenital Disorders</strong>:
<ul>
<li>Mutations or deletions affecting TBX1 are associated with DiGeorge
syndrome, a condition that results in immunodeficiency due to thymic
hypoplasia. This highlights TBX1’s critical role in immune system
integrity and function.</li>
</ul></li>
<li><strong>Potential Impact on Autoimmunity and Inflammation</strong>:
<ul>
<li>Given its regulatory roles, TBX1 may also be involved in autoimmune
processes and inflammatory responses. Dysregulation of TBX1 expression
can lead to aberrant immune activation or tolerance breakdown.</li>
</ul></li>
<li><strong>Interactions with Other Transcription Factors</strong>:
<ul>
<li>TBX1 interacts with other transcription factors involved in T cell
differentiation and function, contributing to a complex network that
governs immune cell behavior.</li>
</ul></li>
</ol>
<p>In summary, TBX1 is a vital transcription factor that plays
significant roles in T cell development, thymic function, and the
regulation of immune responses. Its importance is underscored by its
involvement in congenital immunodeficiencies and potential implications
in autoimmune diseases.</p>
<p>Citations: [1] <a
href="https://www.spandidos-publications.com/10.3892/ol.2016.5296"
class="uri">https://www.spandidos-publications.com/10.3892/ol.2016.5296</a>
[2] <a href="https://en.wikipedia.org/wiki/TBX21"
class="uri">https://en.wikipedia.org/wiki/TBX21</a> [3] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [4]
<a
href="https://news.uthscsa.edu/scientists-create-first-mouse-model-with-complete-functional-human-immune-system/"
class="uri">https://news.uthscsa.edu/scientists-create-first-mouse-model-with-complete-functional-human-immune-system/</a>
[5] <a
href="https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530"
class="uri">https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [7] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[8] <a href="https://medlineplus.gov/genetics/gene/tbx1/"
class="uri">https://medlineplus.gov/genetics/gene/tbx1/</a></p>
</div>
<div id="wnt2-1" class="section level3">
<h3>WNT2</h3>
<p>The immune function of the gene <strong>WNT2</strong> (Wnt Family
Member 2) is primarily associated with its role in modulating immune
responses, particularly through the Wnt signaling pathway. Here are some
key aspects of its immune functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Modulation of Immune Cell Differentiation</strong>:
<ul>
<li>WNT2 is involved in the differentiation and activation of various
immune cells, including T cells and dendritic cells. It plays a role in
promoting T cell lymphopoiesis, which is essential for the development
of a robust adaptive immune response.</li>
</ul></li>
<li><strong>Regulation of Cytokine Production</strong>:
<ul>
<li>WNT2 influences the production of cytokines that are critical for
orchestrating immune responses. For instance, it can enhance the
secretion of pro-inflammatory cytokines, thereby contributing to the
inflammatory response during infections.</li>
</ul></li>
<li><strong>Involvement in Antigen Presentation</strong>:
<ul>
<li>The Wnt signaling pathway, including WNT2, has been shown to affect
the function of antigen-presenting cells (APCs). This includes enhancing
their ability to present antigens to T cells, which is crucial for
initiating adaptive immunity.</li>
</ul></li>
<li><strong>Impact on Tumor Immunology</strong>:
<ul>
<li>WNT2 has been implicated in cancer immunology, where it can
contribute to tumor immune evasion. Activation of Wnt signaling in tumor
cells can inhibit the recruitment and function of cytotoxic T
lymphocytes (CTLs), thereby allowing tumors to escape immune
surveillance.</li>
</ul></li>
<li><strong>Role in Inflammatory Diseases</strong>:
<ul>
<li>Aberrant Wnt signaling, including that mediated by WNT2, has been
linked to various inflammatory diseases. Dysregulation of this pathway
can lead to excessive inflammation or altered immune responses,
contributing to conditions such as rheumatoid arthritis or inflammatory
bowel disease.</li>
</ul></li>
<li><strong>Cross-Talk with Other Signaling Pathways</strong>:
<ul>
<li>WNT2 interacts with other signaling pathways that regulate immune
responses, highlighting its role in a complex network that governs how
immune cells respond to various stimuli.</li>
</ul></li>
</ol>
<p>In summary, WNT2 plays a significant role in regulating immune
functions through its involvement in T cell differentiation, cytokine
production, antigen presentation, and modulation of tumor immunity. Its
influence on inflammatory processes further underscores its importance
in maintaining immune homeostasis and responding effectively to
pathogens and tumors.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6857519/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC6857519/</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6934036/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC6934036/</a> [3] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01985/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01985/full</a>
[4] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.02293/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.02293/full</a>
[5] <a href="https://www.mdpi.com/2073-4409/8/11/1380"
class="uri">https://www.mdpi.com/2073-4409/8/11/1380</a> [6] <a
href="https://jhoonline.biomedcentral.com/articles/10.1186/s13045-017-0471-6"
class="uri">https://jhoonline.biomedcentral.com/articles/10.1186/s13045-017-0471-6</a>
[7] <a
href="https://aacrjournals.org/clincancerres/article/25/10/3074/10693/WNT-catenin-Pathway-Activation-Correlates-with"
class="uri">https://aacrjournals.org/clincancerres/article/25/10/3074/10693/WNT-catenin-Pathway-Activation-Correlates-with</a>
[8] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a></p>
</div>
<div id="rps6kl1-1" class="section level3">
<h3>RPS6KL1</h3>
<p>The immune function of the gene <strong>RPS6KL1</strong> (Ribosomal
Protein S6 Kinase-Like 1) is primarily associated with its role in
regulating immune responses and cell signaling, particularly in the
context of T cell activation and inflammation:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of T Cell Activation</strong>:
<ul>
<li>RPS6KL1 is involved in the signaling pathways that control T cell
activation and proliferation. It may influence the translation of mRNAs
that encode proteins essential for T cell responses, thereby impacting
the overall effectiveness of adaptive immunity.</li>
</ul></li>
<li><strong>Cytokine Production</strong>:
<ul>
<li>The gene has been implicated in the regulation of cytokine
production in immune cells. By modulating the translation and expression
of cytokines, RPS6KL1 can affect inflammatory responses and the
communication between different immune cell types.</li>
</ul></li>
<li><strong>Impact on Inflammatory Responses</strong>:
<ul>
<li>RPS6KL1 may play a role in the inflammatory response by regulating
the production of pro-inflammatory cytokines. This is crucial for
coordinating immune responses during infections or tissue injury.</li>
</ul></li>
<li><strong>Potential Role in Autoimmune Diseases</strong>:
<ul>
<li>Dysregulation of RPS6KL1 could contribute to autoimmune conditions
by affecting T cell activation and leading to inappropriate immune
responses against self-antigens.</li>
</ul></li>
<li><strong>Cellular Proliferation and Survival</strong>:
<ul>
<li>The gene is involved in pathways that regulate cellular
proliferation and survival, which are critical for maintaining healthy
immune cell populations and ensuring effective immune responses.</li>
</ul></li>
<li><strong>Interactions with Other Signaling Pathways</strong>:
<ul>
<li>RPS6KL1 interacts with various signaling pathways that govern immune
cell function, including those related to mTOR (mechanistic target of
rapamycin), which is vital for nutrient sensing and cellular
growth.</li>
</ul></li>
</ol>
<p>In summary, RPS6KL1 plays a significant role in regulating T cell
activation, cytokine production, and inflammatory responses within the
immune system. Its functions highlight its importance in maintaining
immune homeostasis and responding effectively to pathogens. Further
research may provide deeper insights into its specific mechanisms and
potential therapeutic implications in immune-related diseases.</p>
<p>Citations: [1] <a
href="https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530"
class="uri">https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [3] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[4] <a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [5]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/</a> [7] <a
href="https://en.wikipedia.org/wiki/TBX21"
class="uri">https://en.wikipedia.org/wiki/TBX21</a> [8] <a
href="https://newsroom.uw.edu/news-releases/syphilis-eludes-immune-attack-altering-single-gene"
class="uri">https://newsroom.uw.edu/news-releases/syphilis-eludes-immune-attack-altering-single-gene</a></p>
</div>
<div id="mlph-1" class="section level3">
<h3>MLPH</h3>
<p>The immune function of the gene <strong>MLPH</strong> (Melanophilin)
is primarily associated with its role in regulating immune cell dynamics
and responses, particularly in the context of macrophage function and
inflammation:</p>
<ol style="list-style-type: decimal">
<li><strong>Role in Macrophage Function</strong>:
<ul>
<li>MLPH is involved in the regulation of macrophage polarization and
activation. It plays a role in modulating the transition between
pro-inflammatory (M1) and anti-inflammatory (M2) macrophage states. This
is crucial for orchestrating effective immune responses during
infections and tissue repair.</li>
</ul></li>
<li><strong>Influence on Cytokine Production</strong>:
<ul>
<li>MLPH has been implicated in the regulation of cytokine production in
macrophages. By influencing the expression of various cytokines, it
helps coordinate the inflammatory response, impacting how effectively
the immune system can respond to pathogens.</li>
</ul></li>
<li><strong>Impact on Immune Cell Migration</strong>:
<ul>
<li>MLPH is known to play a role in cytoskeletal dynamics, which are
essential for the migration of immune cells to sites of infection or
inflammation. This function is critical for ensuring that immune cells
can effectively reach and respond to areas where they are needed.</li>
</ul></li>
<li><strong>Potential Role in Inflammatory Diseases</strong>:
<ul>
<li>Dysregulation of MLPH may contribute to chronic inflammatory
conditions by affecting macrophage activation and cytokine production.
This could lead to an imbalance in pro-inflammatory and
anti-inflammatory signals, perpetuating inflammation.</li>
</ul></li>
<li><strong>Interaction with Other Signaling Pathways</strong>:
<ul>
<li>MLPH may interact with various signaling pathways that regulate
immune responses, contributing to a complex network that governs immune
cell behavior and function.</li>
</ul></li>
</ol>
<p>In summary, MLPH plays a significant role in regulating macrophage
function, cytokine production, and immune cell migration. Its
involvement in these processes underscores its importance in maintaining
effective immune responses and managing inflammation. Further research
could elucidate its specific mechanisms and potential therapeutic
implications in inflammatory diseases.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/</a> [2] <a
href="https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530"
class="uri">https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [5] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [6]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5884424/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5884424/</a> [8] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a></p>
</div>
<div id="dmrta1" class="section level3">
<h3>DMRTA1</h3>
<p>The immune function of the gene <strong>DMRTA1</strong> (Doublesex
and Mab-3 Related Transcription Factor A1) is not extensively
characterized in the literature, but some insights can be inferred based
on its roles in cellular processes that may influence immune
responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Transcriptional Regulation</strong>:
<ul>
<li>DMRTA1 is a transcription factor that may play a role in regulating
gene expression related to immune functions. By influencing the
transcription of specific genes, DMRTA1 could impact the differentiation
and activation of immune cells.</li>
</ul></li>
<li><strong>Potential Role in T Cell Development</strong>:
<ul>
<li>Although specific studies on DMRTA1’s role in T cell development are
limited, transcription factors in the same family often have critical
functions in cell fate determination and differentiation. This suggests
that DMRTA1 may be involved in T cell maturation or function within the
thymus.</li>
</ul></li>
<li><strong>Influence on Inflammatory Responses</strong>:
<ul>
<li>DMRTA1 could potentially impact inflammatory responses by regulating
cytokine production or influencing the activation states of immune
cells. This would be important for coordinating effective immune
responses during infections or tissue damage.</li>
</ul></li>
<li><strong>Association with Immune Disorders</strong>:
<ul>
<li>While direct associations with specific immune disorders have not
been well-documented, alterations in transcription factors like DMRTA1
can contribute to dysregulated immune responses, which may lead to
autoimmune diseases or chronic inflammation.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>More research is needed to elucidate the specific mechanisms by
which DMRTA1 influences immune functions. Functional studies would help
clarify its role in various immune contexts, including its potential
interactions with other signaling pathways.</li>
</ul></li>
</ol>
<p>In summary, while the specific immune functions of DMRTA1 are not
well-defined, its role as a transcription factor suggests it may
influence T cell development, cytokine production, and overall immune
responses. Further research is necessary to fully understand its
contributions to immunity and potential implications in immune-related
diseases.</p>
<p>Citations: [1] <a
href="https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530"
class="uri">https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1009530</a>
[2] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10507863/</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [5] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/</a> [6] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[7] <a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [8]
<a href="https://en.wikipedia.org/wiki/TBX21"
class="uri">https://en.wikipedia.org/wiki/TBX21</a></p>
</div>
<div id="fbxo38-1" class="section level3">
<h3>FBXO38</h3>
<p>The immune function of the gene <strong>FBXO38</strong> (F-box
protein 38) is primarily associated with its role in regulating immune
responses through the ubiquitin-proteasome system. Here are the key
aspects of its immune functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Ubiquitination and Protein Degradation</strong>:
<ul>
<li>FBXO38 is part of the F-box protein family, which functions as
substrate recognition components of E3 ubiquitin ligases. It plays a
critical role in tagging specific proteins for degradation, thereby
regulating the levels of various signaling molecules involved in immune
responses.</li>
</ul></li>
<li><strong>Regulation of Cytokine Production</strong>:
<ul>
<li>By influencing the degradation of proteins that regulate cytokine
signaling, FBXO38 can modulate the production of pro-inflammatory
cytokines. This regulation is crucial for maintaining balanced immune
responses and preventing excessive inflammation.</li>
</ul></li>
<li><strong>Impact on Immune Cell Activation</strong>:
<ul>
<li>FBXO38 may influence the activation and differentiation of immune
cells, including T cells and macrophages. Its role in protein turnover
can affect how these cells respond to stimuli and their overall
functionality during immune challenges.</li>
</ul></li>
<li><strong>Role in Inflammatory Diseases</strong>:
<ul>
<li>Dysregulation of FBXO38 has been implicated in various inflammatory
diseases. By affecting the stability and activity of key regulatory
proteins, it may contribute to pathological conditions characterized by
chronic inflammation.</li>
</ul></li>
<li><strong>Potential Therapeutic Target</strong>:
<ul>
<li>Given its involvement in regulating immune responses, FBXO38 may
represent a potential therapeutic target for modulating inflammation or
enhancing immune responses in various diseases, including autoimmune
disorders and cancer.</li>
</ul></li>
<li><strong>Interplay with Other Immune Regulators</strong>:
<ul>
<li>FBXO38 interacts with other proteins involved in immune signaling
pathways, contributing to a complex network that governs immune cell
behavior and function.</li>
</ul></li>
</ol>
<p>In summary, FBXO38 plays a significant role in regulating immune
functions through its involvement in protein ubiquitination and
degradation, impacting cytokine production, immune cell activation, and
inflammatory responses. Further research could elucidate its specific
mechanisms and potential therapeutic implications in immune-related
diseases.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8807484/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8807484/</a> [2] <a
href="https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2019.00583/full"
class="uri">https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2019.00583/full</a>
[3] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[4] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [5] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01985/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01985/full</a>
[6] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[7] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.02293/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.02293/full</a>
[8] <a href="https://en.wikipedia.org/wiki/TBX21"
class="uri">https://en.wikipedia.org/wiki/TBX21</a></p>
</div>
<div id="wipi1" class="section level3">
<h3>WIPI1</h3>
<p>The immune function of the gene <strong>WIPI1</strong> (WD Repeat and
Phosphoinositide Interacting Protein 1) is primarily linked to its role
in autophagy and immune responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Involvement in Autophagy</strong>:
<ul>
<li>WIPI1 is a key regulator of autophagy, a cellular process that
degrades and recycles cellular components. It plays a crucial role in
the formation of autophagosomes, which are essential for the degradation
of pathogens and damaged organelles within immune cells. This process is
vital for maintaining cellular homeostasis and responding to
infections.</li>
</ul></li>
<li><strong>Regulation of Immune Responses</strong>:
<ul>
<li>By facilitating autophagy, WIPI1 helps modulate immune responses.
Autophagy is involved in the presentation of antigens to T cells,
enhancing the adaptive immune response. This function is critical for
effective pathogen clearance and the activation of immune cells.</li>
</ul></li>
<li><strong>Role in Inflammation</strong>:
<ul>
<li>WIPI1 may also influence inflammatory responses. Autophagy can
regulate the secretion of pro-inflammatory cytokines, thereby impacting
inflammation levels during immune responses to infections or tissue
damage.</li>
</ul></li>
<li><strong>Interaction with Phosphoinositides</strong>:
<ul>
<li>WIPI1 binds to phosphoinositides, which are important for membrane
trafficking processes in cells. This interaction is crucial for
recruiting other autophagy-related proteins to sites of autophagosome
formation, further supporting its role in immune cell function.</li>
</ul></li>
<li><strong>Implications in Disease</strong>:
<ul>
<li>Dysregulation of WIPI1 and autophagy has been linked to various
diseases, including infections and autoimmune disorders. Proper
functioning of WIPI1 is essential for effective immune responses, and
its dysfunction may contribute to impaired immunity.</li>
</ul></li>
<li><strong>Potential Therapeutic Target</strong>:
<ul>
<li>Given its central role in autophagy and immune regulation, WIPI1
could be a potential therapeutic target for enhancing immune responses
or modulating inflammation in various diseases.</li>
</ul></li>
</ol>
<p>In summary, WIPI1 plays a significant role in regulating autophagy
and modulating immune responses through its involvement in antigen
presentation and inflammatory regulation. Its functions highlight its
importance in maintaining effective immunity and cellular
homeostasis.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [2]
<a href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a> [3] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[4] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9500159/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9500159/</a> [5] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [7] <a
href="https://en.wikipedia.org/wiki/WIPI2"
class="uri">https://en.wikipedia.org/wiki/WIPI2</a> [8] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01985/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01985/full</a></p>
</div>
<div id="osbpl5" class="section level3">
<h3>OSBPL5</h3>
<p>The immune function of the gene <strong>OSBPL5</strong>
(Oxysterol-Binding Protein-Like 5) is increasingly recognized for its
involvement in immune responses, particularly in the context of cancer
and inflammation. Here are the key aspects of its immune functions based
on recent findings:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Cell Infiltration</strong>:
<ul>
<li>OSBPL5 expression has been correlated with the infiltration of
various immune cell types within the tumor microenvironment. For
instance, studies have shown that higher levels of OSBPL5 are associated
with increased infiltration of CD8+ T cells and macrophages, suggesting
a role in promoting an active immune environment in tumors like kidney
renal clear cell carcinoma (KIRC) [1].</li>
</ul></li>
<li><strong>Influence on Cytokine Production</strong>:
<ul>
<li>The expression of OSBPL5 may impact cytokine signaling pathways. It
has been linked to the regulation of pro-inflammatory cytokines, which
are crucial for coordinating immune responses during infections and in
tumor contexts. This suggests that OSBPL5 could modulate inflammatory
responses by affecting cytokine production.</li>
</ul></li>
<li><strong>Potential Biomarker for Immune Responses</strong>:
<ul>
<li>Given its association with immune cell infiltration and cytokine
production, OSBPL5 may serve as a potential biomarker for assessing
immune responses in various cancers. Its expression levels could help
predict patient outcomes and responses to immunotherapy [1][2].</li>
</ul></li>
<li><strong>Interaction with Immune Checkpoints</strong>:
<ul>
<li>There is evidence that OSBPL5 interacts with immune checkpoint
molecules such as PD-L1, which plays a critical role in tumor immune
evasion. The expression of OSBPL5 has been shown to correlate with PD-L1
levels, indicating its potential role in regulating T cell activity and
immune suppression in the tumor microenvironment [1].</li>
</ul></li>
<li><strong>Role in Lipid Metabolism and Immune Function</strong>:
<ul>
<li>As a member of the oxysterol-binding protein-like family, OSBPL5 is
involved in lipid transport and metabolism, which are essential for
maintaining cellular functions and modulating immune responses. Lipid
metabolism can influence the activation and differentiation of immune
cells, further linking OSBPL5 to immune regulation [2][3].</li>
</ul></li>
<li><strong>Implications in Cancer Immunology</strong>:
<ul>
<li>The upregulation of OSBPL5 in tumors suggests it may play a role in
tumor progression and immune evasion mechanisms. Its involvement in
promoting an immunosuppressive environment highlights its significance
in cancer immunology [1][4].</li>
</ul></li>
</ol>
<p>In summary, OSBPL5 plays a significant role in regulating immune
functions through its influence on immune cell infiltration, cytokine
production, interactions with immune checkpoints, and lipid metabolism.
Its potential as a biomarker for cancer prognosis and therapy
underscores its importance in understanding tumor immunity and
developing targeted immunotherapies.</p>
<p>Citations: [1] <a
href="https://assets.researchsquare.com/files/rs-1543271/v1/1390f7c5-258c-4c06-a5e7-c7530fe07213.pdf?c=1655877570"
class="uri">https://assets.researchsquare.com/files/rs-1543271/v1/1390f7c5-258c-4c06-a5e7-c7530fe07213.pdf?c=1655877570</a>
[2] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015719/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015719/</a>
[3] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615799/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615799/</a>
[4] <a
href="https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-023-02824-1"
class="uri">https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-023-02824-1</a>
[5] <a href="https://www.nature.com/articles/s41420-021-00503-2"
class="uri">https://www.nature.com/articles/s41420-021-00503-2</a> [6]
<a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [7]
<a href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a> [8] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a></p>
</div>
<div id="nucks1" class="section level3">
<h3>NUCKS1</h3>
<p>The immune function of the gene <strong>NUCKS1</strong> (Nuclear
Casein Kinase and Cyclin-Dependent Kinase Substrate 1) is associated
with several important roles in immune responses, particularly in
inflammation and cytokine regulation:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Inflammatory Immune Responses</strong>:
<ul>
<li>NUCKS1 is involved in modulating inflammatory responses. Studies
have shown that inhibition of NUCKS1 can affect cytokine modulation,
facilitating recovery in corneal injuries by decreasing the expression
of angiogenic factors like vascular endothelial growth factor (VEGF)
while increasing anti-angiogenic factors such as pigment
epithelium-derived factor (PEDF) [2][3].</li>
</ul></li>
<li><strong>NF-κB Signaling Pathway</strong>:
<ul>
<li>NUCKS1 plays a critical role in the NF-κB signaling pathway, which
is essential for the expression of various pro-inflammatory cytokines.
For instance, following lipopolysaccharide (LPS) stimulation, NUCKS1
knockout cells exhibited reduced phosphorylation of IκB and lower levels
of interleukins (including IL-6), IP10, and tumor necrosis factor-alpha
(TNF-α). This indicates that NUCKS1 is important for the activation of
NF-κB and subsequent cytokine expression [2][3].</li>
</ul></li>
<li><strong>DNA Damage Response</strong>:
<ul>
<li>Beyond its role in inflammation, NUCKS1 is involved in the DNA
damage response and maintenance of genomic stability. This function can
indirectly influence immune responses by ensuring that immune cells can
effectively respond to stressors and maintain their integrity during
inflammatory processes [3].</li>
</ul></li>
<li><strong>Cytokine Modulation</strong>:
<ul>
<li>NUCKS1 has been linked to the modulation of various cytokines,
affecting both pro-inflammatory and anti-inflammatory pathways. Its
ability to regulate these pathways makes it a significant player in
balancing immune responses during infections and inflammatory conditions
[2][3].</li>
</ul></li>
<li><strong>Potential Role in Cancer Immunology</strong>:
<ul>
<li>Elevated levels of NUCKS1 have been associated with increased tumor
invasiveness and may play a role in cancer progression by influencing
immune evasion mechanisms. This suggests that NUCKS1 could affect how
tumors interact with the immune system [3].</li>
</ul></li>
</ol>
<p>In summary, NUCKS1 plays a multifaceted role in immune function by
regulating inflammatory responses through NF-κB signaling, modulating
cytokine production, and maintaining genomic stability in immune cells.
Its involvement in both inflammation and cancer highlights its
significance in understanding immune regulation and potential
therapeutic targets.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5830027/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5830027/</a> [3] <a
href="https://onlinelibrary.wiley.com/doi/10.1155/2018/7969068"
class="uri">https://onlinelibrary.wiley.com/doi/10.1155/2018/7969068</a>
[4] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [6] <a
href="https://jeccr.biomedcentral.com/articles/10.1186/s13046-020-01696-7"
class="uri">https://jeccr.biomedcentral.com/articles/10.1186/s13046-020-01696-7</a>
[7] <a
href="https://www.salk.edu/news-release/salk-scientists-discover-genetic-dial-to-turn-immune-function-up-and-down-to-target-cancer-autoimmune-disease/"
class="uri">https://www.salk.edu/news-release/salk-scientists-discover-genetic-dial-to-turn-immune-function-up-and-down-to-target-cancer-autoimmune-disease/</a>
[8] <a href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a></p>
</div>
<div id="rfc5" class="section level3">
<h3>RFC5</h3>
<p>The immune function of the gene <strong>RFC5</strong> (Replication
Factor C Subunit 5) is primarily associated with its role in DNA
replication and repair, which has significant implications for immune
responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Role in DNA Replication and Repair</strong>:
<ul>
<li>RFC5 is a component of the Replication Factor C (RFC) complex, which
is essential for loading the sliding clamp protein PCNA (Proliferating
Cell Nuclear Antigen) onto DNA during replication. This function is
crucial for maintaining genomic stability in immune cells, particularly
during the rapid proliferation that occurs during immune responses.</li>
</ul></li>
<li><strong>Influence on Immune Cell Proliferation</strong>:
<ul>
<li>By facilitating DNA replication, RFC5 plays a critical role in the
proliferation of immune cells, such as T and B lymphocytes. Proper cell
division is essential for generating sufficient numbers of these cells
to mount an effective adaptive immune response.</li>
</ul></li>
<li><strong>Regulation of Immune Responses</strong>:
<ul>
<li>RFC5 may also influence the expression of genes involved in immune
signaling pathways. Its role in DNA repair processes ensures that immune
cells can respond effectively to stressors, including infections and
inflammation.</li>
</ul></li>
<li><strong>Association with Immune Disorders</strong>:
<ul>
<li>Dysregulation of RFC5 expression has been linked to various cancers
and may affect how immune cells function within the tumor
microenvironment. Increased expression of RFC family members, including
RFC5, has been associated with poor prognosis in certain cancers,
potentially due to their impact on immune cell infiltration and
activity.</li>
</ul></li>
<li><strong>Impact on Immune Cell Infiltration</strong>:
<ul>
<li>Studies have indicated that higher levels of RFC expression
correlate negatively with the infiltration of CD4+ T cells and
macrophages in tumor settings. This suggests that RFC5 may play a role
in modulating the immune landscape within tumors, affecting anti-tumor
immunity.</li>
</ul></li>
<li><strong>Potential Therapeutic Target</strong>:
<ul>
<li>Given its involvement in DNA replication and repair, targeting RFC5
or its associated pathways may offer therapeutic strategies for
enhancing immune responses or improving outcomes in cancer
immunotherapy.</li>
</ul></li>
</ol>
<p>In summary, RFC5 plays a significant role in regulating DNA
replication and repair processes that are crucial for immune cell
proliferation and function. Its influence on immune responses and
potential implications in cancer highlight its importance in maintaining
effective immunity and cellular integrity.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [2] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[3] <a href="https://www.aging-us.com/article/204039/text"
class="uri">https://www.aging-us.com/article/204039/text</a> [4] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[5] <a href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a> [6] <a
href="https://www.salk.edu/news-release/salk-scientists-discover-genetic-dial-to-turn-immune-function-up-and-down-to-target-cancer-autoimmune-disease/"
class="uri">https://www.salk.edu/news-release/salk-scientists-discover-genetic-dial-to-turn-immune-function-up-and-down-to-target-cancer-autoimmune-disease/</a>
[7] <a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [8]
<a href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a></p>
</div>
<div id="mbnl1-1" class="section level3">
<h3>MBNL1</h3>
<p>The immune function of the gene <strong>MBNL1</strong>
(Muscleblind-like splicing regulator 1) is primarily associated with its
role in alternative RNA splicing, particularly in the context of T cell
development and function:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Thymocyte Development</strong>:
<ul>
<li>MBNL1 is essential for normal thymic development, which is critical
for T lymphocyte maturation. It regulates RNA processing during
thymocyte development, ensuring proper expression of genes involved in T
cell differentiation and selection. Loss of MBNL1 leads to dysregulated
gene expression and RNA misprocessing in the thymus, which can adversely
affect T cell development and function [3][4].</li>
</ul></li>
<li><strong>Impact on Immune Cell Function</strong>:
<ul>
<li>By influencing alternative splicing, MBNL1 affects the expression of
various proteins that are crucial for immune responses. This includes
proteins involved in T cell receptor (TCR) signaling, which is vital for
T cell activation and responses to pathogens.</li>
</ul></li>
<li><strong>Cytokine Production</strong>:
<ul>
<li>MBNL1 may play a role in regulating cytokine production by
modulating the splicing of mRNAs that encode cytokines or their
receptors. This regulation is important for coordinating immune
responses during infections and inflammation.</li>
</ul></li>
<li><strong>Association with Immune Disorders</strong>:
<ul>
<li>Dysregulation of MBNL1 has been implicated in various diseases,
including certain leukemias where it is overexpressed. In these
contexts, MBNL1 can influence the splicing of genes involved in cancer
progression, potentially affecting the tumor microenvironment and immune
evasion mechanisms [4].</li>
</ul></li>
<li><strong>Potential as a Therapeutic Target</strong>:
<ul>
<li>Given its role in regulating immune cell development and function,
MBNL1 could be a potential therapeutic target for enhancing immune
responses or correcting dysregulated splicing events in immune-related
diseases.</li>
</ul></li>
</ol>
<p>In summary, MBNL1 plays a significant role in regulating T cell
development through its involvement in alternative RNA splicing. Its
influence on immune cell function and potential implications in immune
disorders highlight its importance in maintaining effective immune
responses. Further research could elucidate its specific mechanisms and
therapeutic potential in various contexts.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [2]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[3] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181699/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181699/</a>
[4] <a href="https://www.nature.com/articles/s41467-020-15733-8"
class="uri">https://www.nature.com/articles/s41467-020-15733-8</a> [5]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [6] <a
href="https://academic.oup.com/nar/advance-article/doi/10.1093/nar/gkae774/7754984?rss=1"
class="uri">https://academic.oup.com/nar/advance-article/doi/10.1093/nar/gkae774/7754984?rss=1</a>
[7] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[8] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a></p>
</div>
<div id="rp11-77h9.1-1" class="section level3">
<h3>RP11-77H9.1</h3>
<p>The immune function of the gene <strong>RP11-77H9.1</strong> (also
known as <strong>RP11-770J1.4</strong>) has been identified in the
context of its regulatory roles in immune responses, particularly in
relation to gliomas:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Responses</strong>:
<ul>
<li>RP11-77H9.1 is involved in regulating the expression of genes
associated with immune responses, specifically through its interaction
with the cytosolic DNA sensing pathway. This pathway is crucial for
detecting intracellular DNA and initiating immune responses against
infections and tumors.</li>
</ul></li>
<li><strong>Interaction with the cGAS-STING Pathway</strong>:
<ul>
<li>The long non-coding RNA (lncRNA) RP11-77H9.1 has been shown to
regulate the expression of <strong>CTXN1</strong> (Cortexin 1) by
sponging hsa-miR-124-3p. Downregulation of RP11-77H9.1 leads to
increased activation of the cGAS-STING pathway, which is vital for
triggering immune responses, particularly the production of type I
interferons that enhance anti-tumor immunity.</li>
</ul></li>
<li><strong>Impact on Tumor Microenvironment</strong>:
<ul>
<li>In glioma models, decreased expression of RP11-77H9.1 correlates
with increased infiltration of CD8+ T cells, which are essential for
effective anti-tumor immunity. This suggests that RP11-77H9.1 may play a
role in modulating the tumor microenvironment by influencing immune cell
infiltration and activity.</li>
</ul></li>
<li><strong>Potential as a Therapeutic Target</strong>:
<ul>
<li>The findings indicate that targeting RP11-77H9.1 could enhance
immune responses in gliomas, making it a potential therapeutic target
for improving outcomes in patients with this type of cancer.</li>
</ul></li>
<li><strong>Correlation with Prognosis</strong>:
<ul>
<li>Survival analyses have demonstrated a close correlation between
RP11-77H9.1 expression and glioma prognosis, suggesting that it may
serve as a biomarker for assessing immune-related features in tumors and
predicting patient outcomes.</li>
</ul></li>
</ol>
<p>In summary, RP11-77H9.1 functions as an important regulator of immune
responses through its involvement in the cGAS-STING pathway and its
impact on T cell infiltration in gliomas. Its role highlights its
potential significance in cancer immunotherapy and as a prognostic
marker in tumor biology.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [2] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[3] <a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [4]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10728758/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10728758/</a>
[5] <a
href="https://www.salk.edu/news-release/salk-scientists-discover-genetic-dial-to-turn-immune-function-up-and-down-to-target-cancer-autoimmune-disease/"
class="uri">https://www.salk.edu/news-release/salk-scientists-discover-genetic-dial-to-turn-immune-function-up-and-down-to-target-cancer-autoimmune-disease/</a>
[6] <a href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a> [7] <a
href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [8]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a></p>
</div>
<div id="uqcc" class="section level3">
<h3>UQCC</h3>
<p>The immune function of the gene <strong>UQCC</strong>
(Ubiquinone-Cytochrome c Reductase Core Component) is primarily
associated with its role in mitochondrial function and cellular
metabolism, which are critical for effective immune responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Mitochondrial Function and Energy Production</strong>:
<ul>
<li>UQCC is involved in the mitochondrial respiratory chain,
specifically in the complex III assembly, which is essential for ATP
production. Adequate energy supply is crucial for the activation and
proliferation of immune cells, particularly during immune responses to
infections.</li>
</ul></li>
<li><strong>Regulation of Reactive Oxygen Species (ROS)</strong>:
<ul>
<li>By participating in mitochondrial electron transport, UQCC helps
regulate the production of reactive oxygen species (ROS). ROS play a
dual role in the immune system; they can act as signaling molecules that
enhance immune responses but can also contribute to tissue damage if
produced excessively. Proper regulation of ROS levels is essential for
maintaining a balanced immune response.</li>
</ul></li>
<li><strong>Influence on Immune Cell Activation</strong>:
<ul>
<li>The activity of UQCC may impact the activation and function of
various immune cells, including T cells and macrophages. Effective
mitochondrial function is vital for these cells to respond adequately to
pathogens and inflammatory signals.</li>
</ul></li>
<li><strong>Potential Role in Inflammation</strong>:
<ul>
<li>UQCC may influence inflammatory processes by affecting the metabolic
state of immune cells. Changes in metabolism can alter cytokine
production and cell signaling pathways, impacting overall inflammatory
responses.</li>
</ul></li>
<li><strong>Association with Disease</strong>:
<ul>
<li>Dysregulation of UQCC and mitochondrial function has been linked to
various diseases, including autoimmune disorders and cancer. Impaired
mitochondrial function can lead to altered immune responses,
contributing to disease pathogenesis.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While the specific immune functions of UQCC are not fully
characterized, further research could elucidate its precise roles in
immune regulation and potential therapeutic implications in
immune-related diseases.</li>
</ul></li>
</ol>
<p>In summary, UQCC plays a significant role in mitochondrial function
and energy production, which are essential for effective immune
responses. Its influence on ROS regulation and potential impact on
inflammation highlight its importance in maintaining immune homeostasis.
Further studies are needed to explore its specific mechanisms and
implications in various diseases.</p>
<p>Citations: [1] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[2] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[3] <a href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10728758/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10728758/</a> [5]
<a
href="https://www.salk.edu/news-release/salk-scientists-discover-genetic-dial-to-turn-immune-function-up-and-down-to-target-cancer-autoimmune-disease/"
class="uri">https://www.salk.edu/news-release/salk-scientists-discover-genetic-dial-to-turn-immune-function-up-and-down-to-target-cancer-autoimmune-disease/</a>
[6] <a href="https://www.aging-us.com/article/204039/text"
class="uri">https://www.aging-us.com/article/204039/text</a> [7] <a
href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [8]
<a href="https://onlinelibrary.wiley.com/doi/10.1155/2018/7969068"
class="uri">https://onlinelibrary.wiley.com/doi/10.1155/2018/7969068</a></p>
</div>
<div id="tgm2-1" class="section level3">
<h3>TGM2</h3>
<p>The immune function of the gene <strong>TGM2</strong>
(Transglutaminase 2) is multifaceted and plays a significant role in
various immune processes:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Inflammation</strong>:
<ul>
<li>TGM2 is involved in the modulation of inflammatory responses. It can
act as a pro-inflammatory factor in certain contexts, promoting the
production of cytokines and chemokines that drive inflammation. This is
particularly relevant in autoimmune diseases where TGM2 expression may
be elevated.</li>
</ul></li>
<li><strong>Antigen Presentation</strong>:
<ul>
<li>TGM2 has been implicated in the process of antigen presentation. It
can modify proteins through cross-linking, which may enhance their
stability and presentation on major histocompatibility complex (MHC)
molecules. This is crucial for the activation of T cells and the
initiation of adaptive immune responses.</li>
</ul></li>
<li><strong>Role in Immune Cell Function</strong>:
<ul>
<li>TGM2 is expressed in various immune cells, including macrophages and
dendritic cells. Its activity influences these cells’ functions, such as
phagocytosis and cytokine secretion, thereby affecting overall immune
responses.</li>
</ul></li>
<li><strong>Involvement in Autoimmunity</strong>:
<ul>
<li>Elevated levels of TGM2 have been associated with several autoimmune
conditions, including celiac disease and systemic lupus erythematosus
(SLE). In these diseases, TGM2 can contribute to tissue damage and
chronic inflammation by modifying self-antigens, leading to an
inappropriate immune response.</li>
</ul></li>
<li><strong>Impact on Regulatory T Cells</strong>:
<ul>
<li>TGM2 can influence the differentiation and function of regulatory T
cells (Tregs), which are essential for maintaining immune tolerance and
preventing autoimmune reactions. By modulating Treg activity, TGM2 can
impact the balance between tolerance and immunity.</li>
</ul></li>
<li><strong>Potential Therapeutic Target</strong>:
<ul>
<li>Given its roles in inflammation and autoimmunity, TGM2 represents a
potential therapeutic target for modulating immune responses in various
diseases. Inhibiting its activity could help reduce inappropriate
inflammatory responses or enhance tolerance.</li>
</ul></li>
</ol>
<p>In summary, TGM2 plays a critical role in regulating inflammation,
antigen presentation, and immune cell function. Its involvement in
autoimmune diseases highlights its significance in maintaining immune
homeostasis and presents opportunities for therapeutic intervention in
immune-related disorders.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [2] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214624/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214624/</a>
[3] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01281/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01281/full</a>
[4] <a href="https://www.nature.com/articles/s41467-017-01886-6"
class="uri">https://www.nature.com/articles/s41467-017-01886-6</a> [5]
<a href="https://medlineplus.gov/genetics/gene/irgm/"
class="uri">https://medlineplus.gov/genetics/gene/irgm/</a> [6] <a
href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [7]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[8] <a
href="https://academic.oup.com/gbe/article/15/9/evad158/7251444?login=false"
class="uri">https://academic.oup.com/gbe/article/15/9/evad158/7251444?login=false</a></p>
</div>
<div id="zbtb38-1" class="section level3">
<h3>ZBTB38</h3>
<p>The immune function of the gene <strong>ZBTB38</strong> (Zinc Finger
and BTB Domain Containing 38) is associated with its role in regulating
immune responses, particularly in the context of T cell differentiation
and function:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of T Cell Differentiation</strong>:
<ul>
<li>ZBTB38 has been identified as a transcription factor that influences
the differentiation of T cells, particularly in promoting the
development of regulatory T cells (Tregs). Tregs are crucial for
maintaining immune tolerance and preventing autoimmune responses.</li>
</ul></li>
<li><strong>Influence on Cytokine Production</strong>:
<ul>
<li>By modulating the expression of genes involved in cytokine
signaling, ZBTB38 can affect the production of key cytokines that
regulate immune responses. This includes promoting anti-inflammatory
cytokines that help control excessive immune activation.</li>
</ul></li>
<li><strong>Role in Immune Tolerance</strong>:
<ul>
<li>ZBTB38 is important for establishing and maintaining immune
tolerance, which is essential for preventing the immune system from
attacking the body’s own tissues. Its function in Tregs helps ensure
that the immune response is appropriately regulated.</li>
</ul></li>
<li><strong>Potential Implications in Autoimmunity and Cancer</strong>:
<ul>
<li>Dysregulation of ZBTB38 has been linked to various autoimmune
diseases where there is a breakdown of tolerance. Conversely, its role
in promoting Treg function may also be significant in cancer, where
enhancing Treg activity can contribute to tumor immune evasion.</li>
</ul></li>
<li><strong>Interplay with Other Transcription Factors</strong>:
<ul>
<li>ZBTB38 interacts with other transcription factors and signaling
pathways that are critical for immune cell function, further
highlighting its role in the complex network that regulates immune
responses.</li>
</ul></li>
</ol>
<p>In summary, ZBTB38 plays a significant role in regulating T cell
differentiation, particularly in promoting regulatory T cell function
and maintaining immune tolerance. Its influence on cytokine production
and potential implications in autoimmune diseases and cancer underscore
its importance in immune regulation. Further research could elucidate
its specific mechanisms and therapeutic potential in various
contexts.</p>
<p>Citations: [1] <a
href="https://www.salk.edu/news-release/salk-scientists-discover-genetic-dial-to-turn-immune-function-up-and-down-to-target-cancer-autoimmune-disease/"
class="uri">https://www.salk.edu/news-release/salk-scientists-discover-genetic-dial-to-turn-immune-function-up-and-down-to-target-cancer-autoimmune-disease/</a>
[2] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9214624/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9214624/</a> [4] <a
href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [5]
<a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[6] <a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [7]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.713294/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.713294/full</a>
[8] <a href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a></p>
</div>
<div id="pik3c2b-1" class="section level3">
<h3>PIK3C2B</h3>
<p>The immune function of the gene <strong>PIK3C2B</strong>
(Phosphoinositide 3-Kinase C2 Beta) is primarily related to its role in
cellular signaling pathways that influence immune responses. Here are
the key aspects of its immune functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Role in Phosphoinositide Signaling</strong>:
<ul>
<li>PIK3C2B is part of the phosphoinositide 3-kinase (PI3K) family,
which plays a crucial role in various cellular processes, including cell
proliferation, survival, and migration. This signaling pathway is vital
for the activation and function of immune cells, particularly during
immune responses.</li>
</ul></li>
<li><strong>Influence on Immune Cell Activation</strong>:
<ul>
<li>PIK3C2B is involved in the activation of T cells and B cells. It
helps regulate the signaling cascades that are triggered upon antigen
recognition, which is essential for effective adaptive immune
responses.</li>
</ul></li>
<li><strong>Regulation of Cytokine Production</strong>:
<ul>
<li>The activity of PIK3C2B can influence the production of cytokines by
immune cells. Cytokines are critical for communication between immune
cells and orchestrating the overall immune response. Dysregulation of
this process can lead to inadequate immune responses or excessive
inflammation.</li>
</ul></li>
<li><strong>Impact on Immune Cell Migration</strong>:
<ul>
<li>PIK3C2B also plays a role in cell migration, which is important for
the movement of immune cells to sites of infection or inflammation.
Proper migration is essential for mounting effective immune responses
and ensuring that immune cells can respond to pathogens.</li>
</ul></li>
<li><strong>Association with Cancer Immunity</strong>:
<ul>
<li>Studies have shown that PIK3C2B may be involved in modulating tumor
immunity. Its expression levels correlate with various immune cell
infiltrations in tumors, suggesting it could influence how tumors
interact with the immune system and affect anti-tumor immunity.</li>
</ul></li>
<li><strong>Potential as a Therapeutic Target</strong>:
<ul>
<li>Given its roles in regulating immune functions and its involvement
in cancer, PIK3C2B may represent a potential therapeutic target for
enhancing immune responses or modulating inflammation in various
diseases.</li>
</ul></li>
</ol>
<p>In summary, PIK3C2B plays a significant role in regulating signaling
pathways that are crucial for T cell and B cell activation, cytokine
production, and immune cell migration. Its involvement in tumor immunity
further underscores its importance in understanding immune regulation
and potential therapeutic applications.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10098324/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10098324/</a> [2]
<a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [3]
<a href="https://en.wikipedia.org/wiki/PIK3C2A"
class="uri">https://en.wikipedia.org/wiki/PIK3C2A</a> [4] <a
href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a> [5] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[6] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [8] <a
href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a></p>
</div>
<div id="stk25" class="section level3">
<h3>STK25</h3>
<p>The immune function of the gene <strong>STK25</strong>
(Serine/Threonine Kinase 25) is associated with several important roles
in regulating immune responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Cell Signaling</strong>:
<ul>
<li>STK25 is involved in signaling pathways that affect the activation
and function of immune cells. It plays a role in the regulation of
various cellular processes, including apoptosis, cell proliferation, and
differentiation, which are crucial for effective immune responses.</li>
</ul></li>
<li><strong>Influence on Inflammatory Responses</strong>:
<ul>
<li>STK25 has been implicated in modulating inflammatory responses. It
can affect the production of pro-inflammatory cytokines and chemokines,
thereby influencing the recruitment and activation of immune cells at
sites of inflammation.</li>
</ul></li>
<li><strong>Role in Metabolic Regulation</strong>:
<ul>
<li>The kinase is involved in metabolic pathways that can impact immune
cell function. Metabolic changes within immune cells are critical for
their activation and ability to respond to pathogens.</li>
</ul></li>
<li><strong>Potential Implications in Autoimmunity and Cancer</strong>:
<ul>
<li>Dysregulation of STK25 has been linked to various diseases,
including autoimmune disorders and cancer. Its role in modulating immune
responses suggests that it could contribute to the pathogenesis of these
conditions by influencing how the immune system interacts with tumors or
self-antigens.</li>
</ul></li>
<li><strong>Interplay with Other Signaling Pathways</strong>:
<ul>
<li>STK25 may interact with other signaling pathways that regulate
immune functions, further highlighting its role in the complex network
governing immune responses.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While there is growing evidence linking STK25 to immune functions,
more targeted research is needed to elucidate its specific mechanisms
and roles in various immune contexts.</li>
</ul></li>
</ol>
<p>In summary, STK25 plays a significant role in regulating immune cell
signaling, inflammatory responses, and metabolic processes that are
crucial for effective immunity. Its involvement in autoimmune diseases
and cancer underscores its importance in understanding immune regulation
and potential therapeutic applications. Further research could clarify
its specific functions and mechanisms within the immune system.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10098324/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10098324/</a> [2]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[3] <a href="https://defensefinder.mdmlab.fr/wiki/defense-systems/stk2/"
class="uri">https://defensefinder.mdmlab.fr/wiki/defense-systems/stk2/</a>
[4] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [5] <a
href="https://www.addgene.org/collections/immunology/"
class="uri">https://www.addgene.org/collections/immunology/</a> [6] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9214624/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9214624/</a> [8] <a
href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a></p>
</div>
<div id="arap1-1" class="section level3">
<h3>ARAP1</h3>
<p>The immune function of the gene <strong>ARAP1</strong> (ArfGAP with
RhoGAP domain, ANK repeat, and PH domain 1) is linked to several
critical roles in immune responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Cell Signaling</strong>:
<ul>
<li>ARAP1 is involved in the regulation of signaling pathways that are
crucial for the activation and function of immune cells, particularly in
T cells and B cells. It modulates the activity of small GTPases, which
are essential for various cellular processes including cell
proliferation, migration, and differentiation.</li>
</ul></li>
<li><strong>Impact on Cytoskeletal Dynamics</strong>:
<ul>
<li>ARAP1 plays a role in cytoskeletal reorganization, which is vital
for immune cell motility and the formation of structures such as
lamellipodia and filopodia. These structures are important for immune
cells to migrate toward sites of infection and to interact with other
cells during immune responses.</li>
</ul></li>
<li><strong>Influence on Phagocytosis</strong>:
<ul>
<li>The protein has been implicated in enhancing phagocytosis, a process
by which immune cells engulf and destroy pathogens. By regulating the
actin cytoskeleton, ARAP1 can facilitate the internalization of
pathogens by phagocytic cells such as macrophages.</li>
</ul></li>
<li><strong>Role in Antigen Presentation</strong>:
<ul>
<li>ARAP1 may also influence antigen presentation by affecting the
trafficking of major histocompatibility complex (MHC) molecules to the
cell surface. This is crucial for T cell activation and the initiation
of adaptive immune responses.</li>
</ul></li>
<li><strong>Potential Implications in Inflammatory Diseases</strong>:
<ul>
<li>Dysregulation of ARAP1 has been associated with various inflammatory
diseases. Its role in modulating immune signaling pathways suggests that
it could contribute to the pathogenesis of conditions characterized by
excessive or inappropriate immune responses.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While the specific mechanisms by which ARAP1 influences immune
functions are still being explored, further research could clarify its
roles in various immune contexts, including its interactions with other
signaling molecules and pathways.</li>
</ul></li>
</ol>
<p>In summary, ARAP1 plays a significant role in regulating immune cell
signaling, cytoskeletal dynamics, phagocytosis, and antigen
presentation. Its involvement in these processes underscores its
importance in maintaining effective immune responses and highlights
potential therapeutic targets for modulating immunity in various
diseases.</p>
<p>Citations: [1] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [3] <a
href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a> [4] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[5] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678915/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678915/</a>
[6] <a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [7]
<a href="https://medlineplus.gov/genetics/gene/irgm/"
class="uri">https://medlineplus.gov/genetics/gene/irgm/</a> [8] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10098324/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10098324/</a></p>
</div>
<div id="btbd2-1" class="section level3">
<h3>BTBD2</h3>
<p>The immune function of the gene <strong>BTBD2</strong> (BTB (POZ)
Domain Containing 2) is associated with several roles in immune
regulation and signaling:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Cell Function</strong>:
<ul>
<li>BTBD2 has been implicated in modulating the activity of immune
cells, including T cells and macrophages. It may influence cell
signaling pathways that are critical for immune activation and response
to pathogens.</li>
</ul></li>
<li><strong>Role in Cytokine Production</strong>:
<ul>
<li>BTBD2 can affect the production of cytokines, which are essential
for communication between immune cells. By regulating cytokine
expression, BTBD2 may play a role in shaping the immune response during
infections or inflammatory conditions.</li>
</ul></li>
<li><strong>Involvement in Immune Tolerance</strong>:
<ul>
<li>The gene may also be involved in maintaining immune tolerance, which
is crucial for preventing autoimmune reactions. Its regulatory functions
could help ensure that the immune system does not attack the body’s own
tissues.</li>
</ul></li>
<li><strong>Potential Implications in Disease</strong>:
<ul>
<li>Dysregulation of BTBD2 has been linked to various diseases,
including autoimmune disorders and cancers. Its role in modulating
immune responses suggests that it could influence disease progression
and outcomes.</li>
</ul></li>
<li><strong>Interaction with Other Proteins</strong>:
<ul>
<li>BTBD2 may interact with other proteins involved in immune signaling
pathways, further highlighting its role in the complex network that
regulates immune functions.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While there is some evidence linking BTBD2 to immune functions, more
targeted research is needed to fully elucidate its specific mechanisms
and roles in various immune contexts.</li>
</ul></li>
</ol>
<p>In summary, BTBD2 plays a significant role in regulating immune cell
function, cytokine production, and maintaining immune tolerance. Its
involvement in autoimmune diseases and cancer underscores its importance
in understanding immune regulation and potential therapeutic
applications. Further research could clarify its specific functions and
interactions within the immune system.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2021.762541/full"
class="uri">https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2021.762541/full</a>
[2] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [4] <a
href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [5]
<a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [6]
<a href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a> [7] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9214624/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9214624/</a> [8] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a></p>
</div>
<div id="ldah" class="section level3">
<h3>LDAH</h3>
<p>The immune function of the gene <strong>LDAH</strong>
(L-2-hydroxyglutarate dehydrogenase) is related to its role in metabolic
processes that can influence immune responses. Here are the key aspects
of LDAH’s immune functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Metabolic Regulation</strong>:
<ul>
<li>LDAH is involved in the metabolism of L-2-hydroxyglutarate (L-2HG),
a metabolite that can accumulate in various pathological conditions,
including cancer. Elevated levels of L-2HG can influence cellular
metabolism and signaling, potentially affecting immune cell
function.</li>
</ul></li>
<li><strong>Influence on Immune Cell Activation</strong>:
<ul>
<li>The accumulation of L-2HG has been shown to have immunomodulatory
effects. High levels of L-2HG can inhibit the activation and function of
T cells and other immune cells, leading to an immunosuppressive
environment. This is particularly relevant in tumor biology, where
cancer cells may exploit this pathway to evade immune detection.</li>
</ul></li>
<li><strong>Role in Inflammation</strong>:
<ul>
<li>LDAH may also play a role in regulating inflammatory responses. By
modulating the levels of L-2HG, it can influence the production of
pro-inflammatory cytokines and the overall inflammatory milieu, which is
crucial for effective immune responses.</li>
</ul></li>
<li><strong>Potential Implications in Cancer Immunotherapy</strong>:
<ul>
<li>Given its role in modulating immune responses through metabolic
pathways, targeting LDAH or its associated pathways may offer
therapeutic strategies for enhancing anti-tumor immunity. This could
involve reducing L-2HG levels to restore T cell function and promote a
more effective immune response against tumors.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While there is growing interest in the metabolic regulation of
immune responses, specific studies directly linking LDAH to immune
functions are limited. Further research is needed to clarify its precise
roles and mechanisms within the immune system.</li>
</ul></li>
</ol>
<p>In summary, LDAH influences immune functions primarily through its
role in regulating the metabolism of L-2-hydroxyglutarate, which can
affect immune cell activation and inflammatory responses. Its potential
implications in cancer immunotherapy highlight its importance in
understanding immune regulation and therapeutic strategies. Further
research could elucidate its specific mechanisms and interactions within
the immune context.</p>
<p>Citations: [1] <a href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [3] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[4] <a href="https://medlineplus.gov/genetics/gene/irgm/"
class="uri">https://medlineplus.gov/genetics/gene/irgm/</a> [5] <a
href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [6]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[7] <a href="https://www.nature.com/articles/s41588-023-01421-y"
class="uri">https://www.nature.com/articles/s41588-023-01421-y</a> [8]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11233176/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC11233176/</a></p>
</div>
<div id="bbc3-1" class="section level3">
<h3>BBC3</h3>
<p>The immune function of the gene <strong>BBC3</strong> (Bcl-2 Binding
Component 3), also known as <strong>PUMA</strong> (p53 Upregulated
Modulator of Apoptosis), is primarily related to its role in regulating
apoptosis and influencing immune responses:</p>
<ol style="list-style-type: decimal">
<li><strong>Induction of Apoptosis</strong>:
<ul>
<li>BBC3 is a pro-apoptotic member of the Bcl-2 family of proteins. It
is activated in response to various stress signals, including DNA damage
and cytokine signaling. By promoting apoptosis in cells, BBC3 plays a
critical role in eliminating damaged or infected cells, which is
essential for maintaining immune homeostasis.</li>
</ul></li>
<li><strong>Role in T Cell Activation</strong>:
<ul>
<li>BBC3 has been shown to influence T cell responses. It can affect the
survival and proliferation of T cells during immune activation. By
regulating apoptosis in T cells, BBC3 helps ensure that only those cells
that are necessary for an effective immune response are allowed to
survive.</li>
</ul></li>
<li><strong>Influence on Tumor Surveillance</strong>:
<ul>
<li>As a pro-apoptotic factor, BBC3 is involved in the immune system’s
ability to recognize and eliminate tumor cells. Its expression can be
upregulated in response to oncogenic stress, promoting the death of
cancerous cells and facilitating anti-tumor immunity.</li>
</ul></li>
<li><strong>Cytokine Production</strong>:
<ul>
<li>BBC3 may also influence cytokine production by immune cells. The
regulation of apoptosis can affect the overall cytokine milieu, which is
crucial for coordinating immune responses during infections or
inflammation.</li>
</ul></li>
<li><strong>Implications in Autoimmunity and Cancer</strong>:
<ul>
<li>Dysregulation of BBC3 has been linked to various autoimmune diseases
and cancers. In autoimmune conditions, inappropriate survival of
autoreactive T cells may occur if apoptotic pathways are disrupted.
Conversely, in cancer, reduced expression of BBC3 can lead to enhanced
survival of tumor cells, contributing to tumor progression.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While the role of BBC3 in apoptosis and T cell regulation is
well-established, further research is needed to fully elucidate its
specific mechanisms within various immune contexts and its potential
therapeutic implications.</li>
</ul></li>
</ol>
<p>In summary, BBC3 plays a significant role in regulating apoptosis
within the immune system, influencing T cell activation, tumor
surveillance, and cytokine production. Its involvement in both
autoimmune diseases and cancer underscores its importance in maintaining
immune balance and highlights its potential as a therapeutic target.</p>
<p>Citations: [1] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[2] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [4] <a
href="https://medlineplus.gov/genetics/gene/irgm/"
class="uri">https://medlineplus.gov/genetics/gene/irgm/</a> [5] <a
href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a> [6] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [7]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9214624/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9214624/</a> [8] <a
href="https://www.nature.com/articles/s41588-023-01421-y"
class="uri">https://www.nature.com/articles/s41588-023-01421-y</a></p>
</div>
<div id="bcl2l11" class="section level3">
<h3>BCL2L11</h3>
<p>The immune function of the gene <strong>BCL2L11</strong> (Bcl-2 Like
11) is primarily associated with its role as a pro-apoptotic member of
the Bcl-2 family of proteins. Here are the key aspects of its immune
functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Induction of Apoptosis</strong>:
<ul>
<li>BCL2L11, also known as <strong>PUMA</strong> (p53 Upregulated
Modulator of Apoptosis), is a critical regulator of apoptosis. It
promotes programmed cell death in response to various stress signals,
including DNA damage and cytokine signaling. This function is essential
for eliminating damaged or infected cells, thereby maintaining immune
homeostasis.</li>
</ul></li>
<li><strong>Role in T Cell Regulation</strong>:
<ul>
<li>BCL2L11 is involved in the regulation of T cell responses. It can
influence the survival and activation of T cells during immune
responses. By promoting apoptosis in T cells that are no longer needed
or that have become autoreactive, BCL2L11 helps maintain tolerance and
prevent autoimmunity.</li>
</ul></li>
<li><strong>Influence on Immune Cell Development</strong>:
<ul>
<li>The expression of BCL2L11 is crucial during the development of
various immune cells, including T and B lymphocytes. Its pro-apoptotic
activity ensures that only functional and properly developed immune
cells survive, which is vital for effective adaptive immune
responses.</li>
</ul></li>
<li><strong>Cytokine Production</strong>:
<ul>
<li>BCL2L11 may also play a role in regulating cytokine production by
immune cells. By influencing apoptosis and cell survival, it can affect
the overall cytokine milieu, which is critical for coordinating immune
responses during infections or inflammatory conditions.</li>
</ul></li>
<li><strong>Implications in Cancer Immunity</strong>:
<ul>
<li>In the context of cancer, BCL2L11 has been shown to facilitate the
elimination of tumor cells by promoting apoptosis in response to
oncogenic stress. Its expression can enhance anti-tumor immunity by
ensuring that malignant cells are efficiently removed by the immune
system.</li>
</ul></li>
<li><strong>Association with Autoimmunity</strong>:
<ul>
<li>Dysregulation of BCL2L11 has been linked to autoimmune diseases,
where inappropriate survival of autoreactive T cells may occur if
apoptotic pathways are disrupted. This highlights its importance in
maintaining self-tolerance within the immune system.</li>
</ul></li>
</ol>
<p>In summary, BCL2L11 plays a significant role in regulating apoptosis
within the immune system, influencing T cell activation and development,
cytokine production, and maintaining immune tolerance. Its involvement
in both cancer immunity and autoimmune diseases underscores its
importance in understanding immune regulation and potential therapeutic
applications.</p>
<p>Citations: [1] <a
href="https://onlinelibrary.wiley.com/doi/10.1155/2013/705294"
class="uri">https://onlinelibrary.wiley.com/doi/10.1155/2013/705294</a>
[2] <a href="https://www.nature.com/articles/s41419-020-2589-7"
class="uri">https://www.nature.com/articles/s41419-020-2589-7</a> [3] <a
href="https://www.nature.com/articles/s41419-019-1407-6"
class="uri">https://www.nature.com/articles/s41419-019-1407-6</a> [4] <a
href="https://pubmed.ncbi.nlm.nih.gov/32424151/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/32424151/</a> [5] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [6]
<a href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a> [7] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10678915/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10678915/</a> [8]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a></p>
</div>
<div id="znf568-1" class="section level3">
<h3>ZNF568</h3>
<p>The immune function of the gene <strong>ZNF568</strong> (Zinc Finger
Protein 568) is primarily associated with its role as a transcription
factor, particularly in the regulation of immune responses. Here are the
key aspects of its immune functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Transcriptional Regulation</strong>:
<ul>
<li>ZNF568 is part of the zinc finger protein family, which is known for
its ability to bind DNA and regulate gene expression. This capability
allows ZNF568 to influence the transcription of genes involved in immune
responses, potentially affecting both innate and adaptive immunity.</li>
</ul></li>
<li><strong>Role in Immune Cell Differentiation</strong>:
<ul>
<li>By regulating specific target genes, ZNF568 may play a role in the
differentiation of various immune cell types, including T cells and B
cells. Proper differentiation is crucial for the development of
effective immune responses.</li>
</ul></li>
<li><strong>Influence on Cytokine Production</strong>:
<ul>
<li>ZNF568 may also impact the production of cytokines, which are
critical for communication between immune cells. By modulating cytokine
expression, it can help shape the overall immune response during
infections or inflammatory conditions.</li>
</ul></li>
<li><strong>Response to Pathogens</strong>:
<ul>
<li>Zinc finger proteins, including ZNF568, have been implicated in the
control of viral replication and other pathogen responses. They may help
regulate the expression of antiviral genes and contribute to the host’s
defense mechanisms against infectious agents.</li>
</ul></li>
<li><strong>Potential Implications in Autoimmunity</strong>:
<ul>
<li>Dysregulation of zinc finger proteins can lead to inappropriate
immune responses, contributing to autoimmune diseases. ZNF568’s role in
transcriptional regulation suggests that it could be involved in
maintaining immune tolerance and preventing autoimmunity.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While there is evidence suggesting that zinc finger proteins play
significant roles in immune regulation, specific studies focusing on
ZNF568’s mechanisms and functions in immunity are still needed to fully
understand its contributions.</li>
</ul></li>
</ol>
<p>In summary, ZNF568 likely plays a significant role in regulating
immune responses through its function as a transcription factor. Its
involvement in immune cell differentiation, cytokine production, and
pathogen response underscores its importance in maintaining effective
immunity and highlights potential implications for autoimmune diseases.
Further research is necessary to elucidate its specific mechanisms
within the immune system.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/</a> [2] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[3] <a href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [4]
<a href="https://www.nature.com/articles/nature09782"
class="uri">https://www.nature.com/articles/nature09782</a> [5] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10069130/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10069130/</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [7] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[8] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a></p>
</div>
<div id="msmb" class="section level3">
<h3>MSMB</h3>
<p>The immune function of the gene <strong>MSMB</strong>
(Microseminoprotein Beta) is associated with several roles in immune
regulation and response, particularly in the context of prostate health
and cancer:</p>
<ol style="list-style-type: decimal">
<li><strong>Role in Immune Modulation</strong>:
<ul>
<li>MSMB is believed to play a role in modulating immune responses,
particularly in the prostate. It has been suggested that MSMB may
influence the immune environment within the prostate gland, potentially
affecting how immune cells interact with prostate cancer cells.</li>
</ul></li>
<li><strong>Potential Anti-Inflammatory Effects</strong>:
<ul>
<li>Some studies indicate that MSMB may have anti-inflammatory
properties. By modulating inflammatory responses, MSMB could help
maintain a balanced immune environment, which is crucial for preventing
chronic inflammation that can lead to cancer progression.</li>
</ul></li>
<li><strong>Involvement in Cancer Immunology</strong>:
<ul>
<li>In the context of prostate cancer, MSMB has been studied for its
potential role as a tumor suppressor. It may help regulate the immune
system’s ability to recognize and eliminate cancer cells. Reduced
expression of MSMB has been associated with advanced stages of prostate
cancer, suggesting that it may play a protective role against tumor
development.</li>
</ul></li>
<li><strong>Influence on Cytokine Production</strong>:
<ul>
<li>MSMB may impact the production of cytokines, which are critical for
communication between immune cells. This regulation can influence
various aspects of the immune response, including inflammation and cell
signaling.</li>
</ul></li>
<li><strong>Association with Immune-Related Diseases</strong>:
<ul>
<li>Dysregulation of MSMB expression has been linked to various
diseases, including autoimmune conditions and cancers. Understanding its
role in these contexts could provide insights into its potential as a
therapeutic target or biomarker.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While there is some evidence linking MSMB to immune functions, more
targeted research is needed to elucidate its specific mechanisms and
roles in various immune contexts.</li>
</ul></li>
</ol>
<p>In summary, MSMB appears to play a significant role in modulating
immune responses, particularly in relation to prostate health and
cancer. Its potential anti-inflammatory effects and involvement in
cytokine production highlight its importance in maintaining immune
balance and preventing disease progression. Further research is
necessary to fully understand its contributions to immunity and
potential implications in immune-related diseases.</p>
<p>Citations: [1] <a
href="https://www.nutraceuticalsworld.com/contents/view_breaking-news/2016-03-24/bergstrom-report-highlights-msms-benefits-for-immunity/"
class="uri">https://www.nutraceuticalsworld.com/contents/view_breaking-news/2016-03-24/bergstrom-report-highlights-msms-benefits-for-immunity/</a>
[2] <a
href="https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2021.712731/full"
class="uri">https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2021.712731/full</a>
[3] <a href="https://www.healthline.com/nutrition/msm-supplements"
class="uri">https://www.healthline.com/nutrition/msm-supplements</a> [4]
<a
href="https://www.sciencedirect.com/science/article/pii/S0032579119406032"
class="uri">https://www.sciencedirect.com/science/article/pii/S0032579119406032</a>
[5] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/</a> [7] <a
href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [8]
<a href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a></p>
</div>
<div id="il11ra" class="section level3">
<h3>IL11RA</h3>
<p>The immune function of the gene <strong>IL11RA</strong> (Interleukin
11 Receptor Alpha) is primarily linked to its role in mediating the
effects of interleukin-11 (IL-11), a cytokine involved in various immune
and inflammatory processes. Here are the key aspects of IL11RA’s immune
functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Receptor for IL-11</strong>:
<ul>
<li>IL11RA is the specific receptor for IL-11, which is part of the IL-6
cytokine family. When IL-11 binds to IL11RA, it forms a signaling
complex with the gp130 receptor, activating intracellular signaling
pathways, including the JAK/STAT pathway, which is crucial for many
immune responses.</li>
</ul></li>
<li><strong>Regulation of Immune Cell Function</strong>:
<ul>
<li>IL-11 signaling through IL11RA has been shown to influence the
differentiation and function of various immune cells. For example, it
can promote the polarization of CD4+ T cells toward Th2 and Th17
phenotypes, which are important for mediating allergic responses and
autoimmune diseases.</li>
</ul></li>
<li><strong>Impact on Macrophage Activity</strong>:
<ul>
<li>IL-11 plays a role in regulating macrophage differentiation and
function. It can enhance macrophage activation and promote a
pro-inflammatory phenotype, contributing to tissue repair and fibrosis
but also potentially exacerbating inflammatory conditions.</li>
</ul></li>
<li><strong>Involvement in Inflammatory Diseases</strong>:
<ul>
<li>Elevated levels of IL-11 and increased expression of IL11RA have
been associated with several inflammatory diseases, such as rheumatoid
arthritis and systemic sclerosis. In these contexts, IL-11 can drive
fibrotic processes and contribute to chronic inflammation.</li>
</ul></li>
<li><strong>Role in Cancer Immunology</strong>:
<ul>
<li>In cancer, IL-11 produced by tumor-associated stromal cells can
suppress pro-inflammatory cytokine secretion from CD4+ T cells, thereby
promoting immune evasion and supporting tumor growth. This highlights
the dual role of IL-11 in both promoting inflammation in certain
contexts while also facilitating tumor progression.</li>
</ul></li>
<li><strong>Potential Therapeutic Target</strong>:
<ul>
<li>Given its involvement in various immune-related processes, targeting
IL11RA or its signaling pathways may offer therapeutic strategies for
treating autoimmune diseases, chronic inflammatory conditions, or
enhancing anti-tumor immunity.</li>
</ul></li>
</ol>
<p>In summary, IL11RA plays a crucial role in mediating the effects of
IL-11 on immune cells, influencing their differentiation and function.
Its involvement in inflammation and potential contributions to disease
processes underscore its importance in immunology and highlight
potential avenues for therapeutic intervention.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10754292/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10754292/</a> [2]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [3] <a
href="https://www.rndsystems.com/pathways/il-11-signaling-pathways"
class="uri">https://www.rndsystems.com/pathways/il-11-signaling-pathways</a>
[4] <a
href="https://www.annualreviews.org/docserver/fulltext/med/71/1/annurev-med-041818-011649.pdf?accname=guest&amp;checksum=E43DCDABF2AA2E61F818528ABA8924AF&amp;expires=1712611497&amp;id=id"
class="uri">https://www.annualreviews.org/docserver/fulltext/med/71/1/annurev-med-041818-011649.pdf?accname=guest&amp;checksum=E43DCDABF2AA2E61F818528ABA8924AF&amp;expires=1712611497&amp;id=id</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8560641/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8560641/</a> [6] <a
href="https://www.nature.com/articles/s41467-023-42754-w"
class="uri">https://www.nature.com/articles/s41467-023-42754-w</a> [7]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[8] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a></p>
</div>
<div id="mapkbp1-1" class="section level3">
<h3>MAPKBP1</h3>
<p>The immune function of the gene <strong>MAPKBP1</strong>
(Mitogen-Activated Protein Kinase Binding Protein 1) is primarily linked
to its role in regulating MAPK (Mitogen-Activated Protein Kinase)
signaling pathways, which are crucial for various immune responses. Here
are the key aspects of MAPKBP1’s immune functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of MAPK Signaling</strong>:
<ul>
<li>MAPKBP1 interacts with MAPKs, particularly p38 and JNK (c-Jun
N-terminal kinase), playing a role in modulating their activity. This
regulation is critical for controlling the production of
pro-inflammatory cytokines during immune responses, particularly in
macrophages and other immune cells.</li>
</ul></li>
<li><strong>Influence on Cytokine Production</strong>:
<ul>
<li>By regulating MAPK pathways, MAPKBP1 can influence the production of
key cytokines such as TNF-α and IL-6. Studies have shown that the
deletion of MAPKBP1 leads to enhanced cytokine production in response to
stimuli like LPS (lipopolysaccharide), indicating its role as a negative
regulator of inflammation.</li>
</ul></li>
<li><strong>Role in Innate Immunity</strong>:
<ul>
<li>MAPKBP1 is important for innate immune responses, particularly in
how macrophages respond to pathogens. It helps to control the activation
and resolution of inflammation, preventing excessive immune reactions
that can lead to tissue damage.</li>
</ul></li>
<li><strong>Feedback Regulation</strong>:
<ul>
<li>As a feedback regulator, MAPKBP1 helps maintain homeostasis within
the immune system by preventing prolonged activation of MAPKs. This is
crucial for avoiding conditions such as septic shock, where uncontrolled
inflammation can lead to severe outcomes.</li>
</ul></li>
<li><strong>Implications in Disease</strong>:
<ul>
<li>Dysregulation of MAPK signaling pathways, including those involving
MAPKBP1, has been implicated in various inflammatory diseases and
conditions characterized by chronic inflammation. Understanding its role
could provide insights into potential therapeutic targets for these
diseases.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While the functions of MAPKBP1 in immune regulation are becoming
clearer, further research is needed to fully elucidate its mechanisms
and interactions within different immune contexts.</li>
</ul></li>
</ol>
<p>In summary, MAPKBP1 plays a significant role in regulating MAPK
signaling pathways that are critical for controlling cytokine production
and innate immune responses. Its function as a negative regulator of
inflammation highlights its importance in maintaining immune homeostasis
and preventing excessive inflammatory responses.</p>
<p>Citations: [1] <a
href="https://rupress.org/jem/article/203/1/131/52258/MAP-kinase-phosphatase-1-controls-innate-immune"
class="uri">https://rupress.org/jem/article/203/1/131/52258/MAP-kinase-phosphatase-1-controls-innate-immune</a>
[2] <a href="https://pubmed.ncbi.nlm.nih.gov/23954936/"
class="uri">https://pubmed.ncbi.nlm.nih.gov/23954936/</a> [3] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[4] <a
href="https://link.springer.com/article/10.1007/s12026-023-09401-4"
class="uri">https://link.springer.com/article/10.1007/s12026-023-09401-4</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [6] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/</a> [7] <a
href="https://www.nature.com/articles/s41598-022-23062-7"
class="uri">https://www.nature.com/articles/s41598-022-23062-7</a> [8]
<a href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a></p>
</div>
<div id="klf7-1" class="section level3">
<h3>KLF7</h3>
<p>The immune function of the gene <strong>KLF7</strong> (Krüppel-like
factor 7) is primarily associated with its role as a transcription
factor that influences various aspects of immune cell development,
differentiation, and function. Here are the key aspects of KLF7’s immune
functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Cell Development</strong>:
<ul>
<li>KLF7 is involved in the differentiation and maturation of several
immune cell types, including T cells and B cells. Its expression is
crucial during lymphocyte development, where it helps regulate the
balance between proliferation and differentiation.</li>
</ul></li>
<li><strong>Influence on Cytokine Production</strong>:
<ul>
<li>As a transcription factor, KLF7 can modulate the expression of genes
involved in cytokine production. This regulation is important for
coordinating immune responses, particularly in inflammatory
conditions.</li>
</ul></li>
<li><strong>Role in T Cell Activation</strong>:
<ul>
<li>KLF7 has been implicated in the activation and function of T cells.
It may influence T cell receptor signaling pathways, which are essential
for T cell activation and subsequent immune responses to pathogens.</li>
</ul></li>
<li><strong>Involvement in Inflammatory Responses</strong>:
<ul>
<li>KLF7 may play a role in regulating inflammatory responses by
influencing the expression of pro-inflammatory cytokines. This function
is critical for maintaining homeostasis during immune responses and
preventing excessive inflammation.</li>
</ul></li>
<li><strong>Potential Implications in Autoimmunity and Cancer</strong>:
<ul>
<li>Dysregulation of KLF7 has been associated with autoimmune diseases
and certain cancers. Its role in T cell function suggests that
alterations in KLF7 expression or activity could contribute to the
pathogenesis of these conditions by affecting immune tolerance or
promoting tumor immunity.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While there is growing evidence linking KLF7 to immune functions,
more targeted studies are needed to elucidate its specific mechanisms
and interactions within different immune contexts.</li>
</ul></li>
</ol>
<p>In summary, KLF7 plays a significant role in regulating immune cell
development, cytokine production, and inflammatory responses. Its
involvement in T cell activation highlights its importance in
maintaining effective immunity and suggests potential implications for
autoimmune diseases and cancer. Further research is necessary to fully
understand its contributions to immunity and its potential as a
therapeutic target.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41598-024-69892-5"
class="uri">https://www.nature.com/articles/s41598-024-69892-5</a> [2]
<a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.819929/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.819929/full</a>
[3] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539188/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539188/</a>
[4] <a href="https://www.nature.com/articles/s41423-021-00806-5"
class="uri">https://www.nature.com/articles/s41423-021-00806-5</a> [5]
<a href="https://www.mdpi.com/1422-0067/18/11/2383"
class="uri">https://www.mdpi.com/1422-0067/18/11/2383</a> [6] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[7] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257580/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257580/</a>
[8] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a></p>
</div>
<div id="chd3-1" class="section level3">
<h3>CHD3</h3>
<p>The immune function of the gene <strong>CHD3</strong> (Chromodomain
Helicase DNA-Binding Protein 3) is primarily linked to its role in
chromatin remodeling and regulation of gene expression, which can
significantly impact immune responses. Here are the key aspects of
CHD3’s immune functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Chromatin Remodeling</strong>:
<ul>
<li>CHD3 is a member of the CHD family of proteins, which are involved
in modifying chromatin structure. By altering chromatin accessibility,
CHD3 can regulate the transcription of genes involved in immune
responses, affecting how immune cells respond to stimuli.</li>
</ul></li>
<li><strong>Regulation of Immune Cell Development</strong>:
<ul>
<li>CHD3 plays a role in the differentiation and function of various
immune cell types, including T cells and B cells. Its involvement in
chromatin remodeling is crucial for the proper activation and
differentiation of these cells during immune responses.</li>
</ul></li>
<li><strong>Influence on Cytokine Production</strong>:
<ul>
<li>By regulating the expression of cytokines and other immune-related
genes, CHD3 can modulate inflammatory responses. This regulation is
important for maintaining homeostasis in the immune system and
preventing excessive inflammation.</li>
</ul></li>
<li><strong>Role in Inflammatory Diseases</strong>:
<ul>
<li>Dysregulation of CHD3 has been linked to various inflammatory
diseases. Its role in chromatin remodeling suggests that it may
contribute to the pathogenesis of conditions characterized by chronic
inflammation or autoimmunity.</li>
</ul></li>
<li><strong>Potential Implications in Cancer Immunology</strong>:
<ul>
<li>In cancer, CHD3 may influence the tumor microenvironment by
modulating immune cell infiltration and activity. Its ability to
regulate gene expression within immune cells can affect how tumors evade
immune detection and response.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While there are indications of CHD3’s involvement in immune
regulation, more targeted studies are needed to elucidate its specific
mechanisms and interactions within different immune contexts.</li>
</ul></li>
</ol>
<p>In summary, CHD3 plays a significant role in regulating chromatin
structure and gene expression, influencing immune cell development,
cytokine production, and inflammatory responses. Its involvement in
various diseases underscores its importance in understanding immune
regulation and potential therapeutic applications. Further research is
necessary to clarify its specific functions within the immune
system.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9439891/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9439891/</a> [2] <a
href="https://www.nature.com/articles/s41598-024-68644-9"
class="uri">https://www.nature.com/articles/s41598-024-68644-9</a> [3]
<a href="https://www.nature.com/articles/s41598-022-26277-w"
class="uri">https://www.nature.com/articles/s41598-022-26277-w</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8636791/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8636791/</a> [5] <a
href="https://www.nature.com/articles/s41598-024-69892-5"
class="uri">https://www.nature.com/articles/s41598-024-69892-5</a> [6]
<a
href="https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2021.701375/full"
class="uri">https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2021.701375/full</a>
[7] <a href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [8]
<a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a></p>
</div>
<div id="grhl1-1" class="section level3">
<h3>GRHL1</h3>
<p>The immune function of the gene <strong>GRHL1</strong>
(Grainyhead-like 1) has been explored in various contexts, particularly
regarding its role in immune regulation and cancer. Here are the key
aspects of GRHL1’s immune functions based on the available
literature:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Immune Cell Proliferation</strong>:
<ul>
<li>GRHL1 has been shown to inhibit the proliferation of CD8+ T cells.
High expression levels of GRHL1 are associated with reduced activation
and proliferation of these critical immune cells, which are essential
for effective anti-tumor immunity. This suggests that GRHL1 may play a
role in immune evasion by tumors, allowing cancer cells to escape immune
surveillance[2].</li>
</ul></li>
<li><strong>Impact on Tumor Microenvironment</strong>:
<ul>
<li>In the context of endometrial cancer (EC), GRHL1 expression is
negatively correlated with various immune markers, including chemokines
that facilitate the recruitment of activated CD8+ T cells to tumor
sites. This indicates that GRHL1 may contribute to a non-inflammatory
tumor microenvironment, which is less conducive to effective immune
responses[2].</li>
</ul></li>
<li><strong>Association with Immune Escape Mechanisms</strong>:
<ul>
<li>The expression of GRHL1 has been linked to immune escape mechanisms
in tumors. By inhibiting T cell activation and proliferation, high
levels of GRHL1 can lead to a decreased presence of effector T cells
within tumors, thereby impairing the effectiveness of immunotherapy and
reducing overall anti-tumor immunity[2].</li>
</ul></li>
<li><strong>Correlation with Immune Markers</strong>:
<ul>
<li>Studies have shown that GRHL1 expression correlates with various
immune-related markers and pathways, suggesting its involvement in
modulating the immune landscape in tumors. For instance, it has been
associated with changes in the abundance of different types of immune
cells within the tumor microenvironment, including regulatory T cells
and neutrophils[2].</li>
</ul></li>
<li><strong>Potential as a Therapeutic Target</strong>:
<ul>
<li>Given its role in inhibiting CD8+ T cell proliferation and
contributing to immune escape, targeting GRHL1 could be a potential
therapeutic strategy in cancer treatment. Modulating its expression or
activity may enhance anti-tumor immunity and improve responses to
immunotherapy[2].</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While there is evidence linking GRHL1 to immune functions, further
research is needed to fully elucidate its specific mechanisms and
interactions within various immune contexts, particularly in different
types of cancers and inflammatory diseases.</li>
</ul></li>
</ol>
<p>In summary, GRHL1 plays a significant role in regulating immune
responses by inhibiting CD8+ T cell proliferation and contributing to an
environment that supports tumor growth and immune evasion. Its
involvement in cancer immunology highlights its potential as a
therapeutic target for enhancing anti-tumor immunity. Further studies
are necessary to explore its broader implications in immunity and
disease.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41467-021-27732-4"
class="uri">https://www.nature.com/articles/s41467-021-27732-4</a> [2]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10999208/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10999208/</a> [3]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [4] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9439891/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9439891/</a> [5] <a
href="https://www.nature.com/articles/s41598-024-69892-5"
class="uri">https://www.nature.com/articles/s41598-024-69892-5</a> [6]
<a href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [7]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8911041/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8911041/</a> [8] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a></p>
</div>
<div id="acpp-1" class="section level3">
<h3>ACPP</h3>
<p>The immune function of the gene <strong>ACPP</strong> (Acid
Phosphatase, Prostate) is primarily associated with its role in immune
regulation and inflammation. Here are the key aspects of ACPP’s immune
functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Role in Immune Response</strong>:
<ul>
<li>ACPP is involved in the regulation of immune responses through its
enzymatic activity. It acts as a phosphatase, which can dephosphorylate
various substrates, influencing signaling pathways that are crucial for
immune cell activation and function.</li>
</ul></li>
<li><strong>Influence on Inflammation</strong>:
<ul>
<li>ACPP is known to be expressed in inflammatory conditions and may
play a role in modulating inflammatory responses. Its activity can
affect the behavior of immune cells, including macrophages, which are
key players in inflammation and tissue repair.</li>
</ul></li>
<li><strong>Association with Prostate Health</strong>:
<ul>
<li>Although primarily studied in the context of prostate health, ACPP’s
expression levels can also reflect inflammatory processes within the
prostate. Elevated levels of ACPP have been associated with prostate
cancer and benign prostatic hyperplasia, indicating its potential
involvement in tumor-associated inflammation.</li>
</ul></li>
<li><strong>Impact on Cytokine Production</strong>:
<ul>
<li>By regulating signaling pathways, ACPP may influence the production
of cytokines, which are critical for communication between immune cells.
This modulation can affect both innate and adaptive immune
responses.</li>
</ul></li>
<li><strong>Potential Implications in Disease</strong>:
<ul>
<li>Dysregulation of ACPP expression or activity may contribute to
various diseases characterized by chronic inflammation or immune
dysregulation, including autoimmune disorders and cancers.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While there is some evidence linking ACPP to immune functions, more
targeted research is needed to elucidate its specific mechanisms and
roles within different immune contexts.</li>
</ul></li>
</ol>
<p>In summary, ACPP plays a significant role in regulating immune
responses and inflammation through its enzymatic activity. Its
involvement in prostate health and potential implications in various
diseases underscore its importance in understanding immune regulation
and therapeutic applications. Further research is necessary to clarify
its specific contributions to immunity and disease processes.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1163466/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1163466/full</a>
[2] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8710480/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8710480/</a> [3] <a
href="https://medlineplus.gov/genetics/gene/acp5/"
class="uri">https://medlineplus.gov/genetics/gene/acp5/</a> [4] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[5] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[6] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [7] <a
href="https://www.nature.com/articles/s41598-022-26277-w"
class="uri">https://www.nature.com/articles/s41598-022-26277-w</a> [8]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/</a></p>
</div>
<div id="rap1gap" class="section level3">
<h3>RAP1GAP</h3>
<p>The immune function of the gene <strong>RAP1GAP</strong> (Rap1
GTPase-Activating Protein) is primarily linked to its role in regulating
the activity of Rap1, a small GTPase that is critical for various immune
cell functions. Here are the key aspects of RAP1GAP’s immune
functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of T Cell Activation</strong>:
<ul>
<li>RAP1GAP acts as a negative regulator of Rap1, which is crucial for T
cell activation. When T cells engage with antigen-presenting cells
(APCs), Rap1 is activated, facilitating the adhesion between T cells and
APCs through integrins like LFA-1. RAP1GAP helps modulate this process
by promoting the inactivation of Rap1, thus influencing the strength and
duration of T cell responses.</li>
</ul></li>
<li><strong>Modulation of Adhesive Interactions</strong>:
<ul>
<li>The activation of Rap1 enhances the adhesive interactions between T
cells and APCs, which is essential for effective T cell receptor (TCR)
signaling and subsequent cytokine production, such as interleukin-2
(IL-2). By regulating Rap1 activity, RAP1GAP can shift T cell responses
from productive activation to activation-induced cell death (AICD),
depending on the context and level of activation.</li>
</ul></li>
<li><strong>Impact on Immune Responses</strong>:
<ul>
<li>The precise control of Rap1 activation by RAP1GAP is crucial for
maintaining a balance in immune responses. Insufficient regulation can
lead to excessive T cell activation or anergy (a state of
unresponsiveness), which can contribute to autoimmune conditions or
ineffective immune responses against pathogens.</li>
</ul></li>
<li><strong>Role in Other Immune Cells</strong>:
<ul>
<li>While much of the research has focused on T cells, RAP1GAP may also
influence other immune cell types where Rap1 signaling plays a role,
including B cells and natural killer (NK) cells. The modulation of Rap1
activity could affect various aspects of these cells’ functions,
including migration, adhesion, and cytokine production.</li>
</ul></li>
<li><strong>Potential Implications in Disease</strong>:
<ul>
<li>Dysregulation of RAP1GAP or its associated pathways may contribute
to inflammatory diseases and cancers by altering normal immune
responses. Understanding its role could provide insights into
therapeutic strategies aimed at modulating immune activity.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While there is evidence supporting RAP1GAP’s involvement in immune
regulation through its effects on Rap1 signaling, further studies are
needed to elucidate its specific mechanisms and broader implications
within different immune contexts.</li>
</ul></li>
</ol>
<p>In summary, RAP1GAP plays a significant role in regulating T cell
activation and adhesive interactions with APCs by modulating Rap1
activity. Its involvement in maintaining immune balance underscores its
importance in both effective immunity and potential disease processes.
Further research is necessary to fully understand its contributions to
immunity and therapeutic potential.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC134636/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC134636/</a> [2] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [3] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[4] <a href="https://medlineplus.gov/genetics/gene/rag1/"
class="uri">https://medlineplus.gov/genetics/gene/rag1/</a> [5] <a
href="https://www.nature.com/articles/s41467-021-27732-4"
class="uri">https://www.nature.com/articles/s41467-021-27732-4</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/</a> [7] <a
href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [8]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10999208/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10999208/</a></p>
</div>
<div id="ctbp2-1" class="section level3">
<h3>CTBP2</h3>
<p>The immune function of the gene <strong>CTBP2</strong> (C-terminal
Binding Protein 2) is primarily associated with its role as a
transcriptional co-regulator that influences immune responses and
inflammation. Here are the key aspects of CTBP2’s immune functions:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Proinflammatory Gene Expression</strong>:
<ul>
<li>CTBP2 has been shown to transactivate proinflammatory genes in
response to various stimuli, including those associated with skin
inflammation and psoriasis. Its expression is elevated in inflammatory
conditions, where it contributes to the upregulation of cytokines such
as IL-1β, IL-6, and TNF-α, which are critical mediators of immune
responses.</li>
</ul></li>
<li><strong>Role in Immune Cell Activation</strong>:
<ul>
<li>CTBP2 is involved in the regulation of immune cell activation. For
example, it has been implicated in the activation of macrophages and
keratinocytes during inflammatory responses. This suggests that CTBP2
plays a role in modulating the behavior of these immune cells during
tissue damage and infection.</li>
</ul></li>
<li><strong>Impact on T Cell Responses</strong>:
<ul>
<li>In T cells, CTBP2 can influence the expression of cytokines and
other factors that are important for T cell differentiation and
function. It has been shown to repress certain cytokine expressions,
thus maintaining a balance between proinflammatory and anti-inflammatory
signals.</li>
</ul></li>
<li><strong>Association with Inflammatory Diseases</strong>:
<ul>
<li>Dysregulation of CTBP2 has been linked to various inflammatory
diseases, including psoriasis and other chronic inflammatory conditions.
Its role in promoting proinflammatory gene expression highlights its
potential as a therapeutic target for modulating immune responses in
such diseases.</li>
</ul></li>
<li><strong>Mechanisms of Action</strong>:
<ul>
<li>CTBP2 functions by interacting with various transcription factors
and recruiting chromatin remodeling proteins to target gene promoters.
This allows it to exert both repressive and activating effects on gene
expression depending on the cellular context.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While there is growing evidence supporting the role of CTBP2 in
immune regulation, further research is needed to fully elucidate its
specific mechanisms and interactions within different immune
contexts.</li>
</ul></li>
</ol>
<p>In summary, CTBP2 plays a significant role in regulating
proinflammatory gene expression and modulating immune cell activation.
Its involvement in inflammatory diseases underscores its importance in
understanding immune regulation and potential therapeutic applications.
Further studies are necessary to clarify its contributions to immunity
and disease processes.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [2] <a
href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770725/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770725/</a>
[3] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC8310398/</a> [4] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[5] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9439891/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9439891/</a> [6] <a
href="https://www.nature.com/articles/s41598-022-26277-w"
class="uri">https://www.nature.com/articles/s41598-022-26277-w</a> [7]
<a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[8] <a
href="https://www.tandfonline.com/doi/full/10.1080/15384047.2017.1323586"
class="uri">https://www.tandfonline.com/doi/full/10.1080/15384047.2017.1323586</a></p>
</div>
<div id="gata2" class="section level3">
<h3>GATA2</h3>
<p>The immune function of the gene <strong>GATA2</strong> (GATA Binding
Protein 2) is significant in various aspects of immune regulation,
particularly in the development and function of immune cells. Here are
the key roles of GATA2 in the immune system:</p>
<ol style="list-style-type: decimal">
<li><strong>Regulation of Hematopoiesis</strong>:
<ul>
<li>GATA2 is a transcription factor that plays a crucial role in
hematopoiesis, the process through which blood cells are formed. It is
essential for the development of hematopoietic stem cells and progenitor
cells, influencing the differentiation into various immune cell
lineages, including myeloid and lymphoid cells.</li>
</ul></li>
<li><strong>Influence on T Cell Development</strong>:
<ul>
<li>GATA2 is involved in T cell development within the thymus. It
regulates the expression of genes necessary for T cell maturation and
differentiation, impacting both CD4+ helper T cells and CD8+ cytotoxic T
cells.</li>
</ul></li>
<li><strong>Role in Dendritic Cells</strong>:
<ul>
<li>GATA2 is important for the development and function of dendritic
cells (DCs), which are critical for antigen presentation and initiating
adaptive immune responses. It helps regulate the maturation of DCs and
their ability to activate T cells.</li>
</ul></li>
<li><strong>Impact on Eosinophil Development</strong>:
<ul>
<li>GATA2, along with GATA1, has been shown to play a role in eosinophil
development, which is important for responses to parasitic infections
and in allergic reactions. GATA factors are involved in promoting
eosinophil lineage commitment from progenitor cells.</li>
</ul></li>
<li><strong>Regulation of Cytokine Production</strong>:
<ul>
<li>GATA2 influences cytokine production by various immune cells. Its
expression can affect the production of key cytokines involved in
inflammation and immune responses, thereby modulating the overall immune
environment.</li>
</ul></li>
<li><strong>Implications in Immune Disorders</strong>:
<ul>
<li>Mutations or dysregulation of GATA2 have been associated with
several immunological disorders, including immunodeficiencies and
myelodysplastic syndromes. Understanding its role can provide insights
into potential therapeutic targets for treating such conditions.</li>
</ul></li>
<li><strong>Research Gaps</strong>:
<ul>
<li>While the functions of GATA2 in immunity are well-established,
ongoing research is needed to fully elucidate its specific mechanisms
across different immune contexts and how it interacts with other
signaling pathways.</li>
</ul></li>
</ol>
<p>In summary, GATA2 plays a critical role in regulating hematopoiesis
and influencing the development and function of various immune cell
types, including T cells, dendritic cells, and eosinophils. Its
involvement in cytokine regulation and implications in immune disorders
highlight its importance in maintaining immune homeostasis and response.
Further studies are necessary to explore its full range of functions
within the immune system.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5627064/</a> [2] <a
href="https://www.cell.com/immunity/pdf/S1074-7613(11)00358-X.pdf"
class="uri">https://www.cell.com/immunity/pdf/S1074-7613(11)00358-X.pdf</a>
[3] <a href="https://www.nature.com/articles/s41467-023-43181-7"
class="uri">https://www.nature.com/articles/s41467-023-43181-7</a> [4]
<a
href="https://rupress.org/jem/article/195/11/1379/39420/Essential-and-Instructive-Roles-of-GATA-Factors-in"
class="uri">https://rupress.org/jem/article/195/11/1379/39420/Essential-and-Instructive-Roles-of-GATA-Factors-in</a>
[5] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[6] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[7] <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10999208/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC10999208/</a> [8]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9439891/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC9439891/</a></p>
</div>
<div id="skil" class="section level3">
<h3>SKIL</h3>
<p>Based on the search results, the immune function of the gene SKIL
(SKI-like proto-oncogene) is primarily related to its role as a negative
regulator of TGF-β signaling. Here are the key points about SKIL’s
immune functions:</p>
<ol style="list-style-type: decimal">
<li>Negative regulation of TGF-β signaling:</li>
</ol>
<ul>
<li>SKIL, like its homolog SKI, acts as a transcriptional co-repressor
that inhibits TGF-β signaling by binding to SMAD proteins and recruiting
other co-repressors and histone deacetylases (HDACs) to repress target
gene expression.</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Interaction with SMAD proteins:</li>
</ol>
<ul>
<li>SKIL interacts with phosphorylated SMAD2 and SMAD3 (R-SMADs) as well
as SMAD4, forming complexes that prevent the activation of TGF-β target
genes.</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Regulation of immune cell function:</li>
</ol>
<ul>
<li>By modulating TGF-β signaling, SKIL likely influences various immune
processes, including cell proliferation, differentiation, and apoptosis
in immune cells.</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Dynamic regulation during TGF-β signaling:</li>
</ol>
<ul>
<li>SKIL is rapidly degraded upon TGF-β stimulation, which allows for
the initial activation of the pathway. However, SKIL expression is then
induced by TGF-β, creating a negative feedback loop to limit the
duration and intensity of TGF-β signaling.</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Potential role in immune-related diseases:</li>
</ol>
<ul>
<li>Dysregulation of SKIL could contribute to immune-related disorders
or cancers by altering the balance of TGF-β signaling, which is crucial
for maintaining immune homeostasis.</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Involvement in transcriptional regulation:</li>
</ol>
<ul>
<li>SKIL can act as both a co-repressor and co-activator for various
transcription factors, potentially influencing the expression of
immune-related genes beyond just TGF-β targets.</li>
</ul>
<p>While the specific immune functions of SKIL are not as extensively
characterized as those of SKI, its role as a key regulator of TGF-β
signaling suggests that it plays an important part in modulating immune
responses and maintaining immune system balance. Further research is
needed to fully elucidate its specific mechanisms and roles in different
immune contexts.</p>
<p>Citations: [1] <a href="https://medlineplus.gov/genetics/gene/ski/"
class="uri">https://medlineplus.gov/genetics/gene/ski/</a> [2] <a
href="https://atlasgeneticsoncology.org/gene/42303/ski-(ski-proto-oncogene)"
class="uri">https://atlasgeneticsoncology.org/gene/42303/ski-(ski-proto-oncogene)</a>
[3] <a href="https://elifesciences.org/articles/63545"
class="uri">https://elifesciences.org/articles/63545</a> [4] <a
href="https://www.nature.com/articles/s41392-018-0015-8"
class="uri">https://www.nature.com/articles/s41392-018-0015-8</a> [5] <a
href="https://dmd.aspetjournals.org/content/50/9/1228"
class="uri">https://dmd.aspetjournals.org/content/50/9/1228</a> [6] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01168/full</a>
[7] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00861/full</a>
[8] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a></p>
</div>
<div id="smad2-1" class="section level3">
<h3>SMAD2</h3>
<p>Based on the search results, SMAD2 plays several important roles in
immune function, particularly in T cell responses and
differentiation:</p>
<ol style="list-style-type: decimal">
<li>T helper 17 (Th17) cell differentiation:</li>
</ol>
<ul>
<li>SMAD2 is essential for promoting Th17 differentiation. It acts as a
transcription cofactor of STAT3 to induce expression of RORγt and
IL-17A, which are critical for Th17 cells [2].</li>
<li>Phosphorylation of SMAD2 at the linker region (Ser255) is required
for its interaction with STAT3 and promotion of Th17 differentiation
[2].</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>T helper 9 (Th9) cell differentiation:</li>
</ol>
<ul>
<li>SMAD2 and SMAD3 are redundantly essential for IL-9 production and
Th9 differentiation [4].</li>
<li>In an ovalbumin-induced asthma model, T cell-specific deletion of
SMAD2 reduced IL-9 levels, indicating SMAD2 is important for Th9
responses in vivo [4].</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>TGF-β signaling in T cells:</li>
</ol>
<ul>
<li>SMAD2 mediates TGF-β signaling in T cells, which is important for
various T cell functions and differentiation processes [2][4].</li>
<li>SMAD2 and SMAD3 cooperate to induce histone modifications at the Il9
promoter in response to TGF-β signaling [4].</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Regulation of autoimmune and allergic responses:</li>
</ol>
<ul>
<li>Through its roles in Th17 and Th9 differentiation, SMAD2 is involved
in regulating autoimmune and allergic responses [2][4].</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Interaction with other transcription factors:</li>
</ol>
<ul>
<li>SMAD2 cooperates with IRF4 to regulate IL-9 production in CD4+ T
cells [4].</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Potential role in cancer immunology:</li>
</ol>
<ul>
<li>While not directly stated for SMAD2, the SMAD family genes were
found to be associated with immune cell infiltration scores in breast
cancer, suggesting a potential role in tumor immunology [1].</li>
</ul>
<p>In summary, SMAD2 plays crucial roles in T cell differentiation and
function, particularly in Th17 and Th9 responses, by mediating TGF-β
signaling and cooperating with other transcription factors. These
functions have implications for autoimmune diseases, allergic responses,
and potentially cancer immunology.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41598-024-57189-6"
class="uri">https://www.nature.com/articles/s41598-024-57189-6</a> [2]
<a href="https://www.nature.com/articles/ncomms8600"
class="uri">https://www.nature.com/articles/ncomms8600</a> [3] <a
href="https://www.nature.com/articles/s41467-023-37592-9"
class="uri">https://www.nature.com/articles/s41467-023-37592-9</a> [4]
<a
href="https://journals.aai.org/jimmunol/article/191/5/2360/43188/Smad2-3-and-IRF4-Play-a-Cooperative-Role-in-IL-9"
class="uri">https://journals.aai.org/jimmunol/article/191/5/2360/43188/Smad2-3-and-IRF4-Play-a-Cooperative-Role-in-IL-9</a>
[5] <a
href="https://journals.aai.org/jimmunol/article/185/2/842/82974/Smad2-and-Smad3-Are-Redundantly-Essential-for-the"
class="uri">https://journals.aai.org/jimmunol/article/185/2/842/82974/Smad2-and-Smad3-Are-Redundantly-Essential-for-the</a>
[6] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.00912/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.00912/full</a>
[7] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[8] <a href="https://www.nature.com/articles/s41420-023-01489-9"
class="uri">https://www.nature.com/articles/s41420-023-01489-9</a></p>
</div>
<div id="tmprss2-1" class="section level3">
<h3>TMPRSS2</h3>
<p>Based on the search results, TMPRSS2 (Transmembrane Serine Protease
2) plays several important roles in immune function, particularly
related to viral infections:</p>
<ol style="list-style-type: decimal">
<li>Viral entry mediator:</li>
</ol>
<ul>
<li>TMPRSS2 is essential for mediating viral entry into host cells for
several viruses, including SARS-CoV-2, SARS-CoV, and influenza viruses
[1][2].</li>
<li>It processes the spike protein of SARS-CoV-2, facilitating viral
entry into host cells [1].</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Role in SARS-CoV-2 infection:</li>
</ol>
<ul>
<li>TMPRSS2 is crucial for SARS-CoV-2-driven entry into host cells
[1][2].</li>
<li>Knockout of TMPRSS2 in mice significantly reduced SARS-CoV-2
infection and associated immune responses [1][2].</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Broad distribution in tissues:</li>
</ol>
<ul>
<li>TMPRSS2 is widely expressed in various cell types and organs,
suggesting a universal function in mediating viral entry across multiple
tissues [1][2].</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Impact on inflammatory responses:</li>
</ol>
<ul>
<li>TMPRSS2 knockout mice showed reduced immune cell infiltration and
lower expression of inflammatory cytokines (e.g., Il6, Cxcl10, Ifnb,
Ifng) in response to SARS-CoV-2 infection [1].</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Interaction with other proteins:</li>
</ol>
<ul>
<li>TMPRSS2 works in conjunction with ACE2 (Angiotensin Converting
Enzyme 2) to facilitate SARS-CoV-2 entry into cells [1][3].</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Potential therapeutic target:</li>
</ol>
<ul>
<li>Due to its role in viral entry, modulating TMPRSS2 expression or its
protease activity is considered a potential method for antiviral
intervention [1].</li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Expression in immune-related tissues:</li>
</ol>
<ul>
<li>TMPRSS2 is expressed in various tissues, including those of the
immune system, though its expression is generally higher in epithelial
cells rather than immune cells themselves [3].</li>
</ul>
<ol start="8" style="list-style-type: decimal">
<li>Variant-specific effects:</li>
</ol>
<ul>
<li>Different SARS-CoV-2 variants may rely on TMPRSS2 to varying degrees
for cell entry, with some variants like Omicron using it less
efficiently [2].</li>
</ul>
<p>In summary, TMPRSS2 plays a critical role in facilitating viral
entry, particularly for coronaviruses and influenza viruses, and its
presence or absence significantly impacts the severity of infection and
subsequent immune responses. This makes it an important factor in
understanding viral pathogenesis and a potential target for therapeutic
interventions.</p>
<p>Citations: [1] <a
href="https://www.nature.com/articles/s41467-021-21171-x"
class="uri">https://www.nature.com/articles/s41467-021-21171-x</a> [2]
<a href="https://www.nature.com/articles/s41467-022-33911-8"
class="uri">https://www.nature.com/articles/s41467-022-33911-8</a> [3]
<a href="https://jitc.bmj.com/content/8/2/e001020"
class="uri">https://jitc.bmj.com/content/8/2/e001020</a> [4] <a
href="https://www.nature.com/articles/s41467-024-53621-7"
class="uri">https://www.nature.com/articles/s41467-024-53621-7</a> [5]
<a
href="https://www.remedypublications.com/open-access/the-novel-role-of-gdi2-a-mini-review-10110.pdf"
class="uri">https://www.remedypublications.com/open-access/the-novel-role-of-gdi2-a-mini-review-10110.pdf</a>
[6] <a
href="https://journals.aai.org/jimmunol/article/185/2/842/82974/Smad2-and-Smad3-Are-Redundantly-Essential-for-the"
class="uri">https://journals.aai.org/jimmunol/article/185/2/842/82974/Smad2-and-Smad3-Are-Redundantly-Essential-for-the</a>
[7] <a href="https://www.nature.com/articles/s41467-023-37592-9"
class="uri">https://www.nature.com/articles/s41467-023-37592-9</a> [8]
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11242344/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11242344/</a></p>
</div>
<div id="efhd1-1" class="section level3">
<h3>EFHD1</h3>
<p>Based on the search results, EFHD1 (EF-hand domain-containing protein
1) has several functions related to the immune system and cellular
processes:</p>
<ol style="list-style-type: decimal">
<li>Mitochondrial regulation:</li>
</ol>
<ul>
<li>EFHD1 is localized in the mitochondria and plays a role in
regulating mitochondrial energy metabolism and morphology [1][2].</li>
<li>It can inhibit the opening of the mitochondrial membrane
permeability transition pore (mPTP), which helps maintain mitochondrial
function [1].</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>Cell survival and drug resistance:</li>
</ol>
<ul>
<li>In osteosarcoma cells, EFHD1 promotes cell survival and
chemoresistance by inhibiting mPTP opening and maintaining mitochondrial
function [1].</li>
<li>It binds to adenine nucleotide translocase-3 (ANT3) and inhibits its
conformational change, which prevents mPTP opening [1].</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Calcium signaling:</li>
</ol>
<ul>
<li>EFHD1 can sense mitochondrial Ca2+ concentration and activate
mitoflashes, which are transient increases in mitochondrial permeability
[1][2].</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Actin interaction:</li>
</ol>
<ul>
<li>EFHD1 has Ca2+-independent β-actin-binding and Ca2+-dependent
β-actin-bundling activities [2].</li>
<li>This interaction with actin may be involved in regulating
mitochondrial morphology [2].</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Immune cell development:</li>
</ol>
<ul>
<li>EFHD1 is involved in the differentiation of pro-/pre-B cells and can
induce metabolic changes during their development [2].</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Neuronal function:</li>
</ol>
<ul>
<li>It plays a role in neuronal differentiation and apoptosis [2].</li>
<li>EFHD1 affects mitochondrial morphology and energy production in
dorsal root ganglion neurons [2].</li>
</ul>
<p>While not directly involved in classical immune functions, EFHD1’s
roles in mitochondrial regulation, cell survival, and B cell development
suggest it has important indirect effects on immune system function. Its
ability to promote cell survival and drug resistance in cancer cells
also indicates a potential role in modulating immune responses to
tumors.</p>
<p>Citations: [1] <a
href="https://link.springer.com/article/10.1007/s00018-024-05254-8"
class="uri">https://link.springer.com/article/10.1007/s00018-024-05254-8</a>
[2] <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848108/"
class="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848108/</a>
[3] <a
href="https://journals.aai.org/jimmunol/article/185/2/842/82974/Smad2-and-Smad3-Are-Redundantly-Essential-for-the"
class="uri">https://journals.aai.org/jimmunol/article/185/2/842/82974/Smad2-and-Smad3-Are-Redundantly-Essential-for-the</a>
[4] <a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[5] <a href="https://www.nature.com/articles/s41598-022-26277-w"
class="uri">https://www.nature.com/articles/s41598-022-26277-w</a> [6]
<a href="https://www.nature.com/articles/s41598-023-34779-4"
class="uri">https://www.nature.com/articles/s41598-023-34779-4</a> [7]
<a href="https://www.nature.com/articles/s41467-023-37592-9"
class="uri">https://www.nature.com/articles/s41467-023-37592-9</a> [8]
<a href="https://www.rcsb.org/structure/7CLT"
class="uri">https://www.rcsb.org/structure/7CLT</a></p>
</div>
<div id="pim1-1" class="section level3">
<h3>PIM1</h3>
<p>Based on the search results, PIM1 (Proviral Integration Site for
Moloney Murine Leukemia Virus 1) plays several important roles in immune
function:</p>
<ol style="list-style-type: decimal">
<li>T cell regulation:</li>
</ol>
<ul>
<li>PIM1 promotes T lymphocyte proliferation and survival by suppressing
apoptosis [3].</li>
<li>It enhances CD8+ T cell survival and memory formation [3].</li>
<li>PIM1 promotes Th1 cell differentiation from precursor T helper cells
[3].</li>
</ul>
<ol start="2" style="list-style-type: decimal">
<li>B cell function:</li>
</ol>
<ul>
<li>PIM1 fosters B cell proliferation [3].</li>
<li>It plays a role in B cell development and differentiation [4].</li>
</ul>
<ol start="3" style="list-style-type: decimal">
<li>Cytokine production:</li>
</ol>
<ul>
<li>PIM1 enhances NFATc activity and IL-2 production, promoting the
proliferation and survival of IL-2-dependent lymphocytes [4].</li>
</ul>
<ol start="4" style="list-style-type: decimal">
<li>Innate immune responses:</li>
</ol>
<ul>
<li>PIM1 plays an essential role in the production of interferon-β
(IFN-β) by macrophages after Toll-like receptor (TLR) pathway activation
[3].</li>
<li>It promotes IRF3 phosphorylation and nuclear translocation,
enhancing IFN-β signaling [3].</li>
</ul>
<ol start="5" style="list-style-type: decimal">
<li>Inflammatory regulation:</li>
</ol>
<ul>
<li>PIM1 is involved in inflammatory signal transduction by
phosphorylating multiple inflammatory protein substrates [1].</li>
<li>It mediates macrophage activation and T lymphocyte cell
specification [1].</li>
</ul>
<ol start="6" style="list-style-type: decimal">
<li>Th17/Treg balance:</li>
</ol>
<ul>
<li>PIM1 regulates the balance between Th17 cells and regulatory T cells
(Tregs) [2].</li>
</ul>
<ol start="7" style="list-style-type: decimal">
<li>Autoimmune diseases:</li>
</ol>
<ul>
<li>PIM1 is implicated in the pathogenesis of various autoimmune and
inflammatory diseases, including autoimmune uveitis, inflammatory bowel
disease, asthma, and rheumatoid arthritis [1].</li>
</ul>
<ol start="8" style="list-style-type: decimal">
<li>Signaling pathways:</li>
</ol>
<ul>
<li>PIM1 is involved in the crosstalk between the JAK2-STAT3/5 pathway
and the NF-κB–IL-6 pathway [1].</li>
<li>It can modulate the AKT/FOXO1 pathway, affecting T cell
differentiation [2].</li>
</ul>
<ol start="9" style="list-style-type: decimal">
<li>Antiviral responses:</li>
</ol>
<ul>
<li>PIM1 participates in TLR-mediated IFN-β production, playing a role
in antiviral innate immune responses [3].</li>
</ul>
<p>In summary, PIM1 is a multifaceted regulator of immune function,
affecting both innate and adaptive immunity through various mechanisms,
including cell proliferation, survival, differentiation, and cytokine
production. Its involvement in multiple immune processes makes it a
potential therapeutic target for immunoinflammatory diseases.</p>
<p>Citations: [1] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1443784/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1443784/full</a>
[2] <a href="https://www.nature.com/articles/s41467-022-33502-7"
class="uri">https://www.nature.com/articles/s41467-022-33502-7</a> [3]
<a href="https://www.nature.com/articles/s12276-022-00893-y"
class="uri">https://www.nature.com/articles/s12276-022-00893-y</a> [4]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7783746/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7783746/</a> [5] <a
href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.629922/full"
class="uri">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.629922/full</a>
[6] <a href="https://en.wikipedia.org/wiki/PIM1"
class="uri">https://en.wikipedia.org/wiki/PIM1</a> [7] <a
href="https://journals.aai.org/jimmunol/article/185/2/842/82974/Smad2-and-Smad3-Are-Redundantly-Essential-for-the"
class="uri">https://journals.aai.org/jimmunol/article/185/2/842/82974/Smad2-and-Smad3-Are-Redundantly-Essential-for-the</a>
[8] <a href="https://www.nature.com/articles/s41598-022-26277-w"
class="uri">https://www.nature.com/articles/s41598-022-26277-w</a></p>
</div>
<div id="casp8" class="section level3">
<h3>CASP8</h3>
<p>Caspase-8 (CASP8) is a critical gene involved in various immune
functions, primarily related to apoptosis (programmed cell death) and
cell survival mechanisms. Here are the key aspects of its immune
function:</p>
<ol style="list-style-type: decimal">
<li><strong>Apoptosis Regulation</strong>:
<ul>
<li>CASP8 is known as an initiator caspase that plays a vital role in
the extrinsic apoptotic pathway, particularly in response to death
receptor signaling (e.g., Fas and TNF receptors) [1]. This function is
crucial for eliminating unwanted or damaged cells during immune
responses.</li>
</ul></li>
<li><strong>Pro-Survival Functions</strong>:
<ul>
<li>Interestingly, CASP8 also has pro-survival functions. It is involved
in protecting cells from necroptosis (a form of programmed necrosis) by
inhibiting pathways that lead to this type of cell death. This dual role
highlights its importance in maintaining the balance between cell death
and survival in immune cells [1].</li>
</ul></li>
<li><strong>T and B Cell Homeostasis</strong>:
<ul>
<li>CASP8 is essential for the proliferation and homeostasis of T and B
lymphocytes. Conditional deletion of CASP8 in mice leads to impaired T
cell proliferation and increased apoptosis, indicating its crucial role
in lymphocyte survival and clonal expansion [1]. Specifically, it is
required for normal responses to T cell receptor (TCR) stimulation.</li>
</ul></li>
<li><strong>Clonal Expansion</strong>:
<ul>
<li>The activity of CASP8 is necessary for clonal expansion of T cells
following antigen receptor stimulation. This function is essential for
effective adaptive immune responses, as it allows for the proliferation
of specific immune cells that can target pathogens [1].</li>
</ul></li>
<li><strong>Interaction with cFLIP</strong>:
<ul>
<li>CASP8 interacts with cFLIP (cellular FLICE-inhibitory protein),
which modulates its activity. This interaction helps determine whether a
cell will undergo apoptosis or survive, thereby influencing immune
responses during infections or inflammation [1].</li>
</ul></li>
<li><strong>Role in Autophagy</strong>:
<ul>
<li>CASP8 has been implicated in modulating autophagy, a process that
can impact immune responses by regulating the turnover of cellular
components and influencing inflammation [1].</li>
</ul></li>
<li><strong>Impact on Immune Activation</strong>:
<ul>
<li>Mutations or deficiencies in CASP8 can lead to decreased activation
of naive lymphocytes, affecting the overall immune response to
infections [1].</li>
</ul></li>
</ol>
<p>In summary, CASP8 plays a multifaceted role in the immune system by
regulating apoptosis, promoting cell survival, facilitating lymphocyte
proliferation, and interacting with other proteins to modulate immune
responses. Its balance between pro-apoptotic and pro-survival functions
is critical for maintaining immune homeostasis and effective responses
to pathogens.</p>
<p>Citations: [1] <a
href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4099255/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC4099255/</a> [2] <a
href="https://www.nature.com/articles/s41598-023-34779-4"
class="uri">https://www.nature.com/articles/s41598-023-34779-4</a> [3]
<a href="https://www.nature.com/articles/s12276-022-00893-y"
class="uri">https://www.nature.com/articles/s12276-022-00893-y</a> [4]
<a
href="https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html"
class="uri">https://www.buffalo.edu/news/releases/2024/04/Uniquely-human-gene-enhances-immune-function.html</a>
[5] <a href="https://www.nature.com/articles/s41598-022-26277-w"
class="uri">https://www.nature.com/articles/s41598-022-26277-w</a> [6]
<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7783746/"
class="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC7783746/</a> [7] <a
href="https://www.nature.com/articles/s41467-023-37592-9"
class="uri">https://www.nature.com/articles/s41467-023-37592-9</a> [8]
<a
href="https://journals.aai.org/jimmunol/article/185/2/842/82974/Smad2-and-Smad3-Are-Redundantly-Essential-for-the"
class="uri">https://journals.aai.org/jimmunol/article/185/2/842/82974/Smad2-and-Smad3-Are-Redundantly-Essential-for-the</a></p>
<br>
<p>
<button type="button" class="btn btn-default btn-workflowr btn-workflowr-sessioninfo" data-toggle="collapse" data-target="#workflowr-sessioninfo" style="display: block;">
<span class="glyphicon glyphicon-wrench" aria-hidden="true"></span>
Session information
</button>
</p>
<div id="workflowr-sessioninfo" class="collapse">
<pre class="r"><code>sessionInfo()</code></pre>
<pre><code>R version 4.4.1 (2024-06-14)
Platform: aarch64-apple-darwin20
Running under: macOS 15.1

Matrix products: default
BLAS:   /Library/Frameworks/R.framework/Versions/4.4-arm64/Resources/lib/libRblas.0.dylib 
LAPACK: /Library/Frameworks/R.framework/Versions/4.4-arm64/Resources/lib/libRlapack.dylib;  LAPACK version 3.12.0

locale:
[1] en_US.UTF-8/en_US.UTF-8/en_US.UTF-8/C/en_US.UTF-8/en_US.UTF-8

time zone: America/New_York
tzcode source: internal

attached base packages:
[1] stats     graphics  grDevices utils     datasets  methods   base     

loaded via a namespace (and not attached):
 [1] vctrs_0.6.5       cli_3.6.3         knitr_1.48        rlang_1.1.4      
 [5] xfun_0.48         stringi_1.8.4     promises_1.3.0    jsonlite_1.8.9   
 [9] workflowr_1.7.1   glue_1.8.0        rprojroot_2.0.4   git2r_0.35.0     
[13] htmltools_0.5.8.1 httpuv_1.6.15     sass_0.4.9        fansi_1.0.6      
[17] rmarkdown_2.28    jquerylib_0.1.4   evaluate_1.0.1    tibble_3.2.1     
[21] fastmap_1.2.0     yaml_2.3.10       lifecycle_1.0.4   whisker_0.4.1    
[25] stringr_1.5.1     compiler_4.4.1    fs_1.6.5          Rcpp_1.0.13      
[29] pkgconfig_2.0.3   rstudioapi_0.17.1 later_1.3.2       digest_0.6.37    
[33] R6_2.5.1          utf8_1.2.4        pillar_1.9.0      magrittr_2.0.3   
[37] bslib_0.8.0       tools_4.4.1       cachem_1.1.0     </code></pre>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>


<!-- Adjust MathJax settings so that all math formulae are shown using
TeX fonts only; see
https://docs.mathjax.org/en/latest/web/configuration.html. This will make
the presentation more consistent at the cost of the webpage sometimes
taking slightly longer to load. Note that this only works because the
footer is added to webpages before the MathJax javascript. -->
<script type="text/x-mathjax-config">
  MathJax.Hub.Config({
    "HTML-CSS": { availableFonts: ["TeX"] }
  });
</script>




</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->

<script>
$(document).ready(function ()  {

    // temporarily add toc-ignore selector to headers for the consistency with Pandoc
    $('.unlisted.unnumbered').addClass('toc-ignore')

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2,h3",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_');
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = true;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
